<?xml version="1.0" encoding="UTF-8"?><search-results xmlns="http://www.w3.org/2005/Atom" xmlns:cto="http://www.elsevier.com/xml/cto/dtd" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:opensearch="http://a9.com/-/spec/opensearch/1.1/" xmlns:dc="http://purl.org/dc/elements/1.1/"><opensearch:totalResults>2992343</opensearch:totalResults><opensearch:startIndex>2300</opensearch:startIndex><opensearch:itemsPerPage>100</opensearch:itemsPerPage><opensearch:Query role="request" searchTerms="heart" startPage="2300"/><link ref="self" href="http://api.elsevier.com:80/content/search/index:scopus?start=2300&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><link ref="first" href="http://api.elsevier.com:80/content/search/index:scopus?start=0&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><link ref="prev" href="http://api.elsevier.com:80/content/search/index:scopus?start=2200&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><link ref="next" href="http://api.elsevier.com:80/content/search/index:scopus?start=2400&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><link ref="last" href="http://api.elsevier.com:80/content/search/index:scopus?start=4900&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929689236"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929689236?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929689236&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929689236&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929689236</prism:url><dc:identifier>SCOPUS_ID:84929689236</dc:identifier><eid>2-s2.0-84929689236</eid><dc:title>Functional Analysis of Two Novel Mutations in TWIST1 Protein Motifs Found in Ventricular Septal Defect Patients</dc:title><dc:creator>Deng X.</dc:creator><prism:publicationName>Pediatric Cardiology</prism:publicationName><prism:issn>01720643</prism:issn><prism:eIssn>14321971</prism:eIssn><prism:coverDate>2015-05-19</prism:coverDate><prism:coverDisplayDate>19 May 2015</prism:coverDisplayDate><prism:doi>10.1007/s00246-015-1202-9</prism:doi><dc:description>Â© 2015 Springer Science+Business Media New York The aim of this study was to investigate the possible genetic effect of sequence variations in TWIST1 on the pathogenesis of ventricular septal defect in humans. We examined the coding region of TWIST1 in a cohort of 196 Chinese people with non-syndromic ventricular septal defect patients and 200 healthy individuals as the controls. We identified two novel potential disease-associated mutations, NM_000474.3:c.247G&gt;A (G83S) and NM_000474.3:c.283A&gt;G (S95G). Both of them were identified for the first time and were not observed in the 200 controls without congenital heart disease. Using a dual-luciferase reporter assay, we showed that both of the mutations significantly down-regulated the repressive effect of TWIST1 on the E-cadherin promoter. Furthermore, a mammalian two-hybrid assay showed that both of the mutations significantly affected the interaction between TWIST1 and KAT2B. New mutations in the transcription factor TWIST1 that affect protein function were identified in 1.0 % (2/196) of Chinese patients with ventricular septal defect. Our data show, for the first time, that TWIST1 has a potential causative effect on the development of ventricular septal defect.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113114500</affiliation-url><afid>113114500</afid><affilname>Shengjing Hospital of China Medical University</affilname><name-variant>Shengjing Hospital of China Medical University</name-variant><affiliation-city>Shenyang</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008706</affiliation-url><afid>60008706</afid><affilname>Peking Union Medical College</affilname><name-variant>Peking Union Medical College Hospital</name-variant><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60073481</affiliation-url><afid>60073481</afid><affilname>National Research Institute for Family Planning, Beijing</affilname><name-variant>Natl. Res. Inst. for Family Planning</name-variant><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027142</affiliation-url><afid>60027142</afid><affilname>Organisation Mondiale de la Sante</affilname><name-variant>WHO</name-variant><affiliation-city>Geneve</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">17</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56652885000</author-url><authid>56652885000</authid><authname>Deng X.</authname><surname>Deng</surname><given-name>Xiaopeng</given-name><initials>X.</initials><afid>113114500</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56509794200</author-url><authid>56509794200</authid><authname>Pan H.</authname><surname>Pan</surname><given-name>Hong</given-name><initials>H.</initials><afid>60008706</afid><afid>60073481</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56509794200</author-url><authid>56509794200</authid><authname>Pan H.</authname><surname>Pan</surname><given-name>Hong</given-name><initials>H.</initials><afid>60008706</afid><afid>60073481</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56063967500</author-url><authid>56063967500</authid><authname>Wang J.</authname><surname>Wang</surname><given-name>Jing</given-name><initials>J.</initials><afid>60008706</afid><afid>60073481</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56063967500</author-url><authid>56063967500</authid><authname>Wang J.</authname><surname>Wang</surname><given-name>Jing</given-name><initials>J.</initials><afid>60008706</afid><afid>60073481</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56195754800</author-url><authid>56195754800</authid><authname>Wang B.</authname><surname>Wang</surname><given-name>Binbin</given-name><initials>B.</initials><afid>60008706</afid><afid>60073481</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56195754800</author-url><authid>56195754800</authid><authname>Wang B.</authname><surname>Wang</surname><given-name>Binbin</given-name><initials>B.</initials><afid>60008706</afid><afid>60073481</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56652902100</author-url><authid>56652902100</authid><authname>Cheng Z.</authname><surname>Cheng</surname><given-name>Zhi</given-name><initials>Z.</initials><afid>60008706</afid><afid>60073481</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56652902100</author-url><authid>56652902100</authid><authname>Cheng Z.</authname><surname>Cheng</surname><given-name>Zhi</given-name><initials>Z.</initials><afid>60008706</afid><afid>60073481</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56652852000</author-url><authid>56652852000</authid><authname>Cheng L.</authname><surname>Cheng</surname><given-name>Longfei</given-name><initials>L.</initials><afid>60008706</afid><afid>60073481</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56652852000</author-url><authid>56652852000</authid><authname>Cheng L.</authname><surname>Cheng</surname><given-name>Longfei</given-name><initials>L.</initials><afid>60008706</afid><afid>60073481</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55165045400</author-url><authid>55165045400</authid><authname>Zhao L.</authname><surname>Zhao</surname><given-name>Lixi</given-name><initials>L.</initials><afid>60008706</afid><afid>60073481</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55165045400</author-url><authid>55165045400</authid><authname>Zhao L.</authname><surname>Zhao</surname><given-name>Lixi</given-name><initials>L.</initials><afid>60008706</afid><afid>60073481</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56457482900</author-url><authid>56457482900</authid><authname>Li H.</authname><surname>Li</surname><given-name>Hui</given-name><initials>H.</initials><afid>113114500</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56652798800</author-url><authid>56652798800</authid><authname>Ma X.</authname><surname>Ma</surname><given-name>Xu</given-name><initials>X.</initials><afid>60008706</afid><afid>60073481</afid><afid>60027142</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56652798800</author-url><authid>56652798800</authid><authname>Ma X.</authname><surname>Ma</surname><given-name>Xu</given-name><initials>X.</initials><afid>60008706</afid><afid>60073481</afid><afid>60027142</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56652798800</author-url><authid>56652798800</authid><authname>Ma X.</authname><surname>Ma</surname><given-name>Xu</given-name><initials>X.</initials><afid>60008706</afid><afid>60073481</afid><afid>60027142</afid></author><authkeywords>Genetics | TWIST1 | Variant | Ventricular septal defect</authkeywords><intid>2035993093</intid><source-id>20526</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929698611"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929698611?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929698611&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929698611&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929698611</prism:url><dc:identifier>SCOPUS_ID:84929698611</dc:identifier><eid>2-s2.0-84929698611</eid><dc:title>Bevacizumab: an option for refractory epistaxis in hereditary haemorrhagic telangiectasia</dc:title><dc:creator>Amann A.</dc:creator><prism:publicationName>Wiener Klinische Wochenschrift</prism:publicationName><prism:issn>00435325</prism:issn><prism:eIssn>16137671</prism:eIssn><prism:coverDate>2015-05-19</prism:coverDate><prism:coverDisplayDate>19 May 2015</prism:coverDisplayDate><prism:doi>10.1007/s00508-015-0789-4</prism:doi><dc:description>Â© 2015 Springer-Verlag Wien Summary: Background: Recurrent epistaxis in hereditary haemorrhagic telangiectasia (HHT) patients significantly decreases their quality of life. Treatment in therapy refractory patients is limited although various options have been tested so far. Summary: Case report: Herein, one patient is described that was treated for HHT for over 20 years with only intermediate benefits. As epistaxis duration and frequency increased continuously, bevacizumab 5 mg/kg was administered every 2 weeks. During the time of treatment (six doses) and up to 3 month afterwards clinical symptoms, blood pressure, cardiac output, pulmonary arterial hypertension (PAH), bleeding duration and frequency were assessed as criteria for treatment benefit. Summary: Results: Duration and frequency of epistaxis decreased immediately after the first application resulting in reduced need of blood transfusions. After completion of six cycles, a further decrease in frequency and duration of bleeding was noted. Cardiac output and PAH decreased or remained stable, respectively, during time and after treatment. No increase in blood pressure could be found but a significant increase in heart rate was experienced after completion of all six applications. Unfortunately, the patient died due to a cerebral abscess. Summary: Conclusion: Bevacizumab led to an improvement of HHT related epistaxis, refractory to other treatments.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008222</affiliation-url><afid>60008222</afid><affilname>Medizinische Universitat Innsbruck</affilname><name-variant>Medical University Innsbruck</name-variant><affiliation-city>Innsbruck</affiliation-city><affiliation-country>Austria</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:52163238900</author-url><authid>52163238900</authid><authname>Amann A.</authname><surname>Amann</surname><given-name>Arno</given-name><initials>A.</initials><afid>60008222</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56417440600</author-url><authid>56417440600</authid><authname>Steiner N.</authname><surname>Steiner</surname><given-name>Normann</given-name><initials>N.</initials><afid>60008222</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7006309171</author-url><authid>7006309171</authid><authname>Gunsilius E.</authname><surname>Gunsilius</surname><given-name>Eberhard</given-name><initials>E.</initials><afid>60008222</afid></author><intid>2035992046</intid><source-id>34776</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930080762"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930080762?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930080762&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930080762&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930080762</prism:url><dc:identifier>SCOPUS_ID:84930080762</dc:identifier><eid>2-s2.0-84930080762</eid><dc:title>Qing-Yi decoction in participants with severe acute pancreatitis: A randomized controlled trial</dc:title><dc:creator>Chen W.</dc:creator><prism:publicationName>Chinese Medicine (United Kingdom)</prism:publicationName><prism:eIssn>17498546</prism:eIssn><prism:coverDate>2015-05-19</prism:coverDate><prism:coverDisplayDate>May 19, 2015</prism:coverDisplayDate><prism:doi>10.1186/s13020-015-0039-8</prism:doi><dc:description>Â© 2015 Chen et al.; licensee BioMed Central. Background: Qing-Yi Decoction (QYD) has been used for severe acute pancreatitis (SAP) patients in China for many years. There were two kinds of QYD: Num 1. QYD (QYD1) which is used in the acute response stage of SAP and Num 2. QYD (QYD2) which is used in the second stage of SAP. This study aims to evaluate the therapeutic efficacy of QYD in participants with SAP. Methods: In this prospective, randomized, double-blind, placebo-controlled trial, participants aged 18-70 years within the first 7 days after acute onset of typical abdominal pain (the definition of SAP was according to the 2007 Guidelines for Management of Severe Acute Pancreatitis in China) were selected. The disease severity was determined by the Ranson, Acute Physiology and Chronic Health Evaluation II, and Balthazar CT scores. The test group received Western medicine and Chinese medicine (Num.1 QYD and Num.2 QYD), while the control group received Western medicine and placebo. The primary end-points were length of hospital stay, total hospitalization expenses, operation rate, and mortality. The secondary end-points were organ complications (i.e., heart failure, respiratory failure, acute renal failure, and hepatic failure), duration of paralytic ileus, infection, intensive care unit stay, and respirator use. Results: From March 2008 to July 2010, a total of 300 participants with severe acute pancreatitis were assessed for eligibility in West China Hospital, and 100 were eligible for randomized allocation. Eighty-five participants (46 in the test group; 39 in the control group) were included in the statistical analyses. The two groups were similar in their baseline clinical characteristics (age, sex, and etiology) and disease severity. After the interventions, there were no differences between the two groups for length of hospital stay (P = 0.323), total hospitalization expenses (P = 0.252), operation rate (P = 0.231), mortality (P = 0.462), organ complications (P &gt; 0.05), intensive care unit stay (P = 0.209), and respirator use (P &gt; 0.05). However, the duration [median (interquartile range)] of paralytic ileus, i.e., 4 (2-6) days vs. 6 (4-8) days (P = 0.014) and rate of infection, i.e., (13.0 % vs. 35.9 %) (P = 0.013) differed significantly. Conclusions: QYD could restore gastrointestinal motility to normal and reduce the infection rates in the SAP patients who completed a full course of QYD treatment according to per protocol analysis.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016521</affiliation-url><afid>60016521</afid><affilname>Sichuan University</affilname><name-variant>Sichuan University</name-variant><affiliation-city>Chengdu</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">12</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56244149300</author-url><authid>56244149300</authid><authname>Chen W.</authname><surname>Chen</surname><given-name>Weiwei</given-name><initials>W.</initials><afid>60016521</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:9238435200</author-url><authid>9238435200</authid><authname>Yang X.</authname><surname>Yang</surname><given-name>Xiaonan</given-name><initials>X.</initials><afid>60016521</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56144933100</author-url><authid>56144933100</authid><authname>Huang L.</authname><surname>Huang</surname><given-name>Lei</given-name><initials>L.</initials><afid>60016521</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:8660744500</author-url><authid>8660744500</authid><authname>Xue P.</authname><surname>Xue</surname><given-name>Ping</given-name><initials>P.</initials><afid>60016521</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7202684927</author-url><authid>7202684927</authid><authname>Wan M.</authname><surname>Wan</surname><given-name>Meihua</given-name><initials>M.</initials><afid>60016521</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56244045400</author-url><authid>56244045400</authid><authname>Guo J.</authname><surname>Guo</surname><given-name>Jia</given-name><initials>J.</initials><afid>60016521</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:37118250300</author-url><authid>37118250300</authid><authname>Zhu L.</authname><surname>Zhu</surname><given-name>Lin</given-name><initials>L.</initials><afid>60016521</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56660279800</author-url><authid>56660279800</authid><authname>Jin T.</authname><surname>Jin</surname><given-name>Tao</given-name><initials>T.</initials><afid>60016521</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7406220432</author-url><authid>7406220432</authid><authname>Huang Z.</authname><surname>Huang</surname><given-name>Zongwen</given-name><initials>Z.</initials><afid>60016521</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:8261529000</author-url><authid>8261529000</authid><authname>Chen G.</authname><surname>Chen</surname><given-name>Guangyuan</given-name><initials>G.</initials><afid>60016521</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:8270566000</author-url><authid>8270566000</authid><authname>Tang W.</authname><surname>Tang</surname><given-name>Wenfu</given-name><initials>W.</initials><afid>60016521</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:35220744500</author-url><authid>35220744500</authid><authname>Xia Q.</authname><surname>Xia</surname><given-name>Qing</given-name><initials>Q.</initials><afid>60016521</afid></author><intid>1536061555</intid><source-id>6400153120</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929630401"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929630401?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929630401&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929630401&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929630401</prism:url><dc:identifier>SCOPUS_ID:84929630401</dc:identifier><eid>2-s2.0-84929630401</eid><dc:title>T-wave/QRS complex amplitude correlations with myocardial edema in patients with takotsubo syndrome</dc:title><dc:creator>Madias J.</dc:creator><prism:publicationName>Heart Failure Reviews</prism:publicationName><prism:issn>13824147</prism:issn><prism:eIssn>15737322</prism:eIssn><prism:coverDate>2015-05-19</prism:coverDate><prism:coverDisplayDate>19 May 2015</prism:coverDisplayDate><prism:doi>10.1007/s10741-015-9491-x</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012981</affiliation-url><afid>60012981</afid><affilname>Icahn School of Medicine at Mount Sinai</affilname><name-variant>Mount Sinai School of Medicine</name-variant><affiliation-city>New York</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016846</affiliation-url><afid>60016846</afid><affilname>Elmhurst Hospital Center</affilname><name-variant>City Hospital Center at Elmhurst</name-variant><affiliation-city>Elmhurst</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7006186911</author-url><authid>7006186911</authid><authname>Madias J.</authname><surname>Madias</surname><given-name>John E.</given-name><initials>J.E.</initials><afid>60012981</afid><afid>60016846</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7006186911</author-url><authid>7006186911</authid><authname>Madias J.</authname><surname>Madias</surname><given-name>John E.</given-name><initials>J.E.</initials><afid>60012981</afid><afid>60016846</afid></author><intid>1785989806</intid><source-id>23234</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929688427"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929688427?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929688427&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929688427&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929688427</prism:url><dc:identifier>SCOPUS_ID:84929688427</dc:identifier><eid>2-s2.0-84929688427</eid><dc:title>Vascular Mechanics in Decellularized Aortas and Coronary Resistance Microvessels in Type 2 Diabetic db/db Mice</dc:title><dc:creator>Anghelescu M.</dc:creator><prism:publicationName>Annals of Biomedical Engineering</prism:publicationName><prism:issn>00906964</prism:issn><prism:eIssn>15739686</prism:eIssn><prism:coverDate>2015-05-19</prism:coverDate><prism:coverDisplayDate>19 May 2015</prism:coverDisplayDate><prism:doi>10.1007/s10439-015-1333-4</prism:doi><dc:description>Â© 2015 Biomedical Engineering Society We previously reported differences in stiffness between macro- and micro-vessels in type 2 diabetes (T2DM). The aim of this study was to define the mechanical properties of the ECM independent of vascular cells in coronary resistance micro-vessels (CRMs) and macro-vessels (aorta) in control Db/db and T2DM db/db mice. Passive vascular remodeling and mechanics were measured in both intact and decellularized CRMs and aortas from 0 to 125 mmHg. We observed no differences in intact control and diabetic aortic diameters, wall thicknesses, or stiffnesses (p &gt; 0.05). Aortic decellularization caused a significant increase in internal and external diameters and incremental modulus over a range of pressures that occurred to a similar degree in T2DM. Differences in aortic diameters due to decellularization occurred at lower pressures (0â75 mmHg) and converged with intact aortas at higher, physiological pressures (100â125 mmHg). In contrast, CRM decellularization caused increased internal diameter and incremental modulus only in the db/db mice, but unlike the aorta, the intact and decellularized CRM curves were more parallel. These data suggest that (1) micro-vessels may be more sensitive to early adverse consequences of diabetes than macro-vessels and (2) the ECM is a structural limit in aortas, but not CRMs.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026688</affiliation-url><afid>60026688</afid><affilname>Ohio Northern University</affilname><name-variant>Ohio Northern University</name-variant><affiliation-city>Ada</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003500</affiliation-url><afid>60003500</afid><affilname>Ohio State University</affilname><name-variant>The Ohio State University</name-variant><affiliation-city>Columbus</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003500</affiliation-url><afid>60003500</afid><affilname>Ohio State University</affilname><name-variant>The Ohio State University</name-variant><affiliation-city>Columbus</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032497</affiliation-url><afid>60032497</afid><affilname>Ohio State University College of Medicine</affilname><name-variant>Ohio State University College of Medicine</name-variant><affiliation-city>Columbus</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003500</affiliation-url><afid>60003500</afid><affilname>Ohio State University</affilname><name-variant>The Ohio State University</name-variant><affiliation-city>Columbus</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:8713837500</author-url><authid>8713837500</authid><authname>Anghelescu M.</authname><surname>Anghelescu</surname><given-name>Mircea</given-name><initials>M.</initials><afid>60026688</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56653407100</author-url><authid>56653407100</authid><authname>Tonniges J.</authname><surname>Tonniges</surname><given-name>Jeffrey R.</given-name><initials>J.R.</initials><afid>60003500</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6505888109</author-url><authid>6505888109</authid><authname>Calomeni E.</authname><surname>Calomeni</surname><given-name>Ed</given-name><initials>E.</initials><afid>60003500</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56653431000</author-url><authid>56653431000</authid><authname>Shamhart P.</authname><surname>Shamhart</surname><given-name>Patricia E.</given-name><initials>P.E.</initials><afid>60032497</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7202933335</author-url><authid>7202933335</authid><authname>Agarwal G.</authname><surname>Agarwal</surname><given-name>Gunjan</given-name><initials>G.</initials><afid>60003500</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7003314532</author-url><authid>7003314532</authid><authname>Gooch K.</authname><surname>Gooch</surname><given-name>Keith J.</given-name><initials>K.J.</initials><afid>60003500</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:26647928300</author-url><authid>26647928300</authid><authname>Trask A.</authname><surname>Trask</surname><given-name>Aaron J.</given-name><initials>A.J.</initials><afid>60032497</afid></author><authkeywords>Extracellular matrix | Pressure myography | Type 2 diabetes | Vascular biomechanics</authkeywords><intid>1035992872</intid><source-id>27474</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929698819"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929698819?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929698819&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929698819&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929698819</prism:url><dc:identifier>SCOPUS_ID:84929698819</dc:identifier><eid>2-s2.0-84929698819</eid><dc:title>Variability in forgoing life-sustaining treatments: reasons and recommendations</dc:title><dc:creator>Sprung C.</dc:creator><prism:publicationName>Intensive Care Medicine</prism:publicationName><prism:issn>03424642</prism:issn><prism:eIssn>14321238</prism:eIssn><prism:coverDate>2015-05-19</prism:coverDate><prism:coverDisplayDate>19 May 2015</prism:coverDisplayDate><prism:doi>10.1007/s00134-015-3868-0</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000087</affiliation-url><afid>60000087</afid><affilname>Hadassah University Medical Centre</affilname><name-variant>Hadassah University Hospital</name-variant><affiliation-city>Jerusalem</affiliation-city><affiliation-country>Israel</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016605</affiliation-url><afid>60016605</afid><affilname>Charles University in Prague</affilname><name-variant>Charles University in Prague</name-variant><affiliation-city>Prague</affiliation-city><affiliation-country>Czech Republic</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013877</affiliation-url><afid>60013877</afid><affilname>Hospital das Clinicas da FMUSP</affilname><name-variant>Universidade de SÃ£o Paulo</name-variant><affiliation-city>Sao Paulo</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7006532930</author-url><authid>7006532930</authid><authname>Sprung C.</authname><surname>Sprung</surname><given-name>Charles L.</given-name><initials>C.L.</initials><afid>60000087</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:25225994400</author-url><authid>25225994400</authid><authname>Rusinova K.</authname><surname>Rusinova</surname><given-name>Katerina</given-name><initials>K.</initials><afid>60016605</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:16679396800</author-url><authid>16679396800</authid><authname>Ranzani O.</authname><surname>Ranzani</surname><given-name>Otavio T.</given-name><initials>O.T.</initials><afid>60013877</afid></author><intid>1785999210</intid><source-id>14719</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929692714"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929692714?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929692714&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929692714&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929692714</prism:url><dc:identifier>SCOPUS_ID:84929692714</dc:identifier><eid>2-s2.0-84929692714</eid><dc:title>Epac2-deficiency leads to more severe retinal swelling, glial reactivity and oxidative stress in transient middle cerebral artery occlusion induced ischemic retinopathy</dc:title><dc:creator>Liu J.</dc:creator><prism:publicationName>Science China Life Sciences</prism:publicationName><prism:issn>16747305</prism:issn><prism:coverDate>2015-05-19</prism:coverDate><prism:coverDisplayDate>19 May 2015</prism:coverDisplayDate><prism:doi>10.1007/s11427-015-4860-1</prism:doi><dc:description>Â© 2015 The Author(s) Ischemia occurs in diabetic retinopathy with neuronal loss, edema, glial cell reactivity and oxidative stress. Epacs, consisting of Epac1 and Epac2, are cAMP mediators playing important roles in maintenance of endothelial barrier and neuronal functions. To investigate the roles of Epacs in the pathogenesis of ischemic retinopathy, transient middle cerebral artery occlusion (tMCAO) was performed on Epac1-deficient (Epac1&lt;sup&gt;â/â&lt;/sup&gt;) mice, Epac2-deficient (Epac2&lt;sup&gt;â/â&lt;/sup&gt;) mice, and their wild type counterparts (Epac1&lt;sup&gt;+/+&lt;/sup&gt; and Epac2&lt;sup&gt;+/+&lt;/sup&gt;). Two-hour occlusion and 22-hour reperfusion were conducted to induce ischemia/reperfusion injury to the retina. After tMCAO, the contralateral retinae displayed similar morphology between different genotypes. Neuronal loss, retinal edema and increase in immunoreactivity for aquaporin 4 (AQP4), glial fibrillary acidic protein (GFAP), peroxiredoxin 6 (Prx6) were observed in ipsilateral retinae. Epac2&lt;sup&gt;â/â&lt;/sup&gt; ipsilateral retinae showed more neuronal loss in retinal ganglion cell layer, increased retinal thickness and stronger immunostaining of AQP4, GFAP, and Prx6 than those of Epac2&lt;sup&gt;+/+&lt;/sup&gt;. However, Epac1&lt;sup&gt;â/â&lt;/sup&gt; ipsilateral retinae displayed similar pathology as those in Epac1&lt;sup&gt;+/+&lt;/sup&gt; mice. Our observations suggest that Epac2-deficiency led to more severe ischemic retinopathy after retinal ischemia/reperfusion injury.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60103563</affiliation-url><afid>60103563</afid><affilname>The University of Hong Kong Li Ka Shing Faculty of Medicine</affilname><name-variant>University of Hong Kong</name-variant><affiliation-city>Hong Kong</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60103563</affiliation-url><afid>60103563</afid><affilname>The University of Hong Kong Li Ka Shing Faculty of Medicine</affilname><name-variant>University of Hong Kong</name-variant><affiliation-city>Hong Kong</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60103563</affiliation-url><afid>60103563</afid><affilname>The University of Hong Kong Li Ka Shing Faculty of Medicine</affilname><name-variant>University of Hong Kong</name-variant><affiliation-city>Hong Kong</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60102713</affiliation-url><afid>60102713</afid><affilname>United International College, China</affilname><name-variant>United International College</name-variant><affiliation-city>Zhuhai</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006541</affiliation-url><afid>60006541</afid><affilname>The University of Hong Kong</affilname><name-variant>University of Hong Kong</name-variant><affiliation-city>Pokfulam</affiliation-city><affiliation-country>Hong Kong</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56653137500</author-url><authid>56653137500</authid><authname>Liu J.</authname><surname>Liu</surname><given-name>Jin</given-name><initials>J.</initials><afid>60103563</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56653186800</author-url><authid>56653186800</authid><authname>Yeung P.</authname><surname>Yeung</surname><given-name>Patrick Ka Kit</given-name><initials>P.K.K.</initials><afid>60103563</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56652855200</author-url><authid>56652855200</authid><authname>Cheng L.</authname><surname>Cheng</surname><given-name>Lu</given-name><initials>L.</initials><afid>60103563</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7102780640</author-url><authid>7102780640</authid><authname>Lo A.</authname><surname>Lo</surname><given-name>Amy Cheuk Yin</given-name><initials>A.C.Y.</initials><afid>60103563</afid><afid>60103563</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7102780640</author-url><authid>7102780640</authid><authname>Lo A.</authname><surname>Lo</surname><given-name>Amy Cheuk Yin</given-name><initials>A.C.Y.</initials><afid>60103563</afid><afid>60103563</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56652871200</author-url><authid>56652871200</authid><authname>Chung S.</authname><surname>Chung</surname><given-name>Stephen Sum Man</given-name><initials>S.S.M.</initials><afid>60102713</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55385604400</author-url><authid>55385604400</authid><authname>Chung S.</authname><surname>Chung</surname><given-name>Sookja Kim</given-name><initials>S.K.</initials><afid>60103563</afid><afid>60103563</afid><afid>60006541</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55385604400</author-url><authid>55385604400</authid><authname>Chung S.</authname><surname>Chung</surname><given-name>Sookja Kim</given-name><initials>S.K.</initials><afid>60103563</afid><afid>60103563</afid><afid>60006541</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55385604400</author-url><authid>55385604400</authid><authname>Chung S.</authname><surname>Chung</surname><given-name>Sookja Kim</given-name><initials>S.K.</initials><afid>60103563</afid><afid>60103563</afid><afid>60006541</afid></author><authkeywords>Epac | ischemia | retina | retinopathy</authkeywords><intid>35996997</intid><source-id>19600162144</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929431447"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929431447?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929431447&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929431447&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929431447</prism:url><dc:identifier>SCOPUS_ID:84929431447</dc:identifier><eid>2-s2.0-84929431447</eid><dc:title>Regulation of oxygen delivery to the body via hypoxic vasodilation</dc:title><dc:creator>Kulandavelu S.</dc:creator><prism:publicationName>Proceedings of the National Academy of Sciences of the United States of America</prism:publicationName><prism:issn>00278424</prism:issn><prism:eIssn>10916490</prism:eIssn><prism:volume>112</prism:volume><prism:issueIdentifier>20</prism:issueIdentifier><prism:pageRange>6254-6255</prism:pageRange><prism:coverDate>2015-05-19</prism:coverDate><prism:coverDisplayDate>19 May 2015</prism:coverDisplayDate><prism:doi>10.1073/pnas.1506523112</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021519</affiliation-url><afid>60021519</afid><affilname>University of Miami Leonard M. Miller School of Medicine</affilname><name-variant>University of Miami</name-variant><affiliation-city>Miami</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>no</subtype><subtypeDescription>Note</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:12786952400</author-url><authid>12786952400</authid><authname>Kulandavelu S.</authname><surname>Kulandavelu</surname><given-name>Shathiyah</given-name><initials>S.</initials><afid>60021519</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56584894400</author-url><authid>56584894400</authid><authname>Balkan W.</authname><surname>Balkan</surname><given-name>Wayne</given-name><initials>W.</initials><afid>60021519</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56584902000</author-url><authid>56584902000</authid><authname>Hare J.</authname><surname>Hare</surname><given-name>Joshua M.</given-name><initials>J.M.</initials><afid>60021519</afid></author><intid>535955638</intid><source-id>21121</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930198364"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930198364?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930198364&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930198364&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930198364</prism:url><dc:identifier>SCOPUS_ID:84930198364</dc:identifier><eid>2-s2.0-84930198364</eid><dc:title>Efficacy and safety of intravenous nimodipine administration for treatment of hypertension in patients with intracerebral hemorrhage</dc:title><dc:creator>Li Y.</dc:creator><prism:publicationName>Neuropsychiatric Disease and Treatment</prism:publicationName><prism:issn>11766328</prism:issn><prism:eIssn>11782021</prism:eIssn><prism:volume>11</prism:volume><prism:pageRange>1231-1238</prism:pageRange><prism:coverDate>2015-05-19</prism:coverDate><prism:coverDisplayDate>19 May 2015</prism:coverDisplayDate><prism:doi>10.2147/NDT.S76882</prism:doi><dc:description>Â© 2015 Li et al. Background: Nicardipine (NC) is the most commonly used antihypertensive drug in neurological patients with hypertension. Although nimodipine (NM) is widely used to treat cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage, trials exploring its antihypertensive effect after intravenous administration in subjects with intracerebral hemorrhage (ICH) are scarce. Methods: A retrospective study was carried out to compare the safety and efficacy of NC and NM administered intravenously in patients with ICH. Therapeutic responses were assessed by achievement of goal blood pressure (BP); use of additional medications for BP control; proportion of time spent within goal; variability in BP; time to goal BP; number of dose adjustments; variability in ICH volume, Glasgow Coma Scale score, and intracranial pressure; and drug-related complications. Results: A total of 87 patients were eligible for analysis (n=46 [NC]; n=41 [NM]), and baseline characteristics between groups were similar. Both agents were effective in achieving goal BP during infusion, with 93.5% and 87.8% patients in the NC and NM groups achieving goal, respectively. Fewer additional medications were needed to control BP in the NC group. BP variability was similar and no differences were observed in the mean time to goal BP and mean numbers of dose adjustments between both groups. Interestingly, intracranial pressure declined (P=0.048) during NC administration but increased (P=0.066) after NM treatment. Finally, the incidences of hematoma expansion, neurological deterioration, and adverse drug events were similar in both groups. Conclusion: NM is effective and safe for BP control in patients with ICH.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60088188</affiliation-url><afid>60088188</afid><affilname>Tangdu Hospital, Fourth Military Medical University</affilname><name-variant>Fourth Military Medical University</name-variant><affiliation-city>Xi'an</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60088188</affiliation-url><afid>60088188</afid><affilname>Tangdu Hospital, Fourth Military Medical University</affilname><name-variant>Fourth Military Medical University</name-variant><affiliation-city>Xi'an</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60088188</affiliation-url><afid>60088188</afid><affilname>Tangdu Hospital, Fourth Military Medical University</affilname><name-variant>Fourth Military Medical University</name-variant><affiliation-city>Xi'an</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">13</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56532545300</author-url><authid>56532545300</authid><authname>Li Y.</authname><surname>Li</surname><given-name>Yuqian</given-name><initials>Y.</initials><afid>60088188</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55520080000</author-url><authid>55520080000</authid><authname>Fang W.</authname><surname>Fang</surname><given-name>Wei</given-name><initials>W.</initials><afid>60088188</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:36883629300</author-url><authid>36883629300</authid><authname>Tao L.</authname><surname>Tao</surname><given-name>Lei</given-name><initials>L.</initials><afid>60088188</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55232921500</author-url><authid>55232921500</authid><authname>Li M.</authname><surname>Li</surname><given-name>Min</given-name><initials>M.</initials><afid>60088188</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55627352500</author-url><authid>55627352500</authid><authname>Yang Y.</authname><surname>Yang</surname><given-name>Yanlong</given-name><initials>Y.</initials><afid>60088188</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56662540300</author-url><authid>56662540300</authid><authname>Gao Y.</authname><surname>Gao</surname><given-name>Yafei</given-name><initials>Y.</initials><afid>60088188</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56452275400</author-url><authid>56452275400</authid><authname>Ge S.</authname><surname>Ge</surname><given-name>Shunnan</given-name><initials>S.</initials><afid>60088188</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56539094400</author-url><authid>56539094400</authid><authname>Gao L.</authname><surname>Gao</surname><given-name>Li</given-name><initials>L.</initials><afid>60088188</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56662535000</author-url><authid>56662535000</authid><authname>Zhang B.</authname><surname>Zhang</surname><given-name>Bin</given-name><initials>B.</initials><afid>60088188</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:55150645000</author-url><authid>55150645000</authid><authname>Li Z.</authname><surname>Li</surname><given-name>Zhihong</given-name><initials>Z.</initials><afid>60088188</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:56662595500</author-url><authid>56662595500</authid><authname>Zhou W.</authname><surname>Zhou</surname><given-name>Wei</given-name><initials>W.</initials><afid>60088188</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:55897636600</author-url><authid>55897636600</authid><authname>Wang B.</authname><surname>Wang</surname><given-name>Boliang</given-name><initials>B.</initials><afid>60088188</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:56532184400</author-url><authid>56532184400</authid><authname>Li L.</authname><surname>Li</surname><given-name>Lihong</given-name><initials>L.</initials><afid>60088188</afid></author><authkeywords>Blood pressure | Intravenous infusion | Nicardipine</authkeywords><intid>2036081481</intid><source-id>4100151703</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930206209"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930206209?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930206209&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930206209&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930206209</prism:url><dc:identifier>SCOPUS_ID:84930206209</dc:identifier><eid>2-s2.0-84930206209</eid><dc:title>Ventilatory abnormalities in patients with cystic fibrosis undergoing the submaximal treadmill exercise test</dc:title><dc:creator>Parazzi P.</dc:creator><prism:publicationName>BMC Pulmonary Medicine</prism:publicationName><prism:eIssn>14712466</prism:eIssn><prism:volume>15</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:coverDate>2015-05-19</prism:coverDate><prism:coverDisplayDate>May 19, 2015</prism:coverDisplayDate><prism:doi>10.1186/s12890-015-0056-5</prism:doi><dc:description>Â© 2015 Parazzi et al.;licensee BioMed Central. Background: Exercise has been studied as a prognostic marker for patients with cystic fibrosis (CF), as well as a tool for improving their quality of life and analyzing lung disease. In this context, the aim of the present study was to evaluate and compare variables of lung functioning. Our data included: (i) volumetric capnography (VCAP) parameters: expiratory minute volume (VE), volume of exhaled carbon dioxide (VCO&lt;inf&gt;2&lt;/inf&gt;), VE/VCO&lt;inf&gt;2&lt;/inf&gt;, ratio of dead space to tidal volume (VD/VT), and end-tidal carbon dioxide (PetCO&lt;inf&gt;2&lt;/inf&gt;); (ii) spirometry parameters: forced vital capacity (FVC), percent forced expiratory volume in the first second of the FVC (FEV&lt;inf&gt;1&lt;/inf&gt;%), and FEV&lt;inf&gt;1&lt;/inf&gt;/FVC%; and (iii) cardiorespiratory parameters: heart rate (HR), respiratory rate, oxygen saturation (SpO&lt;inf&gt;2&lt;/inf&gt;), and Borg scale rating at rest and during exercise. The subjects comprised children, adolescents, and young adults aged 6-25 years with CF (CF group [CFG]) and without CF (control group [CG]). Methods: This was a clinical, prospective, controlled study involving 128 male and female patients (64 with CF) of a university hospital. All patients underwent treadmill exercise tests and provided informed consent after study approval by the institutional ethics committee. Linear regression, Kruskal-Wallis test, and Mann-Whitney test were performed to compare the CFG and CG. The Î± value was set at 0.05. Results: Patients in the CFG showed significantly different VCAP values and spirometry variables throughout the exercise test. Before, during, and after exercise, several variables were different between the two groups; statistically significant differences were seen in the spirometry parameters, SpO&lt;inf&gt;2&lt;/inf&gt;, HR, VCO&lt;inf&gt;2&lt;/inf&gt;, VE/VCO&lt;inf&gt;2&lt;/inf&gt;, PetCO&lt;inf&gt;2&lt;/inf&gt;, and Borg scale rating. VCAP variables changed at each time point analyzed during the exercise test in both groups. Conclusion: VCAP can be used to analyze ventilatory parameters during exercise. All cardiorespiratory, spirometry, and VCAP variables differed between patients in the CFG and CG before, during, and after exercise.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029570</affiliation-url><afid>60029570</afid><affilname>Universidade Estadual de Campinas</affilname><name-variant>State University of Campinas</name-variant><affiliation-city>Campinas</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029570</affiliation-url><afid>60029570</afid><affilname>Universidade Estadual de Campinas</affilname><name-variant>State University of Campinas</name-variant><affiliation-city>Campinas</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029570</affiliation-url><afid>60029570</afid><affilname>Universidade Estadual de Campinas</affilname><name-variant>State University of Campinas</name-variant><affiliation-city>Campinas</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029570</affiliation-url><afid>60029570</afid><affilname>Universidade Estadual de Campinas</affilname><name-variant>State University of Campinas</name-variant><affiliation-city>Campinas</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024094</affiliation-url><afid>60024094</afid><affilname>Universidade do Estado de Santa Catarina</affilname><name-variant>Universidade do Estado de Santa Catarina</name-variant><affiliation-city>Florianopolis</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:50162339500</author-url><authid>50162339500</authid><authname>Parazzi P.</authname><surname>Parazzi</surname><given-name>Paloma Lopes Francisco</given-name><initials>P.L.F.</initials><afid>60029570</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55110225800</author-url><authid>55110225800</authid><authname>Marson F.</authname><surname>Marson</surname><given-name>Fernando Augusto de Lima</given-name><initials>F.A.d.L.</initials><afid>60029570</afid><afid>60029570</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55110225800</author-url><authid>55110225800</authid><authname>Marson F.</authname><surname>Marson</surname><given-name>Fernando Augusto de Lima</given-name><initials>F.A.d.L.</initials><afid>60029570</afid><afid>60029570</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7201715448</author-url><authid>7201715448</authid><authname>Ribeiro M.</authname><surname>Ribeiro</surname><given-name>Maria Angela GonÃ§alves de Oliveira</given-name><initials>M.A.G.d.O.</initials><afid>60029570</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56662820100</author-url><authid>56662820100</authid><authname>de Almeida C.</authname><surname>de Almeida</surname><given-name>Celize Cruz Bresciani</given-name><initials>C.C.B.</initials><afid>60029570</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:24779987100</author-url><authid>24779987100</authid><authname>Martins L.</authname><surname>Martins</surname><given-name>Luiz ClÃ¡udio</given-name><initials>L.C.</initials><afid>60029570</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6507121325</author-url><authid>6507121325</authid><authname>Paschoal I.</authname><surname>Paschoal</surname><given-name>Ilma Aparecida</given-name><initials>I.A.</initials><afid>60029570</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7005592130</author-url><authid>7005592130</authid><authname>Toro A.</authname><surname>Toro</surname><given-name>Adyleia Aparecida Dalbo Contrera</given-name><initials>A.A.D.C.</initials><afid>60029570</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:37111391400</author-url><authid>37111391400</authid><authname>Schivinski C.</authname><surname>Schivinski</surname><given-name>Camila Isabel Santos</given-name><initials>C.I.S.</initials><afid>60024094</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7201677725</author-url><authid>7201677725</authid><authname>Ribeiro J.</authname><surname>Ribeiro</surname><given-name>Jose Dirceu</given-name><initials>J.D.</initials><afid>60029570</afid></author><authkeywords>6-minute walk test | Cystic fibrosis | Spirometry | Volumetric capnography</authkeywords><intid>1536088145</intid><article-number>63</article-number><source-id>18026</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929298570"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929298570?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929298570&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929298570&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0006291X1500145X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929298570</prism:url><dc:identifier>SCOPUS_ID:84929298570</dc:identifier><eid>2-s2.0-84929298570</eid><dc:title>Calmodulin and STIM proteins: Two major calcium sensors in the cytoplasm and endoplasmic reticulum in memory of Professor Koichi Yagi, Hokkaido University.</dc:title><dc:creator>Marshall C.</dc:creator><prism:publicationName>Biochemical and Biophysical Research Communications</prism:publicationName><prism:issn>0006291X</prism:issn><prism:eIssn>10902104</prism:eIssn><prism:volume>460</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>5-21</prism:pageRange><prism:coverDate>2015-05-19</prism:coverDate><prism:coverDisplayDate>19 May 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bbrc.2015.01.106</prism:doi><pii>S0006291X1500145X</pii><dc:description>Â© 2015 Published by Elsevier Inc. The calcium (Ca&lt;sup&gt;2+&lt;/sup&gt;) ion is a universal signalling messenger which plays vital physiological roles in all eukaryotes. To decode highly regulated intracellular Ca&lt;sup&gt;2+&lt;/sup&gt; signals, cells have evolved a number of sensor proteins that are ideally adapted to respond to a specific range of Ca&lt;sup&gt;2+&lt;/sup&gt; levels. Among many such proteins, calmodulin (CaM) is a multi-functional cytoplasmic Ca&lt;sup&gt;2+&lt;/sup&gt; sensor with a remarkable ability to interact with and regulate a plethora of structurally diverse target proteins. CaM achieves this 'multi-talented' functionality through two EF-hand domains, each with an independent capacity to bind targets, and an adaptable flexible linker. By contrast, stromal interaction molecule-1 and -2 (STIMs) have evolved for a specific role in endoplasmic reticulum (ER) Ca&lt;sup&gt;2+&lt;/sup&gt; sensing using EF-hand machinery analogous to CaM; however, whereas CaM structurally adjusts to dissimilar binding partners, STIMs use the EF-hand machinery to self-regulate the stability of the Ca&lt;sup&gt;2+&lt;/sup&gt; sensing domain. The molecular mechanisms underlying the Ca&lt;sup&gt;2+&lt;/sup&gt;-dependent signal transduction by CaM and STIMs have revealed a remarkable repertoire of actions and underscore the flexibility of nature in molecular evolution and adaption to discrete Ca&lt;sup&gt;2+&lt;/sup&gt; levels. Recent genomic sequencing efforts have uncovered a number of disease-associated mutations in both CaM and STIM1. This article aims to highlight the most recent key structural and functional findings in the CaM and STIM fields, and discusses how these two Ca&lt;sup&gt;2+&lt;/sup&gt; sensor proteins execute their biological functions.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014468</affiliation-url><afid>60014468</afid><affilname>University Health Network University of Toronto</affilname><name-variant>University Health Network</name-variant><affiliation-city>Toronto</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025272</affiliation-url><afid>60025272</afid><affilname>University of Tokyo</affilname><name-variant>University of Tokyo</name-variant><affiliation-city>Tokyo</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010884</affiliation-url><afid>60010884</afid><affilname>Western University</affilname><name-variant>University of Western Ontario</name-variant><affiliation-city>London</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7201903301</author-url><authid>7201903301</authid><authname>Marshall C.</authname><surname>Marshall</surname><given-name>Christopher B.</given-name><initials>C.B.</initials><afid>60014468</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56643870700</author-url><authid>56643870700</authid><authname>Nishikawa T.</authname><surname>Nishikawa</surname><given-name>Tadateru</given-name><initials>T.</initials><afid>60014468</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56644094900</author-url><authid>56644094900</authid><authname>Osawa M.</authname><surname>Osawa</surname><given-name>Masanori</given-name><initials>M.</initials><afid>60025272</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6508123582</author-url><authid>6508123582</authid><authname>Stathopulos P.</authname><surname>Stathopulos</surname><given-name>Peter B.</given-name><initials>P.B.</initials><afid>60010884</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7006302539</author-url><authid>7006302539</authid><authname>Ikura M.</authname><surname>Ikura</surname><given-name>Mitsuhiko</given-name><initials>M.</initials><afid>60014468</afid></author><authkeywords>Atomic resolution structure | Calcium sensing | Calmodulin | Calmodulin target interactions | EF-hand | Stromal interaction molecules (STIM)</authkeywords><intid>1535946141</intid><source-id>16845</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929359649"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929359649?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929359649&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929359649&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0006291X15004945"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929359649</prism:url><dc:identifier>SCOPUS_ID:84929359649</dc:identifier><eid>2-s2.0-84929359649</eid><dc:title>Standing of giants shoulders the story of the mitochondrial Na&lt;sup&gt;+&lt;/sup&gt;Ca&lt;sup&gt;2+&lt;/sup&gt; exchanger</dc:title><dc:creator>Sekler I.</dc:creator><prism:publicationName>Biochemical and Biophysical Research Communications</prism:publicationName><prism:issn>0006291X</prism:issn><prism:eIssn>10902104</prism:eIssn><prism:volume>460</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>50-52</prism:pageRange><prism:coverDate>2015-05-19</prism:coverDate><prism:coverDisplayDate>19 May 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bbrc.2015.02.170</prism:doi><pii>S0006291X15004945</pii><dc:description>Â© 2015 Elsevier Inc. All rights reserved. It is now the 40th anniversary of the Journal of Molecular and Cellular Cardiology paper by Ernesto Carafoli and colleagues. This seminal study described for the first time mitochondrial Ca&lt;sup&gt;2+&lt;/sup&gt; extrusion and its coupling to Na&lt;sup&gt;+&lt;/sup&gt;. This short review will describe the profound impact that this work had on mitochondrial signaling and the cross talk between the mitochondria, the ER, and the plasma membrane. It will further tell how the functional identification and in particular its unique cation selectivity to both Li&lt;sup&gt;+&lt;/sup&gt; and Na&lt;sup&gt;+&lt;/sup&gt; eventually contributed to the identification of the mitochondrial Na&lt;sup&gt;+&lt;/sup&gt;/Ca&lt;sup&gt;2+&lt;/sup&gt; exchanger gene NCLX many years later. The last part will describe how molecular tools derived from NCLX identification are used to study the novel physiological aspects of Ca&lt;sup&gt;2+&lt;/sup&gt; signaling.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027161</affiliation-url><afid>60027161</afid><affilname>Ben-Gurion University of the Negev</affilname><name-variant>Ben Gurion University of the Negev</name-variant><affiliation-city>Beer Sheba</affiliation-city><affiliation-country>Israel</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">1</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6701602796</author-url><authid>6701602796</authid><authname>Sekler I.</authname><surname>Sekler</surname><given-name>Israel</given-name><initials>I.</initials><afid>60027161</afid></author><authkeywords>MCU | Mitochondrial Ca&lt;sup&gt;2+&lt;/sup&gt; signaling | Na&lt;sup&gt;+&lt;/sup&gt; signaling | NCLX</authkeywords><intid>535946187</intid><source-id>16845</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930086133"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930086133?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930086133&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930086133&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0003491615000081"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930086133</prism:url><dc:identifier>SCOPUS_ID:84930086133</dc:identifier><eid>2-s2.0-84930086133</eid><dc:title>Clopidogrel Versus Aspirin in Patients with Recent Ischemic Stroke and Established Peripheral Artery Disease: An Economic Evaluation in a Chinese Setting</dc:title><dc:creator>Li T.</dc:creator><prism:publicationName>Clinical Drug Investigation</prism:publicationName><prism:issn>11732563</prism:issn><prism:eIssn>11791918</prism:eIssn><prism:volume>35</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>365-374</prism:pageRange><prism:coverDate>2015-05-19</prism:coverDate><prism:coverDisplayDate>19 May 2015</prism:coverDisplayDate><prism:doi>10.1007/s40261-015-0290-x</prism:doi><dc:description>Â© 2015, Springer International Publishing Switzerland. Background and Objectives: Clopidogrel or aspirin are indicated for patients with recent ischemic stroke (IS) or established peripheral artery disease (PAD). We compared the cost effectiveness of clopidogrel with that of aspirin in Chinese patients with recent IS or established PAD. Methods: A discrete-event simulation was developed to evaluate the economic implications of secondary prevention with clopidogrel versus aspirin. All available evidence was derived from clinical studies. Costs from a Chinese healthcare perspective in 2013 US dollars and quality-adjusted life-years (QALYs) were projected over patientsâ lifetimes. Uncertainties were addressed using sensitivity analyses. Results: Compared with aspirin, clopidogrel yielded a marginally increased life expectancy by 0.46 and 0.21 QALYs at an incremental cost-effectiveness ratio of $US5246 and $US9890 per QALY in patients with recent IS and established PAD, respectively. One-way sensitivity analyses showed that the evaluation of patients with PAD and recent IS was robust except for the parameter of patient age. Given a willingness-to-pay of $US19,877 per QALY gained, clopidogrel had a probability of 90 and 68Â % of being cost effective in the recent IS or established PAD subgroups compared with aspirin, respectively. Conclusions: The analysis suggests that clopidogrel for secondary prevention is cost effective for patients with either PAD or recent IS in a Chinese setting in comparison with aspirin.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013602</affiliation-url><afid>60013602</afid><affilname>Kunming Medical College</affilname><name-variant>Kunming Medical College</name-variant><affiliation-city>Kunming</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115264361</affiliation-url><afid>115264361</afid><affilname>affiliated with Fujian Medical University</affilname><name-variant>affiliated with Fujian Medical University</name-variant><affiliation-city/><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60087536</affiliation-url><afid>60087536</afid><affilname>Renji Hospital</affilname><name-variant>Shanghai Second Medical University</name-variant><affiliation-city>Shanghai</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:101435498</affiliation-url><afid>101435498</afid><affilname>Shanghai Pudong New Area Gongli Hospital</affilname><name-variant>Gongli Hospital of Pudong New Area</name-variant><affiliation-city>Shanghai</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025084</affiliation-url><afid>60025084</afid><affilname>Shanghai Jiaotong University</affilname><name-variant>Shanghai Jiaotong University</name-variant><affiliation-city>Shanghai</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55571035300</author-url><authid>55571035300</authid><authname>Li T.</authname><surname>Li</surname><given-name>Te</given-name><initials>T.</initials><afid>60013602</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56652783900</author-url><authid>56652783900</authid><authname>Liu M.</authname><surname>Liu</surname><given-name>Maobai</given-name><initials>M.</initials><afid>115264361</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56653255800</author-url><authid>56653255800</authid><authname>Ben H.</authname><surname>Ben</surname><given-name>He</given-name><initials>H.</initials><afid>60087536</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56652757200</author-url><authid>56652757200</authid><authname>Xu Z.</authname><surname>Xu</surname><given-name>Zhenxing</given-name><initials>Z.</initials><afid>101435498</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56652963400</author-url><authid>56652963400</authid><authname>Zhong H.</authname><surname>Zhong</surname><given-name>Han</given-name><initials>H.</initials><afid>60025084</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:36041242100</author-url><authid>36041242100</authid><authname>Wu B.</authname><surname>Wu</surname><given-name>Bin</given-name><initials>B.</initials><afid>60025084</afid></author><intid>1036058684</intid><source-id>20603</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929359646"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929359646?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929359646&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929359646&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0006291X15001849"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929359646</prism:url><dc:identifier>SCOPUS_ID:84929359646</dc:identifier><eid>2-s2.0-84929359646</eid><dc:title>Calcium and mitochondria in the regulation of cell death</dc:title><dc:creator>Orrenius S.</dc:creator><prism:publicationName>Biochemical and Biophysical Research Communications</prism:publicationName><prism:issn>0006291X</prism:issn><prism:eIssn>10902104</prism:eIssn><prism:volume>460</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>72-81</prism:pageRange><prism:coverDate>2015-05-19</prism:coverDate><prism:coverDisplayDate>19 May 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bbrc.2015.01.137</prism:doi><pii>S0006291X15001849</pii><dc:description>Â© 2015 Elsevier Inc. All rights reserved. The calcium ion has long been known to play an important role in cell death regulation. Hence, necrotic cell death was early associated with intracellular Ca&lt;sup&gt;2+&lt;/sup&gt; overload, leading to mitochondrial permeability transition and functional collapse. Subsequent characterization of the signaling pathways in apoptosis revealed that Ca&lt;sup&gt;2+&lt;/sup&gt;/calpain was critically involved in the processing of the mitochondrially localized, Apoptosis Inducing Factor. More recently, the calcium ion has been demonstrated to play important regulatory roles also in other cell death modalities, notably autophagic cell death and anoikis. In this review, we summarize current knowledge about the mechanisms involved in Ca&lt;sup&gt;2+&lt;/sup&gt; regulation of these various modes of cell death with a focus on the importance of the mitochondria.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012311</affiliation-url><afid>60012311</afid><affilname>Karolinska Institutet</affilname><name-variant>Karolinska Institutet</name-variant><affiliation-city>Stockholm</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007457</affiliation-url><afid>60007457</afid><affilname>Lomonosov Moscow State University</affilname><name-variant>Moscow State University</name-variant><affiliation-city>Moscow</affiliation-city><affiliation-country>Russian Federation</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36038022200</author-url><authid>36038022200</authid><authname>Orrenius S.</authname><surname>Orrenius</surname><given-name>Sten</given-name><initials>S.</initials><afid>60012311</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56238148800</author-url><authid>56238148800</authid><authname>Gogvadze V.</authname><surname>Gogvadze</surname><given-name>Vladimir</given-name><initials>V.</initials><afid>60012311</afid><afid>60007457</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56238148800</author-url><authid>56238148800</authid><authname>Gogvadze V.</authname><surname>Gogvadze</surname><given-name>Vladimir</given-name><initials>V.</initials><afid>60012311</afid><afid>60007457</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7006323950</author-url><authid>7006323950</authid><authname>Zhivotovsky B.</authname><surname>Zhivotovsky</surname><given-name>Boris</given-name><initials>B.</initials><afid>60012311</afid><afid>60007457</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7006323950</author-url><authid>7006323950</authid><authname>Zhivotovsky B.</authname><surname>Zhivotovsky</surname><given-name>Boris</given-name><initials>B.</initials><afid>60012311</afid><afid>60007457</afid></author><authkeywords>Apoptosis | Autophagy | Calcium | Mitochondria | Necrosis | Reactive oxygen species</authkeywords><intid>35944897</intid><source-id>16845</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929577149"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929577149?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929577149&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929577149&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929577149</prism:url><dc:identifier>SCOPUS_ID:84929577149</dc:identifier><eid>2-s2.0-84929577149</eid><dc:title>Glycation alters ligand binding, enzymatic, and pharmacological properties of human albumin</dc:title><dc:creator>Baraka-Vidot J.</dc:creator><prism:publicationName>Biochemistry</prism:publicationName><prism:issn>00062960</prism:issn><prism:eIssn>15204995</prism:eIssn><prism:volume>54</prism:volume><prism:issueIdentifier>19</prism:issueIdentifier><prism:pageRange>3051-3062</prism:pageRange><prism:coverDate>2015-05-19</prism:coverDate><prism:coverDisplayDate>19 May 2015</prism:coverDisplayDate><prism:doi>10.1021/acs.biochem.5b00273</prism:doi><dc:description>Â© 2015 American Chemical Society. Albumin, the major circulating protein in blood plasma, can be subjected to an increased level of glycation in a diabetic context. Albumin exerts crucial pharmacological activities through its drug binding capacity, i.e., ketoprofen, and via its esterase-like activity, allowing the conversion of prodrugs into active drugs. In this study, the impact of the glucose-mediated glycation on the pharmacological and biochemical properties of human albumin was investigated. Aggregation product levels and the redox state were quantified to assess the impact of glycation-mediated changes on the structural properties of albumin. Glucose-mediated changes in ketoprofen binding properties and esterase-like activity were evaluated using fluorescence spectroscopy and p-nitrophenyl acetate hydrolysis assays, respectively. With the exception of oxidative parameters, significant dose-dependent alterations in biochemical and functional properties of in vitro glycated albumin were observed. We also found that the dose-dependent increase in levels of glycation and protein aggregation and average molecular mass changes correlated with a gradual decrease in the affinity of albumin for ketoprofen and its esterase-like property. In parallel, significant alterations in both pharmacological properties were also evidenced in albumin purified from diabetic patients. Partial least-squares regression analyses established a significant correlation between glycation-mediated changes in biochemical and pharmacological properties of albumin, highlighting the important role for glycation in the variability of the drug response in a diabetic situation.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000905</affiliation-url><afid>60000905</afid><affilname>Inserm</affilname><name-variant>INSERM</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000485</affiliation-url><afid>60000485</afid><affilname>Universite de La Reunion</affilname><name-variant>UniversitÃ© de La RÃ©union</name-variant><affiliation-city>Saint-Denis Messag</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113394851</affiliation-url><afid>113394851</afid><affilname>CHU la RÃ©union</affilname><name-variant>CHU La RÃ©union</name-variant><affiliation-city>Saint-Denis</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017697</affiliation-url><afid>60017697</afid><affilname>Universita degli Studi di Palermo</affilname><name-variant>UniversitÃ  di Palermo</name-variant><affiliation-city>Palermo</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030480</affiliation-url><afid>60030480</afid><affilname>University of Bath</affilname><name-variant>University of Bath</name-variant><affiliation-city>Bath</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">13</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55320134200</author-url><authid>55320134200</authid><authname>Baraka-Vidot J.</authname><surname>Baraka-Vidot</surname><given-name>Jennifer</given-name><initials>J.</initials><afid>60000905</afid><afid>60000485</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55320134200</author-url><authid>55320134200</authid><authname>Baraka-Vidot J.</authname><surname>Baraka-Vidot</surname><given-name>Jennifer</given-name><initials>J.</initials><afid>60000905</afid><afid>60000485</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55861175100</author-url><authid>55861175100</authid><authname>Planesse C.</authname><surname>Planesse</surname><given-name>Cynthia</given-name><initials>C.</initials><afid>60000905</afid><afid>60000485</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55861175100</author-url><authid>55861175100</authid><authname>Planesse C.</authname><surname>Planesse</surname><given-name>Cynthia</given-name><initials>C.</initials><afid>60000905</afid><afid>60000485</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6602094456</author-url><authid>6602094456</authid><authname>Meilhac O.</authname><surname>Meilhac</surname><given-name>Olivier</given-name><initials>O.</initials><afid>60000905</afid><afid>60000485</afid><afid>113394851</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6602094456</author-url><authid>6602094456</authid><authname>Meilhac O.</authname><surname>Meilhac</surname><given-name>Olivier</given-name><initials>O.</initials><afid>60000905</afid><afid>60000485</afid><afid>113394851</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6602094456</author-url><authid>6602094456</authid><authname>Meilhac O.</authname><surname>Meilhac</surname><given-name>Olivier</given-name><initials>O.</initials><afid>60000905</afid><afid>60000485</afid><afid>113394851</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6601985291</author-url><authid>6601985291</authid><authname>Militello V.</authname><surname>Militello</surname><given-name>Valeria</given-name><initials>V.</initials><afid>60017697</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6602415576</author-url><authid>6602415576</authid><authname>Van Den Elsen J.</authname><surname>Van Den Elsen</surname><given-name>Jean</given-name><initials>J.</initials><afid>60030480</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:8619208200</author-url><authid>8619208200</authid><authname>Bourdon E.</authname><surname>Bourdon</surname><given-name>Emmanuel</given-name><initials>E.</initials><afid>60000905</afid><afid>60000485</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:8619208200</author-url><authid>8619208200</authid><authname>Bourdon E.</authname><surname>Bourdon</surname><given-name>Emmanuel</given-name><initials>E.</initials><afid>60000905</afid><afid>60000485</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:6602186227</author-url><authid>6602186227</authid><authname>Rondeau P.</authname><surname>Rondeau</surname><given-name>Philippe</given-name><initials>P.</initials><afid>60000905</afid><afid>60000485</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:6602186227</author-url><authid>6602186227</authid><authname>Rondeau P.</authname><surname>Rondeau</surname><given-name>Philippe</given-name><initials>P.</initials><afid>60000905</afid><afid>60000485</afid></author><intid>35981406</intid><source-id>16867</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929427684"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929427684?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929427684&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929427684&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929427684</prism:url><dc:identifier>SCOPUS_ID:84929427684</dc:identifier><eid>2-s2.0-84929427684</eid><dc:title>Platelet G&lt;inf&gt;i&lt;/inf&gt; protein GÎ±&lt;inf&gt;i2&lt;/inf&gt; is an essential mediator of thrombo-inflammatory organ damage in mice</dc:title><dc:creator>Devanathan V.</dc:creator><prism:publicationName>Proceedings of the National Academy of Sciences of the United States of America</prism:publicationName><prism:issn>00278424</prism:issn><prism:eIssn>10916490</prism:eIssn><prism:volume>112</prism:volume><prism:issueIdentifier>20</prism:issueIdentifier><prism:pageRange>6491-6496</prism:pageRange><prism:coverDate>2015-05-19</prism:coverDate><prism:coverDisplayDate>19 May 2015</prism:coverDisplayDate><prism:doi>10.1073/pnas.1505887112</prism:doi><dc:description>Â© 2015, National Academy of Sciences. All rights reserved. Platelets are crucial for hemostasis and thrombosis and exacerbate tissue injury following ischemia and reperfusion. Important regulators of platelet function are G proteins controlled by seven transmembrane receptors. The Gi protein GÎ±&lt;inf&gt;i2&lt;/inf&gt; mediates platelet activation in vitro, but its in vivo role in hemostasis, arterial thrombosis, and postischemic infarct progression remains to be determined. Here we show that mice lacking GÎ±&lt;inf&gt;i2&lt;/inf&gt; exhibit prolonged tail-bleeding times and markedly impaired thrombus formation and stability in different models of arterial thrombosis. We thus generated mice selectively lacking GÎ±&lt;inf&gt;i2&lt;/inf&gt; in megakaryocytes and platelets (Gnai2&lt;sup&gt;fl/fl&lt;/sup&gt;/PF4-Cre mice) and found bleeding defects comparable to those in global GÎ±&lt;inf&gt;i2&lt;/inf&gt;-deficient mice. To examine the impact of platelet GÎ±&lt;inf&gt;i2&lt;/inf&gt; in postischemic thrombo-inflammatory infarct progression, Gnai2&lt;sup&gt;fl/fl&lt;/sup&gt;/PF4-Cre mice were subjected to experimental models of cerebral and myocardial ischemia/reperfusion injury. In the model of transient middle cerebral artery occlusion stroke Gnai2&lt;sup&gt;fl/fl&lt;/sup&gt;/PF4-Cre mice developed significantly smaller brain infarcts and fewer neurological deficits than littermate controls. Following myocardial ischemia, Gnai2&lt;sup&gt;fl/fl&lt;/sup&gt;/PF4-Cre mice showed dramatically reduced reperfusion injury which correlated with diminished formation of the ADP-dependent platelet neutrophil complex. In conclusion, our data provide definitive evidence that platelet GÎ±&lt;inf&gt;i2&lt;/inf&gt; not only controls hemostatic and thrombotic responses but also is critical for the development of ischemia/reperfusion injury in vivo.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017246</affiliation-url><afid>60017246</afid><affilname>Universitat Tubingen</affilname><name-variant>University of TÃ¼bingen</name-variant><affiliation-city>Tubingen</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017246</affiliation-url><afid>60017246</afid><affilname>Universitat Tubingen</affilname><name-variant>University of TÃ¼bingen</name-variant><affiliation-city>Tubingen</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017246</affiliation-url><afid>60017246</afid><affilname>Universitat Tubingen</affilname><name-variant>University of TÃ¼bingen</name-variant><affiliation-city>Tubingen</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032515</affiliation-url><afid>60032515</afid><affilname>Universitatsklinikum Wurzburg und Medizinische Fakultat</affilname><affiliation-city>Wurzburg</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012689</affiliation-url><afid>60012689</afid><affilname>Julius-Maximilians-Universitat Wurzburg</affilname><name-variant>University of WÃ¼rzburg</name-variant><affiliation-city>Wurzburg</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012689</affiliation-url><afid>60012689</afid><affilname>Julius-Maximilians-Universitat Wurzburg</affilname><name-variant>University of WÃ¼rzburg</name-variant><affiliation-city>Wurzburg</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025310</affiliation-url><afid>60025310</afid><affilname>Heinrich Heine Universitat</affilname><affiliation-city>Dusseldorf</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028652</affiliation-url><afid>60028652</afid><affilname>National Institute of Environmental Health Sciences</affilname><name-variant>Natl. Inst. of Environ. Hlth. Sci.</name-variant><affiliation-city>Research Triangle Park</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">20</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36460731100</author-url><authid>36460731100</authid><authname>Devanathan V.</authname><surname>Devanathan</surname><given-name>Vasudharani</given-name><initials>V.</initials><afid>60017246</afid><afid>60017246</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36460731100</author-url><authid>36460731100</authid><authname>Devanathan V.</authname><surname>Devanathan</surname><given-name>Vasudharani</given-name><initials>V.</initials><afid>60017246</afid><afid>60017246</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35114702100</author-url><authid>35114702100</authid><authname>Hagedorn I.</authname><surname>Hagedorn</surname><given-name>Ina</given-name><initials>I.</initials><afid>60017246</afid><afid>60032515</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35114702100</author-url><authid>35114702100</authid><authname>Hagedorn I.</authname><surname>Hagedorn</surname><given-name>Ina</given-name><initials>I.</initials><afid>60017246</afid><afid>60032515</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:23094092700</author-url><authid>23094092700</authid><authname>KÃ¶hler D.</authname><surname>KÃ¶hler</surname><given-name>David</given-name><initials>D.</initials><afid>60012689</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:16022934000</author-url><authid>16022934000</authid><authname>Pexa K.</authname><surname>Pexa</surname><given-name>Katja</given-name><initials>K.</initials><afid>60012689</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55816088000</author-url><authid>55816088000</authid><authname>Cherpokova D.</authname><surname>Cherpokova</surname><given-name>Deya</given-name><initials>D.</initials><afid>60017246</afid><afid>60032515</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55816088000</author-url><authid>55816088000</authid><authname>Cherpokova D.</authname><surname>Cherpokova</surname><given-name>Deya</given-name><initials>D.</initials><afid>60017246</afid><afid>60032515</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56425378200</author-url><authid>56425378200</authid><authname>Kraft P.</authname><surname>Kraft</surname><given-name>Peter</given-name><initials>P.</initials><afid>60025310</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56645358700</author-url><authid>56645358700</authid><authname>Singh M.</authname><surname>Singh</surname><given-name>Madhurendra</given-name><initials>M.</initials><afid>60012689</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7003708788</author-url><authid>7003708788</authid><authname>Rosenberger P.</authname><surname>Rosenberger</surname><given-name>Peter</given-name><initials>P.</initials><afid>60012689</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56425569400</author-url><authid>56425569400</authid><authname>Stoll G.</authname><surname>Stoll</surname><given-name>Guido</given-name><initials>G.</initials><afid>60025310</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:35401284700</author-url><authid>35401284700</authid><authname>Birnbaumer L.</authname><surname>Birnbaumer</surname><given-name>Lutz</given-name><initials>L.</initials><afid>60028652</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:6603429999</author-url><authid>6603429999</authid><authname>Piekorz R.</authname><surname>Piekorz</surname><given-name>Roland P.</given-name><initials>R.P.</initials><afid>60012689</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:31567498000</author-url><authid>31567498000</authid><authname>Beer-Hammer S.</authname><surname>Beer-Hammer</surname><given-name>Sandra</given-name><initials>S.</initials><afid>60017246</afid><afid>60017246</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:31567498000</author-url><authid>31567498000</authid><authname>Beer-Hammer S.</authname><surname>Beer-Hammer</surname><given-name>Sandra</given-name><initials>S.</initials><afid>60017246</afid><afid>60017246</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:7003534070</author-url><authid>7003534070</authid><authname>Nieswandt B.</authname><surname>Nieswandt</surname><given-name>Bernhard</given-name><initials>B.</initials><afid>60017246</afid><afid>60032515</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:7003534070</author-url><authid>7003534070</authid><authname>Nieswandt B.</authname><surname>Nieswandt</surname><given-name>Bernhard</given-name><initials>B.</initials><afid>60017246</afid><afid>60032515</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:7006609721</author-url><authid>7006609721</authid><authname>NÃ¼rnberg B.</authname><surname>NÃ¼rnberg</surname><given-name>Bernd</given-name><initials>B.</initials><afid>60017246</afid><afid>60017246</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:7006609721</author-url><authid>7006609721</authid><authname>NÃ¼rnberg B.</authname><surname>NÃ¼rnberg</surname><given-name>Bernd</given-name><initials>B.</initials><afid>60017246</afid><afid>60017246</afid></author><authkeywords>G proteins | Ischemia reperfusion injury | P2y&lt;inf&gt;12&lt;/inf&gt; receptor | Platelets | Thrombosis</authkeywords><intid>1785956686</intid><source-id>21121</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929484918"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929484918?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929484918&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929484918&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929484918</prism:url><dc:identifier>SCOPUS_ID:84929484918</dc:identifier><eid>2-s2.0-84929484918</eid><dc:title>Interleukin-6/interleukin-21 signaling axis is critical in the pathogenesis of pulmonary arterial hypertension</dc:title><dc:creator>Hashimoto-Kataoka T.</dc:creator><prism:publicationName>Proceedings of the National Academy of Sciences of the United States of America</prism:publicationName><prism:issn>00278424</prism:issn><prism:eIssn>10916490</prism:eIssn><prism:volume>112</prism:volume><prism:issueIdentifier>20</prism:issueIdentifier><prism:pageRange>E2677-E2686</prism:pageRange><prism:coverDate>2015-05-19</prism:coverDate><prism:coverDisplayDate>19 May 2015</prism:coverDisplayDate><prism:doi>10.1073/pnas.1424774112</prism:doi><dc:description>Â© 2015, National Academy of Sciences. All rights reserved. IL-6 is a multifunctional proinflammatory cytokine that is elevated in the serum of patients with pulmonary arterial hypertension (PAH) and can predict the survival of patients with idiopathic PAH (IPAH). Previous animal experiments and clinical human studies indicate that IL-6 is important in PAH; however, the molecular mechanisms of IL-6-mediated pathogenesis of PAH have been elusive. Here we identified IL-21 as a downstream target of IL-6 signaling in PAH. First, we found that IL-6 blockade by the monoclonal anti-IL-6 receptor antibody, MR16-1, ameliorated hypoxia-induced pulmonary hypertension (HPH) and prevented the hypoxia-induced accumulation of Th17 cells and M2 macrophages in the lungs. Consistently, the expression levels of IL-17 and IL-21 genes, one of the signature genes for Th17 cells, were significantly up-regulated after hypoxia exposure in the lungs of mice treated with control antibody but not in the lungs of mice treated with MR16-1. Although IL-17 blockade with an anti-IL-17A neutralizing antibody had no effect on HPH, IL-21 receptor-deficient mice were resistant to HPH and exhibited no significant accumulation of M2 macrophages in the lungs. In accordance with these findings, IL-21 promoted the polarization of primary alveolar macrophages toward the M2 phenotype. Of note, significantly enhanced expressions of IL-21 and M2 macrophage markers were detected in the lungs of IPAH patients who underwent lung transplantation. Collectively, these findings suggest that IL-21 promotes PAH in association with M2 macrophage polarization, downstream of IL-6-signaling. The IL-6/IL-21-signaling axis may be a potential target for treating PAH.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013829</affiliation-url><afid>60013829</afid><affilname>Osaka University Faculty of Medicine</affilname><name-variant>Osaka University Medical School</name-variant><affiliation-city>Suita</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013829</affiliation-url><afid>60013829</afid><affilname>Osaka University Faculty of Medicine</affilname><name-variant>Osaka University Medical School</name-variant><affiliation-city>Suita</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112940478</affiliation-url><afid>112940478</afid><affilname>National Cerebral and Cardiovascular Center Research Institute</affilname><name-variant>National Cerebral and Cardiovascular Center</name-variant><affiliation-city>Osaka</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013829</affiliation-url><afid>60013829</afid><affilname>Osaka University Faculty of Medicine</affilname><name-variant>Osaka University Medical School</name-variant><affiliation-city>Suita</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013829</affiliation-url><afid>60013829</afid><affilname>Osaka University Faculty of Medicine</affilname><name-variant>Osaka University Medical School</name-variant><affiliation-city>Suita</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013829</affiliation-url><afid>60013829</afid><affilname>Osaka University Faculty of Medicine</affilname><name-variant>Osaka University Medical School</name-variant><affiliation-city>Suita</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014652</affiliation-url><afid>60014652</afid><affilname>Hokkaido University</affilname><name-variant>Hokkaido University</name-variant><affiliation-city>Sapporo</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024322</affiliation-url><afid>60024322</afid><affilname>Osaka University</affilname><name-variant>Osaka University</name-variant><affiliation-city>Suita</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002354</affiliation-url><afid>60002354</afid><affilname>University of Tokyo Faculty of Medicine</affilname><name-variant>University of Tokyo</name-variant><affiliation-city>Tokyo</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015682</affiliation-url><afid>60015682</afid><affilname>Japan Science and Technology Agency</affilname><name-variant>CREST</name-variant><affiliation-city>Kawaguchi</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015682</affiliation-url><afid>60015682</afid><affilname>Japan Science and Technology Agency</affilname><name-variant>CREST</name-variant><affiliation-city>Kawaguchi</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">21</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55947939100</author-url><authid>55947939100</authid><authname>Hashimoto-Kataoka T.</authname><surname>Hashimoto-Kataoka</surname><given-name>Takahiro</given-name><initials>T.</initials><afid>60013829</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55928728700</author-url><authid>55928728700</authid><authname>Hosen N.</authname><surname>Hosen</surname><given-name>Naoki</given-name><initials>N.</initials><afid>60013829</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56501644000</author-url><authid>56501644000</authid><authname>Sonobe T.</authname><surname>Sonobe</surname><given-name>Takashi</given-name><initials>T.</initials><afid>112940478</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:26029723100</author-url><authid>26029723100</authid><authname>Arita Y.</authname><surname>Arita</surname><given-name>Yoh</given-name><initials>Y.</initials><afid>60013829</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55323250400</author-url><authid>55323250400</authid><authname>Yasui T.</authname><surname>Yasui</surname><given-name>Taku</given-name><initials>T.</initials><afid>60013829</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56303454900</author-url><authid>56303454900</authid><authname>Masaki T.</authname><surname>Masaki</surname><given-name>Takeshi</given-name><initials>T.</initials><afid>60013829</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56514642200</author-url><authid>56514642200</authid><authname>Minami M.</authname><surname>Minami</surname><given-name>Masato</given-name><initials>M.</initials><afid>60013829</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:23993553200</author-url><authid>23993553200</authid><authname>Inagaki T.</authname><surname>Inagaki</surname><given-name>Tadakatsu</given-name><initials>T.</initials><afid>112940478</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:55560624700</author-url><authid>55560624700</authid><authname>Miyagawa S.</authname><surname>Miyagawa</surname><given-name>Shigeru</given-name><initials>S.</initials><afid>60013829</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:55428162700</author-url><authid>55428162700</authid><authname>Sawa Y.</authname><surname>Sawa</surname><given-name>Yoshiki</given-name><initials>Y.</initials><afid>60013829</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:56489259900</author-url><authid>56489259900</authid><authname>Murakami M.</authname><surname>Murakami</surname><given-name>Masaaki</given-name><initials>M.</initials><afid>60013829</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:6602726311</author-url><authid>6602726311</authid><authname>Kumanogoh A.</authname><surname>Kumanogoh</surname><given-name>Atsushi</given-name><initials>A.</initials><afid>60014652</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:7003624108</author-url><authid>7003624108</authid><authname>Yamauchi-Takihara K.</authname><surname>Yamauchi-Takihara</surname><given-name>Keiko</given-name><initials>K.</initials><afid>60013829</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:56501367100</author-url><authid>56501367100</authid><authname>Okumura M.</authname><surname>Okumura</surname><given-name>Meinoshin</given-name><initials>M.</initials><afid>60013829</afid></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:55649016500</author-url><authid>55649016500</authid><authname>Kishimoto T.</authname><surname>Kishimoto</surname><given-name>Tadamitsu</given-name><initials>T.</initials><afid>60024322</afid></author><author seq="16"><author-url>http://api.elsevier.com/content/author/author_id:56496412900</author-url><authid>56496412900</authid><authname>Komuro I.</authname><surname>Komuro</surname><given-name>Issei</given-name><initials>I.</initials><afid>60002354</afid><afid>60015682</afid></author><author seq="16"><author-url>http://api.elsevier.com/content/author/author_id:56496412900</author-url><authid>56496412900</authid><authname>Komuro I.</authname><surname>Komuro</surname><given-name>Issei</given-name><initials>I.</initials><afid>60002354</afid><afid>60015682</afid></author><author seq="17"><author-url>http://api.elsevier.com/content/author/author_id:7202109621</author-url><authid>7202109621</authid><authname>Shirai M.</authname><surname>Shirai</surname><given-name>Mikiyasu</given-name><initials>M.</initials><afid>112940478</afid></author><author seq="18"><author-url>http://api.elsevier.com/content/author/author_id:56504623700</author-url><authid>56504623700</authid><authname>Sakata Y.</authname><surname>Sakata</surname><given-name>Yasushi</given-name><initials>Y.</initials><afid>60013829</afid></author><author seq="19"><author-url>http://api.elsevier.com/content/author/author_id:7007175990</author-url><authid>7007175990</authid><authname>Nakaoka Y.</authname><surname>Nakaoka</surname><given-name>Yoshikazu</given-name><initials>Y.</initials><afid>60013829</afid><afid>60015682</afid></author><author seq="19"><author-url>http://api.elsevier.com/content/author/author_id:7007175990</author-url><authid>7007175990</authid><authname>Nakaoka Y.</authname><surname>Nakaoka</surname><given-name>Yoshikazu</given-name><initials>Y.</initials><afid>60013829</afid><afid>60015682</afid></author><authkeywords>Interleukin-21 | Interleukin-6 | M2 macrophage | Pulmonary arterial hypertension | Th17 cells</authkeywords><intid>1035958567</intid><source-id>21121</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929310156"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929310156?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929310156&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929310156&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0006291X15002119"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929310156</prism:url><dc:identifier>SCOPUS_ID:84929310156</dc:identifier><eid>2-s2.0-84929310156</eid><dc:title>Ca&lt;sup&gt;2+&lt;/sup&gt; homeostasis and endoplasmic reticulum (ER) stress: An integrated view of calcium signaling</dc:title><dc:creator>Krebs J.</dc:creator><prism:publicationName>Biochemical and Biophysical Research Communications</prism:publicationName><prism:issn>0006291X</prism:issn><prism:eIssn>10902104</prism:eIssn><prism:volume>460</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>114-121</prism:pageRange><prism:coverDate>2015-05-19</prism:coverDate><prism:coverDisplayDate>19 May 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bbrc.2015.02.004</prism:doi><pii>S0006291X15002119</pii><dc:description>Â© 2015 Elsevier Inc. All rights reserved. Cellular Ca&lt;sup&gt;2+&lt;/sup&gt; homeostasis is maintained through the integrated and coordinated function of Ca&lt;sup&gt;2+&lt;/sup&gt; transport molecules, Ca&lt;sup&gt;2+&lt;/sup&gt; buffers and sensors. These molecules are associated with the plasma membrane and different cellular compartments, such as the cytoplasm, nucleus, mitochondria, and cellular reticular network, including the endoplasmic reticulum (ER) to control free and bound Ca&lt;sup&gt;2+&lt;/sup&gt; levels in all parts of the cell. Loss of nutrients/energy leads to the loss of cellular homeostasis and disruption of Ca&lt;sup&gt;2+&lt;/sup&gt; signaling in both the reticular network and cytoplasmic compartments. As an integral part of cellular physiology and pathology, this leads to activation of ER stress coping responses, such as the unfolded protein response (UPR), and mobilization of pathways to regain ER homeostasis.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032895</affiliation-url><afid>60032895</afid><affilname>Max Planck Institute for Biophysical Chemistry (Karl Friedrich Bonhoeffer Institute)</affilname><name-variant>Max Planck Institute for Biophysical Chemistry</name-variant><affiliation-city>Gottingen</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002494</affiliation-url><afid>60002494</afid><affilname>McGill University</affilname><name-variant>McGill University</name-variant><affiliation-city>Montreal</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030835</affiliation-url><afid>60030835</afid><affilname>University of Alberta</affilname><name-variant>University of Alberta</name-variant><affiliation-city>Edmonton</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7103163054</author-url><authid>7103163054</authid><authname>Krebs J.</authname><surname>Krebs</surname><given-name>Joachim</given-name><initials>J.</initials><afid>60032895</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7005631332</author-url><authid>7005631332</authid><authname>Agellon L.</authname><surname>Agellon</surname><given-name>Luis B.</given-name><initials>L.B.</initials><afid>60002494</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7005541058</author-url><authid>7005541058</authid><authname>Michalak M.</authname><surname>Michalak</surname><given-name>Marek</given-name><initials>M.</initials><afid>60030835</afid></author><authkeywords>Ca&lt;sup&gt;2+&lt;/sup&gt; homeostasis | Ca&lt;sup&gt;2+&lt;/sup&gt;-binding proteins | Calcium transport | ER stress | Membrane contact sites | MicroRNAs | Unfolded protein response (UPR)</authkeywords><intid>1035940652</intid><source-id>16845</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930009277"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930009277?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930009277&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930009277&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0006349515003914"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930009277</prism:url><dc:identifier>SCOPUS_ID:84930009277</dc:identifier><eid>2-s2.0-84930009277</eid><dc:title>In vitro measurement of particle margination in the microchannel flow: Effect of varying hematocrit</dc:title><dc:creator>Fitzgibbon S.</dc:creator><prism:publicationName>Biophysical Journal</prism:publicationName><prism:issn>00063495</prism:issn><prism:eIssn>15420086</prism:eIssn><prism:volume>108</prism:volume><prism:issueIdentifier>10</prism:issueIdentifier><prism:pageRange>2601-2608</prism:pageRange><prism:coverDate>2015-05-19</prism:coverDate><prism:coverDisplayDate>19 May 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bpj.2015.04.013</prism:doi><pii>S0006349515003914</pii><dc:description>Â© 2015 Biophysical Society. It has long been known that platelets undergo margination when flowing in blood vessels, such that there is an excess concentration near the vessel wall. We conduct experiments and three-dimensional boundary integral simulations of platelet-sized spherical particles in a microchannel 30 Î¼m in height to measure the particle-concentration distribution profile and observe its margination at 10%, 20%, and 30% red blood cell hematocrit. The experiments involved adding 2.15-Î¼m-diameter spheres into a solution of red blood cells, plasma, and water and flowing this mixture down a microfluidic channel at a wall shear rate of 1000 s&lt;sup&gt;-1&lt;/sup&gt;. Fluorescence imaging was used to determine the height and velocity of particles in the channel. Experimental results indicate that margination has largely occurred before particles travel 1 cm downstream and that hematocrit plays a role in the degree of margination. With simulations, we can track the trajectories of the particles with higher resolution. These simulations also confirm that margination from an initially uniform distribution of spheres and red blood cells occurs over the length scale of O(1 cm), with higher hematocrit showing faster margination. The results presented here, from both experiments and 3D simulations, may help explain the relationship between bleeding time in vessel trauma and red blood cell hematocrit as platelets move to a vessel wall.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012708</affiliation-url><afid>60012708</afid><affilname>Stanford University</affilname><name-variant>Stanford University</name-variant><affiliation-city>Palo Alto</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012708</affiliation-url><afid>60012708</afid><affilname>Stanford University</affilname><name-variant>Stanford University</name-variant><affiliation-city>Palo Alto</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012708</affiliation-url><afid>60012708</afid><affilname>Stanford University</affilname><name-variant>Stanford University</name-variant><affiliation-city>Palo Alto</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:25928342200</author-url><authid>25928342200</authid><authname>Fitzgibbon S.</authname><surname>Fitzgibbon</surname><given-name>Sean</given-name><initials>S.</initials><afid>60012708</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:54881528900</author-url><authid>54881528900</authid><authname>Spann A.</authname><surname>Spann</surname><given-name>Andrew P.</given-name><initials>A.P.</initials><afid>60012708</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56658313500</author-url><authid>56658313500</authid><authname>Qi Q.</authname><surname>Qi</surname><given-name>Qin M.</given-name><initials>Q.M.</initials><afid>60012708</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7005262140</author-url><authid>7005262140</authid><authname>Shaqfeh E.</authname><surname>Shaqfeh</surname><given-name>Eric S G</given-name><initials>E.S.G.</initials><afid>60012708</afid><afid>60012708</afid><afid>60012708</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7005262140</author-url><authid>7005262140</authid><authname>Shaqfeh E.</authname><surname>Shaqfeh</surname><given-name>Eric S G</given-name><initials>E.S.G.</initials><afid>60012708</afid><afid>60012708</afid><afid>60012708</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7005262140</author-url><authid>7005262140</authid><authname>Shaqfeh E.</authname><surname>Shaqfeh</surname><given-name>Eric S G</given-name><initials>E.S.G.</initials><afid>60012708</afid><afid>60012708</afid><afid>60012708</afid></author><intid>2036044333</intid><source-id>14859</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929439746"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929439746?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929439746&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929439746&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929439746</prism:url><dc:identifier>SCOPUS_ID:84929439746</dc:identifier><eid>2-s2.0-84929439746</eid><dc:title>G-protein Î²Î³ subunits are positive regulators of Kv7.4 and native vascular Kv7 channel activity</dc:title><dc:creator>Stott J.</dc:creator><prism:publicationName>Proceedings of the National Academy of Sciences of the United States of America</prism:publicationName><prism:issn>00278424</prism:issn><prism:eIssn>10916490</prism:eIssn><prism:volume>112</prism:volume><prism:issueIdentifier>20</prism:issueIdentifier><prism:pageRange>6497-6502</prism:pageRange><prism:coverDate>2015-05-19</prism:coverDate><prism:coverDisplayDate>19 May 2015</prism:coverDisplayDate><prism:doi>10.1073/pnas.1418605112</prism:doi><dc:description>Â© 2015, National Academy of Sciences. All rights reserved. Kv7.4 channels are a crucial determinant of arterial diameter both at rest and in response to endogenous vasodilators. However, nothing is known about the factors that ensure effective activity of these channels. We report that G-protein Î²Î³ subunits increase the amplitude and activation rate of whole-cell voltage-dependent K&lt;sup&gt;+&lt;/sup&gt; currents sensitive to the Kv7 blocker linopirdine in HEK cells heterologously expressing Kv7.4, and in rat renal artery myocytes. In excised patch recordings, GÎ²Î³ subunits (2-250 ng /mL) enhanced the open probability of Kv7.4 channels without changing unitary conductance. Kv7 channel activity was also augmented by stimulation of G-protein-coupled receptors. Gallein, an inhibitor of GÎ²Î³ subunits, prevented these stimulatory effects. Moreover, gallein and two other structurally different GÎ²Î³ subunit inhibitors (GRK2i and a Î²-subunit antibody) abolished Kv7 channel currents in the absence of either GÎ²Î³ subunit enrichment or G-protein-coupled receptor stimulation. Proximity ligation assay revealed that Kv7.4 and GÎ²Î³ subunits colocalized in HEK cells and renal artery smooth muscle cells. Gallein disrupted this colocalization, contracted whole renal arteries to a similar degree as the Kv7 inhibitor linopirdine, and impaired isoproterenol-induced relaxations. Furthermore, mSIRK, which disassociates GÎ²Î³ subunits from Î± subunits without stimulating nucleotide exchange, relaxed precontracted arteries in a linopirdine-sensitive manner. These results reveal that GÎ²Î³ subunits are fundamental for Kv7.4 activation and crucial for vascular Kv7 channel activity, which has major consequences for the regulation of arterial tone.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010426</affiliation-url><afid>60010426</afid><affilname>St George's Hospital, London</affilname><name-variant>St George's Hospital</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55967814100</author-url><authid>55967814100</authid><authname>Stott J.</authname><surname>Stott</surname><given-name>Jennifer B.</given-name><initials>J.B.</initials><afid>60010426</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6506355531</author-url><authid>6506355531</authid><authname>Povstyan O.</authname><surname>Povstyan</surname><given-name>Oleksandr V.</given-name><initials>O.V.</initials><afid>60010426</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56037248500</author-url><authid>56037248500</authid><authname>Carr G.</authname><surname>Carr</surname><given-name>Georgina</given-name><initials>G.</initials><afid>60010426</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:9639484400</author-url><authid>9639484400</authid><authname>Barrese V.</authname><surname>Barrese</surname><given-name>Vincenzo</given-name><initials>V.</initials><afid>60010426</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7003480897</author-url><authid>7003480897</authid><authname>Greenwood I.</authname><surname>Greenwood</surname><given-name>Iain A.</given-name><initials>I.A.</initials><afid>60010426</afid></author><authkeywords>Electrophysiology | G-protein beta gamma subunits | KCNQ genes | Kv7 channels | Vascular biology</authkeywords><intid>1535956042</intid><source-id>21121</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929590920"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929590920?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929590920&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929590920&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929590920</prism:url><dc:identifier>SCOPUS_ID:84929590920</dc:identifier><eid>2-s2.0-84929590920</eid><dc:title>Three dimensional liquid chromatography coupling ion exchange chromatography/hydrophobic interaction chromatography/reverse phase chromatography for effective protein separation in top-down proteomics</dc:title><dc:creator>Valeja S.</dc:creator><prism:publicationName>Analytical Chemistry</prism:publicationName><prism:issn>00032700</prism:issn><prism:eIssn>15206882</prism:eIssn><prism:volume>87</prism:volume><prism:issueIdentifier>10</prism:issueIdentifier><prism:pageRange>5363-5371</prism:pageRange><prism:coverDate>2015-05-19</prism:coverDate><prism:coverDisplayDate>19 May 2015</prism:coverDisplayDate><prism:doi>10.1021/acs.analchem.5b00657</prism:doi><dc:description>Â© 2015 American Chemical Society. To address the complexity of the proteome in mass spectrometry (MS)-based top-down proteomics, multidimensional liquid chromatography (MDLC) strategies that can effectively separate proteins with high resolution and automation are highly desirable. Although various MDLC methods that can effectively separate peptides from protein digests exist, very few MDLC strategies, primarily consisting of 2DLC, are available for intact protein separation, which is insufficient to address the complexity of the proteome. We recently demonstrated that hydrophobic interaction chromatography (HIC) utilizing a MS-compatible salt can provide high resolution separation of intact proteins for top-down proteomics. Herein, we have developed a novel 3DLC strategy by coupling HIC with ion exchange chromatography (IEC) and reverse phase chromatography (RPC) for intact protein separation. We demonstrated that a 3D (IEC-HIC-RPC) approach greatly outperformed the conventional 2D IEC-RPC approach. For the same IEC fraction (out of 35 fractions) from a crude HEK 293 cell lysate, a total of 640 proteins were identified in the 3D approach (corresponding to 201 nonredundant proteins) as compared to 47 in the 2D approach, whereas simply prolonging the gradients in RPC in the 2D approach only led to minimal improvement in protein separation and identifications. Therefore, this novel 3DLC method has great potential for effective separation of intact proteins to achieve deep proteome coverage in top-down proteomics.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032179</affiliation-url><afid>60032179</afid><affilname>University of Wisconsin Madison</affilname><name-variant>University of Wisconsin</name-variant><affiliation-city>Madison</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032179</affiliation-url><afid>60032179</afid><affilname>University of Wisconsin Madison</affilname><name-variant>University of Wisconsin</name-variant><affiliation-city>Madison</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032179</affiliation-url><afid>60032179</afid><affilname>University of Wisconsin Madison</affilname><name-variant>University of Wisconsin</name-variant><affiliation-city>Madison</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032179</affiliation-url><afid>60032179</afid><affilname>University of Wisconsin Madison</affilname><name-variant>University of Wisconsin</name-variant><affiliation-city>Madison</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:37027334300</author-url><authid>37027334300</authid><authname>Valeja S.</authname><surname>Valeja</surname><given-name>Santosh G.</given-name><initials>S.G.</initials><afid>60032179</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56516463900</author-url><authid>56516463900</authid><authname>Xiu L.</authname><surname>Xiu</surname><given-name>Lichen</given-name><initials>L.</initials><afid>60032179</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55571847700</author-url><authid>55571847700</authid><authname>Gregorich Z.</authname><surname>Gregorich</surname><given-name>Zachery R.</given-name><initials>Z.R.</initials><afid>60032179</afid><afid>60032179</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55571847700</author-url><authid>55571847700</authid><authname>Gregorich Z.</authname><surname>Gregorich</surname><given-name>Zachery R.</given-name><initials>Z.R.</initials><afid>60032179</afid><afid>60032179</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:46561151200</author-url><authid>46561151200</authid><authname>Guner H.</authname><surname>Guner</surname><given-name>Huseyin</given-name><initials>H.</initials><afid>60032179</afid><afid>60032179</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:46561151200</author-url><authid>46561151200</authid><authname>Guner H.</authname><surname>Guner</surname><given-name>Huseyin</given-name><initials>H.</initials><afid>60032179</afid><afid>60032179</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56650428300</author-url><authid>56650428300</authid><authname>Jin S.</authname><surname>Jin</surname><given-name>Song</given-name><initials>S.</initials><afid>60032179</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:54895055300</author-url><authid>54895055300</authid><authname>Ge Y.</authname><surname>Ge</surname><given-name>Ying</given-name><initials>Y.</initials><afid>60032179</afid><afid>60032179</afid><afid>60032179</afid><afid>60032179</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:54895055300</author-url><authid>54895055300</authid><authname>Ge Y.</authname><surname>Ge</surname><given-name>Ying</given-name><initials>Y.</initials><afid>60032179</afid><afid>60032179</afid><afid>60032179</afid><afid>60032179</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:54895055300</author-url><authid>54895055300</authid><authname>Ge Y.</authname><surname>Ge</surname><given-name>Ying</given-name><initials>Y.</initials><afid>60032179</afid><afid>60032179</afid><afid>60032179</afid><afid>60032179</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:54895055300</author-url><authid>54895055300</authid><authname>Ge Y.</authname><surname>Ge</surname><given-name>Ying</given-name><initials>Y.</initials><afid>60032179</afid><afid>60032179</afid><afid>60032179</afid><afid>60032179</afid></author><intid>1535981663</intid><source-id>23915</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929630793"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929630793?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929630793&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929630793&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929630793</prism:url><dc:identifier>SCOPUS_ID:84929630793</dc:identifier><eid>2-s2.0-84929630793</eid><dc:title>Specific turn-on fluorescent probe with aggregation-induced emission characteristics for SIRT1 modulator screening and living-cell imaging</dc:title><dc:creator>Wang Y.</dc:creator><prism:publicationName>Analytical Chemistry</prism:publicationName><prism:issn>00032700</prism:issn><prism:eIssn>15206882</prism:eIssn><prism:volume>87</prism:volume><prism:issueIdentifier>10</prism:issueIdentifier><prism:pageRange>5046-5049</prism:pageRange><prism:coverDate>2015-05-19</prism:coverDate><prism:coverDisplayDate>19 May 2015</prism:coverDisplayDate><prism:doi>10.1021/acs.analchem.5b01069</prism:doi><dc:description>Â© 2015 American Chemical Society. SIRT1 is an important protein that catalyzes the nicotinamide adenine dinucleotide (NAD)&lt;sup&gt;+&lt;/sup&gt;-dependent deacetylation reaction, which is regarded as a novel target to treat metabolic disorders and aging-related diseases. However, there is lack of appropriate approach for SIRT1 modulator screening and bioimaging of SIRT1 in living cells. We designed and synthesized a "turn-on" fluorescent probe by connecting a specifically recognized peptide to tetraphenylethene core. It exhibits excellent selectivity and sensitivity in homogeneous measurement of SIRT1 activity for screening both SIRT1 inhibitors and activators. 20(S)-ginsenoside Rg&lt;inf&gt;3&lt;/inf&gt; and ophiopogonin Dâ² were found to activate SIRT1. It was also successfully applied to monitor SIRT1 modulation in the cardiomyocytes as well as in the wild-type and SIRT1&lt;sup&gt;-/-&lt;/sup&gt; mesenchymal stem cells.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003970</affiliation-url><afid>60003970</afid><affilname>Zhejiang University</affilname><name-variant>Zhejiang University</name-variant><affiliation-city>Hangzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60082198</affiliation-url><afid>60082198</afid><affilname>Zhejiang Chinese Medical University</affilname><name-variant>Zhejiang Chinese Medical University</name-variant><affiliation-city>Hangzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56638782100</author-url><authid>56638782100</authid><authname>Wang Y.</authname><surname>Wang</surname><given-name>Yi</given-name><initials>Y.</initials><afid>60003970</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56647711700</author-url><authid>56647711700</authid><authname>Chen Y.</authname><surname>Chen</surname><given-name>Yaqi</given-name><initials>Y.</initials><afid>60003970</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56404880000</author-url><authid>56404880000</authid><authname>Wang H.</authname><surname>Wang</surname><given-name>Haibo</given-name><initials>H.</initials><afid>60003970</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56404854500</author-url><authid>56404854500</authid><authname>Cheng Y.</authname><surname>Cheng</surname><given-name>Yiyu</given-name><initials>Y.</initials><afid>60003970</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56245383300</author-url><authid>56245383300</authid><authname>Zhao X.</authname><surname>Zhao</surname><given-name>Xiaoping</given-name><initials>X.</initials><afid>60082198</afid></author><intid>35989239</intid><source-id>23915</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929593629"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929593629?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929593629&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929593629&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929593629</prism:url><dc:identifier>SCOPUS_ID:84929593629</dc:identifier><eid>2-s2.0-84929593629</eid><dc:title>The functional property changes of muscular Na&lt;inf&gt;v&lt;/inf&gt;1.4 and cardiac Na&lt;inf&gt;v&lt;/inf&gt;1.5 induced by scorpion toxin BmK AGP-SYPU1 mutants Y42F and Y5F</dc:title><dc:creator>Meng X.</dc:creator><prism:publicationName>Biochemistry</prism:publicationName><prism:issn>00062960</prism:issn><prism:eIssn>15204995</prism:eIssn><prism:volume>54</prism:volume><prism:issueIdentifier>19</prism:issueIdentifier><prism:pageRange>2988-2995</prism:pageRange><prism:coverDate>2015-05-19</prism:coverDate><prism:coverDisplayDate>19 May 2015</prism:coverDisplayDate><prism:doi>10.1021/acs.biochem.5b00067</prism:doi><dc:description>Â© 2015 American Chemical Society. Scorpion toxins are invaluable therapeutic leads and pharmacological tools which influence the voltage-gated sodium channels. However, the details were still unclear about the structure-function relationship of scorpion toxins on VGSC subtypes. In the previous study, we reported one Î±-type scorpion toxin Bmk AGP-SYPU1 and its two mutants (Y5F and Y42F) which had been demonstrated to ease pain in mice acetic acid writhing test. However, the function of Bmk AGP-SYPU1 on VGSCs is still unknown. In this study, we examined the effects of BmK AGP-SYPU1 and its two mutants (Y5F and Y42F) on hNa&lt;inf&gt;v&lt;/inf&gt;1.4 and hNa&lt;inf&gt;v&lt;/inf&gt;1.5 heterologously expressed CHO cell lines by using Na&lt;sup&gt;+&lt;/sup&gt;-specialized fluorescent dye and whole-cell patch clamp. The data showed that BmK AGP-SYPU1 displayed as an activator of hNa&lt;inf&gt;v&lt;/inf&gt;1.4 and hNa&lt;inf&gt;v&lt;/inf&gt;1.5, which might indeed contribute to its biotoxicity to muscular and cardiac system and exhibited the functional properties of both the Î±-type and Î²-type scorpion toxin. Notably, Y5F mutant exhibited lower activatory effects on hNa&lt;inf&gt;v&lt;/inf&gt;1.4 and hNa&lt;inf&gt;v&lt;/inf&gt;1.5 compared with BmK AGP-SYPU1. Y42F was an enhanced activator and confirmed that the conserved Tyr42 was the key amino acid involved in bioactivity or biotoxicity. These data provided a deep insight into the structure-function relationship of BmK AGP-SYPU1, which may be the guidance for engineering Î±-toxin with high selectivity on VGSC subtypes.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007269</affiliation-url><afid>60007269</afid><affilname>Shenyang Pharmaceutical University</affilname><name-variant>Shenyang Pharmaceutical University</name-variant><affiliation-city>Shenyang</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007269</affiliation-url><afid>60007269</afid><affilname>Shenyang Pharmaceutical University</affilname><name-variant>Shenyang Pharmaceutical University</name-variant><affiliation-city>Shenyang</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007269</affiliation-url><afid>60007269</afid><affilname>Shenyang Pharmaceutical University</affilname><name-variant>Shenyang Pharmaceutical University</name-variant><affiliation-city>Shenyang</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">12</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56080435700</author-url><authid>56080435700</authid><authname>Meng X.</authname><surname>Meng</surname><given-name>Xiangxue</given-name><initials>X.</initials><afid>60007269</afid><afid>60007269</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56080435700</author-url><authid>56080435700</authid><authname>Meng X.</authname><surname>Meng</surname><given-name>Xiangxue</given-name><initials>X.</initials><afid>60007269</afid><afid>60007269</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56650319400</author-url><authid>56650319400</authid><authname>Xu Y.</authname><surname>Xu</surname><given-name>Yijia</given-name><initials>Y.</initials><afid>60007269</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55477808500</author-url><authid>55477808500</authid><authname>Zhao M.</authname><surname>Zhao</surname><given-name>Mingyi</given-name><initials>M.</initials><afid>60007269</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56650298600</author-url><authid>56650298600</authid><authname>Wang F.</authname><surname>Wang</surname><given-name>Fangyang</given-name><initials>F.</initials><afid>60007269</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56650314800</author-url><authid>56650314800</authid><authname>Ma Y.</authname><surname>Ma</surname><given-name>Yuanyuan</given-name><initials>Y.</initials><afid>60007269</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56079874800</author-url><authid>56079874800</authid><authname>Jin Y.</authname><surname>Jin</surname><given-name>Yao</given-name><initials>Y.</initials><afid>60007269</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55199749400</author-url><authid>55199749400</authid><authname>Liu Y.</authname><surname>Liu</surname><given-name>Yanfeng</given-name><initials>Y.</initials><afid>60007269</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56650334400</author-url><authid>56650334400</authid><authname>Song Y.</authname><surname>Song</surname><given-name>Yongbo</given-name><initials>Y.</initials><afid>60007269</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56335273100</author-url><authid>56335273100</authid><authname>Zhang J.</authname><surname>Zhang</surname><given-name>Jinghai</given-name><initials>J.</initials><afid>60007269</afid><afid>60007269</afid><afid>60007269</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56335273100</author-url><authid>56335273100</authid><authname>Zhang J.</authname><surname>Zhang</surname><given-name>Jinghai</given-name><initials>J.</initials><afid>60007269</afid><afid>60007269</afid><afid>60007269</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56335273100</author-url><authid>56335273100</authid><authname>Zhang J.</authname><surname>Zhang</surname><given-name>Jinghai</given-name><initials>J.</initials><afid>60007269</afid><afid>60007269</afid><afid>60007269</afid></author><intid>35980693</intid><source-id>16867</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929645916"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929645916?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929645916&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929645916&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929645916</prism:url><dc:identifier>SCOPUS_ID:84929645916</dc:identifier><eid>2-s2.0-84929645916</eid><dc:title>Simple and effective label-free capillary electrophoretic analysis of sugars by complexation using quinoline boronic acids</dc:title><dc:creator>Kubo T.</dc:creator><prism:publicationName>Analytical Chemistry</prism:publicationName><prism:issn>00032700</prism:issn><prism:eIssn>15206882</prism:eIssn><prism:volume>87</prism:volume><prism:issueIdentifier>10</prism:issueIdentifier><prism:pageRange>5068-5073</prism:pageRange><prism:coverDate>2015-05-19</prism:coverDate><prism:coverDisplayDate>19 May 2015</prism:coverDisplayDate><prism:doi>10.1021/acs.analchem.5b00998</prism:doi><dc:description>Â© 2015 American Chemical Society. An effective separation and detection procedure for sugars by capillary electrophoresis (CE) using a complexation between quinolineboronic acid (QBA) and multiple hydroxyl structure of sugar alcohol is reported. We investigated the variation of fluorescence spectra of a variety of QBAs with sorbitol at a wide range of pH conditions and then found that 5-isoQBA strongly enhanced the fluorescence intensity by the complexation at basic pH conditions. The other sugar alcohols having multiple hydroxyls also revealed the enhancement of the fluorescence intensity with 5-isoQBA, whereas the alternation of the intensity was not found in the sugars such as glucose. After optimization of the 5-isoQBA concentration and pH of the buffered solution in CE analysis, 6 sugar alcohols were successfully separated in the order based on the formation constants with 5-isoQBA, which were calculated from the variation of the fluorescence intensity with each sugar alcohol and 5-isoQBA. Furthermore, the limits of detection for sorbitol and xylitol by the CE method were estimated at 15 and 27 Î¼M, respectively.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011001</affiliation-url><afid>60011001</afid><affilname>Kyoto University</affilname><name-variant>Kyoto University</name-variant><affiliation-city>Kyoto</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016648</affiliation-url><afid>60016648</afid><affilname>Riken</affilname><name-variant>RIKEN</name-variant><affiliation-city>Wako</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008107</affiliation-url><afid>60008107</afid><affilname>Osaka Prefecture University</affilname><name-variant>Osaka Prefecture University</name-variant><affiliation-city>Sakai</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35268927100</author-url><authid>35268927100</authid><authname>Kubo T.</authname><surname>Kubo</surname><given-name>Takuya</given-name><initials>T.</initials><afid>60011001</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56652296500</author-url><authid>56652296500</authid><authname>Kanemori K.</authname><surname>Kanemori</surname><given-name>Koichi</given-name><initials>K.</initials><afid>60011001</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56652110500</author-url><authid>56652110500</authid><authname>Kusumoto R.</authname><surname>Kusumoto</surname><given-name>Risa</given-name><initials>R.</initials><afid>60011001</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7403560074</author-url><authid>7403560074</authid><authname>Kawai T.</authname><surname>Kawai</surname><given-name>Takayuki</given-name><initials>T.</initials><afid>60016648</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55695727900</author-url><authid>55695727900</authid><authname>Sueyoshi K.</authname><surname>Sueyoshi</surname><given-name>Kenji</given-name><initials>K.</initials><afid>60008107</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56651705600</author-url><authid>56651705600</authid><authname>Naito T.</authname><surname>Naito</surname><given-name>Toyohiro</given-name><initials>T.</initials><afid>60011001</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56651681500</author-url><authid>56651681500</authid><authname>Otsuka K.</authname><surname>Otsuka</surname><given-name>Koji</given-name><initials>K.</initials><afid>60011001</afid></author><intid>535989343</intid><source-id>23915</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929332702"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929332702?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929332702&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929332702&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929332702</prism:url><dc:identifier>SCOPUS_ID:84929332702</dc:identifier><eid>2-s2.0-84929332702</eid><dc:title>A candidate gene study reveals association between a variant of the Peroxisome Proliferator-Activated Receptor Gamma (PPAR-Î³) gene and systemic sclerosis</dc:title><dc:creator>Marangoni R.</dc:creator><prism:publicationName>Arthritis Research and Therapy</prism:publicationName><prism:issn>14786354</prism:issn><prism:eIssn>14786362</prism:eIssn><prism:volume>17</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:coverDate>2015-05-19</prism:coverDate><prism:coverDisplayDate>May 19, 2015</prism:coverDisplayDate><prism:doi>10.1186/s13075-015-0641-2</prism:doi><dc:description>Â© Marangoni et al.; licensee BioMed Central. Introduction: The multifunctional nuclear receptor peroxisome proliferator-activated receptor gamma (PPAR-Î³) has potent anti-fibrotic effects, and its expression and activity are impaired in patients with systemic sclerosis (SSc). We investigated PPAR-Î³ gene (PPARG) single nucleotide polymorphisms (SNPs) associated with SSc. Methods: Tag SNPs spanning PPARG were genotyped in a European ancestry US discovery cohort comprising 152 SSc patients and 450 controls, with replication of our top signal in a European cohort (1031 SSc patients and 1014 controls from France). Clinical parameters and disease severity were analyzed to evaluate clinical associations with PPARG variants. Results: In the discovery cohort, a single PPARG intronic SNP (rs10865710) was associated with SSc (p = 0.010; odds ratio = 1.52 per C allele, 95% confidence interval 1.10-2.08). This association was replicated in the French validation cohort (p = 0.052; odds ratio = 1.16 per C allele, 95% confidence interval 1.00-1.35). Meta-analysis of both cohorts indicated stronger evidence for association (p = 0.002; odds ratio = 1.22 per C allele, 95% confidence interval 1.07-1.40). The rs10865710 C allele was also associated with pulmonary arterial hypertension in the French SSc cohort (p = 0.002; odds ratio = 2.33 per C allele, 95% confidence interval 1.34-4.03). Conclusions: A PPARG variant is associated with susceptibility to SSc, consistent with a role of PPAR-Î³ in the pathogenesis of SSc.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013227</affiliation-url><afid>60013227</afid><affilname>Northwestern University Feinberg School of Medicine</affilname><name-variant>Northwestern University</name-variant><affiliation-city>Chicago</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028950</affiliation-url><afid>60028950</afid><affilname>Universite Paris Descartes</affilname><name-variant>UniversitÃ© Paris Descartes</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028950</affiliation-url><afid>60028950</afid><affilname>Universite Paris Descartes</affilname><name-variant>UniversitÃ© Paris Descartes</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005711</affiliation-url><afid>60005711</afid><affilname>Universite Paris 7- Denis Diderot</affilname><name-variant>UniversitÃ© Paris 7</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013227</affiliation-url><afid>60013227</afid><affilname>Northwestern University Feinberg School of Medicine</affilname><name-variant>Northwestern University</name-variant><affiliation-city>Chicago</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013227</affiliation-url><afid>60013227</afid><affilname>Northwestern University Feinberg School of Medicine</affilname><name-variant>Northwestern University</name-variant><affiliation-city>Chicago</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000245</affiliation-url><afid>60000245</afid><affilname>Universite Lille 2 Droit et Sante</affilname><name-variant>University of Lille</name-variant><affiliation-city>Lille</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001422</affiliation-url><afid>60001422</afid><affilname>Universite Pierre et Marie Curie</affilname><name-variant>UniversitÃ© Pierre et Marie Curie</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005851</affiliation-url><afid>60005851</afid><affilname>Centre Hospitalier Universitaire de Grenoble</affilname><name-variant>CHU</name-variant><affiliation-city>Grenoble</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013227</affiliation-url><afid>60013227</afid><affilname>Northwestern University Feinberg School of Medicine</affilname><name-variant>Northwestern University</name-variant><affiliation-city>Chicago</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013227</affiliation-url><afid>60013227</afid><affilname>Northwestern University Feinberg School of Medicine</affilname><name-variant>Northwestern University</name-variant><affiliation-city>Chicago</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007363</affiliation-url><afid>60007363</afid><affilname>Northwestern University</affilname><name-variant>Northwestern University</name-variant><affiliation-city>Evanston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">20</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36004929100</author-url><authid>36004929100</authid><authname>Marangoni R.</authname><surname>Marangoni</surname><given-name>Roberta Goncalves</given-name><initials>R.G.</initials><afid>60013227</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36446004400</author-url><authid>36446004400</authid><authname>Korman B.</authname><surname>Korman</surname><given-name>Benjamin D.</given-name><initials>B.D.</initials><afid>60013227</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7003519327</author-url><authid>7003519327</authid><authname>Allanore Y.</authname><surname>Allanore</surname><given-name>Yannick</given-name><initials>Y.</initials><afid>60028950</afid><afid>60028950</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7003519327</author-url><authid>7003519327</authid><authname>Allanore Y.</authname><surname>Allanore</surname><given-name>Yannick</given-name><initials>Y.</initials><afid>60028950</afid><afid>60028950</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56206750400</author-url><authid>56206750400</authid><authname>Dieude P.</authname><surname>Dieude</surname><given-name>Philippe</given-name><initials>P.</initials><afid>60005711</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56644141300</author-url><authid>56644141300</authid><authname>Armstrong L.</authname><surname>Armstrong</surname><given-name>Loren L.</given-name><initials>L.L.</initials><afid>60013227</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6507650120</author-url><authid>6507650120</authid><authname>Rzhetskaya M.</authname><surname>Rzhetskaya</surname><given-name>Margarita</given-name><initials>M.</initials><afid>60013227</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:16042037800</author-url><authid>16042037800</authid><authname>Hinchcliff M.</authname><surname>Hinchcliff</surname><given-name>Monique</given-name><initials>M.</initials><afid>60013227</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:54396862800</author-url><authid>54396862800</authid><authname>Carns M.</authname><surname>Carns</surname><given-name>Mary</given-name><initials>M.</initials><afid>60013227</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:53981846500</author-url><authid>53981846500</authid><authname>Podlusky S.</authname><surname>Podlusky</surname><given-name>Sofia</given-name><initials>S.</initials><afid>60013227</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:12545068000</author-url><authid>12545068000</authid><authname>Shah S.</authname><surname>Shah</surname><given-name>Sanjiv J.</given-name><initials>S.J.</initials><afid>60013227</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:25641775300</author-url><authid>25641775300</authid><authname>Ruiz B.</authname><surname>Ruiz</surname><given-name>Barbara</given-name><initials>B.</initials><afid>60028950</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:35377410100</author-url><authid>35377410100</authid><authname>Hachulla E.</authname><surname>Hachulla</surname><given-name>Eric</given-name><initials>E.</initials><afid>60000245</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:10040839700</author-url><authid>10040839700</authid><authname>Tiev K.</authname><surname>Tiev</surname><given-name>Kiet</given-name><initials>K.</initials><afid>60001422</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:7005878536</author-url><authid>7005878536</authid><authname>Cracowski J.</authname><surname>Cracowski</surname><given-name>Jean Luc</given-name><initials>J.L.</initials><afid>60005851</afid></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:35392550200</author-url><authid>35392550200</authid><authname>Varga J.</authname><surname>Varga</surname><given-name>John</given-name><initials>J.</initials><afid>60013227</afid><afid>60013227</afid></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:35392550200</author-url><authid>35392550200</authid><authname>Varga J.</authname><surname>Varga</surname><given-name>John</given-name><initials>J.</initials><afid>60013227</afid><afid>60013227</afid></author><author seq="16"><author-url>http://api.elsevier.com/content/author/author_id:56542517100</author-url><authid>56542517100</authid><authname>Hayes M.</authname><surname>Hayes</surname><given-name>M. Geoffrey</given-name><initials>M.G.</initials><afid>60013227</afid><afid>60013227</afid><afid>60007363</afid></author><author seq="16"><author-url>http://api.elsevier.com/content/author/author_id:56542517100</author-url><authid>56542517100</authid><authname>Hayes M.</authname><surname>Hayes</surname><given-name>M. Geoffrey</given-name><initials>M.G.</initials><afid>60013227</afid><afid>60013227</afid><afid>60007363</afid></author><author seq="16"><author-url>http://api.elsevier.com/content/author/author_id:56542517100</author-url><authid>56542517100</authid><authname>Hayes M.</authname><surname>Hayes</surname><given-name>M. Geoffrey</given-name><initials>M.G.</initials><afid>60013227</afid><afid>60013227</afid><afid>60007363</afid></author><intid>35944185</intid><article-number>128</article-number><source-id>27592</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930005134"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930005134?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930005134&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930005134&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930005134</prism:url><dc:identifier>SCOPUS_ID:84930005134</dc:identifier><eid>2-s2.0-84930005134</eid><dc:title>Electrochemical analyses of redox-active iron minerals: A review of nonmediated and mediated approaches</dc:title><dc:creator>Sander M.</dc:creator><prism:publicationName>Environmental Science and Technology</prism:publicationName><prism:issn>0013936X</prism:issn><prism:eIssn>15205851</prism:eIssn><prism:volume>49</prism:volume><prism:issueIdentifier>10</prism:issueIdentifier><prism:pageRange>5862-5878</prism:pageRange><prism:coverDate>2015-05-19</prism:coverDate><prism:coverDisplayDate>19 May 2015</prism:coverDisplayDate><prism:doi>10.1021/acs.est.5b00006</prism:doi><dc:description>Â© 2015 American Chemical Society. Redox-active minerals are ubiquitous in the environment and are involved in numerous electron transfer reactions that significantly affect biogeochemical processes and cycles as well as pollutant dynamics. As a consequence, research in different scientific disciplines is devoted to elucidating the redox properties and reactivities of minerals. This review focuses on the characterization of mineral redox properties using electrochemical approaches from an applied (bio)geochemical and environmental analytical chemistry perspective. Establishing redox equilibria between the minerals and working electrodes is a major challenge in electrochemical measurements, which we discuss in an overview of traditional electrochemical techniques. These issues can be overcome with mediated electrochemical analyses in which dissolved redox mediators are used to increase the rate of electron transfer and to facilitate redox equilibration between working electrodes and minerals in both amperometric and potentiometric measurements. Using experimental data on an iron-bearing clay mineral, we illustrate how mediated electrochemical analyses can be employed to derive important thermodynamic and kinetic data on electron transfer to and from structural iron. We summarize anticipated methodological advancements that will further contribute to advance an improved understanding of electron transfer to and from minerals in environmentally relevant redox processes.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025858</affiliation-url><afid>60025858</afid><affilname>Eidgenossische Technische Hochschule Zurich</affilname><name-variant>ETH Zurich</name-variant><affiliation-city>Zurich</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002612</affiliation-url><afid>60002612</afid><affilname>Swiss Federal Institute of Aquatic Science and Technology</affilname><name-variant>Eawag</name-variant><affiliation-city>Dubendorf</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001439</affiliation-url><afid>60001439</afid><affilname>Pennsylvania State University</affilname><name-variant>Pennsylvania State University</name-variant><affiliation-city>State College</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:8602844800</author-url><authid>8602844800</authid><authname>Sander M.</authname><surname>Sander</surname><given-name>Michael</given-name><initials>M.</initials><afid>60025858</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6602185063</author-url><authid>6602185063</authid><authname>Hofstetter T.</authname><surname>Hofstetter</surname><given-name>Thomas B.</given-name><initials>T.B.</initials><afid>60002612</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6602116159</author-url><authid>6602116159</authid><authname>Gorski C.</authname><surname>Gorski</surname><given-name>Christopher A.</given-name><initials>C.A.</initials><afid>60001439</afid></author><intid>1036045314</intid><source-id>21537</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930212138"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930212138?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930212138&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930212138&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930212138</prism:url><dc:identifier>SCOPUS_ID:84930212138</dc:identifier><eid>2-s2.0-84930212138</eid><dc:title>Low-dose memantine attenuated methadone dose in opioid-dependent patients: A 12-week double-blind randomized controlled trial</dc:title><dc:creator>Lee S.</dc:creator><prism:publicationName>Scientific Reports</prism:publicationName><prism:eIssn>20452322</prism:eIssn><prism:volume>5</prism:volume><prism:coverDate>2015-05-19</prism:coverDate><prism:coverDisplayDate>19 May 2015</prism:coverDisplayDate><prism:doi>10.1038/srep10140</prism:doi><pii>srep10140</pii><dc:description>Low-dose memantine might have anti-inflammatory and neurotrophic effects mechanistically remote from an NMDA receptor. We investigated whether add-on memantine reduced cytokine levels and benefitted patients with opioid dependence undergoing methadone maintenance therapy (MMT) in a randomized, double-blind, controlled 12-week study. Patients were randomly assigned to a group: Memantine (5 mg/day) (n = 53) or Placebo (n = 75). The methadone dose required and retention in treatment were monitored. Plasma tumor necrosis factor (TNF)-Î±, C-reactive protein (CRP), interleukin (IL)-6, IL-8, transforming growth factor (TGF)-Î²1, and brain-derived neurotrophic factor (BDNF) levels were examined during weeks 0, 1, 4, 8, and 12. General linear mixed models were used to examine therapeutic effect. After 12 weeks, Memantine-group required a somewhat lower methadone dose than did Placebo-group (P = 0.039). They also had significantly lower plasma TNF-Î± and significantly higher TGF-Î²1 levels. We provide evidence of the benefit of add-on memantine in opioid dependent patients undergoing MMT.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021605</affiliation-url><afid>60021605</afid><affilname>Veterans General Hospital-Kaohsiung Taiwan</affilname><name-variant>Kaohsiung Veterans General Hospital</name-variant><affiliation-city>Kaohsiung</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014982</affiliation-url><afid>60014982</afid><affilname>National Cheng Kung University</affilname><name-variant>National Cheng Kung University</name-variant><affiliation-city>Tainan</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012256</affiliation-url><afid>60012256</afid><affilname>Kaohsiung Medical University</affilname><name-variant>Kaohsiung Medical University</name-variant><affiliation-city>Kaohsiung</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:107890070</affiliation-url><afid>107890070</afid><affilname>Institute of Allied Health Sciences</affilname><name-variant>Institute of Allied Health Sciences</name-variant><affiliation-city>Tainan</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011828</affiliation-url><afid>60011828</afid><affilname>Triservice General Hospital Taiwan</affilname><name-variant>Tri-Service General Hospital</name-variant><affiliation-city>Taipei</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012256</affiliation-url><afid>60012256</afid><affilname>Kaohsiung Medical University</affilname><name-variant>Kaohsiung Medical University</name-variant><affiliation-city>Kaohsiung</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028652</affiliation-url><afid>60028652</afid><affilname>National Institute of Environmental Health Sciences</affilname><name-variant>Natl. Inst. of Environ. Hlth. Sci.</name-variant><affiliation-city>Research Triangle Park</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115293562</affiliation-url><afid>115293562</afid><affilname>College of Medicine and Hospital</affilname><name-variant>College of Medicine and Hospital</name-variant><affiliation-city/><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014982</affiliation-url><afid>60014982</afid><affilname>National Cheng Kung University</affilname><name-variant>National Cheng Kung University</name-variant><affiliation-city>Tainan</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010037</affiliation-url><afid>60010037</afid><affilname>National Health Research Institutes Taiwan</affilname><name-variant>National Health Research Institutes</name-variant><affiliation-city>Zhunan</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">19</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55068246400</author-url><authid>55068246400</authid><authname>Lee S.</authname><surname>Lee</surname><given-name>Sheng Yu</given-name><initials>S.Y.</initials><afid>60021605</afid><afid>60014982</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55068246400</author-url><authid>55068246400</authid><authname>Lee S.</authname><surname>Lee</surname><given-name>Sheng Yu</given-name><initials>S.Y.</initials><afid>60021605</afid><afid>60014982</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:27067447300</author-url><authid>27067447300</authid><authname>Chen S.</authname><surname>Chen</surname><given-name>Shiou Lan</given-name><initials>S.L.</initials><afid>60014982</afid><afid>60012256</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:27067447300</author-url><authid>27067447300</authid><authname>Chen S.</authname><surname>Chen</surname><given-name>Shiou Lan</given-name><initials>S.L.</initials><afid>60014982</afid><afid>60012256</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35726502800</author-url><authid>35726502800</authid><authname>Chang Y.</authname><surname>Chang</surname><given-name>Yun Hsuan</given-name><initials>Y.H.</initials><afid>107890070</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:34976265200</author-url><authid>34976265200</authid><authname>Chen P.</authname><surname>Chen</surname><given-name>Po See</given-name><initials>P.S.</initials><afid>60014982</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55653385100</author-url><authid>55653385100</authid><authname>Huang S.</authname><surname>Huang</surname><given-name>San Yuan</given-name><initials>S.Y.</initials><afid>60011828</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:35243724900</author-url><authid>35243724900</authid><authname>Tzeng N.</authname><surname>Tzeng</surname><given-name>Nian Sheng</given-name><initials>N.S.</initials><afid>60011828</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55778111100</author-url><authid>55778111100</authid><authname>Wang L.</authname><surname>Wang</surname><given-name>Liang Jen</given-name><initials>L.J.</initials><afid>60012256</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:16031066800</author-url><authid>16031066800</authid><authname>Lee I.</authname><surname>Lee</surname><given-name>I. Hui</given-name><initials>I.H.</initials><afid>60014982</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7405560129</author-url><authid>7405560129</authid><authname>Wang T.</authname><surname>Wang</surname><given-name>Tzu Yun</given-name><initials>T.Y.</initials><afid>60014982</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:55082543500</author-url><authid>55082543500</authid><authname>Chen K.</authname><surname>Chen</surname><given-name>Kao Chin</given-name><initials>K.C.</initials><afid>60014982</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7409391420</author-url><authid>7409391420</authid><authname>Yang Y.</authname><surname>Yang</surname><given-name>Yen Kuang</given-name><initials>Y.K.</initials><afid>60014982</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:7404117981</author-url><authid>7404117981</authid><authname>Hong J.</authname><surname>Hong</surname><given-name>Jau Shyong</given-name><initials>J.S.</initials><afid>60028652</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:7402969959</author-url><authid>7402969959</authid><authname>Lu R.</authname><surname>Lu</surname><given-name>Ru Band</given-name><initials>R.B.</initials><afid>60014982</afid><afid>107890070</afid><afid>115293562</afid><afid>60014982</afid><afid>60010037</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:7402969959</author-url><authid>7402969959</authid><authname>Lu R.</authname><surname>Lu</surname><given-name>Ru Band</given-name><initials>R.B.</initials><afid>60014982</afid><afid>107890070</afid><afid>115293562</afid><afid>60014982</afid><afid>60010037</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:7402969959</author-url><authid>7402969959</authid><authname>Lu R.</authname><surname>Lu</surname><given-name>Ru Band</given-name><initials>R.B.</initials><afid>60014982</afid><afid>107890070</afid><afid>115293562</afid><afid>60014982</afid><afid>60010037</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:7402969959</author-url><authid>7402969959</authid><authname>Lu R.</authname><surname>Lu</surname><given-name>Ru Band</given-name><initials>R.B.</initials><afid>60014982</afid><afid>107890070</afid><afid>115293562</afid><afid>60014982</afid><afid>60010037</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:7402969959</author-url><authid>7402969959</authid><authname>Lu R.</authname><surname>Lu</surname><given-name>Ru Band</given-name><initials>R.B.</initials><afid>60014982</afid><afid>107890070</afid><afid>115293562</afid><afid>60014982</afid><afid>60010037</afid></author><intid>1786087016</intid><article-number>10140</article-number><source-id>21100200805</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930180792"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930180792?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930180792&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930180792&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930180792</prism:url><dc:identifier>SCOPUS_ID:84930180792</dc:identifier><eid>2-s2.0-84930180792</eid><dc:title>Liraglutide: A review of its use in the management of obesity</dc:title><dc:creator>Scott L.</dc:creator><prism:publicationName>Drugs</prism:publicationName><prism:issn>00126667</prism:issn><prism:eIssn>11791950</prism:eIssn><prism:volume>75</prism:volume><prism:issueIdentifier>8</prism:issueIdentifier><prism:pageRange>899-910</prism:pageRange><prism:coverDate>2015-05-19</prism:coverDate><prism:coverDisplayDate>19 May 2015</prism:coverDisplayDate><prism:doi>10.1007/s40265-015-0408-8</prism:doi><dc:description>Â© 2015 Springer International Publishing Switzerland. Globally, obesity has reached epidemic proportions and poses an ever increasing burden from a societal and healthpayer perspective. Although lifestyle interventions are fundamental in its management, in the real world setting most obese or overweight adults require adjunctive pharmacotherapy to achieve clinically relevant reductions in bodyweight (i.e. a 5 % reduction). Subcutaneous liraglutide (Saxenda&lt;sup&gt;Â®&lt;/sup&gt;) 3 mg once daily is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic bodyweight management in adults with an initial body mass index (BMI) of 30 kg/m&lt;sup&gt;2&lt;/sup&gt; (obese) or a BMI of 27 kg/m&lt;sup&gt;2&lt;/sup&gt; (overweight) and at least one bodyweight-related comorbidity [e.g. hypertension, dyslipidaemia, type 2 diabetes mellitus or obstructive sleep apnoea (OSA)]. In phase III trials (32 or 56 weeks' duration) in these populations, subcutaneous liraglutide was associated with clinically relevant reductions in fasting bodyweight and was generally well tolerated. Liraglutide was significantly more effective than placebo in terms of reductions in fasting bodyweight and waist circumference, and improvements in some biomarkers of cardiovascular risk. Improvements in bodyweight were maintained after up 2 years of liraglutide therapy. In nondiabetic adults with moderate to severe OSA, liraglutide improved apnoea-hypopnoea index scores at 32 weeks, which was largely driven by significant reductions in bodyweight. In the absence of head-to-head trials, the relative position of individual anti-obesity drugs remains to be fully determined. In the meantime, liraglutide is an emerging option, as an adjunct to a reduced-calorie diet and increased physical activity, for chronic bodyweight management in obese adults and overweight adults with at least one bodyweight-related comorbidity.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname/><affiliation-city>Auckland</affiliation-city><affiliation-country>New Zealand</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">1</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7402406069</author-url><authid>7402406069</authid><authname>Scott L.</authname><surname>Scott</surname><given-name>Lesley J.</given-name><initials>L.J.</initials><afid/></author><intid>2036074178</intid><source-id>21239</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929428247"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929428247?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929428247&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929428247&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929428247</prism:url><dc:identifier>SCOPUS_ID:84929428247</dc:identifier><eid>2-s2.0-84929428247</eid><dc:title>Hemoglobin Î²Cys93 is essential for cardiovascular function and integrated response to hypoxia</dc:title><dc:creator>Zhang R.</dc:creator><prism:publicationName>Proceedings of the National Academy of Sciences of the United States of America</prism:publicationName><prism:issn>00278424</prism:issn><prism:eIssn>10916490</prism:eIssn><prism:volume>112</prism:volume><prism:issueIdentifier>20</prism:issueIdentifier><prism:pageRange>6425-6430</prism:pageRange><prism:coverDate>2015-05-19</prism:coverDate><prism:coverDisplayDate>19 May 2015</prism:coverDisplayDate><prism:doi>10.1073/pnas.1502285112</prism:doi><dc:description>Â© 2015, National Academy of Sciences. All rights reserved. Oxygen delivery by Hb is essential for vertebrate life. Three amino acids in Hb are strictly conserved in all mammals and birds, but only two of those, a His and a Phe that stabilize the heme moiety, are needed to carry O&lt;inf&gt;2&lt;/inf&gt;. The third conserved residue is a Cys within the Î²-chain (Î²Cys93) that has been assigned a role in S-nitrosothiol (SNO)-based hypoxic vasodilation by RBCs. Under this model, the delivery of SNO-based NO bioactivity by Hb redefines the respiratory cycle as a triune system (NO/O&lt;inf&gt;2&lt;/inf&gt;/CO&lt;inf&gt;2&lt;/inf&gt;). However, the physiological ramifications of RBC-mediated vasodilation are unknown, and the apparently essential nature of Î²Cys93 remains unclear. Here we report that mice with a Î²Cys93Ala mutation are deficient in hypoxic vasodilation that governs blood flow autoregulation, the classic physiological mechanism that controls tissue oxygenation but whose molecular basis has been a longstanding mystery. Peripheral blood flow and tissue oxygenation are decreased at baseline in mutant animals and decline excessively during hypoxia. In addition, Î²Cys93Ala mutation results in myocardial ischemia under basal normoxic conditions and in acute cardiac decompensation and enhanced mortality during transient hypoxia. Fetal viability is diminished also. Thus, Î²Cys93-derived SNO bioactivity is essential for tissue oxygenation by RBCs within the respiratory cycle that is required for both normal cardiovascular function and circulatory adaptation to hypoxia.</dc:description><citedby-count>1</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006404</affiliation-url><afid>60006404</afid><affilname>CASE School of Medicine</affilname><name-variant>Case Western Reserve University School of Medicine</name-variant><affiliation-city>Cleveland</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006404</affiliation-url><afid>60006404</afid><affilname>CASE School of Medicine</affilname><name-variant>Case Western Reserve University School of Medicine</name-variant><affiliation-city>Cleveland</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006404</affiliation-url><afid>60006404</afid><affilname>CASE School of Medicine</affilname><name-variant>Case Western Reserve University School of Medicine</name-variant><affiliation-city>Cleveland</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021578</affiliation-url><afid>60021578</afid><affilname>University Hospitals Case Medical Center</affilname><name-variant>University Hospitals Case Medical Center</name-variant><affiliation-city>Cleveland</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">17</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56645196900</author-url><authid>56645196900</authid><authname>Zhang R.</authname><surname>Zhang</surname><given-name>Rongli</given-name><initials>R.</initials><afid>60006404</afid><afid>60006404</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56645196900</author-url><authid>56645196900</authid><authname>Zhang R.</authname><surname>Zhang</surname><given-name>Rongli</given-name><initials>R.</initials><afid>60006404</afid><afid>60006404</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7202440058</author-url><authid>7202440058</authid><authname>Hess D.</authname><surname>Hess</surname><given-name>Douglas T.</given-name><initials>D.T.</initials><afid>60006404</afid><afid>60006404</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7202440058</author-url><authid>7202440058</authid><authname>Hess D.</authname><surname>Hess</surname><given-name>Douglas T.</given-name><initials>D.T.</initials><afid>60006404</afid><afid>60006404</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56645570200</author-url><authid>56645570200</authid><authname>Qian Z.</authname><surname>Qian</surname><given-name>Zhaoxia</given-name><initials>Z.</initials><afid>60006404</afid><afid>60006404</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56645570200</author-url><authid>56645570200</authid><authname>Qian Z.</authname><surname>Qian</surname><given-name>Zhaoxia</given-name><initials>Z.</initials><afid>60006404</afid><afid>60006404</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6602167642</author-url><authid>6602167642</authid><authname>Hausladen A.</authname><surname>Hausladen</surname><given-name>Alfred</given-name><initials>A.</initials><afid>60006404</afid><afid>60006404</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6602167642</author-url><authid>6602167642</authid><authname>Hausladen A.</authname><surname>Hausladen</surname><given-name>Alfred</given-name><initials>A.</initials><afid>60006404</afid><afid>60006404</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56509075300</author-url><authid>56509075300</authid><authname>Fonseca F.</authname><surname>Fonseca</surname><given-name>Fabio</given-name><initials>F.</initials><afid>60006404</afid><afid>60006404</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56509075300</author-url><authid>56509075300</authid><authname>Fonseca F.</authname><surname>Fonseca</surname><given-name>Fabio</given-name><initials>F.</initials><afid>60006404</afid><afid>60006404</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:24576645700</author-url><authid>24576645700</authid><authname>Chaube R.</authname><surname>Chaube</surname><given-name>Ruchi</given-name><initials>R.</initials><afid>60006404</afid><afid>60006404</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:24576645700</author-url><authid>24576645700</authid><authname>Chaube R.</authname><surname>Chaube</surname><given-name>Ruchi</given-name><initials>R.</initials><afid>60006404</afid><afid>60006404</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55465975400</author-url><authid>55465975400</authid><authname>Reynolds J.</authname><surname>Reynolds</surname><given-name>James D.</given-name><initials>J.D.</initials><afid>60006404</afid><afid>60006404</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55465975400</author-url><authid>55465975400</authid><authname>Reynolds J.</authname><surname>Reynolds</surname><given-name>James D.</given-name><initials>J.D.</initials><afid>60006404</afid><afid>60006404</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7201521280</author-url><authid>7201521280</authid><authname>Stamler J.</authname><surname>Stamler</surname><given-name>Jonathan S.</given-name><initials>J.S.</initials><afid>60006404</afid><afid>60006404</afid><afid>60021578</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7201521280</author-url><authid>7201521280</authid><authname>Stamler J.</authname><surname>Stamler</surname><given-name>Jonathan S.</given-name><initials>J.S.</initials><afid>60006404</afid><afid>60006404</afid><afid>60021578</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7201521280</author-url><authid>7201521280</authid><authname>Stamler J.</authname><surname>Stamler</surname><given-name>Jonathan S.</given-name><initials>J.S.</initials><afid>60006404</afid><afid>60006404</afid><afid>60021578</afid></author><authkeywords>Hypoxic vasodilation | Nitric oxide | S-nitrosohemoglobin | S-nitrosylation</authkeywords><intid>35954094</intid><source-id>21121</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930207594"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930207594?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930207594&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930207594&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930207594</prism:url><dc:identifier>SCOPUS_ID:84930207594</dc:identifier><eid>2-s2.0-84930207594</eid><dc:title>Mangiferin supplementation improves serum lipid profiles in overweight patients with hyperlipidemia: A double-blind randomized controlled trial</dc:title><dc:creator>Na L.</dc:creator><prism:publicationName>Scientific Reports</prism:publicationName><prism:eIssn>20452322</prism:eIssn><prism:volume>5</prism:volume><prism:coverDate>2015-05-19</prism:coverDate><prism:coverDisplayDate>19 May 2015</prism:coverDisplayDate><prism:doi>10.1038/srep10344</prism:doi><pii>srep10344</pii><dc:description>Our previous studies have shown that mangiferin decreased serum triglycerides and free fatty acids (FFAs) by increasing FFAs oxidation in both animal and cell experiments. This study sought to evaluate the effects of mangiferin on serum lipid profiles in overweight patients with hyperlipidemia. Overweight patients with hyperlipidemia (serum triglyceride 1.70mmol/L, and total cholesterol 5.2mmol/L) were included in this double-blind randomized controlled trial. Participants were randomly allocated to groups, either receiving mangiferin (150mg/day) or identical placebo for 12 weeks. The lipid profile and serum levels of mangiferin, glucose, L-carnitine, Î²-hydroxybutyrate, and acetoacetate were determined at baseline and 12 weeks. A total of 97 participants completed the trial. Compared with the placebo control, mangiferin supplementation significantly decreased the serum levels of triglycerides and FFAs, and insulin resistance index. Mangiferin supplementation also significantly increased the serum levels of mangiferin, high-density lipoprotein cholesterol, L-carnitine, Î²-hydroxybutyrate, and acetoacetate, and increased lipoprotein lipase activity. However, there were no differences in the serum levels of total cholesterol, low-density lipoprotein cholesterol, serum glucose, and insulin between groups. Mangiferin supplementation could improve serum lipid profiles by reducing serum triglycerides and FFAs in overweight patients with hyperlipidemia, partly due to the promotion of FFAs oxidation.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021615</affiliation-url><afid>60021615</afid><affilname>Harbin Medical University</affilname><name-variant>Harbin Medical University</name-variant><affiliation-city>Harbin</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6701832150</author-url><authid>6701832150</authid><authname>Na L.</authname><surname>Na</surname><given-name>Lixin</given-name><initials>L.</initials><afid>60021615</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56662549400</author-url><authid>56662549400</authid><authname>Zhang Q.</authname><surname>Zhang</surname><given-name>Qiao</given-name><initials>Q.</initials><afid>60021615</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56512829800</author-url><authid>56512829800</authid><authname>Jiang S.</authname><surname>Jiang</surname><given-name>Shuo</given-name><initials>S.</initials><afid>60021615</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56459458600</author-url><authid>56459458600</authid><authname>Du S.</authname><surname>Du</surname><given-name>Shanshan</given-name><initials>S.</initials><afid>60021615</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56182977600</author-url><authid>56182977600</authid><authname>Zhang W.</authname><surname>Zhang</surname><given-name>Wei</given-name><initials>W.</initials><afid>60021615</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56254114000</author-url><authid>56254114000</authid><authname>Li Y.</authname><surname>Li</surname><given-name>Ying</given-name><initials>Y.</initials><afid>60021615</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7404248892</author-url><authid>7404248892</authid><authname>Sun C.</authname><surname>Sun</surname><given-name>Changhao</given-name><initials>C.</initials><afid>60021615</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:35485139600</author-url><authid>35485139600</authid><authname>Niu Y.</authname><surname>Niu</surname><given-name>Yucun</given-name><initials>Y.</initials><afid>60021615</afid></author><intid>36086467</intid><article-number>10344</article-number><source-id>21100200805</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927945861"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927945861?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927945861&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927945861&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0304394015003092"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927945861</prism:url><dc:identifier>SCOPUS_ID:84927945861</dc:identifier><eid>2-s2.0-84927945861</eid><dc:title>The role of autophagy and lipolysis in survival of astrocytes under nutrient deprivation</dc:title><dc:creator>KoreniÄ A.</dc:creator><prism:publicationName>Neuroscience Letters</prism:publicationName><prism:issn>03043940</prism:issn><prism:eIssn>18727972</prism:eIssn><prism:volume>595</prism:volume><prism:pageRange>128-133</prism:pageRange><prism:coverDate>2015-05-19</prism:coverDate><prism:coverDisplayDate>May 19, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.neulet.2015.04.020</prism:doi><pii>S0304394015003092</pii><dc:description>Â© 2015 Elsevier Ireland Ltd. Astrocytes can survive nutrient deprivation (ND) for days. However, the pro-survival strategy of astrocytes under such a metabolic challenge is still not clear. In the present study, we examined the effects of inhibition of two potential steps in energy acquisition during ND: autophagy (using chloroquine) and lipolysis (using orlistat). The inhibition of autophagy did not show significant effects on cell viability until 8-9. h of ND. From that point onwards, the number of dead cells gradually increased, reaching ~60% between 10 and 12. h of ND. In addition, early inhibition of autophagy made astrocytes more vulnerable to the latter ND. The inhibition of lipolysis decreased the viability of cells exposed to ND, but this appeared much later compared to the inhibition of autophagy. The application of orlistat prevented ND-related hyperpolarization of the mitochondrial membrane, and mitochondria became swollen. This study clearly shows that autophagy and lipolysis are essential for the survival of astrocytes under ND conditions, which might be related to their role as neuron-supporting cells.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60068815</affiliation-url><afid>60068815</afid><affilname>University of Belgrade</affilname><name-variant>University of Belgrade</name-variant><affiliation-city>Belgrade</affiliation-city><affiliation-country>Serbia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60068815</affiliation-url><afid>60068815</afid><affilname>University of Belgrade</affilname><name-variant>University of Belgrade</name-variant><affiliation-city>Belgrade</affiliation-city><affiliation-country>Serbia</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:37032572300</author-url><authid>37032572300</authid><authname>KoreniÄ A.</authname><surname>KoreniÄ</surname><given-name>Andrej</given-name><initials>A.</initials><afid>60068815</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6603805616</author-url><authid>6603805616</authid><authname>Andjus P.</authname><surname>Andjus</surname><given-name>Pavle</given-name><initials>P.</initials><afid>60068815</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55890057100</author-url><authid>55890057100</authid><authname>RadenoviÄ L.</authname><surname>RadenoviÄ</surname><given-name>Lidija</given-name><initials>L.</initials><afid>60068815</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:50062382400</author-url><authid>50062382400</authid><authname>SpasojeviÄ I.</authname><surname>SpasojeviÄ</surname><given-name>Ivan</given-name><initials>I.</initials><afid>60068815</afid></author><authkeywords>Astrocytes | Autophagy | Lipolysis | Mitochondrial membrane potential | Nutrient deprivation</authkeywords><intid>1535701583</intid><source-id>18046</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929338966"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929338966?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929338966&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929338966&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1567133X15000344"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929338966</prism:url><dc:identifier>SCOPUS_ID:84929338966</dc:identifier><eid>2-s2.0-84929338966</eid><dc:title>Differential expression pattern of Annexin A6 in chick neural crest and placode cells during cranial gangliogenesis</dc:title><dc:creator>Shah A.</dc:creator><prism:publicationName>Gene Expression Patterns</prism:publicationName><prism:issn>1567133X</prism:issn><prism:eIssn>18727298</prism:eIssn><prism:volume>18</prism:volume><prism:issueIdentifier>1-2</prism:issueIdentifier><prism:pageRange>21-28</prism:pageRange><prism:coverDate>2015-05-19</prism:coverDate><prism:coverDisplayDate>19 May 2015</prism:coverDisplayDate><prism:doi>10.1016/j.gep.2015.05.001</prism:doi><pii>S1567133X15000344</pii><dc:description>Â© 2015 Elsevier B.V. All rights reserved. The cranial trigeminal and epibranchial ganglia are components of the peripheral nervous system that possess an important somatosensory role. These ganglia arise from the intermixing and coalescence of two different migratory cell types, neural crest cells and neurogenic placodes cells, and thus typify the phenomena of cell migration and intercellular interactions for their creation. The underlying molecular mechanisms of ganglia formation, however, are still poorly understood. To address this, we have analyzed the spatio-temporal expression profile of Annexin A6 during chick gangliogenesis, as Annexin proteins play important, conserved roles in ganglia development and physiology. We observe Annexin A6 protein in cranial neural crest cells prior to, during and after their emergence from the neural tube. Fully migratory cranial neural crest cells, however, are devoid of Annexin A6. Interestingly, we note Annexin A6 protein in trigeminal and epibranchial placode cells as these cells ingress from the ectoderm to initiate ganglia formation. This expression is also maintained in the sensory placodes later on when they coalesce with neural crest cells to assemble the cranial ganglia. These results suggest that the dynamic expression of Annexin A6 in various embryonic cell types may allow Annexin A6 to serve distinct functions throughout embryonic development.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020304</affiliation-url><afid>60020304</afid><affilname>University of Maryland</affilname><name-variant>University of Maryland</name-variant><affiliation-city>College Park</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56643678900</author-url><authid>56643678900</authid><authname>Shah A.</authname><surname>Shah</surname><given-name>Ankita</given-name><initials>A.</initials><afid>60020304</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6505942886</author-url><authid>6505942886</authid><authname>Taneyhill L.</authname><surname>Taneyhill</surname><given-name>Lisa A.</given-name><initials>L.A.</initials><afid>60020304</afid></author><authkeywords>Annexin A6 | Cranial ganglia | Neural crest cells | Placode cells</authkeywords><intid>1035939349</intid><source-id>22122</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929340327"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929340327?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929340327&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929340327&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0091305715001343"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929340327</prism:url><dc:identifier>SCOPUS_ID:84929340327</dc:identifier><eid>2-s2.0-84929340327</eid><dc:title>Chloroquine-induced scratching is mediated by NO/cGMP pathway in mice</dc:title><dc:creator>Foroutan A.</dc:creator><prism:publicationName>Pharmacology Biochemistry and Behavior</prism:publicationName><prism:issn>00913057</prism:issn><prism:eIssn>18735177</prism:eIssn><prism:volume>134</prism:volume><prism:pageRange>79-84</prism:pageRange><prism:coverDate>2015-05-19</prism:coverDate><prism:coverDisplayDate>19 May 2015</prism:coverDisplayDate><prism:doi>10.1016/j.pbb.2015.04.016</prism:doi><pii>S0091305715001343</pii><dc:description>Â© 2015 Elsevier Inc. All rights reserved. Chloroquine (CQ), a 4-aminoquinoline drug, has long been used in the treatment and prevention of malaria. However its side effect generalized pruritus contributes to treatment failures, and consequently results in the development of chloroquine resistant strains of Plasmodium falciparum. It was proposed that the administration of CQ correlated with increase in nitric oxide (NO) production. Nitric oxide is involved in some pruritic disorders such as atopic dermatitis, psoriasis and scratching behavior evoked by pruritogens like substance P. Therefore, the aim of this study was to investigate the involvement of NO/cGMP pathway in CQ-induced scratching in mice. Scratching behaviors were recorded by a camera after intradermal (ID) injection of CQ in the shaved rostral back of the mice. The results obtained show that CQ elicited scratching in a dose-dependent manner with a peak effective dose of 400 Î¼g/site. Injection of non-specific NOS inhibitor, N-nitro-l-arginine methyl ester or neuronal NOS selective inhibitor and 7-nitroindazole, reduced CQ-induced scratching significantly. On the other hand, administration of aminoguanidine as inducible NOS inhibitor has no inhibitory effect on this behavior. Also, injection of l-arginine as a precursor of NO significantly increased this response. Conversely, accumulation of cGMP by sildenafil as a selective phosphodiesterase type 5 inhibitor, potentiated the scratching behavior by CQ. This study therefore shows that CQ-induced scratching behavior is mediated by the NO/cGMP pathway.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027708</affiliation-url><afid>60027708</afid><affilname>Tehran University of Medical Sciences</affilname><name-variant>Tehran University of Medical Sciences</name-variant><affiliation-city>Tehran</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027708</affiliation-url><afid>60027708</afid><affilname>Tehran University of Medical Sciences</affilname><name-variant>Tehran University of Medical Sciences</name-variant><affiliation-city>Tehran</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027708</affiliation-url><afid>60027708</afid><affilname>Tehran University of Medical Sciences</affilname><name-variant>Tehran University of Medical Sciences</name-variant><affiliation-city>Tehran</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">12</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56079262000</author-url><authid>56079262000</authid><authname>Foroutan A.</authname><surname>Foroutan</surname><given-name>Arash</given-name><initials>A.</initials><afid>60027708</afid><afid>60027708</afid><afid>60027708</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56079262000</author-url><authid>56079262000</authid><authname>Foroutan A.</authname><surname>Foroutan</surname><given-name>Arash</given-name><initials>A.</initials><afid>60027708</afid><afid>60027708</afid><afid>60027708</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56079262000</author-url><authid>56079262000</authid><authname>Foroutan A.</authname><surname>Foroutan</surname><given-name>Arash</given-name><initials>A.</initials><afid>60027708</afid><afid>60027708</afid><afid>60027708</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56644650100</author-url><authid>56644650100</authid><authname>Haddadi N.</authname><surname>Haddadi</surname><given-name>Nazgol Sadat</given-name><initials>N.S.</initials><afid>60027708</afid><afid>60027708</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56644650100</author-url><authid>56644650100</authid><authname>Haddadi N.</authname><surname>Haddadi</surname><given-name>Nazgol Sadat</given-name><initials>N.S.</initials><afid>60027708</afid><afid>60027708</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55216300000</author-url><authid>55216300000</authid><authname>Ostadhadi S.</authname><surname>Ostadhadi</surname><given-name>Sattar</given-name><initials>S.</initials><afid>60027708</afid><afid>60027708</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55216300000</author-url><authid>55216300000</authid><authname>Ostadhadi S.</authname><surname>Ostadhadi</surname><given-name>Sattar</given-name><initials>S.</initials><afid>60027708</afid><afid>60027708</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56032376500</author-url><authid>56032376500</authid><authname>Sistany N.</authname><surname>Sistany</surname><given-name>Narges</given-name><initials>N.</initials><afid>60027708</afid><afid>60027708</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56032376500</author-url><authid>56032376500</authid><authname>Sistany N.</authname><surname>Sistany</surname><given-name>Narges</given-name><initials>N.</initials><afid>60027708</afid><afid>60027708</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7005678616</author-url><authid>7005678616</authid><authname>Dehpour A.</authname><surname>Dehpour</surname><given-name>Ahmad Reza</given-name><initials>A.R.</initials><afid>60027708</afid><afid>60027708</afid><afid>60027708</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7005678616</author-url><authid>7005678616</authid><authname>Dehpour A.</authname><surname>Dehpour</surname><given-name>Ahmad Reza</given-name><initials>A.R.</initials><afid>60027708</afid><afid>60027708</afid><afid>60027708</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7005678616</author-url><authid>7005678616</authid><authname>Dehpour A.</authname><surname>Dehpour</surname><given-name>Ahmad Reza</given-name><initials>A.R.</initials><afid>60027708</afid><afid>60027708</afid><afid>60027708</afid></author><authkeywords>Chloroquine | Cyclic GMP | Mice | Nitric oxide | Scratching</authkeywords><intid>35944652</intid><source-id>21197</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929643224"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929643224?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929643224&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929643224&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929643224</prism:url><dc:identifier>SCOPUS_ID:84929643224</dc:identifier><eid>2-s2.0-84929643224</eid><dc:title>Dispersants have limited effects on exposure rates of oil spills on fish eggs and larvae in shelf seas</dc:title><dc:creator>VikebÃ¸ F.</dc:creator><prism:publicationName>Environmental Science and Technology</prism:publicationName><prism:issn>0013936X</prism:issn><prism:eIssn>15205851</prism:eIssn><prism:volume>49</prism:volume><prism:issueIdentifier>10</prism:issueIdentifier><prism:pageRange>6061-6069</prism:pageRange><prism:coverDate>2015-05-19</prism:coverDate><prism:coverDisplayDate>19 May 2015</prism:coverDisplayDate><prism:doi>10.1021/acs.est.5b00016</prism:doi><dc:description>Â© 2015 American Chemical Society. Early life stages of fish are particularly vulnerable to oil spills. Simulations of overlap of fish eggs and larvae with oil from different oil-spill scenarios, both without and with the dispersant Corexit 9500, enable quantitative comparisons of dispersants as a mitigation alternative. We have used model simulations of a blow out of 4500 m&lt;sup&gt;3&lt;/sup&gt; of crude oil per day (Statfjord light crude) for 30 days at three locations along the Norwegian coast. Eggs were released from nine different known spawning grounds, in the period from March 1st until the end of April, and all spawning products were followed for 90 days from the spill start at April first independent of time for spawning. We have modeled overlap between spawning products and oil concentrations giving a total polycyclic hydrocarbon (TPAH) concentration of more than 1.0 or 0.1 ppb (Î¼g/l). At these orders of magnitude, we expect acute mortality or sublethal effects, respectively. In general, adding dispersants results in higher concentrations of TPAHs in a reduced volume of water compared to not adding dispersants. Also, the TPAHs are displaced deeper in the water column. Model simulations of the spill scenarios showed that addition of chemical dispersant in general moderately decreased the fraction of eggs and larvae that were exposed above the selected threshold values.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023659</affiliation-url><afid>60023659</afid><affilname>Havforskningsinstituttet</affilname><name-variant>Institute of Marine Research</name-variant><affiliation-city>Bergen</affiliation-city><affiliation-country>Norway</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>SINTEF</affilname><affiliation-city>Trondheim</affiliation-city><affiliation-country>Norway</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:23006461000</author-url><authid>23006461000</authid><authname>VikebÃ¸ F.</authname><surname>VikebÃ¸</surname><given-name>Frode B.</given-name><initials>F.B.</initials><afid>60023659</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55353773500</author-url><authid>55353773500</authid><authname>RÃ¸nningen P.</authname><surname>RÃ¸nningen</surname><given-name>Petter</given-name><initials>P.</initials><afid/></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:14030404300</author-url><authid>14030404300</authid><authname>Meier S.</authname><surname>Meier</surname><given-name>Sonnich</given-name><initials>S.</initials><afid>60023659</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6603425282</author-url><authid>6603425282</authid><authname>GrÃ¸svik B.</authname><surname>GrÃ¸svik</surname><given-name>BjÃ¸rn Einar</given-name><initials>B.E.</initials><afid>60023659</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:24759067400</author-url><authid>24759067400</authid><authname>Lien V.</authname><surname>Lien</surname><given-name>Vidar S.</given-name><initials>V.S.</initials><afid>60023659</afid></author><intid>1535988490</intid><source-id>21537</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929587026"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929587026?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929587026&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929587026&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929587026</prism:url><dc:identifier>SCOPUS_ID:84929587026</dc:identifier><eid>2-s2.0-84929587026</eid><dc:title>Autofluorescence from NADH conformations associated with different metabolic pathways monitored using nanosecond-gated spectroscopy and spectral phasor analysis</dc:title><dc:creator>Maltas J.</dc:creator><prism:publicationName>Analytical Chemistry</prism:publicationName><prism:issn>00032700</prism:issn><prism:eIssn>15206882</prism:eIssn><prism:volume>87</prism:volume><prism:issueIdentifier>10</prism:issueIdentifier><prism:pageRange>5117-5124</prism:pageRange><prism:coverDate>2015-05-19</prism:coverDate><prism:coverDisplayDate>19 May 2015</prism:coverDisplayDate><prism:doi>10.1021/ac504386x</prism:doi><dc:description>Â© 2015 American Chemical Society. Cellular NADH conformation is increasingly recognized as an endogenous optical biomarker and metabolic indicator. Recently, we reported a real-time approach for tracking metabolism on the basis of the quantification of UV-excited autofluorescence spectrum shape. Here, we use nanosecond-gated spectral acquisition, combined with spectrum-shape quantification, to monitor the long excited-state lifetime autofluorescence (usually associated with protein-bound NADH conformations) separately from the autofluorescence signal as a whole. We observe that the autofluorescence response induced by two NADH-oxidation inhibitors-cyanide and ethanol-are similar in Saccharomyces cerevisiae when monitored using time-integrated detection but easily distinguished using time-gated detection. Results are consistent with the observation of multiple NADH conformations as assessed using spectral phasor analysis. Further, because well-known oxidation inhibitors are used, changes in spectrum shape can be associated with NADH conformations involved in the different metabolic pathways, giving bioanalytic utility to the spectral responses.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032706</affiliation-url><afid>60032706</afid><affilname>Miami University</affilname><name-variant>Miami University</name-variant><affiliation-city>Oxford</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56063546800</author-url><authid>56063546800</authid><authname>Maltas J.</authname><surname>Maltas</surname><given-name>Jeff</given-name><initials>J.</initials><afid>60032706</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56650948700</author-url><authid>56650948700</authid><authname>Amer L.</authname><surname>Amer</surname><given-name>Lana</given-name><initials>L.</initials><afid>60032706</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56063343800</author-url><authid>56063343800</authid><authname>Long Z.</authname><surname>Long</surname><given-name>Zac</given-name><initials>Z.</initials><afid>60032706</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56650845600</author-url><authid>56650845600</authid><authname>Palo D.</authname><surname>Palo</surname><given-name>Dylan</given-name><initials>D.</initials><afid>60032706</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56650618600</author-url><authid>56650618600</authid><authname>Oliva A.</authname><surname>Oliva</surname><given-name>Arthur</given-name><initials>A.</initials><afid>60032706</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56650871700</author-url><authid>56650871700</authid><authname>Folz J.</authname><surname>Folz</surname><given-name>Jeff</given-name><initials>J.</initials><afid>60032706</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:6507635275</author-url><authid>6507635275</authid><authname>Urayama P.</authname><surname>Urayama</surname><given-name>Paul</given-name><initials>P.</initials><afid>60032706</afid></author><intid>35980188</intid><source-id>23915</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929590174"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929590174?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929590174&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929590174&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929590174</prism:url><dc:identifier>SCOPUS_ID:84929590174</dc:identifier><eid>2-s2.0-84929590174</eid><dc:title>Transferability and generalizability of regression models of ultrafine particles in urban neighborhoods in the boston area</dc:title><dc:creator>Patton A.</dc:creator><prism:publicationName>Environmental Science and Technology</prism:publicationName><prism:issn>0013936X</prism:issn><prism:eIssn>15205851</prism:eIssn><prism:volume>49</prism:volume><prism:issueIdentifier>10</prism:issueIdentifier><prism:pageRange>6051-6060</prism:pageRange><prism:coverDate>2015-05-19</prism:coverDate><prism:coverDisplayDate>19 May 2015</prism:coverDisplayDate><prism:doi>10.1021/es5061676</prism:doi><dc:description>Â© 2015 American Chemical Society. Land use regression (LUR) models have been used to assess air pollutant exposure, but limited evidence exists on whether location-specific LUR models are applicable to other locations (transferability) or general models are applicable to smaller areas (generalizability). We tested transferability and generalizability of spatial-temporal LUR models of hourly particle number concentration (PNC) for Boston-area (MA, U.S.A.) urban neighborhoods near Interstate 93. Four neighborhood-specific regression models and one Boston-area model were developed from mobile monitoring measurements (34-46 days/neighborhood over one year each). Transferability was tested by applying each neighborhood-specific model to the other neighborhoods; generalizability was tested by applying the Boston-area model to each neighborhood. Both the transferability and generalizability of models were tested with and without neighborhood-specific calibration. Important PNC predictors (adjusted-R&lt;sup&gt;2&lt;/sup&gt; = 0.24-0.43) included wind speed and direction, temperature, highway traffic volume, and distance from the highway edge. Direct model transferability was poor (R&lt;sup&gt;2&lt;/sup&gt; &lt; 0.17). Locally-calibrated transferred models (R&lt;sup&gt;2&lt;/sup&gt; = 0.19-0.40) and the Boston-area model (adjusted-R&lt;sup&gt;2&lt;/sup&gt; = 0.26, range: 0.13-0.30) performed similarly to neighborhood-specific models; however, some coefficients of locally calibrated transferred models were uninterpretable. Our results show that transferability of neighborhood-specific LUR models of hourly PNC was limited, but that a general model performed acceptably in multiple areas when calibrated with local data.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023143</affiliation-url><afid>60023143</afid><affilname>Tufts University</affilname><name-variant>Tufts University</name-variant><affiliation-city>Medford</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>Somerville Transportation Equity Partnership</affilname><affiliation-city>Somerville</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018701</affiliation-url><afid>60018701</afid><affilname>Boston University School of Public Health</affilname><name-variant>Boston University School of Public Health</name-variant><affiliation-city>Boston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023143</affiliation-url><afid>60023143</afid><affilname>Tufts University</affilname><name-variant>Tufts University</name-variant><affiliation-city>Medford</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030623</affiliation-url><afid>60030623</afid><affilname>Rutgers, The State University of New Jersey</affilname><name-variant>Rutgers University</name-variant><affiliation-city>New Brunswick</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55331094600</author-url><authid>55331094600</authid><authname>Patton A.</authname><surname>Patton</surname><given-name>Allison P.</given-name><initials>A.P.</initials><afid>60023143</afid><afid>60030623</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55331094600</author-url><authid>55331094600</authid><authname>Patton A.</authname><surname>Patton</surname><given-name>Allison P.</given-name><initials>A.P.</initials><afid>60023143</afid><afid>60030623</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36188906900</author-url><authid>36188906900</authid><authname>Zamore W.</authname><surname>Zamore</surname><given-name>Wig</given-name><initials>W.</initials><afid/></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7005017327</author-url><authid>7005017327</authid><authname>Naumova E.</authname><surname>Naumova</surname><given-name>Elena N.</given-name><initials>E.N.</initials><afid>60023143</afid><afid>60023143</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7005017327</author-url><authid>7005017327</authid><authname>Naumova E.</authname><surname>Naumova</surname><given-name>Elena N.</given-name><initials>E.N.</initials><afid>60023143</afid><afid>60023143</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56652431800</author-url><authid>56652431800</authid><authname>Levy J.</authname><surname>Levy</surname><given-name>Jonathan I.</given-name><initials>J.I.</initials><afid>60018701</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6701821612</author-url><authid>6701821612</authid><authname>Brugge D.</authname><surname>Brugge</surname><given-name>Doug</given-name><initials>D.</initials><afid>60023143</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7102025776</author-url><authid>7102025776</authid><authname>Durant J.</authname><surname>Durant</surname><given-name>John L.</given-name><initials>J.L.</initials><afid>60023143</afid></author><intid>35981411</intid><source-id>21537</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929440328"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929440328?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929440328&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929440328&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929440328</prism:url><dc:identifier>SCOPUS_ID:84929440328</dc:identifier><eid>2-s2.0-84929440328</eid><dc:title>Frailty syndrome and self-care ability in elderly patients with heart failure</dc:title><dc:creator>Uchmanowicz I.</dc:creator><prism:publicationName>Clinical Interventions in Aging</prism:publicationName><prism:issn>11769092</prism:issn><prism:eIssn>11781998</prism:eIssn><prism:volume>10</prism:volume><prism:pageRange>871-877</prism:pageRange><prism:coverDate>2015-05-18</prism:coverDate><prism:coverDisplayDate>18 May 2015</prism:coverDisplayDate><prism:doi>10.2147/CIA.S83414</prism:doi><dc:description>Â© 2015 Uchmanowicz et al. Background: Chronic heart failure is a serious medical condition. Recently, there has been an increasing interest in frailty syndrome and self-care levels among patients with cardiovascular conditions. Demonstrating the influence of frailty syndrome on self-care could improve the quality of self-care and prevent the adverse effects of frailty syndrome. The purpose of this study was to assess the influence of frailty syndrome on the self-care capabilities of patients with chronic heart failure, and to identify factors associated with frailty. Methods: The data were collected between January and July 2014. The study included 110 patients with chronic heart failure who were hospitalized in the cardiology clinic. Frailty syndrome was assessed using the Tilburg Frailty Indicator, a self-report questionnaire, and self-care behavior was assessed using the European Heart Failure Self-Care Behavior Scale. Results: Fifty-four percent of the study patients were male and 46% were female. The mean age was 66Â±11 years, the mean Tilburg Frailty Indicator score was 7.45Â±3.02 points, and the mean self-care level was 27.6Â±7.13 points. Correlation analyses showed that patients with higher scores in the social components of the frailty scale had better self-care capabilities. Frailty was associated with age, education, duration of heart failure, number of hospitalizations, and New York Heart Association class. The effects of these patient characteristics differed across components of frailty (physical, psychological, social). Conclusion: The social components of frailty syndrome adversely affect the ability to self-care in elderly patients with heart failure. It is relevant to use a multidimensional measurement of frailty.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007108</affiliation-url><afid>60007108</afid><affilname>AKademia Medyczna Wroclawiu</affilname><name-variant>Wroclaw Medical University</name-variant><affiliation-city>Wroclaw</affiliation-city><affiliation-country>Poland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60085434</affiliation-url><afid>60085434</afid><affilname>Hogeschool INHOLLAND</affilname><name-variant>INHOLLAND University</name-variant><affiliation-city>Haarlem</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:107870997</affiliation-url><afid>107870997</afid><affilname>Zonnehuisgroep Amstelland</affilname><name-variant>Zonnehuisgroep Amstelland</name-variant><affiliation-city>Amstelveen</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:28268113500</author-url><authid>28268113500</authid><authname>Uchmanowicz I.</authname><surname>Uchmanowicz</surname><given-name>Izabella</given-name><initials>I.</initials><afid>60007108</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55986054100</author-url><authid>55986054100</authid><authname>Wleklik M.</authname><surname>Wleklik</surname><given-name>Marta</given-name><initials>M.</initials><afid>60007108</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:16642610100</author-url><authid>16642610100</authid><authname>Gobbens R.</authname><surname>Gobbens</surname><given-name>Robbert J J</given-name><initials>R.J.J.</initials><afid>60085434</afid><afid>107870997</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:16642610100</author-url><authid>16642610100</authid><authname>Gobbens R.</authname><surname>Gobbens</surname><given-name>Robbert J J</given-name><initials>R.J.J.</initials><afid>60085434</afid><afid>107870997</afid></author><authkeywords>Frailty syndrome | Heart failure | Self-care</authkeywords><intid>2035951175</intid><source-id>10300153341</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929340656"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929340656?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929340656&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929340656&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929340656</prism:url><dc:identifier>SCOPUS_ID:84929340656</dc:identifier><eid>2-s2.0-84929340656</eid><dc:title>PDGFRÎ± demarcates the cardiogenic clonogenic Sca1&lt;sup&gt;+&lt;/sup&gt; stem/progenitor cell in adult murine myocardium</dc:title><dc:creator>Noseda M.</dc:creator><prism:publicationName>Nature Communications</prism:publicationName><prism:eIssn>20411723</prism:eIssn><prism:volume>6</prism:volume><prism:coverDate>2015-05-18</prism:coverDate><prism:coverDisplayDate>18 May 2015</prism:coverDisplayDate><prism:doi>10.1038/ncomms7930</prism:doi><pii>ncomms7930</pii><dc:description>Â© 2015 Macmillan Publishers Limited. All rights reserved. Cardiac progenitor/stem cells in adult hearts represent an attractive therapeutic target for heart regeneration, though (inter)-relationships among reported cells remain obscure. Using single-cell qRT-PCR and clonal analyses, here we define four subpopulations of cardiac progenitor/stem cells in adult mouse myocardium all sharing stem cell antigen-1 (Sca1), based on side population (SP) phenotype, PECAM-1 (CD31) and platelet-derived growth factor receptor-Î± (PDGFRÎ±) expression. SP status predicts clonogenicity and cardiogenic gene expression (Gata4/6, Hand2 and Tbx5/20), properties segregating more specifically to PDGFRÎ± + cells. Clonal progeny of single Sca1&lt;sup&gt;+&lt;/sup&gt; SP cells show cardiomyocyte, endothelial and smooth muscle lineage potential after cardiac grafting, augmenting cardiac function although durable engraftment is rare. PDGFRÎ± &lt;sup&gt;-&lt;/sup&gt; cells are characterized by Kdr/Flk1, Cdh5, CD31 and lack of clonogenicity. PDGFRÎ±&lt;sup&gt;+&lt;/sup&gt;/CD31&lt;sup&gt;-&lt;/sup&gt; cells derive from cells formerly expressing Mesp1, Nkx2-5, Isl1, Gata5 and Wt1, distinct from PDGFRÎ±&lt;sup&gt;-&lt;/sup&gt;/CD31&lt;sup&gt;+&lt;/sup&gt; cells (Gata5 low; Flk1 and Tie2 high). Thus, PDGFRÎ± demarcates the clonogenic cardiogenic Sca1&lt;sup&gt;+&lt;/sup&gt; stem/progenitor cell.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60100024</affiliation-url><afid>60100024</afid><affilname>British Heart Foundation</affilname><name-variant>British Heart Foundation</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010719</affiliation-url><afid>60010719</afid><affilname>National Heart and Lung Institute</affilname><name-variant>National Heart and Lung Institute</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022148</affiliation-url><afid>60022148</afid><affilname>UCL</affilname><name-variant>University College</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011520</affiliation-url><afid>60011520</afid><affilname>King's College London</affilname><name-variant>King's College London</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001633</affiliation-url><afid>60001633</afid><affilname>Weatherall Institute of Molecular Medicine</affilname><name-variant>University of Oxford</name-variant><affiliation-city>Oxford</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015150</affiliation-url><afid>60015150</afid><affilname>Imperial College London</affilname><name-variant>Imperial College</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023691</affiliation-url><afid>60023691</afid><affilname>University of California, San Francisco</affilname><name-variant>University of California, San Francisco</name-variant><affiliation-city>San Francisco</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002441</affiliation-url><afid>60002441</afid><affilname>Baylor College of Medicine</affilname><name-variant>Baylor College of Medicine</name-variant><affiliation-city>Houston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002441</affiliation-url><afid>60002441</afid><affilname>Baylor College of Medicine</affilname><name-variant>Baylor College of Medicine</name-variant><affiliation-city>Houston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015150</affiliation-url><afid>60015150</afid><affilname>Imperial College London</affilname><name-variant>Imperial College</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">37</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6701426579</author-url><authid>6701426579</authid><authname>Noseda M.</authname><surname>Noseda</surname><given-name>Michela</given-name><initials>M.</initials><afid>60100024</afid><afid>60010719</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6701426579</author-url><authid>6701426579</authid><authname>Noseda M.</authname><surname>Noseda</surname><given-name>Michela</given-name><initials>M.</initials><afid>60100024</afid><afid>60010719</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56643783100</author-url><authid>56643783100</authid><authname>Harada M.</authname><surname>Harada</surname><given-name>Mutsuo</given-name><initials>M.</initials><afid>60100024</afid><afid>60010719</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56643783100</author-url><authid>56643783100</authid><authname>Harada M.</authname><surname>Harada</surname><given-name>Mutsuo</given-name><initials>M.</initials><afid>60100024</afid><afid>60010719</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:36537537200</author-url><authid>36537537200</authid><authname>McSweeney S.</authname><surname>McSweeney</surname><given-name>Sara</given-name><initials>S.</initials><afid>60100024</afid><afid>60010719</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:36537537200</author-url><authid>36537537200</authid><authname>McSweeney S.</authname><surname>McSweeney</surname><given-name>Sara</given-name><initials>S.</initials><afid>60100024</afid><afid>60010719</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56179533200</author-url><authid>56179533200</authid><authname>Leja T.</authname><surname>Leja</surname><given-name>Thomas</given-name><initials>T.</initials><afid>60100024</afid><afid>60010719</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56179533200</author-url><authid>56179533200</authid><authname>Leja T.</authname><surname>Leja</surname><given-name>Thomas</given-name><initials>T.</initials><afid>60100024</afid><afid>60010719</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:36101082700</author-url><authid>36101082700</authid><authname>Belian E.</authname><surname>Belian</surname><given-name>Elisa</given-name><initials>E.</initials><afid>60100024</afid><afid>60010719</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:36101082700</author-url><authid>36101082700</authid><authname>Belian E.</authname><surname>Belian</surname><given-name>Elisa</given-name><initials>E.</initials><afid>60100024</afid><afid>60010719</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:14820025000</author-url><authid>14820025000</authid><authname>Stuckey D.</authname><surname>Stuckey</surname><given-name>Daniel J.</given-name><initials>D.J.</initials><afid>60100024</afid><afid>60010719</afid><afid>60022148</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:14820025000</author-url><authid>14820025000</authid><authname>Stuckey D.</authname><surname>Stuckey</surname><given-name>Daniel J.</given-name><initials>D.J.</initials><afid>60100024</afid><afid>60010719</afid><afid>60022148</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:14820025000</author-url><authid>14820025000</authid><authname>Stuckey D.</authname><surname>Stuckey</surname><given-name>Daniel J.</given-name><initials>D.J.</initials><afid>60100024</afid><afid>60010719</afid><afid>60022148</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56644829400</author-url><authid>56644829400</authid><authname>Abreu Paiva M.</authname><surname>Abreu Paiva</surname><given-name>Marta S.</given-name><initials>M.S.</initials><afid>60100024</afid><afid>60010719</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56644829400</author-url><authid>56644829400</authid><authname>Abreu Paiva M.</authname><surname>Abreu Paiva</surname><given-name>Marta S.</given-name><initials>M.S.</initials><afid>60100024</afid><afid>60010719</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56157963800</author-url><authid>56157963800</authid><authname>Habib J.</authname><surname>Habib</surname><given-name>Josef</given-name><initials>J.</initials><afid>60100024</afid><afid>60010719</afid><afid>60011520</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56157963800</author-url><authid>56157963800</authid><authname>Habib J.</authname><surname>Habib</surname><given-name>Josef</given-name><initials>J.</initials><afid>60100024</afid><afid>60010719</afid><afid>60011520</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56157963800</author-url><authid>56157963800</authid><authname>Habib J.</authname><surname>Habib</surname><given-name>Josef</given-name><initials>J.</initials><afid>60100024</afid><afid>60010719</afid><afid>60011520</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:11738843900</author-url><authid>11738843900</authid><authname>Macaulay I.</authname><surname>Macaulay</surname><given-name>Iain</given-name><initials>I.</initials><afid>60001633</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:16416776100</author-url><authid>16416776100</authid><authname>De Smith A.</authname><surname>De Smith</surname><given-name>Adam J.</given-name><initials>A.J.</initials><afid>60015150</afid><afid>60023691</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:16416776100</author-url><authid>16416776100</authid><authname>De Smith A.</authname><surname>De Smith</surname><given-name>Adam J.</given-name><initials>A.J.</initials><afid>60015150</afid><afid>60023691</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:56644688900</author-url><authid>56644688900</authid><authname>Al-Beidh F.</authname><surname>Al-Beidh</surname><given-name>Farah</given-name><initials>F.</initials><afid>60100024</afid><afid>60010719</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:56644688900</author-url><authid>56644688900</authid><authname>Al-Beidh F.</authname><surname>Al-Beidh</surname><given-name>Farah</given-name><initials>F.</initials><afid>60100024</afid><afid>60010719</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:56644314600</author-url><authid>56644314600</authid><authname>Sampson R.</authname><surname>Sampson</surname><given-name>Robert</given-name><initials>R.</initials><afid>60100024</afid><afid>60010719</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:56644314600</author-url><authid>56644314600</authid><authname>Sampson R.</authname><surname>Sampson</surname><given-name>Robert</given-name><initials>R.</initials><afid>60100024</afid><afid>60010719</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:56644842700</author-url><authid>56644842700</authid><authname>Lumbers R.</authname><surname>Lumbers</surname><given-name>R. Thomas</given-name><initials>R.T.</initials><afid>60100024</afid><afid>60010719</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:56644842700</author-url><authid>56644842700</authid><authname>Lumbers R.</authname><surname>Lumbers</surname><given-name>R. Thomas</given-name><initials>R.T.</initials><afid>60100024</afid><afid>60010719</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:56612656100</author-url><authid>56612656100</authid><authname>Rao P.</authname><surname>Rao</surname><given-name>Pulivarthi</given-name><initials>P.</initials><afid>60002441</afid><afid>60002441</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:56612656100</author-url><authid>56612656100</authid><authname>Rao P.</authname><surname>Rao</surname><given-name>Pulivarthi</given-name><initials>P.</initials><afid>60002441</afid><afid>60002441</afid></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:56562479400</author-url><authid>56562479400</authid><authname>Harding S.</authname><surname>Harding</surname><given-name>Sian E.</given-name><initials>S.E.</initials><afid>60100024</afid><afid>60010719</afid></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:56562479400</author-url><authid>56562479400</authid><authname>Harding S.</authname><surname>Harding</surname><given-name>Sian E.</given-name><initials>S.E.</initials><afid>60100024</afid><afid>60010719</afid></author><author seq="16"><author-url>http://api.elsevier.com/content/author/author_id:7004341371</author-url><authid>7004341371</authid><authname>Blakemore A.</authname><surname>Blakemore</surname><given-name>Alexandra I F</given-name><initials>A.I.F.</initials><afid>60015150</afid></author><author seq="17"><author-url>http://api.elsevier.com/content/author/author_id:8079382800</author-url><authid>8079382800</authid><authname>Jacobsen S.</authname><surname>Jacobsen</surname><given-name>Sten Eirik</given-name><initials>S.E.</initials><afid>60001633</afid></author><author seq="18"><author-url>http://api.elsevier.com/content/author/author_id:7004545407</author-url><authid>7004545407</authid><authname>Barahona M.</authname><surname>Barahona</surname><given-name>Mauricio</given-name><initials>M.</initials><afid>60100024</afid><afid>60015150</afid></author><author seq="18"><author-url>http://api.elsevier.com/content/author/author_id:7004545407</author-url><authid>7004545407</authid><authname>Barahona M.</authname><surname>Barahona</surname><given-name>Mauricio</given-name><initials>M.</initials><afid>60100024</afid><afid>60015150</afid></author><author seq="19"><author-url>http://api.elsevier.com/content/author/author_id:7404064103</author-url><authid>7404064103</authid><authname>Schneider M.</authname><surname>Schneider</surname><given-name>Michael D.</given-name><initials>M.D.</initials><afid>60100024</afid><afid>60010719</afid></author><author seq="19"><author-url>http://api.elsevier.com/content/author/author_id:7404064103</author-url><authid>7404064103</authid><authname>Schneider M.</authname><surname>Schneider</surname><given-name>Michael D.</given-name><initials>M.D.</initials><afid>60100024</afid><afid>60010719</afid></author><intid>1785945245</intid><article-number>6930</article-number><source-id>19700182758</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929402129"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929402129?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929402129&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929402129&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929402129</prism:url><dc:identifier>SCOPUS_ID:84929402129</dc:identifier><eid>2-s2.0-84929402129</eid><dc:title>Clinical analysis of patients with myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis</dc:title><dc:creator>Shuai Z.</dc:creator><prism:publicationName>Genetics and Molecular Research</prism:publicationName><prism:eIssn>16765680</prism:eIssn><prism:volume>14</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>5296-5303</prism:pageRange><prism:coverDate>2015-05-18</prism:coverDate><prism:coverDisplayDate>18 May 2015</prism:coverDisplayDate><prism:doi>10.4238/2015.May.18.22</prism:doi><dc:description>Â© FUNPEC-RP. This prospective study analyzed the clinical characteristics of myeloperoxidase antineutrophil cytoplasmic antibody (MPOANCA)-associated vasculitis and explored the relationship between MPO-ANCA and clinical manifestations of the associated vasculitis in 132 p-ANCA and MPO-ANCA-positive patients (average age, 62.3 Â± 14.8 years) who were initially diagnosed with ANCA-associated vasculitis. The p-ANCA and MPO-ANCA levels in peripheral blood were detected in all patients. Among these, 128 (97%) had microscopic polyangiitis (MPA), 3 (2.3%) had granulomatous polyangiitis, and 1 (0.7%) had eosinophilic granulomatous vasculitis. The average time of diagnosis was 10.2 Â± 18 months; only 14 (10.6%) patients were diagnosed within 1 month. The main organs involved and the corresponding number of patients were: renal, 95 (72%); lung, 89 (67.4%); joints, 35 (26.5%); heart, 26 (19.7%); peripheral nerve, 23 (17.4%); skin rash, 14 (10.6%); and CNS, 13 (9.8%). Older patients were more likely to show lung involvement in the early disease stage, whereas the joints were involved mostly in the younger patients. The p-ANCA levels (mean titers, 1:60) were not correlated with disease activity and extent of organ involvement, and the MPO-ANCA levels were positively correlated with disease activity, but had no correlation with the extent of organ involvement. MPO-ANCA vasculitis is a common occurrence in China; it mainly involves the elderly and presents as clinical manifestations of MPA. However, the multiple organ damage is not specific leading to delay in diagnosis. MPO-ANCA may play a pathogenic role in the associated vasculitis, and the diverse clinical manifestations might be related with the different characteristics of MPO-ANCA.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:101897227</affiliation-url><afid>101897227</afid><affilname>First Affiliated Hospital of Anhui Medical University</affilname><name-variant>First Affiliated Hospital of Anhui Medical University</name-variant><affiliation-city>Hefei</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56646014700</author-url><authid>56646014700</authid><authname>Shuai Z.</authname><surname>Shuai</surname><given-name>Z. W.</given-name><initials>Z.W.</initials><afid>101897227</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56645616900</author-url><authid>56645616900</authid><authname>Lv Y.</authname><surname>Lv</surname><given-name>Y. F.</given-name><initials>Y.F.</initials><afid>101897227</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56645143700</author-url><authid>56645143700</authid><authname>Zhang M.</authname><surname>Zhang</surname><given-name>M. M.</given-name><initials>M.M.</initials><afid>101897227</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56645284900</author-url><authid>56645284900</authid><authname>Hu Z.</authname><surname>Hu</surname><given-name>Z. Y.</given-name><initials>Z.Y.</initials><afid>101897227</afid></author><authkeywords>ANCA-associated vasculitis | Antimyeloperoxidase antibody | Antineutrophil cytoplasmic antibody | Clinical damage | Pathogenic mechanism</authkeywords><intid>2035949339</intid><source-id>22190</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929431496"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929431496?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929431496&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929431496&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929431496</prism:url><dc:identifier>SCOPUS_ID:84929431496</dc:identifier><eid>2-s2.0-84929431496</eid><dc:title>âIt Has to Come from the Hearts of the Peopleâ: Evangelicals, Fundamentalists, Race, and the 1964 Civil Rights Act</dc:title><dc:creator>STEPHENS R.</dc:creator><prism:publicationName>Journal of American Studies</prism:publicationName><prism:issn>00218758</prism:issn><prism:eIssn>14695154</prism:eIssn><prism:coverDate>2015-05-18</prism:coverDate><prism:coverDisplayDate>18 May 2015</prism:coverDisplayDate><prism:doi>10.1017/S0021875815000687</prism:doi><pii>S0021875815000687</pii><dc:description>Copyright Â© Cambridge University Press and British Association for American Studies 2015 In recent years historians and scholars of religious studies have chronicled and debated the critical role that black and white liberal Protestants, Catholics, and Jews played in the civil rights struggles of the 1950s and 1960s. At every stage of the movement, mainline and traditional black churches proved vital. Less is known about the actions and reactions of conservative or moderate white believers. The churches that these fundamentalists and evangelicals belonged to would grow tremendously in the coming decades, eventually claiming roughly 26 percent of the American population. From the 1960s forward, conservative Protestants would also become key political players, helping to decide national elections. Their responses to the landmark 1964 Civil Rights Act, which intended to end discrimination on the basis of race, color, religion, or national origin, and the heated debates that led up to the law reveal much about how conservative Christians related to the state and to a changing society. Responses to the bill ranged from resigned acceptance to racist denunciation. But believers were united in their antistatism and in their opposition to political and theological liberalism. This article examines how evangelicals and fundamentalists engaged in politics and understood race and racism in personal terms. It also analyzes the religious dimensions of modern American conservatism.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004636</affiliation-url><afid>60004636</afid><affilname>University of Northumbria</affilname><name-variant>Northumbria University</name-variant><affiliation-city>Newcastle</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">1</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56645686300</author-url><authid>56645686300</authid><authname>STEPHENS R.</authname><surname>STEPHENS</surname><given-name>RANDALL J.</given-name><initials>R.J.</initials><afid>60004636</afid></author><intid>35954745</intid><source-id>26270</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929448695"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929448695?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929448695&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929448695&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929448695</prism:url><dc:identifier>SCOPUS_ID:84929448695</dc:identifier><eid>2-s2.0-84929448695</eid><dc:title>B-type natriuretic peptide and cirrhosis progression</dc:title><dc:creator>Shi L.</dc:creator><prism:publicationName>Genetics and Molecular Research</prism:publicationName><prism:eIssn>16765680</prism:eIssn><prism:volume>14</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>5188-5196</prism:pageRange><prism:coverDate>2015-05-18</prism:coverDate><prism:coverDisplayDate>18 May 2015</prism:coverDisplayDate><prism:doi>10.4238/2015.May.18.9</prism:doi><dc:description>Â©FUNPEC-RP. Brain natriuretic peptide (BNP) is used as a marker of cardiac dysfunction to predict heart failure mortality. The significance of the prognostic ability of BNP for liver cirrhosis remains unknown, although the levels of BNP seen in cirrhosis are high. We aimed to determine whether the BNP level is related to the stage of cirrhosis and could serve as a prognostic marker of cirrhosis (predict the 1-year all-cause mortality). We recruited 92 patients at different stages of cirrhosis and 81 controls matched by age and gender for this study. At admission, cardiac physical examination and BNP measurements were performed. Upon discharge, the 89 patients were followed up for 12 months. The median BNP levels of patients with cirrhosis were 167.0 pg/mL, which were significantly higher than those of the control group (167.0 vs 34.8 pg/mL, P = 0.001). Serum BNP levels were positively correlated with the Child score, the grade of esophageal varices, a history of spontaneous bacterial peritonitis, and the presence of ascites and collateral circulation. BNP levels above the median were associated with an increased occurrence of death within 12 months of discharge (log rank P = 0.025), as determined by univariate and multivariate Cox regression analyses. Esophageal varices, large/medium volume ascites, and BNP levels were related to the clinical outcome (P = 0.034, 0.030, and 0.025, respectively). Together, these results suggested that serum BNP levels are significantly correlated with the stage of cirrhosis, suggesting that BNP levels might serve as a significant predictor for 1-year all-cause mortality.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008073</affiliation-url><afid>60008073</afid><affilname>Wenzhou Medical College</affilname><name-variant>Wenzhou Medical College</name-variant><affiliation-city>Wenzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008073</affiliation-url><afid>60008073</afid><affilname>Wenzhou Medical College</affilname><name-variant>Wenzhou Medical College</name-variant><affiliation-city>Wenzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008073</affiliation-url><afid>60008073</afid><affilname>Wenzhou Medical College</affilname><name-variant>Wenzhou Medical College</name-variant><affiliation-city>Wenzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:101569825</affiliation-url><afid>101569825</afid><affilname>Shanghai Tenth People's Hospital</affilname><name-variant>Shanghai Tenth People's Hospital</name-variant><affiliation-city>Shanghai</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56645351200</author-url><authid>56645351200</authid><authname>Shi L.</authname><surname>Shi</surname><given-name>L. Y.</given-name><initials>L.Y.</initials><afid>60008073</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56645680000</author-url><authid>56645680000</authid><authname>Jin R.</authname><surname>Jin</surname><given-name>R.</given-name><initials>R.</initials><afid>60008073</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56645105600</author-url><authid>56645105600</authid><authname>Lin C.</authname><surname>Lin</surname><given-name>C. J.</given-name><initials>C.J.</initials><afid>60008073</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56645153000</author-url><authid>56645153000</authid><authname>Wu J.</authname><surname>Wu</surname><given-name>J. S.</given-name><initials>J.S.</initials><afid>60008073</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56645541700</author-url><authid>56645541700</authid><authname>Chen X.</authname><surname>Chen</surname><given-name>X. W.</given-name><initials>X.W.</initials><afid>60008073</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56645276400</author-url><authid>56645276400</authid><authname>Yu Z.</authname><surname>Yu</surname><given-name>Z.</given-name><initials>Z.</initials><afid>101569825</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56645262500</author-url><authid>56645262500</authid><authname>Zhang P.</authname><surname>Zhang</surname><given-name>P. C.</given-name><initials>P.C.</initials><afid>60008073</afid></author><authkeywords>B-type natriuretic peptide | Cirrhosis | Clinical outcome</authkeywords><intid>1535954891</intid><source-id>22190</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929578258"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929578258?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929578258&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929578258&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929578258</prism:url><dc:identifier>SCOPUS_ID:84929578258</dc:identifier><eid>2-s2.0-84929578258</eid><dc:title>Activation of the endoplasmic reticulum stress response in skeletal muscle of G93a*SOD1 amyotrophic lateral sclerosis mice</dc:title><dc:creator>Chen D.</dc:creator><prism:publicationName>Frontiers in Cellular Neuroscience</prism:publicationName><prism:issn>16625102</prism:issn><prism:volume>9</prism:volume><prism:issueIdentifier>MAY</prism:issueIdentifier><prism:coverDate>2015-05-18</prism:coverDate><prism:coverDisplayDate>18 May 2015</prism:coverDisplayDate><prism:doi>10.3389/fncel.2015.00170</prism:doi><dc:description>Â© 2015 Chen, Wang and Chin. Mutations in Cu/Zn superoxide dismutase (SOD1) are one of the genetic causes of Amyotrophic Lateral Sclerosis (ALS). Although the primary symptom of ALS is muscle weakness, the link between SOD1 mutations, cellular dysfunction and muscle atrophy and weakness is not well understood. The purpose of this study was to characterize cellular markers of ER stress in skeletal muscle across the lifespan of G93A*SOD1 (ALS-Tg) mice. Muscles were obtained from ALS-Tg and age-matched wild type (WT) mice at 70d (pre-symptomatic), 90d and 120-140d (symptomatic) and analyzed for ER stress markers. In white gastrocnemius (WG) muscle, ER stress sensors PERK and IRE1Î± were upregulated â¼2-fold at 70d and remained (PERK) or increased further (IRE1Î±) at translation, was increased by 70d and increased further to 12.9-fold at 120-140d. IRE1Î± upregulation leads to increased splicing of X-box binding protein 1 (XBP-1) to the XBP-1s isoform. XBP-1s transcript was increased at 90d and 120-140d indicating activation of IRE1Î± signaling. The ER chaperone/heat shock protein Grp78/BiP was upregulated 2-fold at 70d and 90d and increased to 6.1-fold by 120-140d. The ER-stress-specific apoptotic signaling protein CHOP was upregulated 2-fold at 70d and 90d and increased to 13.3-fold at 120-140d indicating progressive activation of an apoptotic signal in muscle. There was a greater increase in Grp78/BiP and CHOP in WG vs. the more oxidative red gastrocnemius (RG) ALS-Tg at 120-140d indicating greater ER stress and apoptosis in fast glycolytic muscle. These data show that the ER stress response is activated in skeletal muscle of ALS-Tg mice by an early pre-symptomatic age and increases with disease progression. These data suggest a mechanism by which myocellular ER stress leads to reduced protein translation and contributes to muscle atrophy and weakness in ALS.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020304</affiliation-url><afid>60020304</afid><affilname>University of Maryland</affilname><name-variant>University of Maryland</name-variant><affiliation-city>College Park</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020304</affiliation-url><afid>60020304</afid><affilname>University of Maryland</affilname><name-variant>University of Maryland</name-variant><affiliation-city>College Park</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56434702400</author-url><authid>56434702400</authid><authname>Chen D.</authname><surname>Chen</surname><given-name>Dapeng</given-name><initials>D.</initials><afid>60020304</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56650821900</author-url><authid>56650821900</authid><authname>Wang Y.</authname><surname>Wang</surname><given-name>Yan</given-name><initials>Y.</initials><afid>60020304</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7005100577</author-url><authid>7005100577</authid><authname>Chin E.</authname><surname>Chin</surname><given-name>Eva R.</given-name><initials>E.R.</initials><afid>60020304</afid></author><authkeywords>Amyotrophic lateral sclerosis | Endoplasmic reticulum stress | Misfolded proteins | Muscle atrophy | Protein synthesis | Skeletal muscle | Unfolded protein response</authkeywords><intid>1535980945</intid><article-number>170</article-number><source-id>19700175163</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929448006"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929448006?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929448006&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929448006&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929448006</prism:url><dc:identifier>SCOPUS_ID:84929448006</dc:identifier><eid>2-s2.0-84929448006</eid><dc:title>Effect of heat stress on heat-shock protein (Hsp60) mRNA expression in rainbow trout Oncorhynchus mykiss</dc:title><dc:creator>Shi H.</dc:creator><prism:publicationName>Genetics and Molecular Research</prism:publicationName><prism:eIssn>16765680</prism:eIssn><prism:volume>14</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>5280-5286</prism:pageRange><prism:coverDate>2015-05-18</prism:coverDate><prism:coverDisplayDate>18 May 2015</prism:coverDisplayDate><prism:doi>10.4238/2015.May.18.20</prism:doi><dc:description>Â© FUNPEC-RP. The enhanced expression of heat shock proteins (hsps) in organisms can be detected in response to many kinds of stressor. For fish, high temperature is an important stressor, and hsp expression is associated with differences in environmental temperature. In this study, rainbow trout (Oncorhynchus mykiss) that were accustomed to an aquatic temperature of 18Â°C were exposed to an elevated temperature (25Â°C), and hsp60 expression in the gill, liver, spleen, heart, and head kidney was quantified using real-time polymerase chain reaction in unstressed and heat-stressed animals. The fish responded to heat stress in a time- and tissue-specific manner. Cardiac hsp60 mRNA levels were largely unchanged, and the greatest induction of hsp60 in heat-stressed animals was recorded in the liver, suggesting that protein damage and the consequent requirement for the Hsp60 protein are probably greater in hepatic tissue. Therefore, fish must be provided with optimal temperature conditions in order to realize their potential growth and maximize fish farm profits.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024295</affiliation-url><afid>60024295</afid><affilname>Gansu Agricultural University</affilname><name-variant>Gansu Agricultural University</name-variant><affiliation-city>Lanzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56231285400</author-url><authid>56231285400</authid><authname>Shi H.</authname><surname>Shi</surname><given-name>H. N.</given-name><initials>H.N.</initials><afid>60024295</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55625967100</author-url><authid>55625967100</authid><authname>Liu Z.</authname><surname>Liu</surname><given-name>Z.</given-name><initials>Z.</initials><afid>60024295</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56231356000</author-url><authid>56231356000</authid><authname>Zhang J.</authname><surname>Zhang</surname><given-name>J. P.</given-name><initials>J.P.</initials><afid>60024295</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56231224800</author-url><authid>56231224800</authid><authname>Kang Y.</authname><surname>Kang</surname><given-name>Y. J.</given-name><initials>Y.J.</initials><afid>60024295</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56646674000</author-url><authid>56646674000</authid><authname>Wang J.</authname><surname>Wang</surname><given-name>J. F.</given-name><initials>J.F.</initials><afid>60024295</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56645145700</author-url><authid>56645145700</authid><authname>Huang J.</authname><surname>Huang</surname><given-name>J. Q.</given-name><initials>J.Q.</initials><afid>60024295</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56645435900</author-url><authid>56645435900</authid><authname>Wang W.</authname><surname>Wang</surname><given-name>W. M.</given-name><initials>W.M.</initials><afid>60024295</afid></author><authkeywords>Heat stress | Hsp60 | mRNA expression | Oncorhynchus mykiss</authkeywords><intid>1535955266</intid><source-id>22190</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929590638"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929590638?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929590638&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929590638&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929590638</prism:url><dc:identifier>SCOPUS_ID:84929590638</dc:identifier><eid>2-s2.0-84929590638</eid><dc:title>Tuning Ligand Effects and Probing the Inner-Workings of Bond Activation Steps: Generation of Ruthenium Complexes with Tailor-Made Properties</dc:title><dc:creator>Weisser F.</dc:creator><prism:publicationName>Inorganic Chemistry</prism:publicationName><prism:issn>00201669</prism:issn><prism:eIssn>1520510X</prism:eIssn><prism:volume>54</prism:volume><prism:issueIdentifier>10</prism:issueIdentifier><prism:pageRange>4621-4635</prism:pageRange><prism:coverDate>2015-05-18</prism:coverDate><prism:coverDisplayDate>18 May 2015</prism:coverDisplayDate><prism:doi>10.1021/ic502807d</prism:doi><dc:description>Â© 2015 American Chemical Society. Activating chemical bonds through external triggers and understanding the underlying mechanism are at the heart of developing molecules with catalytic and switchable functions. Thermal, photochemical, and electrochemical bond activation pathways are useful for many chemical reactions. In this Article, a series of Ru&lt;sup&gt;II&lt;/sup&gt; complexes containing a bidentate and a tripodal ligand were synthesized. Starting from all-pyridine complex 1&lt;sup&gt;2+&lt;/sup&gt;, the pyridines were stepwise substituted with "click" triazoles (2&lt;sup&gt;2+&lt;/sup&gt;-7&lt;sup&gt;2+&lt;/sup&gt;). Whereas the thermo- and photoreactivity of 1&lt;sup&gt;2+&lt;/sup&gt; are due to steric repulsion within the equatorial plane of the complex, 3&lt;sup&gt;2+&lt;/sup&gt;-6&lt;sup&gt;2+&lt;/sup&gt; are reactive because of triazoles in axial positions, and 4&lt;sup&gt;2+&lt;/sup&gt; shows unprecedented photoreactivity. Complexes that feature neither steric interactions nor axial triazoles (2&lt;sup&gt;2+&lt;/sup&gt; and 7&lt;sup&gt;2+&lt;/sup&gt;) do not show any reactivity. Furthermore, a redox-triggered conversion mechanism was discovered in 1&lt;sup&gt;2+&lt;/sup&gt;, 3&lt;sup&gt;2+&lt;/sup&gt;, and 4&lt;sup&gt;2+&lt;/sup&gt;. We show here ligand design principles required to convert a completely inert molecule to a reactive one and vice versa, and provide mechanistic insights into their functioning. The results presented here will likely have consequences for developing a future generation of catalysts, sensors, and molecular switches. (Chemical Equation Presented).</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030718</affiliation-url><afid>60030718</afid><affilname>Freie Universitat Berlin</affilname><name-variant>Freie UniversitÃ¤t Berlin</name-variant><affiliation-city>Berlin</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015815</affiliation-url><afid>60015815</afid><affilname>Universitat Stuttgart</affilname><name-variant>University of Stuttgart</name-variant><affiliation-city>Stuttgart</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35073258600</author-url><authid>35073258600</authid><authname>Weisser F.</authname><surname>Weisser</surname><given-name>Fritz</given-name><initials>F.</initials><afid>60030718</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55990468900</author-url><authid>55990468900</authid><authname>Plebst S.</authname><surname>Plebst</surname><given-name>Sebastian</given-name><initials>S.</initials><afid>60015815</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:42061562400</author-url><authid>42061562400</authid><authname>Hohloch S.</authname><surname>Hohloch</surname><given-name>Stephan</given-name><initials>S.</initials><afid>60030718</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56303579000</author-url><authid>56303579000</authid><authname>Van Der Meer M.</authname><surname>Van Der Meer</surname><given-name>Margarethe</given-name><initials>M.</initials><afid>60030718</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56650938400</author-url><authid>56650938400</authid><authname>Manck S.</authname><surname>Manck</surname><given-name>Sinja</given-name><initials>S.</initials><afid>60030718</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56201352400</author-url><authid>56201352400</authid><authname>FÃ¼hrer F.</authname><surname>FÃ¼hrer</surname><given-name>Felix</given-name><initials>F.</initials><afid>60030718</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56449034900</author-url><authid>56449034900</authid><authname>Radtke V.</authname><surname>Radtke</surname><given-name>Vanessa</given-name><initials>V.</initials><afid>60030718</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:55711835000</author-url><authid>55711835000</authid><authname>Leichnitz D.</authname><surname>Leichnitz</surname><given-name>Daniel</given-name><initials>D.</initials><afid>60030718</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7202875667</author-url><authid>7202875667</authid><authname>Sarkar B.</authname><surname>Sarkar</surname><given-name>Biprajit</given-name><initials>B.</initials><afid>60030718</afid></author><intid>1785982746</intid><source-id>25264</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929590606"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929590606?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929590606&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929590606&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929590606</prism:url><dc:identifier>SCOPUS_ID:84929590606</dc:identifier><eid>2-s2.0-84929590606</eid><dc:title>Is dispositional optimism or dispositional pessimism predictive of ideal cardiovascular health? The Young Finns Study</dc:title><dc:creator>Serlachius A.</dc:creator><prism:publicationName>Psychology and Health</prism:publicationName><prism:issn>08870446</prism:issn><prism:eIssn>14768321</prism:eIssn><prism:coverDate>2015-05-18</prism:coverDate><prism:coverDisplayDate>18 May 2015</prism:coverDisplayDate><prism:doi>10.1080/08870446.2015.1041394</prism:doi><dc:description>Â© 2015 Taylor &amp; Francis Objective: We examined the independent association between dispositional optimism compared to dispositional pessimism and ideal cardiovascular health (defined by the American Heart Association). Design: A prospective design with a study sample of 1113 participants aged 24â39Â years from the longitudinal Young Finns Study. Main outcome measures: Ideal cardiovascular health (comprised of seven ideal cardiovascular health metrics) was measured in 2001. The ideal cardiovascular health metrics were reassessed in 2007. Results: Low pessimism rather than high optimism was a better predictor of ideal cardiovascular health in 2007. When examining the association between optimism and pessimism and the seven ideal cardiovascular health metrics in 2007 (BMI, diet, physical activity, smoking status, blood pressure, total cholesterol and plasma glucose), low pessimism predicted non-smoking status, ideal physical activity and eating a healthy diet, while high optimism was associated with eating a healthy diet. Conclusion: Our findings suggest that low pessimism rather than high optimism is associated with ideal cardiovascular health, especially with health behaviours such as not smoking, being physically active and eating a healthy diet. Socio-economic status was the potential mediating or confounding factor. Future studies should examine the differential meaning of the optimism/pessimism concepts to further clarify their relation to health outcomes.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002952</affiliation-url><afid>60002952</afid><affilname>Helsingin Yliopisto</affilname><name-variant>University of Helsinki</name-variant><affiliation-city>Helsinki</affiliation-city><affiliation-country>Finland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002952</affiliation-url><afid>60002952</afid><affilname>Helsingin Yliopisto</affilname><name-variant>University of Helsinki</name-variant><affiliation-city>Helsinki</affiliation-city><affiliation-country>Finland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113191513</affiliation-url><afid>113191513</afid><affilname>Institute for Health and Welfare</affilname><name-variant>1National Institute for Health and Welfare</name-variant><affiliation-city>Helsinki</affiliation-city><affiliation-country>Finland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002952</affiliation-url><afid>60002952</afid><affilname>Helsingin Yliopisto</affilname><name-variant>University of Helsinki</name-variant><affiliation-city>Helsinki</affiliation-city><affiliation-country>Finland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006876</affiliation-url><afid>60006876</afid><affilname>Turun yliopisto</affilname><name-variant>University of Turku</name-variant><affiliation-city>Abo (Turku)</affiliation-city><affiliation-country>Finland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025765</affiliation-url><afid>60025765</afid><affilname>Turun Yliopistollinen Keskussairaala</affilname><name-variant>Turku University Central Hospital</name-variant><affiliation-city>Abo</affiliation-city><affiliation-country>Finland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112755091</affiliation-url><afid>112755091</afid><affilname>Fimlab Laboratories</affilname><name-variant>Fimlab</name-variant><affiliation-city>Tampere</affiliation-city><affiliation-country>Finland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011170</affiliation-url><afid>60011170</afid><affilname>Tampereen Yliopisto</affilname><name-variant>University of Tampere</name-variant><affiliation-city>Tampere</affiliation-city><affiliation-country>Finland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025765</affiliation-url><afid>60025765</afid><affilname>Turun Yliopistollinen Keskussairaala</affilname><name-variant>Turku University Central Hospital</name-variant><affiliation-city>Abo</affiliation-city><affiliation-country>Finland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">18</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:22942034100</author-url><authid>22942034100</authid><authname>Serlachius A.</authname><surname>Serlachius</surname><given-name>Anna</given-name><initials>A.</initials><afid>60002952</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:8402684300</author-url><authid>8402684300</authid><authname>Pulkki-RÃ¥back L.</authname><surname>Pulkki-RÃ¥back</surname><given-name>Laura</given-name><initials>L.</initials><afid>60002952</afid><afid>60002952</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:8402684300</author-url><authid>8402684300</authid><authname>Pulkki-RÃ¥back L.</authname><surname>Pulkki-RÃ¥back</surname><given-name>Laura</given-name><initials>L.</initials><afid>60002952</afid><afid>60002952</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7003614400</author-url><authid>7003614400</authid><authname>Elovainio M.</authname><surname>Elovainio</surname><given-name>Marko</given-name><initials>M.</initials><afid>60002952</afid><afid>113191513</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7003614400</author-url><authid>7003614400</authid><authname>Elovainio M.</authname><surname>Elovainio</surname><given-name>Marko</given-name><initials>M.</initials><afid>60002952</afid><afid>113191513</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:8892161900</author-url><authid>8892161900</authid><authname>Hintsanen M.</authname><surname>Hintsanen</surname><given-name>Mirka</given-name><initials>M.</initials><afid>60002952</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6507785492</author-url><authid>6507785492</authid><authname>MikkilÃ¤ V.</authname><surname>MikkilÃ¤</surname><given-name>Vera</given-name><initials>V.</initials><afid>60002952</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55534141249</author-url><authid>55534141249</authid><authname>Laitinen T.</authname><surname>Laitinen</surname><given-name>Tomi T.</given-name><initials>T.T.</initials><afid>60006876</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:16030844400</author-url><authid>16030844400</authid><authname>Jokela M.</authname><surname>Jokela</surname><given-name>Markus</given-name><initials>M.</initials><afid>60002952</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:35811217200</author-url><authid>35811217200</authid><authname>RosenstrÃ¶m T.</authname><surname>RosenstrÃ¶m</surname><given-name>Tom</given-name><initials>T.</initials><afid>60002952</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:54397118300</author-url><authid>54397118300</authid><authname>Josefsson K.</authname><surname>Josefsson</surname><given-name>Kim</given-name><initials>K.</initials><afid>60002952</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:6505819732</author-url><authid>6505819732</authid><authname>Juonala M.</authname><surname>Juonala</surname><given-name>Markus</given-name><initials>M.</initials><afid>60006876</afid><afid>60025765</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:6505819732</author-url><authid>6505819732</authid><authname>Juonala M.</authname><surname>Juonala</surname><given-name>Markus</given-name><initials>M.</initials><afid>60006876</afid><afid>60025765</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7006539182</author-url><authid>7006539182</authid><authname>LehtimÃ¤ki T.</authname><surname>LehtimÃ¤ki</surname><given-name>Terho</given-name><initials>T.</initials><afid>112755091</afid><afid>60011170</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7006539182</author-url><authid>7006539182</authid><authname>LehtimÃ¤ki T.</authname><surname>LehtimÃ¤ki</surname><given-name>Terho</given-name><initials>T.</initials><afid>112755091</afid><afid>60011170</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:7004828916</author-url><authid>7004828916</authid><authname>Raitakari O.</authname><surname>Raitakari</surname><given-name>Olli</given-name><initials>O.</initials><afid>60006876</afid><afid>60025765</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:7004828916</author-url><authid>7004828916</authid><authname>Raitakari O.</authname><surname>Raitakari</surname><given-name>Olli</given-name><initials>O.</initials><afid>60006876</afid><afid>60025765</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:56212905500</author-url><authid>56212905500</authid><authname>Keltikangas-JÃ¤rvinen L.</authname><surname>Keltikangas-JÃ¤rvinen</surname><given-name>Liisa</given-name><initials>L.</initials><afid>60002952</afid></author><authkeywords>epidemiology | ideal cardiovascular health | optimism | pessimism | prospective study</authkeywords><intid>35980625</intid><source-id>14012</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929603558"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929603558?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929603558&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929603558&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929603558</prism:url><dc:identifier>SCOPUS_ID:84929603558</dc:identifier><eid>2-s2.0-84929603558</eid><dc:title>Impact of JAK2(V617F) mutation status on treatment response to anagrelide in essential thrombocythemia: An observational, hypothesis-generating study</dc:title><dc:creator>Cascavilla N.</dc:creator><prism:publicationName>Drug Design, Development and Therapy</prism:publicationName><prism:issn>11778881</prism:issn><prism:eIssn>11778881</prism:eIssn><prism:volume>9</prism:volume><prism:pageRange>2687-2694</prism:pageRange><prism:coverDate>2015-05-18</prism:coverDate><prism:coverDisplayDate>18 May 2015</prism:coverDisplayDate><prism:doi>10.2147/DDDT.S79576</prism:doi><dc:description>Â© 2015 Cascavilla et al. A JAK2(V617F) mutation is found in approximately 55% of patients with essential thrombocythemia (ET), and represents a key World Health Organization diagnostic criterion. This hypothesis-generating study (NCT01352585) explored the impact of JAK2(V617F) mutation status on treatment response to anagrelide in patients with ET who were intolerant/refractory to their current cytoreductive therapy. The primary objective was to compare the proportion of JAK2-positive versus JAK2-negative patients who achieved at least a partial platelet response (â¤600Ã10&lt;sup&gt;9&lt;/sup&gt;/L) after anagrelide therapy. Of the 47 patients enrolled, 46 were included in the full analysis set (JAK2-positive, n=22; JAK2-negative, n=24). At 12 months, 35 patients (n=14 and n=21, respectively) had a suitable platelet sample; of these, 74.3% (n=26) achieved at least a partial response. The response rate was higher in JAK2-positive (85.7%, n=12) versus JAK2-negative patients (66.7%, n=14) (odds ratio [OR] 3.00; 95% confidence interval [CI] 0.44, 33.97). By using the last observation carried forward approach in the sensitivity analysis, which considered the imbalance in patients with suitable samples between groups, the overall response rate was 71.7% (n=33/46), with 77.3% (n=17/22) of JAK2-positive and 66.7% (n=16/24) of JAK2-negative patients achieving at least a partial response (OR 1.70; 95% CI 0.39, 8.02). There was no significant change in median allele burden over 12 months in the 12 patients who achieved a response. In conclusion, the overall platelet response rate was high in both JAK2-positive and JAK2-negative patients; however, a larger study would be required to confirm the differences observed according to JAK2(V617F) mutation status.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60070410</affiliation-url><afid>60070410</afid><affilname>IRCCS Casa Sollievo della Sofferenza</affilname><name-variant>IRCCS Casa Sollievo della Sofferenza</name-variant><affiliation-city>San Giovanni Rotondo</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031984</affiliation-url><afid>60031984</afid><affilname>Universita Cattolica del Sacro Cuore, Rome</affilname><name-variant>Catholic University</name-variant><affiliation-city>Rome</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017293</affiliation-url><afid>60017293</afid><affilname>Universita degli Studi di Napoli Federico II</affilname><name-variant>University of Naples Federico II</name-variant><affiliation-city>Naples</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021859</affiliation-url><afid>60021859</afid><affilname>Universita degli Studi di Firenze</affilname><name-variant>UniversitÃ  di Firenze</name-variant><affiliation-city>Florence</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007067</affiliation-url><afid>60007067</afid><affilname>Ospedale Maggiore Policlinico Milano</affilname><name-variant>Ospedale Maggiore</name-variant><affiliation-city>Milan</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115259659</affiliation-url><afid>115259659</afid><affilname>IRCCSAOU San Martino</affilname><name-variant>IRCCSAOU San Martino</name-variant><affiliation-city>Genoa</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028218</affiliation-url><afid>60028218</afid><affilname>Alma Mater Studiorum Universita di Bologna</affilname><name-variant>University of Bologna</name-variant><affiliation-city>Bologna</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022778</affiliation-url><afid>60022778</afid><affilname>Universita degli Studi di Bari</affilname><name-variant>UniversitÃ  di Bari</name-variant><affiliation-city>Bari</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60083546</affiliation-url><afid>60083546</afid><affilname>Azienda Ospedaliera S. Maria di Terni</affilname><name-variant>Azienda Ospedaliera S. Maria</name-variant><affiliation-city>Terni</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011918</affiliation-url><afid>60011918</afid><affilname>Spedali Civili Di Brescia</affilname><name-variant>Spedali Civili</name-variant><affiliation-city>Brescia</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027548</affiliation-url><afid>60027548</afid><affilname>Universita degli Studi del Piemonte Orientale Amedeo Avogadro, Novara</affilname><name-variant>University of Eastern Piedmont</name-variant><affiliation-city>Novara</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115259453</affiliation-url><afid>115259453</afid><affilname>Shire GmbH</affilname><name-variant>Shire GmbH</name-variant><affiliation-city/><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112578467</affiliation-url><afid>112578467</afid><affilname>Shire Pharmaceutical Development Ltd</affilname><name-variant>Shire Pharmaceutical Development Ltd</name-variant><affiliation-city>Basingstoke</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">16</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7004041932</author-url><authid>7004041932</authid><authname>Cascavilla N.</authname><surname>Cascavilla</surname><given-name>Nicola</given-name><initials>N.</initials><afid>60070410</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7006192748</author-url><authid>7006192748</authid><authname>De Stefano V.</authname><surname>De Stefano</surname><given-name>Valerio</given-name><initials>V.</initials><afid>60031984</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55949288100</author-url><authid>55949288100</authid><authname>Pane F.</authname><surname>Pane</surname><given-name>Fabrizio</given-name><initials>F.</initials><afid>60017293</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:8074319800</author-url><authid>8074319800</authid><authname>Pancrazzi A.</authname><surname>Pancrazzi</surname><given-name>Alessandro</given-name><initials>A.</initials><afid>60021859</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6603640166</author-url><authid>6603640166</authid><authname>Iurlo A.</authname><surname>Iurlo</surname><given-name>Alessandra</given-name><initials>A.</initials><afid>60007067</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55647163669</author-url><authid>55647163669</authid><authname>Gobbi M.</authname><surname>Gobbi</surname><given-name>Marco</given-name><initials>M.</initials><afid>115259659</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:23009859900</author-url><authid>23009859900</authid><authname>Palandri F.</authname><surname>Palandri</surname><given-name>Francesca</given-name><initials>F.</initials><afid>60028218</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:55141985600</author-url><authid>55141985600</authid><authname>Specchia G.</authname><surname>Specchia</surname><given-name>Giorgina</given-name><initials>G.</initials><afid>60022778</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:55336206300</author-url><authid>55336206300</authid><authname>Marina Liberati A.</authname><surname>Marina Liberati</surname><given-name>A.</given-name><initials>A.</initials><afid>60083546</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56650982100</author-url><authid>56650982100</authid><authname>DâAdda M.</authname><surname>DâAdda</surname><given-name>Mariella</given-name><initials>M.</initials><afid>60011918</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:36559253700</author-url><authid>36559253700</authid><authname>Gaidano G.</authname><surname>Gaidano</surname><given-name>Gianluca</given-name><initials>G.</initials><afid>60027548</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:55638368000</author-url><authid>55638368000</authid><authname>Fjerza R.</authname><surname>Fjerza</surname><given-name>Rajmonda</given-name><initials>R.</initials><afid>60021859</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:56334890100</author-url><authid>56334890100</authid><authname>Achenbach H.</authname><surname>Achenbach</surname><given-name>Heinrich</given-name><initials>H.</initials><afid>115259453</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:7410169977</author-url><authid>7410169977</authid><authname>Smith J.</authname><surname>Smith</surname><given-name>Jonathan</given-name><initials>J.</initials><afid>112578467</afid></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:56650699300</author-url><authid>56650699300</authid><authname>Wilde P.</authname><surname>Wilde</surname><given-name>Paul</given-name><initials>P.</initials><afid>112578467</afid></author><author seq="16"><author-url>http://api.elsevier.com/content/author/author_id:7005217248</author-url><authid>7005217248</authid><authname>Vannucchi A.</authname><surname>Vannucchi</surname><given-name>Alessandro M.</given-name><initials>A.M.</initials><afid>60021859</afid></author><authkeywords>Allele burden | Anagrelide | Essential thrombocythemia | JAK2 | Mutation | Treatment response</authkeywords><intid>1785982773</intid><source-id>19700175230</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930198938"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930198938?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930198938&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930198938&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930198938</prism:url><dc:identifier>SCOPUS_ID:84930198938</dc:identifier><eid>2-s2.0-84930198938</eid><dc:title>Generation and Detection of Spin Currents in Semiconductor Nanostructures with Strong Spin-Orbit Interaction</dc:title><dc:creator>Nichele F.</dc:creator><prism:publicationName>Physical Review Letters</prism:publicationName><prism:issn>00319007</prism:issn><prism:eIssn>10797114</prism:eIssn><prism:volume>114</prism:volume><prism:issueIdentifier>20</prism:issueIdentifier><prism:coverDate>2015-05-18</prism:coverDate><prism:coverDisplayDate>18 May 2015</prism:coverDisplayDate><prism:doi>10.1103/PhysRevLett.114.206601</prism:doi><dc:description>Â© 2015 American Physical Society. Storing, transmitting, and manipulating information using the electron spin resides at the heart of spintronics. Fundamental for future spintronics applications is the ability to control spin currents in solid state systems. Among the different platforms proposed so far, semiconductors with strong spin-orbit interaction are especially attractive as they promise fast and scalable spin control with all-electrical protocols. Here we demonstrate both the generation and measurement of pure spin currents in semiconductor nanostructures. Generation is purely electrical and mediated by the spin dynamics in materials with a strong spin-orbit field. Measurement is accomplished using a spin-to-charge conversion technique, based on the magnetic field symmetry of easily measurable electrical quantities. Calibrating the spin-to-charge conversion via the conductance of a quantum point contact, we quantitatively measure the mesoscopic spin Hall effect in a multiterminal GaAs dot. We report spin currents of 174 pA, corresponding to a spin Hall angle of 34%.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025858</affiliation-url><afid>60025858</afid><affilname>Eidgenossische Technische Hochschule Zurich</affilname><name-variant>ETH Zurich</name-variant><affiliation-city>Zurich</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016648</affiliation-url><afid>60016648</afid><affilname>Riken</affilname><name-variant>RIKEN</name-variant><affiliation-city>Wako</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024373</affiliation-url><afid>60024373</afid><affilname>Institute of Physics Slovak Academy of Sciences</affilname><name-variant>Slovak Academy of Sciences</name-variant><affiliation-city>Bratislava</affiliation-city><affiliation-country>Slovakia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:108858119</affiliation-url><afid>108858119</afid><affilname>HES-SO</affilname><name-variant>HES-SO</name-variant><affiliation-city>Sion</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36721954100</author-url><authid>36721954100</authid><authname>Nichele F.</authname><surname>Nichele</surname><given-name>Fabrizio</given-name><initials>F.</initials><afid>60025858</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55632586200</author-url><authid>55632586200</authid><authname>Hennel S.</authname><surname>Hennel</surname><given-name>Szymon</given-name><initials>S.</initials><afid>60025858</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55856919800</author-url><authid>55856919800</authid><authname>Pietsch P.</authname><surname>Pietsch</surname><given-name>Patrick</given-name><initials>P.</initials><afid>60025858</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7102380569</author-url><authid>7102380569</authid><authname>Wegscheider W.</authname><surname>Wegscheider</surname><given-name>Werner</given-name><initials>W.</initials><afid>60025858</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:24469159600</author-url><authid>24469159600</authid><authname>Stano P.</authname><surname>Stano</surname><given-name>Peter</given-name><initials>P.</initials><afid>60016648</afid><afid>60024373</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:24469159600</author-url><authid>24469159600</authid><authname>Stano P.</authname><surname>Stano</surname><given-name>Peter</given-name><initials>P.</initials><afid>60016648</afid><afid>60024373</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7004181938</author-url><authid>7004181938</authid><authname>Jacquod P.</authname><surname>Jacquod</surname><given-name>Philippe</given-name><initials>P.</initials><afid>108858119</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:26643615300</author-url><authid>26643615300</authid><authname>Ihn T.</authname><surname>Ihn</surname><given-name>Thomas</given-name><initials>T.</initials><afid>60025858</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:13105221900</author-url><authid>13105221900</authid><authname>Ensslin K.</authname><surname>Ensslin</surname><given-name>Klaus</given-name><initials>K.</initials><afid>60025858</afid></author><intid>1786088206</intid><article-number>206601</article-number><source-id>29150</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929377202"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929377202?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929377202&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929377202&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929377202</prism:url><dc:identifier>SCOPUS_ID:84929377202</dc:identifier><eid>2-s2.0-84929377202</eid><dc:title>Rethinking Indian monsoon rainfall prediction in the context of recent global warming</dc:title><dc:creator>Wang B.</dc:creator><prism:publicationName>Nature Communications</prism:publicationName><prism:eIssn>20411723</prism:eIssn><prism:volume>6</prism:volume><prism:coverDate>2015-05-18</prism:coverDate><prism:coverDisplayDate>18 May 2015</prism:coverDisplayDate><prism:doi>10.1038/ncomms8154</prism:doi><pii>ncomms8154</pii><dc:description>Â© 2015 Macmillan Publishers Limited. All rights reserved. Prediction of Indian summer monsoon rainfall (ISMR) is at the heart of tropical climate prediction. Despite enormous progress having been made in predicting ISMR since 1886, the operational forecasts during recent decades (1989-2012) have little skill. Here we show, with both dynamical and physical-empirical models, that this recent failure is largely due to the models' inability to capture new predictability sources emerging during recent global warming, that is, the development of the central-Pacific El Nino-Southern Oscillation (CP-ENSO), the rapid deepening of the Asian Low and the strengthening of North and South Pacific Highs during boreal spring. A physical-empirical model that captures these new predictors can produce an independent forecast skill of 0.51 for 1989-2012 and a 92-year retrospective forecast skill of 0.64 for 1921-2012. The recent low skills of the dynamical models are attributed to deficiencies in capturing the developing CP-ENSO and anomalous Asian Low. The results reveal a considerable gap between ISMR prediction skill and predictability.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003579</affiliation-url><afid>60003579</afid><affilname>University of Hawaii at Manoa School of Ocean and Earth Science and Technology</affilname><name-variant>University of Hawaii at Manoa</name-variant><affiliation-city>Honolulu</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60064143</affiliation-url><afid>60064143</afid><affilname>Nanjing University of Information Science and Technology</affilname><name-variant>Nanjing University of Information Science and Technology</name-variant><affiliation-city>Nanjing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:101535797</affiliation-url><afid>101535797</afid><affilname>NOAA Geophysical Fluid Dynamics Laboratory</affilname><name-variant>NOAA/Geophysical Fluid Dynamics Laboratory</name-variant><affiliation-city>Princeton</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015590</affiliation-url><afid>60015590</afid><affilname>University Corporation for Atmospheric Research</affilname><name-variant>University Corporation for Atmospheric Research</name-variant><affiliation-city>Boulder</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019647</affiliation-url><afid>60019647</afid><affilname>Georgia Institute of Technology</affilname><name-variant>Georgia Institute of Technology</name-variant><affiliation-city>Atlanta</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114556957</affiliation-url><afid>114556957</afid><affilname>Earth System Science Organization</affilname><name-variant>Earth System Science Organization</name-variant><affiliation-city>Pune</affiliation-city><affiliation-country>India</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020258</affiliation-url><afid>60020258</afid><affilname>Nanjing Normal University</affilname><name-variant>Nanjing Normal University</name-variant><affiliation-city>Nanjing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114774522</affiliation-url><afid>114774522</afid><affilname>Jiangsu Center for Collaborative Innovation in Geographical Information Resource Development and Application</affilname><name-variant>Jiangsu Center for Collaborative Innovation in Geographical Information Resource Development and Application</name-variant><affiliation-city>Nanjing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008783</affiliation-url><afid>60008783</afid><affilname>Pusan National University</affilname><name-variant>Pusan National University</name-variant><affiliation-city>Busan</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36013550200</author-url><authid>36013550200</authid><authname>Wang B.</authname><surname>Wang</surname><given-name>Bin</given-name><initials>B.</initials><afid>60003579</afid><afid>60064143</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36013550200</author-url><authid>36013550200</authid><authname>Wang B.</authname><surname>Wang</surname><given-name>Bin</given-name><initials>B.</initials><afid>60003579</afid><afid>60064143</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:12244212300</author-url><authid>12244212300</authid><authname>Xiang B.</authname><surname>Xiang</surname><given-name>Baoqiang</given-name><initials>B.</initials><afid>101535797</afid><afid>60015590</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:12244212300</author-url><authid>12244212300</authid><authname>Xiang B.</authname><surname>Xiang</surname><given-name>Baoqiang</given-name><initials>B.</initials><afid>101535797</afid><afid>60015590</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56410752500</author-url><authid>56410752500</authid><authname>Li J.</authname><surname>Li</surname><given-name>Juan</given-name><initials>J.</initials><afid>60003579</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56644123300</author-url><authid>56644123300</authid><authname>Webster P.</authname><surname>Webster</surname><given-name>Peter J.</given-name><initials>P.J.</initials><afid>60019647</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7004202450</author-url><authid>7004202450</authid><authname>Rajeevan M.</authname><surname>Rajeevan</surname><given-name>Madhavan N.</given-name><initials>M.N.</initials><afid>114556957</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56112897200</author-url><authid>56112897200</authid><authname>Liu J.</authname><surname>Liu</surname><given-name>Jian</given-name><initials>J.</initials><afid>60020258</afid><afid>114774522</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56112897200</author-url><authid>56112897200</authid><authname>Liu J.</authname><surname>Liu</surname><given-name>Jian</given-name><initials>J.</initials><afid>60020258</afid><afid>114774522</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:8839231800</author-url><authid>8839231800</authid><authname>Ha K.</authname><surname>Ha</surname><given-name>Kyung Ja</given-name><initials>K.J.</initials><afid>60008783</afid></author><intid>535947383</intid><article-number>7154</article-number><source-id>19700182758</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929396266"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929396266?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929396266&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929396266&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929396266</prism:url><dc:identifier>SCOPUS_ID:84929396266</dc:identifier><eid>2-s2.0-84929396266</eid><dc:title>Early impact of treatment with tiotropium, long-acting anticholinergic preparation, in patients with COPD â real-life experience from an observational study</dc:title><dc:creator>Jahnz-RÃ³Å¼yk K.</dc:creator><prism:publicationName>International Journal of COPD</prism:publicationName><prism:issn>11769106</prism:issn><prism:eIssn>11782005</prism:eIssn><prism:volume>10</prism:volume><prism:pageRange>613-623</prism:pageRange><prism:coverDate>2015-05-18</prism:coverDate><prism:coverDisplayDate>18 May 2015</prism:coverDisplayDate><prism:doi>10.2147/COPD.S77144</prism:doi><dc:description>Â© 2015 Jahnz-RÃ³Å¼yk and Szepiel. Background: Long-acting inhaled bronchodilators, including anticholinergic tiotropium, are recommended for the maintenance therapy of chronic obstructive pulmonary disease (COPD). It has been shown in a number of studies that treatment with tiotropium alleviates symptoms, improves exercise tolerance, health status, and reduces exacerbations in patients with moderate to very severe stage COPD. Aim: The aim of this noninterventional study was to observe the early effects of the maintenance treatment with tiotropium in patients with COPD of different severities, who had been previously treated on a regular basis, or as required, with at least one short-acting bronchodilator, in a real-life setting in Poland. The effect of the treatment was assessed through the collection of COPD Assessment Test (CAT) data. Patients and methods: The MATHS clinical study was an observational, noninterventional, open-label, prospective, uncontrolled, single-arm, postmarketing, surveillance, real-life study conducted with the involvement of 236 pulmonology clinics based in Poland. The tiotropium observational period was 3 months. The health and COPD status was measured with the CAT questionnaire. The primary efficacy endpoint was the mean change from the baseline in the total CAT score at the end of the 3-month observational period. Results: Patients treated with 18 Î¼g of tiotropium once daily for 3 months showed a statistically significant result, with a clinically meaningful mean reduction (improvement) of 7.0 points in the total CAT score. The improvement was slightly greater in patients with more severe COPD; the mean change in the total CAT score was 7.6 in the subgroup of patients with more severe COPD and 6.7 points in the subgroup of patients with moderate COPD. Conclusion: Results of this real-life study provide further support for the use of tiotropium as a first-line maintenance treatment for patients with COPD of different severities in Poland.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60087273</affiliation-url><afid>60087273</afid><affilname>Wojskowy Instytut Medycyny Lotniczej, Warsaw</affilname><name-variant>Military Medical Institute</name-variant><affiliation-city>Warsaw</affiliation-city><affiliation-country>Poland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114513391</affiliation-url><afid>114513391</afid><affilname>Boehringer Ingelheim Sp. z o.o</affilname><name-variant>Boehringer Ingelheim Marketing Sp. Z O.o</name-variant><affiliation-city>Warsaw</affiliation-city><affiliation-country>Poland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56264490700</author-url><authid>56264490700</authid><authname>Jahnz-RÃ³Å¼yk K.</authname><surname>Jahnz-RÃ³Å¼yk</surname><given-name>Karina</given-name><initials>K.</initials><afid>60087273</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56558531000</author-url><authid>56558531000</authid><authname>Szepiel P.</authname><surname>Szepiel</surname><given-name>PaweÅ</given-name><initials>P.</initials><afid>114513391</afid></author><authkeywords>CAT | Chronic obstructive pulmonary disease | GOLD classification | Spiriva&lt;sup&gt;Â®&lt;/sup&gt; HandiHaler&lt;sup&gt;Â®&lt;/sup&gt;</authkeywords><intid>1785956638</intid><source-id>6200180178</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930227161"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930227161?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930227161&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930227161&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930227161</prism:url><dc:identifier>SCOPUS_ID:84930227161</dc:identifier><eid>2-s2.0-84930227161</eid><dc:title>Suppression and Revival of Weak Localization through Control of Time-Reversal Symmetry</dc:title><dc:creator>MÃ¼ller K.</dc:creator><prism:publicationName>Physical Review Letters</prism:publicationName><prism:issn>00319007</prism:issn><prism:eIssn>10797114</prism:eIssn><prism:volume>114</prism:volume><prism:issueIdentifier>20</prism:issueIdentifier><prism:coverDate>2015-05-18</prism:coverDate><prism:coverDisplayDate>18 May 2015</prism:coverDisplayDate><prism:doi>10.1103/PhysRevLett.114.205301</prism:doi><dc:description>Â© 2015 American Physical Society. We report on the observation of suppression and revival of coherent backscattering of ultracold atoms launched in an optical disorder in a quasi-2D geometry and submitted to a short dephasing pulse, as proposed by Micklitz, MÃ¼ller, and Altland [Phys. Rev. B 91, 064203 (2015)]. This observation demonstrates a novel and general method to study weak localization by manipulating time reversal symmetry in disordered systems. In future experiments, this scheme could be extended to investigate higher order localization processes at the heart of Anderson (strong) localization.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024652</affiliation-url><afid>60024652</afid><affilname>Universite Paris-Sud XI</affilname><name-variant>UniversitÃ© Paris-Sud</name-variant><affiliation-city>Orsay</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018779</affiliation-url><afid>60018779</afid><affilname>Universite Bordeaux 1</affilname><name-variant>UniversitÃ© de Bordeaux I</name-variant><affiliation-city>Talence</affiliation-city><affiliation-country>France</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7403205666</author-url><authid>7403205666</authid><authname>MÃ¼ller K.</authname><surname>MÃ¼ller</surname><given-name>K.</given-name><initials>K.</initials><afid>60024652</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7402649076</author-url><authid>7402649076</authid><authname>Richard J.</authname><surname>Richard</surname><given-name>J.</given-name><initials>J.</initials><afid>60024652</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:36343087500</author-url><authid>36343087500</authid><authname>Volchkov V.</authname><surname>Volchkov</surname><given-name>V. V.</given-name><initials>V.V.</initials><afid>60024652</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56663280500</author-url><authid>56663280500</authid><authname>Denechaud V.</authname><surname>Denechaud</surname><given-name>V.</given-name><initials>V.</initials><afid>60024652</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:16018868300</author-url><authid>16018868300</authid><authname>Bouyer P.</authname><surname>Bouyer</surname><given-name>P.</given-name><initials>P.</initials><afid>60018779</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56250709000</author-url><authid>56250709000</authid><authname>Aspect A.</authname><surname>Aspect</surname><given-name>A.</given-name><initials>A.</initials><afid>60024652</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:6602621675</author-url><authid>6602621675</authid><authname>Josse V.</authname><surname>Josse</surname><given-name>V.</given-name><initials>V.</initials><afid>60024652</afid></author><intid>1536087016</intid><article-number>205301</article-number><source-id>29150</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929427732"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929427732?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929427732&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929427732&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929427732</prism:url><dc:identifier>SCOPUS_ID:84929427732</dc:identifier><eid>2-s2.0-84929427732</eid><dc:title>An artificial molecular pump</dc:title><dc:creator>Cheng C.</dc:creator><prism:publicationName>Nature Nanotechnology</prism:publicationName><prism:issn>17483387</prism:issn><prism:eIssn>17483395</prism:eIssn><prism:coverDate>2015-05-18</prism:coverDate><prism:coverDisplayDate>18 May 2015</prism:coverDisplayDate><prism:doi>10.1038/nnano.2015.96</prism:doi><pii>nnano.2015.96</pii><dc:description>Â© 2015 Nature Publishing Group Carrier proteins consume fuel in order to pump ions or molecules across cell membranes, creating concentration gradients. Their control over diffusion pathways, effected entirely through noncovalent bonding interactions, has inspired chemists to devise artificial systems that mimic their function. Here, we report a wholly artificial compound that acts on small molecules to create a gradient in their local concentration. It does so by using redox energy and precisely organized noncovalent bonding interactions to pump positively charged rings from solution and ensnare them around an oligomethylene chain, as part of a kinetically trapped entanglement. A redox-active viologen unit at the heart of a dumbbell-shaped molecular pump plays a dual role, first attracting and then repelling the rings during redox cycling, thereby enacting a flashing energy ratchet mechanism with a minimalistic design. Our artificial molecular pump performs work repetitively for two cycles of operation and drives rings away from equilibrium toward a higher local concentration.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007363</affiliation-url><afid>60007363</afid><affilname>Northwestern University</affilname><name-variant>Northwestern University</name-variant><affiliation-city>Evanston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55622693500</author-url><authid>55622693500</authid><authname>Cheng C.</authname><surname>Cheng</surname><given-name>Chuyang</given-name><initials>C.</initials><afid>60007363</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35213627900</author-url><authid>35213627900</authid><authname>McGonigal P.</authname><surname>McGonigal</surname><given-name>Paul R.</given-name><initials>P.R.</initials><afid>60007363</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:26645204900</author-url><authid>26645204900</authid><authname>Schneebeli S.</authname><surname>Schneebeli</surname><given-name>Severin T.</given-name><initials>S.T.</initials><afid>60007363</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56398664500</author-url><authid>56398664500</authid><authname>Li H.</authname><surname>Li</surname><given-name>Hao</given-name><initials>H.</initials><afid>60007363</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:15752114300</author-url><authid>15752114300</authid><authname>Vermeulen N.</authname><surname>Vermeulen</surname><given-name>Nicolaas A.</given-name><initials>N.A.</initials><afid>60007363</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56612875200</author-url><authid>56612875200</authid><authname>Ke C.</authname><surname>Ke</surname><given-name>Chenfeng</given-name><initials>C.</initials><afid>60007363</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56550234700</author-url><authid>56550234700</authid><authname>Stoddart J.</authname><surname>Stoddart</surname><given-name>J. Fraser</given-name><initials>J.F.</initials><afid>60007363</afid></author><intid>1535954722</intid><source-id>5200152704</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929688910"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929688910?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929688910&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929688910&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929688910</prism:url><dc:identifier>SCOPUS_ID:84929688910</dc:identifier><eid>2-s2.0-84929688910</eid><dc:title>Clinical comorbidity predictive measures in ex vivo T-cell-depleted allogeneic hematopoietic stem cell transplantation</dc:title><dc:creator>Le R.</dc:creator><prism:publicationName>Bone Marrow Transplantation</prism:publicationName><prism:issn>02683369</prism:issn><prism:eIssn>14765365</prism:eIssn><prism:coverDate>2015-05-18</prism:coverDate><prism:coverDisplayDate>18 May 2015</prism:coverDisplayDate><prism:doi>10.1038/bmt.2015.112</prism:doi><pii>bmt2015112</pii><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005281</affiliation-url><afid>60005281</afid><affilname>National Heart, Lung, and Blood Institute</affilname><name-variant>NIH</name-variant><affiliation-city>Bethesda</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56425881400</author-url><authid>56425881400</authid><authname>Le R.</authname><surname>Le</surname><given-name>R. Q.</given-name><initials>R.Q.</initials><afid>60005281</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56424647100</author-url><authid>56424647100</authid><authname>Tian X.</authname><surname>Tian</surname><given-name>X.</given-name><initials>X.</initials></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55927375300</author-url><authid>55927375300</authid><authname>Jain N.</authname><surname>Jain</surname><given-name>N. A.</given-name><initials>N.A.</initials></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56424773500</author-url><authid>56424773500</authid><authname>Lu K.</authname><surname>Lu</surname><given-name>K.</given-name><initials>K.</initials></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56424520500</author-url><authid>56424520500</authid><authname>Ito S.</authname><surname>Ito</surname><given-name>S.</given-name><initials>S.</initials></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56217845900</author-url><authid>56217845900</authid><authname>Draper D.</authname><surname>Draper</surname><given-name>D. A.</given-name><initials>D.A.</initials></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56600669300</author-url><authid>56600669300</authid><authname>Anandi P.</authname><surname>Anandi</surname><given-name>P.</given-name><initials>P.</initials></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:55884808500</author-url><authid>55884808500</authid><authname>Hourigan C.</authname><surname>Hourigan</surname><given-name>C. S.</given-name><initials>C.S.</initials></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56052794900</author-url><authid>56052794900</authid><authname>Dunavin N.</authname><surname>Dunavin</surname><given-name>N.</given-name><initials>N.</initials></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:54787853800</author-url><authid>54787853800</authid><authname>John Barrett A.</authname><surname>John Barrett</surname><given-name>A.</given-name><initials>A.</initials></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:8526336400</author-url><authid>8526336400</authid><authname>Battiwalla M.</authname><surname>Battiwalla</surname><given-name>M.</given-name><initials>M.</initials></author><intid>1035992444</intid><source-id>26781</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929593873"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929593873?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929593873&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929593873&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929593873</prism:url><dc:identifier>SCOPUS_ID:84929593873</dc:identifier><eid>2-s2.0-84929593873</eid><dc:title>Characterization of flavonoid glycosides from rapeseed bee pollen using a combination of chromatography, spectrometry and nuclear magnetic resonance with a step-wise separation strategy</dc:title><dc:creator>Li Y.</dc:creator><prism:publicationName>Natural Product Research</prism:publicationName><prism:issn>14786419</prism:issn><prism:eIssn>14786427</prism:eIssn><prism:coverDate>2015-05-18</prism:coverDate><prism:coverDisplayDate>18 May 2015</prism:coverDisplayDate><prism:doi>10.1080/14786419.2015.1041942</prism:doi><dc:description>Â© 2015 Taylor &amp; Francis To identify the structures of flavonoid glycosides in bee pollen collected from rapeseed plants (Brassica napus L.), we utilised an approach that combined liquid chromatographyâdiode array detectorâelectrospray ionizationâmass spectrometry (LCâDADâESIâMS) and nuclear magnetic resonance (NMR) technology with a step-wise separation strategy. We identified four constituents of high purity in rape bee pollen samples: (1) quercetin-3-O-Î²-D-glucosyl-(2âl)-Î²-glucoside, (2) kaempferol-3, 4â²-di-O-Î²-D-glucoside, (3) 5, 7, 4â²-trihydroxy-3â²-methoxyflavone-3-O-Î²-D-sophoroside and (4) kaempferol-3-O-Î²-D-glucosyl-(2âl)-Î²-D-glucoside. This study will also provide useful reference standards for qualification and quantification of four flavonoid glycosides in natural products.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017705</affiliation-url><afid>60017705</afid><affilname>Chinese Academy of Agricultural Sciences</affilname><name-variant>Chinese Academy of Agricultural Sciences</name-variant><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60087826</affiliation-url><afid>60087826</afid><affilname>Ministry of Agriculture of the People's Republic of China</affilname><name-variant>Ministry of Agriculture</name-variant><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60087826</affiliation-url><afid>60087826</afid><affilname>Ministry of Agriculture of the People's Republic of China</affilname><name-variant>Ministry of Agriculture</name-variant><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024790</affiliation-url><afid>60024790</afid><affilname>St. Luke's Episcopal Hospital Houston</affilname><name-variant>St. Luke's Episcopal Hospital</name-variant><affiliation-city>Houston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015023</affiliation-url><afid>60015023</afid><affilname>University of Texas M. D. Anderson Cancer Center</affilname><name-variant>University of Texas</name-variant><affiliation-city>Houston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60103284</affiliation-url><afid>60103284</afid><affilname>China Academy of Chinese Medical Sciences</affilname><name-variant>China Academy of Chinese Medical Sciences</name-variant><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003146</affiliation-url><afid>60003146</afid><affilname>Henan University</affilname><name-variant>Henan University</name-variant><affiliation-city>Kaifeng</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60087826</affiliation-url><afid>60087826</afid><affilname>Ministry of Agriculture of the People's Republic of China</affilname><name-variant>Ministry of Agriculture</name-variant><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">12</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:54965865700</author-url><authid>54965865700</authid><authname>Li Y.</authname><surname>Li</surname><given-name>Y.</given-name><initials>Y.</initials><afid>60017705</afid><afid>60087826</afid><afid>60087826</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:54965865700</author-url><authid>54965865700</authid><authname>Li Y.</authname><surname>Li</surname><given-name>Y.</given-name><initials>Y.</initials><afid>60017705</afid><afid>60087826</afid><afid>60087826</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:54965865700</author-url><authid>54965865700</authid><authname>Li Y.</authname><surname>Li</surname><given-name>Y.</given-name><initials>Y.</initials><afid>60017705</afid><afid>60087826</afid><afid>60087826</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56650453200</author-url><authid>56650453200</authid><authname>Qi Y.</authname><surname>Qi</surname><given-name>Yitao</given-name><initials>Y.</initials><afid>60024790</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56016444500</author-url><authid>56016444500</authid><authname>Ritho J.</authname><surname>Ritho</surname><given-name>Joan</given-name><initials>J.</initials><afid>60015023</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56609848700</author-url><authid>56609848700</authid><authname>Zhang Y.</authname><surname>Zhang</surname><given-name>Yongxin</given-name><initials>Y.</initials><afid>60103284</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56609523200</author-url><authid>56609523200</authid><authname>Zheng X.</authname><surname>Zheng</surname><given-name>Xiaowei</given-name><initials>X.</initials><afid>60003146</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56549114400</author-url><authid>56549114400</authid><authname>Zhou J.</authname><surname>Zhou</surname><given-name>Jinhui</given-name><initials>J.</initials><afid>60017705</afid><afid>60087826</afid><afid>60087826</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56549114400</author-url><authid>56549114400</authid><authname>Zhou J.</authname><surname>Zhou</surname><given-name>Jinhui</given-name><initials>J.</initials><afid>60017705</afid><afid>60087826</afid><afid>60087826</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56549114400</author-url><authid>56549114400</authid><authname>Zhou J.</authname><surname>Zhou</surname><given-name>Jinhui</given-name><initials>J.</initials><afid>60017705</afid><afid>60087826</afid><afid>60087826</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55700853900</author-url><authid>55700853900</authid><authname>Sun L.</authname><surname>Sun</surname><given-name>Liping</given-name><initials>L.</initials><afid>60017705</afid><afid>60087826</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55700853900</author-url><authid>55700853900</authid><authname>Sun L.</authname><surname>Sun</surname><given-name>Liping</given-name><initials>L.</initials><afid>60017705</afid><afid>60087826</afid></author><authkeywords>bee pollen | flavonoid glycosides | LCâDADâESIâMS | NMR | semi-preparative HPLC | step-wise separation strategy</authkeywords><intid>1035977637</intid><source-id>24819</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929448758"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929448758?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929448758&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929448758&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929448758</prism:url><dc:identifier>SCOPUS_ID:84929448758</dc:identifier><eid>2-s2.0-84929448758</eid><dc:title>Serum IGFBP7 levels associate with insulin resistance and the risk of metabolic syndrome in a Chinese population</dc:title><dc:creator>Liu Y.</dc:creator><prism:publicationName>Scientific Reports</prism:publicationName><prism:eIssn>20452322</prism:eIssn><prism:volume>5</prism:volume><prism:coverDate>2015-05-18</prism:coverDate><prism:coverDisplayDate>18 May 2015</prism:coverDisplayDate><prism:doi>10.1038/srep10227</prism:doi><dc:description>Â© 2015, Nature Publishing Group. All rights reserved. Metabolic syndrome (MetS), one of the major public health concerns, is regarded as the "common soil" of incidence of common chronic diseases and may increase the risk of type 2 diabetes. The predominant underlying mechanism of MetS is insulin resistance (IR). Additionally, previous studies have indicated that IGFBP7 has high affinity of binding with insulin and might induce IR. The objective of this study was to firstly evaluate the associations of serum IGFBP7 levels with IR and MetS with a relatively large sample and population based design. In a population based MetS case-control study, HOMA-IR was used to evaluate the insulin sensitivity and serum IGFBP7 levels were determined with chemiluminescence-linked immunoassay. As a result, the subjects of MetS and IR had higher serum levels of IGFBP7 than control healthy subjects. High serum IGFBP7 levels increased the risk of MetS and IR. Serum IGFBP7 levels were also found to be significantly correlated with metabolic-associated parameters of Waist-to-hip ratio (WHR), HDL and LDL. These findings suggest that serum IGFBP7 levels are associated with IR and MetS, providing new insight into the mechanism of IR and Mets. IGFBP7 may be a potential interventional target for IR and Mets. uggest that serum IGFBP7 levels are associated with IR and MetS, providing new insight into the mechanism of IR and Mets. IGFBP7 may be a potential interventional target for IR and Mets.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003970</affiliation-url><afid>60003970</afid><affilname>Zhejiang University</affilname><name-variant>Zhejiang University</name-variant><affiliation-city>Hangzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003970</affiliation-url><afid>60003970</afid><affilname>Zhejiang University</affilname><name-variant>Zhejiang University</name-variant><affiliation-city>Hangzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112831820</affiliation-url><afid>112831820</afid><affilname>Xiaoshan Hospital</affilname><name-variant>Xiaoshan Hospital</name-variant><affiliation-city>Hangzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003970</affiliation-url><afid>60003970</afid><affilname>Zhejiang University</affilname><name-variant>Zhejiang University</name-variant><affiliation-city>Hangzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019295</affiliation-url><afid>60019295</afid><affilname>Karolinska University Hospital</affilname><name-variant>Karolinska University Hospital</name-variant><affiliation-city>Stockholm</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56388814500</author-url><authid>56388814500</authid><authname>Liu Y.</authname><surname>Liu</surname><given-name>Yi</given-name><initials>Y.</initials><afid>60003970</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:8694204000</author-url><authid>8694204000</authid><authname>Wu M.</authname><surname>Wu</surname><given-name>Minliang</given-name><initials>M.</initials><afid>60003970</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55445628700</author-url><authid>55445628700</authid><authname>Ling J.</authname><surname>Ling</surname><given-name>Jie</given-name><initials>J.</initials><afid>60003970</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56645510500</author-url><authid>56645510500</authid><authname>Cai L.</authname><surname>Cai</surname><given-name>Libing</given-name><initials>L.</initials><afid>112831820</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56645148800</author-url><authid>56645148800</authid><authname>Zhang D.</authname><surname>Zhang</surname><given-name>Dandan</given-name><initials>D.</initials><afid>60003970</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56423028000</author-url><authid>56423028000</authid><authname>Gu H.</authname><surname>Gu</surname><given-name>Harvest F.</given-name><initials>H.F.</initials><afid>60019295</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55445856800</author-url><authid>55445856800</authid><authname>Wang H.</authname><surname>Wang</surname><given-name>Hao</given-name><initials>H.</initials><afid>60003970</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7406072612</author-url><authid>7406072612</authid><authname>Zhu Y.</authname><surname>Zhu</surname><given-name>Yimin</given-name><initials>Y.</initials><afid>60003970</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7401808601</author-url><authid>7401808601</authid><authname>Lai M.</authname><surname>Lai</surname><given-name>Maode</given-name><initials>M.</initials><afid>60003970</afid></author><intid>1785955613</intid><article-number>10227</article-number><source-id>21100200805</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929590570"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929590570?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929590570&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929590570&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929590570</prism:url><dc:identifier>SCOPUS_ID:84929590570</dc:identifier><eid>2-s2.0-84929590570</eid><dc:title>Chronic hypoxia in pregnancy affected vascular tone of renal interlobar arteries in the offspring</dc:title><dc:creator>Tang J.</dc:creator><prism:publicationName>Scientific Reports</prism:publicationName><prism:eIssn>20452322</prism:eIssn><prism:volume>5</prism:volume><prism:coverDate>2015-05-18</prism:coverDate><prism:coverDisplayDate>18 May 2015</prism:coverDisplayDate><prism:doi>10.1038/srep09723</prism:doi><pii>srep09723</pii><dc:description>Hypoxia during pregnancy could affect development of fetuses as well as cardiovascular systems in the offspring. This study was the first to demonstrate the influence and related mechanisms of prenatal hypoxia (PH) on renal interlobar arteries (RIA) in the 5-month-old male rat offspring. Following chronic hypoxia during pregnancy, phenylephrine induced significantly higher pressor responses and greater vasoconstrictions in the offspring. Nitric oxide mediated vessel relaxation was altered in the RIA. Phenylephrine-stimulated free intracellular calcium was significantly higher in the RIA of the PH group. The activity and expression of L-type calcium channel (Cav1.2), not T-type calcium channel (Cav3.2), was up-regulated. The whole-cell currents of calcium channels and the currents of Cav1.2 were increased compared with the control. In addition, the whole-cell K + currents were decreased in the offspring exposed to prenatal hypoxia. Activity of large-conductance Ca 2+-activated K + channels and the expression of MaxiKÎ± was decreased in the PH group. The results provide new information regarding the influence of prenatal hypoxia on the development of the renal vascular system, and possible underlying cellular and ion channel mechanisms involved.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010432</affiliation-url><afid>60010432</afid><affilname>Soochow University</affilname><name-variant>Suzhou University</name-variant><affiliation-city>Suzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010342</affiliation-url><afid>60010342</afid><affilname>Loma Linda University Adventist Health Sciences Center</affilname><name-variant>Loma Linda University</name-variant><affiliation-city>Loma Linda</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">19</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55654927200</author-url><authid>55654927200</authid><authname>Tang J.</authname><surname>Tang</surname><given-name>Jiaqi</given-name><initials>J.</initials><afid>60010432</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55655746500</author-url><authid>55655746500</authid><authname>Zhu Z.</authname><surname>Zhu</surname><given-name>Zhoufeng</given-name><initials>Z.</initials><afid>60010432</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55760205700</author-url><authid>55760205700</authid><authname>Xia S.</authname><surname>Xia</surname><given-name>Shuixiu</given-name><initials>S.</initials><afid>60010432</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56606530500</author-url><authid>56606530500</authid><authname>Li N.</authname><surname>Li</surname><given-name>Na</given-name><initials>N.</initials><afid>60010432</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55654750400</author-url><authid>55654750400</authid><authname>Chen N.</authname><surname>Chen</surname><given-name>Ningjing</given-name><initials>N.</initials><afid>60010432</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56194307800</author-url><authid>56194307800</authid><authname>Gao Q.</authname><surname>Gao</surname><given-name>Qinqin</given-name><initials>Q.</initials><afid>60010432</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56650578100</author-url><authid>56650578100</authid><authname>Li L.</authname><surname>Li</surname><given-name>Lingjun</given-name><initials>L.</initials><afid>60010432</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56650319300</author-url><authid>56650319300</authid><authname>Zhou X.</authname><surname>Zhou</surname><given-name>Xiuwen</given-name><initials>X.</initials><afid>60010432</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56587030200</author-url><authid>56587030200</authid><authname>Li D.</authname><surname>Li</surname><given-name>Dawei</given-name><initials>D.</initials><afid>60010432</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56194785800</author-url><authid>56194785800</authid><authname>Zhu X.</authname><surname>Zhu</surname><given-name>Xiaolin</given-name><initials>X.</initials><afid>60010432</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:56650677500</author-url><authid>56650677500</authid><authname>Tu Q.</authname><surname>Tu</surname><given-name>Qing</given-name><initials>Q.</initials><afid>60010432</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:56527499400</author-url><authid>56527499400</authid><authname>Li W.</authname><surname>Li</surname><given-name>Weisheng</given-name><initials>W.</initials><afid>60010432</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:55655620700</author-url><authid>55655620700</authid><authname>Wu C.</authname><surname>Wu</surname><given-name>Chonglong</given-name><initials>C.</initials><afid>60010432</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:55656083600</author-url><authid>55656083600</authid><authname>Li J.</authname><surname>Li</surname><given-name>Jiayue</given-name><initials>J.</initials><afid>60010432</afid></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:56650467400</author-url><authid>56650467400</authid><authname>Zhong Y.</authname><surname>Zhong</surname><given-name>Yuan</given-name><initials>Y.</initials><afid>60010432</afid></author><author seq="16"><author-url>http://api.elsevier.com/content/author/author_id:56650341200</author-url><authid>56650341200</authid><authname>Li X.</authname><surname>Li</surname><given-name>Xiang</given-name><initials>X.</initials><afid>60010432</afid></author><author seq="17"><author-url>http://api.elsevier.com/content/author/author_id:9842878900</author-url><authid>9842878900</authid><authname>Mao C.</authname><surname>Mao</surname><given-name>Caiping</given-name><initials>C.</initials><afid>60010432</afid></author><author seq="18"><author-url>http://api.elsevier.com/content/author/author_id:8087017500</author-url><authid>8087017500</authid><authname>Xu Z.</authname><surname>Xu</surname><given-name>Zhice</given-name><initials>Z.</initials><afid>60010432</afid><afid>60010342</afid></author><author seq="18"><author-url>http://api.elsevier.com/content/author/author_id:8087017500</author-url><authid>8087017500</authid><authname>Xu Z.</authname><surname>Xu</surname><given-name>Zhice</given-name><initials>Z.</initials><afid>60010432</afid><afid>60010342</afid></author><intid>35981136</intid><article-number>9723</article-number><source-id>21100200805</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929417404"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929417404?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929417404&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929417404&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929417404</prism:url><dc:identifier>SCOPUS_ID:84929417404</dc:identifier><eid>2-s2.0-84929417404</eid><dc:title>Length of stay of COPD hospital admissions between 2006 and 2010: A retrospective longitudinal study</dc:title><dc:creator>Harries T.</dc:creator><prism:publicationName>International Journal of COPD</prism:publicationName><prism:issn>11769106</prism:issn><prism:eIssn>11782005</prism:eIssn><prism:volume>10</prism:volume><prism:pageRange>603-611</prism:pageRange><prism:coverDate>2015-05-18</prism:coverDate><prism:coverDisplayDate>18 May 2015</prism:coverDisplayDate><prism:doi>10.2147/COPD.S77092</prism:doi><dc:description>Â© 2015 Harries et al. Background: Hospitalizations for COPD are associated with poor patient prognosis. Length of stay (LOS) of COPD admissions in a large urban area and patient and hospital factors associated with it are described. Methods: Retrospective longitudinal study. All COPD patients registered with London general practitioners and admitted as an emergency with COPD (2006â2010), not having been admitted with COPD in the preceding 12 months were included. Association of patient and hospital characteristics with mean LOS of COPD admissions was assessed. Association between hospital and LOS was determined by negative binomial regression. Results: The total number of admissions was 38,504, from 22,462 patients. The mean LOS for first admissions fell by 0.8 days (95% confidence interval [CI]: 0.7â1.5) from 8.2 to 7.0 days between 2006 and 2010. Seventy-nine percent of first admissions were â¤10 days, with a mean LOS of 3.7 days (2009â2010). The mean LOS of successive COPD admissions of the same patients was the same or less throughout the study period. The interval between successive admissions fell from a mean of 357 days between the first and second admission to a mean of 19 days after eight admissions. Age accounted for 2.3% of the variance in LOS. Socioeconomic deprivation did not predict LOS. Fewer discharges happened at the weekend (1,893/day) than on weekdays (5,218/day). The mean LOS varied between hospitals, from 4.9 days (95% CI: 3.8â5.9) to 9.5 days (95% CI: 8.6â10.3) when adjusting for clustering, age, sex, and socioeconomic deprivation. Conclusion: The fall in LOS of the first COPD admission between 2006 and 2010 reflects international trends. The stability of LOS in successive admissions suggests that increasing severity of disease does not affect recovery time from an exacerbation. Variations between hospitals of nearly 5 days in LOS for COPD admissions suggests that significant improvements in patient outcomes and in savings in health care utilization could be made in hospitals with longer LOS.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011520</affiliation-url><afid>60011520</afid><affilname>King's College London</affilname><name-variant>King's College London</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020650</affiliation-url><afid>60020650</afid><affilname>University of Bristol</affilname><name-variant>University of Bristol</name-variant><affiliation-city>Bristol</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:23492710200</author-url><authid>23492710200</authid><authname>Harries T.</authname><surname>Harries</surname><given-name>Timothy H.</given-name><initials>T.H.</initials><afid>60011520</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55004125700</author-url><authid>55004125700</authid><authname>Thornton H.</authname><surname>Thornton</surname><given-name>Hannah V.</given-name><initials>H.V.</initials><afid>60020650</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:34067584300</author-url><authid>34067584300</authid><authname>Crichton S.</authname><surname>Crichton</surname><given-name>Siobhan</given-name><initials>S.</initials><afid>60011520</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:26434899300</author-url><authid>26434899300</authid><authname>Schofield P.</authname><surname>Schofield</surname><given-name>Peter</given-name><initials>P.</initials><afid>60011520</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56646285600</author-url><authid>56646285600</authid><authname>Gilkes A.</authname><surname>Gilkes</surname><given-name>Alexander</given-name><initials>A.</initials><afid>60011520</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:35587016600</author-url><authid>35587016600</authid><authname>White P.</authname><surname>White</surname><given-name>Patrick T.</given-name><initials>P.T.</initials><afid>60011520</afid></author><authkeywords>General practice | Hospitalization | LOS</authkeywords><intid>1035950701</intid><source-id>6200180178</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929168423"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929168423?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929168423&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929168423&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929168423</prism:url><dc:identifier>SCOPUS_ID:84929168423</dc:identifier><eid>2-s2.0-84929168423</eid><dc:title>DFT-aided vibrational circular dichroism spectroscopy study of (-)-S-cotinine</dc:title><dc:creator>RodrÃ­guez Ortega P.</dc:creator><prism:publicationName>ChemPhysChem</prism:publicationName><prism:issn>14394235</prism:issn><prism:eIssn>14397641</prism:eIssn><prism:volume>16</prism:volume><prism:issueIdentifier>7</prism:issueIdentifier><prism:pageRange>1416-1427</prism:pageRange><prism:coverDate>2015-05-18</prism:coverDate><prism:coverDisplayDate>18 May 2015</prism:coverDisplayDate><prism:doi>10.1002/cphc.201500018</prism:doi><dc:description>Â© 2015 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim. The implementation of a strategy comprising the use of vibrational circular dichroism spectroscopy and DFT calculations allows determination of the solution-state conformational distribution in (-)-S-cotinine, giving further proof of the extra conformer-discriminating potential of this experimental technique, which may offer unique molecular fingerprints of subtly dissimilar molecular conformers of chiral samples. Natural bond orbital electronic structure calculations of the rotational barrier height between the two main conformers of the species indicate that hyperconjugative effects are the key force governing the conformational equilibrium. The negligible effect of the solvent's polarity over both structure and conformational energy profile supports this result.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014586</affiliation-url><afid>60014586</afid><affilname>Universidad de Jaen</affilname><name-variant>University of JaÃ©n</name-variant><affiliation-city>Jaen</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56641765000</author-url><authid>56641765000</authid><authname>RodrÃ­guez Ortega P.</authname><surname>RodrÃ­guez Ortega</surname><given-name>Pilar G.</given-name><initials>P.G.</initials><afid>60014586</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:8420004000</author-url><authid>8420004000</authid><authname>Montejo M.</authname><surname>Montejo</surname><given-name>Manuel</given-name><initials>M.</initials><afid>60014586</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7006406414</author-url><authid>7006406414</authid><authname>MÃ¡rquez F.</authname><surname>MÃ¡rquez</surname><given-name>Fernando</given-name><initials>F.</initials><afid>60014586</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56570818600</author-url><authid>56570818600</authid><authname>LÃµpez GonzÃ¡lez J.</authname><surname>LÃµpez GonzÃ¡lez</surname><given-name>Juan J.</given-name><initials>J.J.</initials><afid>60014586</afid></author><authkeywords>(-)-S-cotinine | conformational landscapes | density functional calculations | molecular structures | vibrational circular dichroism</authkeywords><intid>535918002</intid><source-id>26588</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930221585"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930221585?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930221585&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930221585&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930221585</prism:url><dc:identifier>SCOPUS_ID:84930221585</dc:identifier><eid>2-s2.0-84930221585</eid><dc:title>Improving the replica-exchange molecular-dynamics method for efficient sampling in the temperature space</dc:title><dc:creator>Chen C.</dc:creator><prism:publicationName>Physical Review E - Statistical, Nonlinear, and Soft Matter Physics</prism:publicationName><prism:issn>15393755</prism:issn><prism:eIssn>15502376</prism:eIssn><prism:volume>91</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:coverDate>2015-05-18</prism:coverDate><prism:coverDisplayDate>18 May 2015</prism:coverDisplayDate><prism:doi>10.1103/PhysRevE.91.052708</prism:doi><dc:description>Â© 2015 American Physical Society. Replica-exchange molecular dynamics (REMD) is a popular sampling method in the molecular simulation. By frequently exchanging the replicas at different temperatures, the molecule can jump out of the minima and sample efficiently in the conformational space. Although REMD has been shown to be practical in a lot of applications, it does have a critical limitation. All the replicas at all the temperatures must be simulated for a period between the replica-exchange steps. This may be problematic for the reaction with high free energy barriers. In that case, too many replicas are required in the simulation. To reduce the calculation quantity and improve its performance, in this paper we propose a modified REMD method. During the simulation, each replica at each temperature can stay in either the active or inactive state and only switch between the states at the exchange step. In the active state, the replica moves freely in the canonical ensemble by the normal molecular dynamics, and in the inactive state, the replica is frozen temporarily until the next exchange step. The number of the replicas in the active states (active replicas) depends on the number of CPUs in the computer. Using the additional inactive replicas, one can perform an REMD simulation in a wider temperature space. The practical applications show that the modified REMD method is reliable. With the same number of active replicas, this REMD method can produce a more reasonable free energy surface around the free energy minima than the standard REMD method.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025761</affiliation-url><afid>60025761</afid><affilname>Huazhong University of Science and Technology</affilname><name-variant>Huazhong Univ. of Sci. and Technol.</name-variant><affiliation-city>Wuhan</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35995345700</author-url><authid>35995345700</authid><authname>Chen C.</authname><surname>Chen</surname><given-name>Changjun</given-name><initials>C.</initials><afid>60025761</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7403260346</author-url><authid>7403260346</authid><authname>Xiao Y.</authname><surname>Xiao</surname><given-name>Yi</given-name><initials>Y.</initials><afid>60025761</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56393395700</author-url><authid>56393395700</authid><authname>Huang Y.</authname><surname>Huang</surname><given-name>Yanzhao</given-name><initials>Y.</initials><afid>60025761</afid></author><intid>1536088040</intid><article-number>052708</article-number><source-id>29148</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929393273"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929393273?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929393273&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929393273&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929393273</prism:url><dc:identifier>SCOPUS_ID:84929393273</dc:identifier><eid>2-s2.0-84929393273</eid><dc:title>Single-dose local simvastatin injection improves implant fixation via increased angiogenesis and bone formation in an ovariectomized rat model</dc:title><dc:creator>Tan J.</dc:creator><prism:publicationName>Medical Science Monitor</prism:publicationName><prism:issn>12341010</prism:issn><prism:eIssn>16433750</prism:eIssn><prism:volume>21</prism:volume><prism:pageRange>1428-1439</prism:pageRange><prism:coverDate>2015-05-18</prism:coverDate><prism:coverDisplayDate>18 May 2015</prism:coverDisplayDate><prism:doi>10.12659/MSM.892247</prism:doi><dc:description>Â© Med Sci Monit. Background: Statins have been reported to promote bone formation. However, taken orally, their bioavailability is low to the bones. Implant therapies require a local repair response, topical application of osteoinductive agents, or biomaterials that promote implant fixation. Material/Methods: The present study evaluated the effect of a single local injection of simvastatin on screw fixation in an ovariectomized rat model of osteoporosis. Results: Dual-energy X-ray absorptiometry, micro-computed tomography, histology, and biomechanical tests revealed that 5 and 10 mg simvastatin significantly improved bone mineral density by 18.2% and 22.4%, respectively (P&lt;0.05); increased bone volume fraction by 51.0% and 57.9%, trabecular thickness by 16.4% and 18.9%, trabeculae number by 112.0% and 107.1%, and percentage of osseointegration by 115.7% and 126.3%; and decreased trabeculae separation by 34.1% and 36.6%, respectively (all P&lt;0.01). Bone mineral apposition rate was significantly increased (P&lt;0.01). Furthermore, implant fixation was significantly increased (P&lt;0.05), and bone morphogenetic protein 2 (BMP2) expression was markedly increased. Local injection of a single dose of simvastatin also promoted angiogenesis. Vessel number, volume, thickness, surface area, and vascular volume per tissue volume were significantly increased (all P&lt;0.01). Vascular endothelial growth factor (VEGF), VEGF receptor- 2, von Willebrand factor, and platelet endothelial cell adhesion molecule-1 expression were enhanced. Conclusions: A single local injection of simvastatin significantly increased bone formation, promoted osseointegration, and enhanced implant fixation in ovariectomized rats. The underlying mechanism appears to involve enhanced BMP2 expression and angiogenesis in the target bone.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014966</affiliation-url><afid>60014966</afid><affilname>Peking University</affilname><name-variant>Peking University</name-variant><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113629683</affiliation-url><afid>113629683</afid><affilname>Beijing Key Laboratory of Emerging Infectious Diseases</affilname><name-variant>Beijing Key Laboratory of Emerging and Reemerging Infectious Diseases</name-variant><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014966</affiliation-url><afid>60014966</afid><affilname>Peking University</affilname><name-variant>Peking University</name-variant><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">14</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55812697600</author-url><authid>55812697600</authid><authname>Tan J.</authname><surname>Tan</surname><given-name>Jie</given-name><initials>J.</initials><afid>60014966</afid><afid>113629683</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55812697600</author-url><authid>55812697600</authid><authname>Tan J.</authname><surname>Tan</surname><given-name>Jie</given-name><initials>J.</initials><afid>60014966</afid><afid>113629683</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55812285800</author-url><authid>55812285800</authid><authname>Yang N.</authname><surname>Yang</surname><given-name>Ning</given-name><initials>N.</initials><afid>60014966</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56645393700</author-url><authid>56645393700</authid><authname>Fu X.</authname><surname>Fu</surname><given-name>Xin</given-name><initials>X.</initials><afid>60014966</afid><afid>113629683</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56645393700</author-url><authid>56645393700</authid><authname>Fu X.</authname><surname>Fu</surname><given-name>Xin</given-name><initials>X.</initials><afid>60014966</afid><afid>113629683</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55255269200</author-url><authid>55255269200</authid><authname>Cui Y.</authname><surname>Cui</surname><given-name>Yueyi</given-name><initials>Y.</initials><afid>60014966</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56645413800</author-url><authid>56645413800</authid><authname>Guo Q.</authname><surname>Guo</surname><given-name>Qi</given-name><initials>Q.</initials><afid>60014966</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56645545900</author-url><authid>56645545900</authid><authname>Ma T.</authname><surname>Ma</surname><given-name>Teng</given-name><initials>T.</initials><afid>60014966</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7401674292</author-url><authid>7401674292</authid><authname>Yin X.</authname><surname>Yin</surname><given-name>Xiaoxue</given-name><initials>X.</initials><afid>60014966</afid><afid>113629683</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7401674292</author-url><authid>7401674292</authid><authname>Yin X.</authname><surname>Yin</surname><given-name>Xiaoxue</given-name><initials>X.</initials><afid>60014966</afid><afid>113629683</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56646063600</author-url><authid>56646063600</authid><authname>Leng H.</authname><surname>Leng</surname><given-name>Huijie</given-name><initials>H.</initials><afid>60014966</afid><afid>113629683</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56646063600</author-url><authid>56646063600</authid><authname>Leng H.</authname><surname>Leng</surname><given-name>Huijie</given-name><initials>H.</initials><afid>60014966</afid><afid>113629683</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7403252764</author-url><authid>7403252764</authid><authname>Song C.</authname><surname>Song</surname><given-name>Chunli</given-name><initials>C.</initials><afid>60014966</afid><afid>113629683</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7403252764</author-url><authid>7403252764</authid><authname>Song C.</authname><surname>Song</surname><given-name>Chunli</given-name><initials>C.</initials><afid>60014966</afid><afid>113629683</afid></author><authkeywords>Angiogenesis inducing agents | Osseointegration | Osteoporosis | Simvastatin</authkeywords><intid>535956340</intid><source-id>18344</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929573574"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929573574?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929573574&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929573574&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929573574</prism:url><dc:identifier>SCOPUS_ID:84929573574</dc:identifier><eid>2-s2.0-84929573574</eid><dc:title>Mitochondrial Carnitine/Acylcarnitine Transporter, a Novel Target of Mercury Toxicity</dc:title><dc:creator>Tonazzi A.</dc:creator><prism:publicationName>Chemical Research in Toxicology</prism:publicationName><prism:issn>0893228X</prism:issn><prism:eIssn>15205010</prism:eIssn><prism:volume>28</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:pageRange>1015-1022</prism:pageRange><prism:coverDate>2015-05-18</prism:coverDate><prism:coverDisplayDate>18 May 2015</prism:coverDisplayDate><prism:doi>10.1021/acs.chemrestox.5b00050</prism:doi><dc:description>Â© 2015 American Chemical Society. The effect of Hg&lt;sup&gt;2+&lt;/sup&gt; and CH&lt;inf&gt;3&lt;/inf&gt;Hg&lt;sup&gt;+&lt;/sup&gt; on the mitochondrial carnitine/acylcarnitine transporter (CACT) has been studied on the recombinant protein and on the CACT extracted from HeLa cells or Zebrafish and reconstituted in proteoliposomes. Transport was abolished upon treatment of the recombinant CACT in proteoliposomes by Hg&lt;sup&gt;2+&lt;/sup&gt; or CH&lt;inf&gt;3&lt;/inf&gt;Hg&lt;sup&gt;+&lt;/sup&gt;. Inhibition was reversed by the SH reducing agent 1,4-dithioerythritol, GSH, and N-acetylcysteine. IC&lt;inf&gt;50&lt;/inf&gt; for Hg&lt;sup&gt;2+&lt;/sup&gt; and CH&lt;inf&gt;3&lt;/inf&gt;Hg&lt;sup&gt;+&lt;/sup&gt; of 90 nM and 137 nM, respectively, were measured by dose-response analyses. Inhibition was abolished in the C-less CACT mutant. Strong reduction of inhibition by both reagents was observed in the C136A and some reduction in the C155A mutants. Inhibition similar to that of the WT was observed in the C23V/C58V/C89S/C155V/C283S mutant, containing only C136. Optimal inhibition by Hg&lt;sup&gt;2+&lt;/sup&gt;was found in the four replacement mutants C23V/C58V/C89S/C283S containing both C136 and C155 indicating cross-reaction of Hg&lt;sup&gt;2+&lt;/sup&gt; with the two Cys residues. Inhibition kinetic analysis showed mixed inhibition by Hg&lt;sup&gt;2+&lt;/sup&gt; or competitive inhibition by CH&lt;inf&gt;3&lt;/inf&gt;Hg&lt;sup&gt;+&lt;/sup&gt;. HeLa cells or Zebrafish were treated with the more potent inhibitor. Ten micromolar HgCl&lt;inf&gt;2&lt;/inf&gt; caused clear impairment of viability of HeLa cells. The transport assay in proteoliposomes with CACT extracted from treated cells showed that the transporter was inactivated and that DTE rescued the activity. Nearly identical results were observed with Zebrafish upon extraction of the CACT from the liver of the treated animals that, indeed, showed accumulation of the mercurial compound. (Chemical Presented).</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114696592</affiliation-url><afid>114696592</afid><affilname>CNR Institute of Biomembranes and Bioenergetics</affilname><name-variant>CNR Institute of Biomembranes and Bioenergetics</name-variant><affiliation-city/><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022778</affiliation-url><afid>60022778</afid><affilname>Universita degli Studi di Bari</affilname><name-variant>UniversitÃ  di Bari</name-variant><affiliation-city>Bari</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020261</affiliation-url><afid>60020261</afid><affilname>Universita della Calabria</affilname><name-variant>UniversitÃ  della Calabria</name-variant><affiliation-city>Cosenza</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">12</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6602700416</author-url><authid>6602700416</authid><authname>Tonazzi A.</authname><surname>Tonazzi</surname><given-name>Annamaria</given-name><initials>A.</initials><afid>114696592</afid><afid>60022778</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6602700416</author-url><authid>6602700416</authid><authname>Tonazzi A.</authname><surname>Tonazzi</surname><given-name>Annamaria</given-name><initials>A.</initials><afid>114696592</afid><afid>60022778</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7004041314</author-url><authid>7004041314</authid><authname>Giangregorio N.</authname><surname>Giangregorio</surname><given-name>Nicola</given-name><initials>N.</initials><afid>114696592</afid><afid>60022778</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7004041314</author-url><authid>7004041314</authid><authname>Giangregorio N.</authname><surname>Giangregorio</surname><given-name>Nicola</given-name><initials>N.</initials><afid>114696592</afid><afid>60022778</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:37011991100</author-url><authid>37011991100</authid><authname>Console L.</authname><surname>Console</surname><given-name>Lara</given-name><initials>L.</initials><afid>60020261</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:25824484100</author-url><authid>25824484100</authid><authname>Scalise M.</authname><surname>Scalise</surname><given-name>Mariafrancesca</given-name><initials>M.</initials><afid>60020261</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55863557100</author-url><authid>55863557100</authid><authname>La Russa D.</authname><surname>La Russa</surname><given-name>Daniele</given-name><initials>D.</initials><afid>60020261</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56650930200</author-url><authid>56650930200</authid><authname>Notaristefano C.</authname><surname>Notaristefano</surname><given-name>Caterina</given-name><initials>C.</initials><afid>60022778</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:8856770000</author-url><authid>8856770000</authid><authname>Brunelli E.</authname><surname>Brunelli</surname><given-name>Elvira</given-name><initials>E.</initials><afid>60020261</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:6506628572</author-url><authid>6506628572</authid><authname>Barca D.</authname><surname>Barca</surname><given-name>Donatella</given-name><initials>D.</initials><afid>60020261</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7003417826</author-url><authid>7003417826</authid><authname>Indiveri C.</authname><surname>Indiveri</surname><given-name>Cesare</given-name><initials>C.</initials><afid>114696592</afid><afid>60020261</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7003417826</author-url><authid>7003417826</authid><authname>Indiveri C.</authname><surname>Indiveri</surname><given-name>Cesare</given-name><initials>C.</initials><afid>114696592</afid><afid>60020261</afid></author><intid>1785981962</intid><source-id>24649</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929587330"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929587330?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929587330&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929587330&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929587330</prism:url><dc:identifier>SCOPUS_ID:84929587330</dc:identifier><eid>2-s2.0-84929587330</eid><dc:title>The Smc5-Smc6 heterodimer associates with DNA through several independent binding domains</dc:title><dc:creator>Roy M.</dc:creator><prism:publicationName>Scientific Reports</prism:publicationName><prism:eIssn>20452322</prism:eIssn><prism:volume>5</prism:volume><prism:coverDate>2015-05-18</prism:coverDate><prism:coverDisplayDate>18 May 2015</prism:coverDisplayDate><prism:doi>10.1038/srep09797</prism:doi><pii>srep09797</pii><dc:description>The Smc5-6 complex is required for the maintenance of genome integrity through its functions in DNA repair and chromosome biogenesis. However, the specific mode of action of Smc5 and Smc6 in these processes remains largely unknown. We previously showed that individual components of the Smc5-Smc6 complex bind strongly to DNA as monomers, despite the absence of a canonical DNA-binding domain (DBD) in these proteins. How heterodimerization of Smc5-6 affects its binding to DNA, and which parts of the SMC molecules confer DNA-binding activity is not known at present. To address this knowledge gap, we characterized the functional domains of the Smc5-6 heterodimer and identify two DBDs in each SMC molecule. The first DBD is located within the SMC hinge region and its adjacent coiled-coil arms, while the second is found in the conserved ATPase head domain. These DBDs can independently recapitulate the substrate preference of the full-length Smc5 and Smc6 proteins. We also show that heterodimerization of full-length proteins specifically increases the affinity of the resulting complex for double-stranded DNA substrates. Collectively, our findings provide critical insights into the structural requirements for effective binding of the Smc5-6 complex to DNA repair substrates in vitro and in live cells.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009507</affiliation-url><afid>60009507</afid><affilname>Universite de Montreal</affilname><name-variant>University of Montreal</name-variant><affiliation-city>Montreal</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:50162247900</author-url><authid>50162247900</authid><authname>Roy M.</authname><surname>Roy</surname><given-name>Marc AndrÃ©</given-name><initials>M.A.</initials><afid>60009507</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55312224600</author-url><authid>55312224600</authid><authname>Dhanaraman T.</authname><surname>Dhanaraman</surname><given-name>Thillaivillalan</given-name><initials>T.</initials><afid>60009507</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6603585623</author-url><authid>6603585623</authid><authname>D'Amours D.</authname><surname>D'Amours</surname><given-name>Damien</given-name><initials>D.</initials><afid>60009507</afid></author><intid>2035976274</intid><article-number>9797</article-number><source-id>21100200805</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929448013"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929448013?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929448013&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929448013&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929448013</prism:url><dc:identifier>SCOPUS_ID:84929448013</dc:identifier><eid>2-s2.0-84929448013</eid><dc:title>Effect of high-concentrate diet on amino acid transporter expression and milk quality in Holstein dairy cows</dc:title><dc:creator>Xie Z.</dc:creator><prism:publicationName>Genetics and Molecular Research</prism:publicationName><prism:eIssn>16765680</prism:eIssn><prism:volume>14</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>5246-5257</prism:pageRange><prism:coverDate>2015-05-18</prism:coverDate><prism:coverDisplayDate>18 May 2015</prism:coverDisplayDate><prism:doi>10.4238/2015.May.18.16</prism:doi><dc:description>Â©FUNPEC-RP. In order to evaluate the effect of high-concentrate diet supplementation on milk protein content, six Holstein dairy cows were assigned into high-concentrate diet (HC) or low-concentrate diet (LC) groups (N = 3/group) for 50 days. With regard to milk protein, HC feeding significantly reduced the percentage of milk protein (P &lt; 0.01), and milk protein yield also reduced. The milk somatic cell count numbers and N-acetyl-D-glucosaminidase activity was significantly higher (P &lt; 0.01) in the HC group than in the LC group. A pre-column derivatization procedure of o-phthalaldehyde was used to analyze the milk amino acid profile, the contents of Asp, Gln, Ala, Ile, Leu, and Lys were significantly lower in milk (P &lt; 0.05), but Arg and Phe were significantly higher (P &lt; 0.05) in the HC group than in the LC group. The mRNA abundance for amino acid transporters SLC7A8, SLC7A10 (P &lt; 0.05), SLC1A3 (P &lt; 0.05), and SLC16A10 (P &lt; 0.05) were decreased in the HC group. These data indicate that expression of amino acid transporters alters regulation of amino acid utilization and decreases milk quality in dairy cows.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024045</affiliation-url><afid>60024045</afid><affilname>Nanjing Agricultural University</affilname><name-variant>Nanjing Agricultural University</name-variant><affiliation-city>Nanjing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56484987800</author-url><authid>56484987800</authid><authname>Xie Z.</authname><surname>Xie</surname><given-name>Z. L.</given-name><initials>Z.L.</initials><afid>60024045</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56485207000</author-url><authid>56485207000</authid><authname>Ye P.</authname><surname>Ye</surname><given-name>P. S.</given-name><initials>P.S.</initials><afid>60024045</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56645446500</author-url><authid>56645446500</authid><authname>Zhang Y.</authname><surname>Zhang</surname><given-name>Y. S.</given-name><initials>Y.S.</initials><afid>60024045</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:18342262100</author-url><authid>18342262100</authid><authname>Shen X.</authname><surname>Shen</surname><given-name>X. Z.</given-name><initials>X.Z.</initials><afid>60024045</afid></author><authkeywords>Amino acid | Amino acid transporter | Cows | High-concentrate diet | Milk quality</authkeywords><intid>1035951398</intid><source-id>22190</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929162810"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929162810?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929162810&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929162810&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929162810</prism:url><dc:identifier>SCOPUS_ID:84929162810</dc:identifier><eid>2-s2.0-84929162810</eid><dc:title>Red cell distribution width and neurological scoring systems in acute stroke patients</dc:title><dc:creator>Kara H.</dc:creator><prism:publicationName>Neuropsychiatric Disease and Treatment</prism:publicationName><prism:issn>11766328</prism:issn><prism:eIssn>11782021</prism:eIssn><prism:volume>11</prism:volume><prism:pageRange>733-739</prism:pageRange><prism:coverDate>2015-05-18</prism:coverDate><prism:coverDisplayDate>18 May 2015</prism:coverDisplayDate><prism:doi>10.2147/NDT.S81525</prism:doi><dc:description>Â© 2015 Masopust et al. Objectives: The purpose of the present study was to evaluate the association between the red blood cell distribution width (RDW) and the Glasgow Coma Scale (GCS), Canadian NeuroÂ­logical Scale (CNS), and National Institutes of Health Stroke Scale (NIHSS) scores in patients who had acute ischemic stroke. Methods: This prospective observational cohort study included 88 patients who have had acute ischemic stroke and a control group of 40 patients who were evaluated in the Emergency DepartÂ­ment for disorders other than acute ischemic stroke. All subjects had RDW determined, and stroke patients had scoring with the GCS, CNS, and NIHSS scores. The GCS, CNS, and NIHSS scores of the patients were rated as mild, moderate, or severe and compared with RDW. Results: Stroke patients had significantly higher median RDW than control subjects. The median RDW values were significantly elevated in patients who had more severe rather than milder strokes rated with all three scoring systems (GCS, CNS, and NIHSS). The median RDW values were significantly elevated for patients who had moderate rather than mild strokes rated by GCS and CNS and for patients who had severe rather than mild strokes rated by NIHSS. The area under the receiver operating characteristic curve was 0.760 (95% confidence interval, 0.676â0.844). Separation of stroke patients and control groups was optimal with RDW 14% (sensitivity, 71.6%; specificity, 67.5%; accuracy, 70.3%). Conclusion: In stroke patients who have symptoms ,24 hours, the RDW may be useful in predicting the severity and functional outcomes of the stroke.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013575</affiliation-url><afid>60013575</afid><affilname>Selcuk Universitesi</affilname><name-variant>SelÃ§uk University</name-variant><affiliation-city>Konya</affiliation-city><affiliation-country>Turkey</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013575</affiliation-url><afid>60013575</afid><affilname>Selcuk Universitesi</affilname><name-variant>SelÃ§uk University</name-variant><affiliation-city>Konya</affiliation-city><affiliation-country>Turkey</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60085899</affiliation-url><afid>60085899</afid><affilname>Karabuk Universitesi</affilname><name-variant>Karabuk University</name-variant><affiliation-city>Karabuk</affiliation-city><affiliation-country>Turkey</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35808007400</author-url><authid>35808007400</authid><authname>Kara H.</authname><surname>Kara</surname><given-name>Hasan</given-name><initials>H.</initials><afid>60013575</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55769355000</author-url><authid>55769355000</authid><authname>Degirmenci S.</authname><surname>Degirmenci</surname><given-name>Selim</given-name><initials>S.</initials><afid>60013575</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6506315010</author-url><authid>6506315010</authid><authname>Bayir A.</authname><surname>Bayir</surname><given-name>Aysegul</given-name><initials>A.</initials><afid>60013575</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6602302032</author-url><authid>6602302032</authid><authname>Ak A.</authname><surname>Ak</surname><given-name>Ahmet</given-name><initials>A.</initials><afid>60013575</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55962712600</author-url><authid>55962712600</authid><authname>Akinci M.</authname><surname>Akinci</surname><given-name>Murat</given-name><initials>M.</initials><afid>60013575</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56351785500</author-url><authid>56351785500</authid><authname>Dogru A.</authname><surname>Dogru</surname><given-name>Ali</given-name><initials>A.</initials><afid>60013575</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55579555600</author-url><authid>55579555600</authid><authname>Akyurek F.</authname><surname>Akyurek</surname><given-name>Fikret</given-name><initials>F.</initials><afid>60013575</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:15128477900</author-url><authid>15128477900</authid><authname>Kayis S.</authname><surname>Kayis</surname><given-name>Seyit Ali</given-name><initials>S.A.</initials><afid>60085899</afid></author><authkeywords>Cerebrovascular accident | Hematology | Prognosis | Severity</authkeywords><intid>35918388</intid><source-id>4100151703</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930007690"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930007690?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930007690&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930007690&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930007690</prism:url><dc:identifier>SCOPUS_ID:84930007690</dc:identifier><eid>2-s2.0-84930007690</eid><dc:title>Optogenetic control of nerve growth</dc:title><dc:creator>Park S.</dc:creator><prism:publicationName>Scientific Reports</prism:publicationName><prism:eIssn>20452322</prism:eIssn><prism:volume>5</prism:volume><prism:coverDate>2015-05-18</prism:coverDate><prism:coverDisplayDate>18 May 2015</prism:coverDisplayDate><prism:doi>10.1038/srep09669</prism:doi><pii>srep09669</pii><dc:description>Due to the limited regenerative ability of neural tissue, a diverse set of biochemical and biophysical cues for increasing nerve growth has been investigated, including neurotrophic factors, topography, and electrical stimulation. In this report, we explore optogenetic control of neurite growth as a cell-specific alternative to electrical stimulation. By investigating a broad range of optical stimulation parameters on dorsal root ganglia (DRGs) expressing channelrhodopsin 2 (ChR2), we identified conditions that enhance neurite outgrowth by three-fold as compared to unstimulated or wild-type (WT) controls. Furthermore, optogenetic stimulation of ChR2 expressing DRGs induces directional outgrowth in WT DRGs co-cultured within a 10 mm vicinity of the optically sensitive ganglia. This observed enhancement and polarization of neurite growth was accompanied by an increased expression of neural growth and brain derived neurotrophic factors (NGF, BDNF). This work highlights the potential for implementing optogenetics to drive nerve growth in specific cell populations.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022195</affiliation-url><afid>60022195</afid><affilname>Massachusetts Institute of Technology</affilname><name-variant>Massachusetts Inst. of Technology</name-variant><affiliation-city>Cambridge</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022195</affiliation-url><afid>60022195</afid><affilname>Massachusetts Institute of Technology</affilname><name-variant>Massachusetts Inst. of Technology</name-variant><affiliation-city>Cambridge</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022195</affiliation-url><afid>60022195</afid><affilname>Massachusetts Institute of Technology</affilname><name-variant>Massachusetts Inst. of Technology</name-variant><affiliation-city>Cambridge</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017198</affiliation-url><afid>60017198</afid><affilname>Charles Stark Draper Lab Inc</affilname><name-variant>Draper Laboratory</name-variant><affiliation-city>Cambridge</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022195</affiliation-url><afid>60022195</afid><affilname>Massachusetts Institute of Technology</affilname><name-variant>Massachusetts Inst. of Technology</name-variant><affiliation-city>Cambridge</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56658093900</author-url><authid>56658093900</authid><authname>Park S.</authname><surname>Park</surname><given-name>Seongjun</given-name><initials>S.</initials><afid>60022195</afid><afid>60022195</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56658093900</author-url><authid>56658093900</authid><authname>Park S.</authname><surname>Park</surname><given-name>Seongjun</given-name><initials>S.</initials><afid>60022195</afid><afid>60022195</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36007202300</author-url><authid>36007202300</authid><authname>Koppes R.</authname><surname>Koppes</surname><given-name>Ryan A.</given-name><initials>R.A.</initials><afid>60022195</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:54787544400</author-url><authid>54787544400</authid><authname>Froriep U.</authname><surname>Froriep</surname><given-name>Ulrich P.</given-name><initials>U.P.</initials><afid>60022195</afid><afid>60022195</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:54787544400</author-url><authid>54787544400</authid><authname>Froriep U.</authname><surname>Froriep</surname><given-name>Ulrich P.</given-name><initials>U.P.</initials><afid>60022195</afid><afid>60022195</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56525854600</author-url><authid>56525854600</authid><authname>Jia X.</authname><surname>Jia</surname><given-name>Xiaoting</given-name><initials>X.</initials><afid>60022195</afid><afid>60022195</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56525854600</author-url><authid>56525854600</authid><authname>Jia X.</authname><surname>Jia</surname><given-name>Xiaoting</given-name><initials>X.</initials><afid>60022195</afid><afid>60022195</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:26433161600</author-url><authid>26433161600</authid><authname>Achyuta A.</authname><surname>Achyuta</surname><given-name>Anil Kumar H</given-name><initials>A.K.H.</initials><afid>60017198</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56193725800</author-url><authid>56193725800</authid><authname>McLaughlin B.</authname><surname>McLaughlin</surname><given-name>Bryan L.</given-name><initials>B.L.</initials><afid>60017198</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:14521859300</author-url><authid>14521859300</authid><authname>Anikeeva P.</authname><surname>Anikeeva</surname><given-name>Polina</given-name><initials>P.</initials><afid>60022195</afid><afid>60022195</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:14521859300</author-url><authid>14521859300</authid><authname>Anikeeva P.</authname><surname>Anikeeva</surname><given-name>Polina</given-name><initials>P.</initials><afid>60022195</afid><afid>60022195</afid></author><intid>536050329</intid><article-number>9669</article-number><source-id>21100200805</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929440723"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929440723?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929440723&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929440723&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929440723</prism:url><dc:identifier>SCOPUS_ID:84929440723</dc:identifier><eid>2-s2.0-84929440723</eid><dc:title>Effect of recombinant human endostatin on the expression of c-Myc and bFGF in mouse gastric cancer cells</dc:title><dc:creator>Guo Z.</dc:creator><prism:publicationName>Genetics and Molecular Research</prism:publicationName><prism:eIssn>16765680</prism:eIssn><prism:volume>14</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>5258-5265</prism:pageRange><prism:coverDate>2015-05-18</prism:coverDate><prism:coverDisplayDate>18 May 2015</prism:coverDisplayDate><prism:doi>10.4238/2015.May.18.17</prism:doi><dc:description>Â©FUNPEC-RP. The aim of this study was to observe the effects of recombinant human endostatin on the proliferation and apoptosis of mouse gastric cancer cells, and explore some possible mechanisms of recombinant human endostatin inhibition of cancer. A murine gastric cancer xenograft model was established. A total of 20 mice were divided into two groups (control and experimental groups). The expression of c-Myc and basic fibroblast growth factor (bFGF) was determined by reverse transcription-polymerase chain reaction, Western blotting, and immunohistochemical staining methods. Tumor volume was measured and a growth curve was calculated. The tumor diameter in the experimental group was significantly smaller than that in the control group after treatment with endostatin for 21 days. The expression levels of c-Myc and bFGF in the experimental group were significantly lower than those of the control group (P &lt; 0.05). There was a positive correlation between the expression of c-Myc and bFGF in the experimental group. Microvessel density was significantly inhibited in the experimental group (P &lt; 0.05). These results demonstrated that recombinant human endostatin could inhibit tumor metastasis by inhibition of the expression of c-Myc and bFGF in gastric cancer tissue as well as by inhibition of angiogenesis.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112810475</affiliation-url><afid>112810475</afid><affilname>Affiliated Hospital of Hebei Medical University</affilname><name-variant>Affiliated Hospital of HeBei Medical University</name-variant><affiliation-city>Handan</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56645290800</author-url><authid>56645290800</authid><authname>Guo Z.</authname><surname>Guo</surname><given-name>Z. Y.</given-name><initials>Z.Y.</initials><afid>112810475</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56645695000</author-url><authid>56645695000</authid><authname>Yao G.</authname><surname>Yao</surname><given-name>G. D.</given-name><initials>G.D.</initials><afid>112810475</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56645481700</author-url><authid>56645481700</authid><authname>Fu L.</authname><surname>Fu</surname><given-name>L. P.</given-name><initials>L.P.</initials><afid>112810475</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56645499500</author-url><authid>56645499500</authid><authname>Fu Z.</authname><surname>Fu</surname><given-name>Z. G.</given-name><initials>Z.G.</initials><afid>112810475</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56645796500</author-url><authid>56645796500</authid><authname>Hou B.</authname><surname>Hou</surname><given-name>B.</given-name><initials>B.</initials><afid>112810475</afid></author><authkeywords>Angiogenesis | bFGF | c-Myc | Gastric cancer | Recombinant human endostatin | Tumor metastasis</authkeywords><intid>35954977</intid><source-id>22190</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929650440"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929650440?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929650440&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929650440&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929650440</prism:url><dc:identifier>SCOPUS_ID:84929650440</dc:identifier><eid>2-s2.0-84929650440</eid><dc:title>SMAD&lt;inf&gt;3&lt;/inf&gt; deficiency promotes vessel wall remodeling, collagen fiber reorganization and leukocyte infiltration in an inflammatory abdominal aortic aneurysm mouse model</dc:title><dc:creator>Dai X.</dc:creator><prism:publicationName>Scientific Reports</prism:publicationName><prism:eIssn>20452322</prism:eIssn><prism:volume>5</prism:volume><prism:coverDate>2015-05-18</prism:coverDate><prism:coverDisplayDate>18 May 2015</prism:coverDisplayDate><prism:doi>10.1038/srep10180</prism:doi><pii>srep10180</pii><dc:description>TGF-Î² signaling plays critical roles in the pathogenesis of aneurysms; however, it is still unclear whether its role is protective or destructive. In this study, we investigate the role of SMAD&lt;inf&gt;3&lt;/inf&gt; in the pathogenesis of calcium chloride (CaCl&lt;inf&gt;2&lt;/inf&gt;)-induced abdominal aortic aneurysms (AAA) in Smad&lt;inf&gt;3&lt;/inf&gt;&lt;sup&gt;-/-&lt;/sup&gt;, Smad&lt;inf&gt;3&lt;/inf&gt;&lt;sup&gt;+/-&lt;/sup&gt; and Smad&lt;inf&gt;3&lt;/inf&gt;&lt;sup&gt;+/+&lt;/sup&gt; mice. We find that loss of SMAD&lt;inf&gt;3&lt;/inf&gt; drastically increases wall thickening of the abdominal aorta. Histological analyses show significant vessel wall remodeling with elastic fiber fragmentation. Remarkably, under polarized light, collagen fibers in the hyperplastic adventitia of Smad&lt;inf&gt;3&lt;/inf&gt;&lt;sup&gt;-/-&lt;/sup&gt; mice show extensive reorganization accompanied by loosely packed thin and radial collagen fibers. The expressions of matrix metalloproteinases including MMP2, MMP9, and MMP12 and infiltration of macrophage/T cells are drastically enhanced in the vascular wall of Smad&lt;inf&gt;3&lt;/inf&gt;&lt;sup&gt;-/-&lt;/sup&gt; mice. We also observe marked increase of NF-ÎºB and ERK1/2 signaling as well as the expression of nuclear Smad2, Smad4 and TGF-Î²1 in the vessel wall of Smad&lt;inf&gt;3&lt;/inf&gt;&lt;sup&gt;-/-&lt;/sup&gt; mice. In addition, we find that SMAD3 expression is reduced in the dedifferentiated medial smooth muscle-like cells of human AAA patients. These findings provide direct in vivo evidence to support the essential roles of SMAD3 in protecting vessel wall integrity and suppressing inflammation in the pathogenesis of AAAs.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009408</affiliation-url><afid>60009408</afid><affilname>Wayne State University</affilname><name-variant>Wayne State University</name-variant><affiliation-city>Detroit</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009408</affiliation-url><afid>60009408</afid><affilname>Wayne State University</affilname><name-variant>Wayne State University</name-variant><affiliation-city>Detroit</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009408</affiliation-url><afid>60009408</afid><affilname>Wayne State University</affilname><name-variant>Wayne State University</name-variant><affiliation-city>Detroit</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009408</affiliation-url><afid>60009408</afid><affilname>Wayne State University</affilname><name-variant>Wayne State University</name-variant><affiliation-city>Detroit</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014232</affiliation-url><afid>60014232</afid><affilname>VA Medical Center</affilname><affiliation-city/><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029752</affiliation-url><afid>60029752</afid><affilname>Weis Center for Research</affilname><name-variant>Weis Center for Research</name-variant><affiliation-city>Danville</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008724</affiliation-url><afid>60008724</afid><affilname>Duke University</affilname><name-variant>Duke University</name-variant><affiliation-city>Durham</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008578</affiliation-url><afid>60008578</afid><affilname>Henry Ford Hospital</affilname><name-variant>Henry Ford Hospital</name-variant><affiliation-city>Detroit</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013894</affiliation-url><afid>60013894</afid><affilname>University of Massachusetts System</affilname><name-variant>University of Massachusetts</name-variant><affiliation-city>Boston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005455</affiliation-url><afid>60005455</afid><affilname>Yale University</affilname><name-variant>Yale University</name-variant><affiliation-city>New Haven</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">21</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56651552900</author-url><authid>56651552900</authid><authname>Dai X.</authname><surname>Dai</surname><given-name>Xiaohua</given-name><initials>X.</initials><afid>60009408</afid><afid>60009408</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56651552900</author-url><authid>56651552900</authid><authname>Dai X.</authname><surname>Dai</surname><given-name>Xiaohua</given-name><initials>X.</initials><afid>60009408</afid><afid>60009408</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36098305700</author-url><authid>36098305700</authid><authname>Shen J.</authname><surname>Shen</surname><given-name>Jianbin</given-name><initials>J.</initials><afid>60009408</afid><afid>60009408</afid><afid>60009408</afid><afid>60005455</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36098305700</author-url><authid>36098305700</authid><authname>Shen J.</authname><surname>Shen</surname><given-name>Jianbin</given-name><initials>J.</initials><afid>60009408</afid><afid>60009408</afid><afid>60009408</afid><afid>60005455</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36098305700</author-url><authid>36098305700</authid><authname>Shen J.</authname><surname>Shen</surname><given-name>Jianbin</given-name><initials>J.</initials><afid>60009408</afid><afid>60009408</afid><afid>60009408</afid><afid>60005455</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36098305700</author-url><authid>36098305700</authid><authname>Shen J.</authname><surname>Shen</surname><given-name>Jianbin</given-name><initials>J.</initials><afid>60009408</afid><afid>60009408</afid><afid>60009408</afid><afid>60005455</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56652291200</author-url><authid>56652291200</authid><authname>Priyanka Annam N.</authname><surname>Priyanka Annam</surname><given-name>Neeraja</given-name><initials>N.</initials><afid>60009408</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56651345400</author-url><authid>56651345400</authid><authname>Jiang H.</authname><surname>Jiang</surname><given-name>Hong</given-name><initials>H.</initials><afid>60009408</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56651850600</author-url><authid>56651850600</authid><authname>Levi E.</authname><surname>Levi</surname><given-name>Edi</given-name><initials>E.</initials><afid>60014232</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7003798409</author-url><authid>7003798409</authid><authname>Schworer C.</authname><surname>Schworer</surname><given-name>Charles M.</given-name><initials>C.M.</initials><afid>60029752</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7005814412</author-url><authid>7005814412</authid><authname>Tromp G.</authname><surname>Tromp</surname><given-name>Gerard</given-name><initials>G.</initials><afid>60029752</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56651736800</author-url><authid>56651736800</authid><authname>Arora A.</authname><surname>Arora</surname><given-name>Anandita</given-name><initials>A.</initials><afid>60009408</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56651757900</author-url><authid>56651757900</authid><authname>Higgins M.</authname><surname>Higgins</surname><given-name>Mary</given-name><initials>M.</initials><afid>60009408</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56651851700</author-url><authid>56651851700</authid><authname>Wang X.</authname><surname>Wang</surname><given-name>Xiao Fan</given-name><initials>X.F.</initials><afid>60008724</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:56376929800</author-url><authid>56376929800</authid><authname>Yang M.</authname><surname>Yang</surname><given-name>Maozhou</given-name><initials>M.</initials><afid>60008578</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:56651249600</author-url><authid>56651249600</authid><authname>Li H.</authname><surname>Li</surname><given-name>Hui J.</given-name><initials>H.J.</initials><afid>60013894</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:56651358800</author-url><authid>56651358800</authid><authname>Zhang K.</authname><surname>Zhang</surname><given-name>Kezhong</given-name><initials>K.</initials><afid>60009408</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:7005985231</author-url><authid>7005985231</authid><authname>Kuivaniemi H.</authname><surname>Kuivaniemi</surname><given-name>Helena</given-name><initials>H.</initials><afid>60029752</afid></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:36663702200</author-url><authid>36663702200</authid><authname>Li L.</authname><surname>Li</surname><given-name>Li</given-name><initials>L.</initials><afid>60009408</afid><afid>60009408</afid><afid>60009408</afid></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:36663702200</author-url><authid>36663702200</authid><authname>Li L.</authname><surname>Li</surname><given-name>Li</given-name><initials>L.</initials><afid>60009408</afid><afid>60009408</afid><afid>60009408</afid></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:36663702200</author-url><authid>36663702200</authid><authname>Li L.</authname><surname>Li</surname><given-name>Li</given-name><initials>L.</initials><afid>60009408</afid><afid>60009408</afid><afid>60009408</afid></author><intid>1535988744</intid><article-number>10180</article-number><source-id>21100200805</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929689018"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929689018?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929689018&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929689018&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929689018</prism:url><dc:identifier>SCOPUS_ID:84929689018</dc:identifier><eid>2-s2.0-84929689018</eid><dc:title>Exercise Performance in Children and Young Adults After Complete and Incomplete Repair of Congenital Heart Disease</dc:title><dc:creator>Rosenblum O.</dc:creator><prism:publicationName>Pediatric Cardiology</prism:publicationName><prism:issn>01720643</prism:issn><prism:eIssn>14321971</prism:eIssn><prism:coverDate>2015-05-17</prism:coverDate><prism:coverDisplayDate>17 May 2015</prism:coverDisplayDate><prism:doi>10.1007/s00246-015-1198-1</prism:doi><dc:description>Â© 2015 Springer Science+Business Media New York Few previous studies have addressed exercise capacity in patients with corrected congenital heart disease (CHD) and significant anatomical residua. The aim of this study was to determine the aerobic fitness and peak cardiac function of patients with corrected CHD with complete or incomplete repairs, as determined by resting echocardiography. Children, adolescents and young adults (&lt;40 years) with CHD from both sexes, who had previously undergone biventricular corrective therapeutic interventions (n = 73), and non-CHD control participants (n = 76) underwent cardiopulmonary exercise testing. The CHD group was further divided according to the absence/presence of significant anatomical residua on a resting echocardiogram (âcompleteâ/âincompleteâ repair groups). Aerobic fitness and cardiac function were compared between groups using linear regression and analysis of covariance. Peak oxygen consumption, O&lt;inf&gt;2&lt;/inf&gt; pulse and ventilatory threshold were significantly lower in CHD patients compared with controls (all p &lt; 0.01). Compared with the complete repair group, the incomplete repair group had a significantly lower mean peak work rate, age-adjusted O&lt;inf&gt;2&lt;/inf&gt; pulse (expressed as % predicted) and a higher V&lt;inf&gt;E&lt;/inf&gt;/VCO&lt;inf&gt;2&lt;/inf&gt; ratio (all p â¤ 0.05). Peak oxygen consumption was comparable between the subgroups. Patients after corrected CHD have lower peak and submaximal exercise parameters. Patients with incomplete repair of their heart defect had decreased aerobic fitness, with evidence of impaired peak cardiac function and lower pulmonary perfusion. Patients that had undergone a complete repair had decreased aerobic fitness attributed only to deconditioning. These newly identified differences explain why in previous studies, the lowest fitness was seen in patients with the most hemodynamically significant heart malformations.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005037</affiliation-url><afid>60005037</afid><affilname>Tel Aviv University, Sackler Faculty of Medicine</affilname><name-variant>Tel Aviv University</name-variant><affiliation-city>Ramal Aviv</affiliation-city><affiliation-country>Israel</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011766</affiliation-url><afid>60011766</afid><affilname>Chaim Sheba Medical Center Israel</affilname><name-variant>Chaim Sheba Medical Center</name-variant><affiliation-city>Tel Aviv-Yafo</affiliation-city><affiliation-country>Israel</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026479</affiliation-url><afid>60026479</afid><affilname>University of Exeter</affilname><name-variant>University of Exeter</name-variant><affiliation-city>Exeter</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011766</affiliation-url><afid>60011766</afid><affilname>Chaim Sheba Medical Center Israel</affilname><name-variant>Chaim Sheba Medical Center</name-variant><affiliation-city>Tel Aviv-Yafo</affiliation-city><affiliation-country>Israel</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56653344500</author-url><authid>56653344500</authid><authname>Rosenblum O.</authname><surname>Rosenblum</surname><given-name>Omer</given-name><initials>O.</initials><afid>60005037</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55318518000</author-url><authid>55318518000</authid><authname>Katz U.</authname><surname>Katz</surname><given-name>Uriel</given-name><initials>U.</initials><afid>60005037</afid><afid>60011766</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55318518000</author-url><authid>55318518000</authid><authname>Katz U.</authname><surname>Katz</surname><given-name>Uriel</given-name><initials>U.</initials><afid>60005037</afid><afid>60011766</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:8261642400</author-url><authid>8261642400</authid><authname>Reuveny R.</authname><surname>Reuveny</surname><given-name>Ronen</given-name><initials>R.</initials><afid>60011766</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55707255400</author-url><authid>55707255400</authid><authname>Williams C.</authname><surname>Williams</surname><given-name>Craig A.</given-name><initials>C.A.</initials><afid>60026479</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55959791700</author-url><authid>55959791700</authid><authname>Dubnov-Raz G.</authname><surname>Dubnov-Raz</surname><given-name>Gal</given-name><initials>G.</initials><afid>60005037</afid><afid>60011766</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55959791700</author-url><authid>55959791700</authid><authname>Dubnov-Raz G.</authname><surname>Dubnov-Raz</surname><given-name>Gal</given-name><initials>G.</initials><afid>60005037</afid><afid>60011766</afid></author><authkeywords>Cardiac | Congenital | Fitness | Heart | Malformation</authkeywords><intid>1785998566</intid><source-id>20526</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929692799"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929692799?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929692799&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929692799&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929692799</prism:url><dc:identifier>SCOPUS_ID:84929692799</dc:identifier><eid>2-s2.0-84929692799</eid><dc:title>Plasma Levels of Acylated Ghrelin in Children with Pulmonary Hypertension Associated with Congenital Heart Disease</dc:title><dc:creator>Li G.</dc:creator><prism:publicationName>Pediatric Cardiology</prism:publicationName><prism:issn>01720643</prism:issn><prism:eIssn>14321971</prism:eIssn><prism:coverDate>2015-05-17</prism:coverDate><prism:coverDisplayDate>17 May 2015</prism:coverDisplayDate><prism:doi>10.1007/s00246-015-1178-5</prism:doi><dc:description>Â© 2015 Springer Science+Business Media New York This study aims to estimate plasma levels of acylated ghrelin in children with pulmonary hypertension (PH) associated with congenital heart disease (CHD) and to correlate the levels of acylated ghrelin with endothelin-1 (ET-1), nitric oxide (NO), and clinical hemodynamic parameters. We investigated the plasma concentration of acylated ghrelin, ET-1, NO, and the hemodynamic parameters in 20 children with CHD, 20 children with PH-CHD, and 20 normal children. Plasma-acylated ghrelin and NO levels were significantly higher in CHD group than in control subjects (P &lt; 0.001). Moreover, plasma-acylated ghrelin, ET-1, and NO levels were significantly elevated in PH-CHD group compared with the CHD group (P &lt; 0.05). In PH-CHD children, plasma-acylated ghrelin levels correlated positively with pulmonary artery systolic pressure (PASP; r = 0.740, P &lt; 0.001), pulmonary artery diastolic pressure (PADP; r = 0.613, P = 0.004), right ventricular systolic pressure (RVSP; r = 0.642, P = 0.002), mean pulmonary arterial hypertension (mPAP; r = 0.685, P = 0.001), right ventricle diameter (RVD; r = 0.473, P = 0.035), pulmonary artery trunk diameter (PAD; r = 0.613, P = 0.004), NO (r = 0.463, P = 0.04), and ET-1 (r = 0.524, P = 0.018). Plasma-acylated ghrelin levels were elevated both in CHD and in PH-CHD. Increased acylated ghrelin levels correlated positively with ET-1, NO, PASP, PADP, RVSP, mPAP, RVD, and PAD. Acylated ghrelin may be a new biomarker of PH-CHD.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018702</affiliation-url><afid>60018702</afid><affilname>Luzhou Medical College</affilname><name-variant>Hospital of Luzhou Medical College</name-variant><affiliation-city>Luzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018702</affiliation-url><afid>60018702</afid><affilname>Luzhou Medical College</affilname><name-variant>Hospital of Luzhou Medical College</name-variant><affiliation-city>Luzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018702</affiliation-url><afid>60018702</afid><affilname>Luzhou Medical College</affilname><name-variant>Hospital of Luzhou Medical College</name-variant><affiliation-city>Luzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55849055300</author-url><authid>55849055300</authid><authname>Li G.</authname><surname>Li</surname><given-name>Gang</given-name><initials>G.</initials><afid>60018702</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56652917900</author-url><authid>56652917900</authid><authname>Xia J.</authname><surname>Xia</surname><given-name>Jiyi</given-name><initials>J.</initials><afid>60018702</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55641865600</author-url><authid>55641865600</authid><authname>Jia P.</authname><surname>Jia</surname><given-name>Peng</given-name><initials>P.</initials><afid>60018702</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56652818700</author-url><authid>56652818700</authid><authname>Zhao J.</authname><surname>Zhao</surname><given-name>Jian</given-name><initials>J.</initials><afid>60018702</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55622531400</author-url><authid>55622531400</authid><authname>Sun Y.</authname><surname>Sun</surname><given-name>Yuqin</given-name><initials>Y.</initials><afid>60018702</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56652803500</author-url><authid>56652803500</authid><authname>Wu C.</authname><surname>Wu</surname><given-name>Changxue</given-name><initials>C.</initials><afid>60018702</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55642058700</author-url><authid>55642058700</authid><authname>Liu B.</authname><surname>Liu</surname><given-name>Bin</given-name><initials>B.</initials><afid>60018702</afid></author><authkeywords>Acylated ghrelin | Congenital heart disease | Endothelin-1 | Nitric oxide | Pulmonary hypertension</authkeywords><intid>535999151</intid><source-id>20526</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929692481"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929692481?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929692481&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929692481&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929692481</prism:url><dc:identifier>SCOPUS_ID:84929692481</dc:identifier><eid>2-s2.0-84929692481</eid><dc:title>The A1298C Methylenetetrahydrofolate Reductase Gene Variant as a Susceptibility Gene for Non-Syndromic Conotruncal Heart Defects in an Indian Population</dc:title><dc:creator>Koshy T.</dc:creator><prism:publicationName>Pediatric Cardiology</prism:publicationName><prism:issn>01720643</prism:issn><prism:eIssn>14321971</prism:eIssn><prism:coverDate>2015-05-17</prism:coverDate><prism:coverDisplayDate>17 May 2015</prism:coverDisplayDate><prism:doi>10.1007/s00246-015-1188-3</prism:doi><dc:description>Â© 2015 Springer Science+Business Media New York Conotruncal heart defects (CTHDS) are a subgroup of congenital heart malformations that are considered to be a folate-sensitive birth defect. It has been hypothesized that polymorphisms in genes that code for key enzymes in the folate pathway may alter enzyme activity, leading to disruptions in folate metabolism and thus may influence the risk of such heart defects. This study was designed to investigate the association of six selected folate-metabolizing gene polymorphisms with the risk of non-syndromic CTHDs in an Indian population. This was a caseâcontrol study involving 96 cases of CTHDs and 100 control samples, ranging in age from birth to 18 years. Genotyping using Sanger sequencing was performed for six single nucleotide polymorphisms of genes involved in folate metabolism. Logistic regression analyses revealed that for the 5,10-methylenetetrahydrofolate (MTHFR) A1298C polymorphism, the CC variant homozygote genotype was associated with a significantly increased risk of CTHDs. The results of this study support an association between the inherited MTHFR A1298C genotype and the risk of CTHDs in an Indian population.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023483</affiliation-url><afid>60023483</afid><affilname>Sri Ramachandra University</affilname><name-variant>Sri Ramachandra University</name-variant><affiliation-city>Chennai</affiliation-city><affiliation-country>India</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012073</affiliation-url><afid>60012073</afid><affilname>Manipal Hospital</affilname><name-variant>Manipal Hospital</name-variant><affiliation-city>Bangalore</affiliation-city><affiliation-country>India</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7004224524</author-url><authid>7004224524</authid><authname>Koshy T.</authname><surname>Koshy</surname><given-name>Teena</given-name><initials>T.</initials><afid>60023483</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:12793186700</author-url><authid>12793186700</authid><authname>Venkatesan V.</authname><surname>Venkatesan</surname><given-name>Vettriselvi</given-name><initials>V.</initials><afid>60023483</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56653296700</author-url><authid>56653296700</authid><authname>Perumal V.</authname><surname>Perumal</surname><given-name>Venkatachalam</given-name><initials>V.</initials><afid>60023483</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56653118000</author-url><authid>56653118000</authid><authname>Hegde S.</authname><surname>Hegde</surname><given-name>Sridevi</given-name><initials>S.</initials><afid>60012073</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55622612300</author-url><authid>55622612300</authid><authname>Paul S.</authname><surname>Paul</surname><given-name>Solomon Franklin Durairaj</given-name><initials>S.F.D.</initials><afid>60023483</afid></author><authkeywords>Deoxyribonucleic acid | Folate metabolism | Logistic regression | Sanger sequencing | Single nucleotide polymorphism</authkeywords><intid>1035993115</intid><source-id>20526</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929692167"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929692167?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929692167&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929692167&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929692167</prism:url><dc:identifier>SCOPUS_ID:84929692167</dc:identifier><eid>2-s2.0-84929692167</eid><dc:title>Molecular genetics-nutrition interactions in the expression of AANAT, ADRB3, BTG2 and FASN genes in the heart, kidney and liver of Australian lambs supplemented with Spirulina (Arthrospira platensis)</dc:title><dc:creator>Malau-Aduli A.</dc:creator><prism:publicationName>Genes and Genomics</prism:publicationName><prism:issn>19769571</prism:issn><prism:eIssn>20929293</prism:eIssn><prism:coverDate>2015-05-17</prism:coverDate><prism:coverDisplayDate>17 May 2015</prism:coverDisplayDate><prism:doi>10.1007/s13258-015-0294-1</prism:doi><dc:description>Â© 2015 The Genetics Society of Korea and Springer-Science and Media Quantitative reverse transcriptase polymerase chain reaction was used to assess the messenger RNA (mRNA) transcription levels and expressions of Aralkylamine N-acetyltransferase, Adrenergic beta-3 receptor, Bcell translocation gene 2, and Fatty acid synthase genes. In total, 432 heart, kidney and liver samples from 48 purebred and crossbred Australian prime lambs supplemented with Spirulina (Arthrospira platensis) blue-green cyanobacterial microalgae over a 9-week feeding trial were utilized for fatty acid composition and mRNA extraction. The aim was to assess the effect of dietary Spirulina supplementation on the mRNA expression profiles of genes controlling fatty acid metabolism in the heart, kidney and liver. Fourty-eight weaned lambs belonging to four breeds under the same management conditions were maintained on ryegrass pasture and randomly allocated to three treatment groups that comprised the control and two levels of Spirulina supplementation: Low (100 mL/head/day of 1 g Spirulina powder dissolved in 10 mL of water (10 % wt:vol)) and High (200 mL/head/day of 2 g of Spirulina dissolved in 10 mL of water (20 % wt:vol)). Both the low and high levels of Spirulina supplementation regimes strongly up-regulated the transcription of all the selected genes and increased Ï-3 and Ï-6 polyunsaturated fatty acid compositions in the tested organs. Breed and sex did not influence gene expression patterns; however, significant variations in response to Spirulina supplementation underpin the genetics-nutrition interactions that could be of practical importance for manipulating meat quality in the Australian dual-purpose prime lamb industry for a healthy polyunsaturated fatty acid profile.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015356</affiliation-url><afid>60015356</afid><affilname>University of Tasmania</affilname><name-variant>University of Tasmania</name-variant><affiliation-city>Hobart</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:109349431</affiliation-url><afid>109349431</afid><affilname>James Cook University</affilname><name-variant>James Cook University</name-variant><affiliation-city>Townsville</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6701709277</author-url><authid>6701709277</authid><authname>Malau-Aduli A.</authname><surname>Malau-Aduli</surname><given-name>Aduli Enoch Othniel</given-name><initials>A.E.O.</initials><afid>60015356</afid><afid>109349431</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6701709277</author-url><authid>6701709277</authid><authname>Malau-Aduli A.</authname><surname>Malau-Aduli</surname><given-name>Aduli Enoch Othniel</given-name><initials>A.E.O.</initials><afid>60015356</afid><afid>109349431</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56162664000</author-url><authid>56162664000</authid><authname>Kashani A.</authname><surname>Kashani</surname><given-name>Arash</given-name><initials>A.</initials><afid>60015356</afid></author><authkeywords>AANAT | ADRB3 | BTG2 | FASN | mRNA | Spirulina</authkeywords><intid>35996419</intid><source-id>12000154520</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929336007"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929336007?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929336007&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929336007&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1746809415000762"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929336007</prism:url><dc:identifier>SCOPUS_ID:84929336007</dc:identifier><eid>2-s2.0-84929336007</eid><dc:title>Prognostic value of the total cosine R to T measured in high resolution body surface potential mapping during exercise test</dc:title><dc:creator>Kania M.</dc:creator><prism:publicationName>Biomedical Signal Processing and Control</prism:publicationName><prism:issn>17468094</prism:issn><prism:eIssn>17468108</prism:eIssn><prism:volume>20</prism:volume><prism:pageRange>135-141</prism:pageRange><prism:coverDate>2015-05-17</prism:coverDate><prism:coverDisplayDate>17 May 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bspc.2015.04.013</prism:doi><pii>S1746809415000762</pii><dc:description>Â© 2015 Elsevier Ltd. All rights reserved. Background: The total cosine R-to-T (TCRT) is a vectorcardiographic measure of differences in propagation of depolarization and repolarization in the heart. The high TCRT value reflects increased heterogeneity of repolarization process. The aim of study was to assess the prognostic value of the TCRT measured during exercise stress test. Methods: The high-resolution body surface potential maps were recorded at rest and during exercise test in the group of 90 cardiac patients and 33 healthy volunteers. The TCRT was computed from averaged in time ECG signals. The prognostic value of TCRT parameter was determined based on the results of SPECT and echocardiography. Results: TCRT was heart rate dependent and its magnitude decreased when measured at peak exercise in comparison to TCRT measured at rest. The significant differences in TCRT were obtained between patients with low (LVEF â¤ 40%,) and high (LVEF &gt; 40%) left ventricular ejection fraction. These differences were greater if the TCRT was determined from a 67-lead ECG than computed from the standard ECG leads and were more pronounced for TCRT determined at peak exercise than at rest. The separation capacity was farther improved for TCRT normalized to mean heart rate. Simulation and experimental results showed that presence and localization of myocardial ischemia or post-infarction scar tissue have negligible impact on TCRT. Conclusions: Wider R-to-T angle was associated with lower LVEF. The statistically significant differences of TCRT in patients with low LVEF and high LVEF may suggest high prognostic value of TCRT parameter in risk assessment of ventricular arrhythmia.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028874</affiliation-url><afid>60028874</afid><affilname>Institute of Biocybernetics and Biomedical Engineering of the Polish Academy of Sciences</affilname><name-variant>Polish Academy of Sciences</name-variant><affiliation-city>Warsaw</affiliation-city><affiliation-country>Poland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60069009</affiliation-url><afid>60069009</afid><affilname>Medical University of Warsaw</affilname><name-variant>Medical University of Warsaw</name-variant><affiliation-city>Warsaw</affiliation-city><affiliation-country>Poland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60069009</affiliation-url><afid>60069009</afid><affilname>Medical University of Warsaw</affilname><name-variant>Medical University of Warsaw</name-variant><affiliation-city>Warsaw</affiliation-city><affiliation-country>Poland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:16745001100</author-url><authid>16745001100</authid><authname>Kania M.</authname><surname>Kania</surname><given-name>MichaÅ</given-name><initials>M.</initials><afid>60028874</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36924260800</author-url><authid>36924260800</authid><authname>Maniewski R.</authname><surname>Maniewski</surname><given-name>Roman</given-name><initials>R.</initials><afid>60028874</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6507048509</author-url><authid>6507048509</authid><authname>Kobylecka M.</authname><surname>Kobylecka</surname><given-name>MaÅgorzata</given-name><initials>M.</initials><afid>60069009</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7004832989</author-url><authid>7004832989</authid><authname>Zaczek R.</authname><surname>Zaczek</surname><given-name>Rajmund</given-name><initials>R.</initials><afid>60069009</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55915712500</author-url><authid>55915712500</authid><authname>KrÃ³licki L.</authname><surname>KrÃ³licki</surname><given-name>Leszek</given-name><initials>L.</initials><afid>60069009</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55711952200</author-url><authid>55711952200</authid><authname>Opolski G.</authname><surname>Opolski</surname><given-name>Grzegorz</given-name><initials>G.</initials><afid>60069009</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:8441253400</author-url><authid>8441253400</authid><authname>Janusek D.</authname><surname>Janusek</surname><given-name>Dariusz</given-name><initials>D.</initials><afid>60028874</afid></author><intid>1535945757</intid><source-id>4700152237</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929692642"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929692642?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929692642&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929692642&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929692642</prism:url><dc:identifier>SCOPUS_ID:84929692642</dc:identifier><eid>2-s2.0-84929692642</eid><dc:title>Catheter ablation of pediatric AV nodal reentrant tachycardia: results in small children</dc:title><dc:creator>Krause U.</dc:creator><prism:publicationName>Clinical Research in Cardiology</prism:publicationName><prism:issn>18610684</prism:issn><prism:eIssn>18610692</prism:eIssn><prism:coverDate>2015-05-17</prism:coverDate><prism:coverDisplayDate>17 May 2015</prism:coverDisplayDate><prism:doi>10.1007/s00392-015-0868-6</prism:doi><dc:description>Â© 2015 Springer-Verlag Berlin Heidelberg Background: AV nodal reentrant tachycardia (AVNRT) is commonly encountered in pediatric patients. Definite treatment can be achieved by catheter ablation. The purpose of the study was to evaluate the efficacy and safety of AVNRT ablation focusing on children with a body weight â¤25 kg. Patients and results: Catheter ablation of AVNRT was attempted in 253 patients. Median age was 12.5 years; median body weight was 48.7 kg. 25 (9.9 %) children had a body weight â¤25 kg. Congenital heart disease was present in 6 patients (2.4 %). Procedural success was achieved in 98 % using radiofrequency, in 100 % using cryoenergy alone, and in 94 % using both energy sources. In patients with a body weight â¤25 kg, success was achieved in 96 %. In patients â¤25 kg, fluoroscopy and procedure duration did not differ from those &gt;25 kg. The rate of major complications was significantly higher in the patients â¤25 kg (12 vs. 2.2 %, p = 0.04). Permanent AV block after RF ablation occurred in 2 patients with congenital heart disease and one infant with a body weight of 8.7 kg. Conclusions: Catheter ablation of AVNRT in children and adolescents was safe and effective. Infants and small children with a body weight â¤25 kg had a higher prevalence of serious complications. This should alert physicians in decision making toward catheter ablation in these patients. In patients with congenital heart disease and different anatomy of the cardiac conduction system, operators must be aware of an increased risk for AV block.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021110</affiliation-url><afid>60021110</afid><affilname>Universitatsmedizin Gottingen</affilname><affiliation-city>Gottingen</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:37261409500</author-url><authid>37261409500</authid><authname>Krause U.</authname><surname>Krause</surname><given-name>Ulrich</given-name><initials>U.</initials><afid>60021110</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55792684600</author-url><authid>55792684600</authid><authname>Backhoff D.</authname><surname>Backhoff</surname><given-name>David</given-name><initials>D.</initials><afid>60021110</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56653539600</author-url><authid>56653539600</authid><authname>Klehs S.</authname><surname>Klehs</surname><given-name>Sophia</given-name><initials>S.</initials><afid>60021110</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6602466005</author-url><authid>6602466005</authid><authname>Kriebel T.</authname><surname>Kriebel</surname><given-name>Thomas</given-name><initials>T.</initials><afid>60021110</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56589501100</author-url><authid>56589501100</authid><authname>Paul T.</authname><surname>Paul</surname><given-name>Thomas</given-name><initials>T.</initials><afid>60021110</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:26326548700</author-url><authid>26326548700</authid><authname>Schneider H.</authname><surname>Schneider</surname><given-name>Heike E.</given-name><initials>H.E.</initials><afid>60021110</afid></author><authkeywords>AV nodal reentrant tachycardia | Catheter ablation | Congenital heart disease | Cryoenergy | Pediatric | Radiofrequency current</authkeywords><intid>1785997960</intid><source-id>3100147501</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929589778"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929589778?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929589778&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929589778&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929589778</prism:url><dc:identifier>SCOPUS_ID:84929589778</dc:identifier><eid>2-s2.0-84929589778</eid><dc:title>Post-exotic India: on remixed histories and smart images</dc:title><dc:creator>Kaur R.</dc:creator><prism:publicationName>Identities</prism:publicationName><prism:issn>1070289X</prism:issn><prism:eIssn>15473384</prism:eIssn><prism:coverDate>2015-05-17</prism:coverDate><prism:coverDisplayDate>17 May 2015</prism:coverDisplayDate><prism:doi>10.1080/1070289X.2015.1034134</prism:doi><dc:description>Â© 2015 Taylor &amp; Francis This paper examines the aesthetics of remixing history at the heart of the neoliberal project of Indiaâs image makeover as the âland of limitless opportunityâ for global tourists and investors. I argue that the project of remixing Indiaâs history is predicated upon the ontological fault line of how to retain and erase the original simultaneously while shaping the new in the contemporary global. Taking the Incredible India campaign as an example, I show how the original essence of India is revealed and authenticated in the very moment of its disappearance as it is morphed in the aesthetics of the contemporary global. The post-exotic self, I further argue, is not produced by effacing the exotic past, but by condensing, accelerating and fast-forwarding it into a timeless, infinite global present. And in doing so, it also reveals the blueprint of the ongoing visual rearrangement of nationâs civilisational past in the making of new India.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030840</affiliation-url><afid>60030840</afid><affilname>Kobenhavns Universitet</affilname><name-variant>University of Copenhagen</name-variant><affiliation-city>Copenhagen</affiliation-city><affiliation-country>Denmark</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">1</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55172989800</author-url><authid>55172989800</authid><authname>Kaur R.</authname><surname>Kaur</surname><given-name>Ravinder</given-name><initials>R.</initials><afid>60030840</afid></author><authkeywords>civilisational culture | globalisation | images | Incredible India | post-exotic | remixed history</authkeywords><intid>1535981178</intid><source-id>26809</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929683359"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929683359?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929683359&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929683359&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929683359</prism:url><dc:identifier>SCOPUS_ID:84929683359</dc:identifier><eid>2-s2.0-84929683359</eid><dc:title>Autonomic control of post-air-breathing tachycardia in Clarias gariepinus (Teleostei: Clariidae)</dc:title><dc:creator>Teixeira M.</dc:creator><prism:publicationName>Journal of Comparative Physiology B: Biochemical, Systemic, and Environmental Physiology</prism:publicationName><prism:issn>01741578</prism:issn><prism:coverDate>2015-05-17</prism:coverDate><prism:coverDisplayDate>17 May 2015</prism:coverDisplayDate><prism:doi>10.1007/s00360-015-0910-z</prism:doi><dc:description>Â© 2015 Springer-Verlag Berlin Heidelberg The African catfish (Clarias gariepinus) is a teleost with bimodal respiration that utilizes a paired suprabranchial chamber located in the gill cavity as an air-breathing organ. Like all air-breathing fishes studied to date, the African catfish exhibits pronounced changes in heart rate (f&lt;inf&gt;H&lt;/inf&gt;) that are associated with air-breathing events. We acquired f&lt;inf&gt;H&lt;/inf&gt;, gill-breathing frequency (f&lt;inf&gt;G&lt;/inf&gt;) and air-breathing frequency (f&lt;inf&gt;AB&lt;/inf&gt;) in situations that require or do not require air breathing (during normoxia and hypoxia), and we assessed the autonomic control of post-air-breathing tachycardia using an infusion of the Î²-adrenergic antagonist propranolol and the muscarinic cholinergic antagonist atropine. During normoxia, C. gariepinus presented low f&lt;inf&gt;AB&lt;/inf&gt; (1.85 Â± 0.73 AB h&lt;sup&gt;â1&lt;/sup&gt;) and a constant f&lt;inf&gt;G&lt;/inf&gt; (43.16 Â± 1.74 breaths min&lt;sup&gt;â1&lt;/sup&gt;). During non-critical hypoxia (PO&lt;inf&gt;2&lt;/inf&gt; = 60 mmHg), f&lt;inf&gt;AB&lt;/inf&gt; in the African catfish increased to 5.42 Â± 1.19 AB h&lt;sup&gt;â1&lt;/sup&gt; and f&lt;inf&gt;G&lt;/inf&gt; decreased to 39.12 Â± 1.58 breaths min&lt;sup&gt;â1&lt;/sup&gt;. During critical hypoxia (PO&lt;inf&gt;2&lt;/inf&gt; = 20 mmHg), f&lt;inf&gt;AB&lt;/inf&gt; increased to 7.4 Â± 1.39 AB h&lt;sup&gt;â1&lt;/sup&gt; and f&lt;inf&gt;G&lt;/inf&gt; decreased to 34.97 Â± 1.78 breaths min&lt;sup&gt;â1&lt;/sup&gt;. These results were expected for a facultative air breather. Each air breath (AB) was followed by a brief but significant tachycardia, which in the critical hypoxia trials, reached a maximum of 143 % of the pre-AB f&lt;inf&gt;H&lt;/inf&gt; values of untreated animals. Pharmacological blockade allowed the calculation of cardiac autonomic tones, which showed that post-AB tachycardia is predominantly regulated by the parasympathetic subdivision of the autonomic nervous system.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006028</affiliation-url><afid>60006028</afid><affilname>UNESP-Universidade Estadual Paulista</affilname><name-variant>Universidade Estadual Paulista</name-variant><affiliation-city>Sao Paulo</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013792</affiliation-url><afid>60013792</afid><affilname>Universidade Federal de Sao Carlos</affilname><name-variant>Federal University of SÃ£o Carlos</name-variant><affiliation-city>Sao Carlos</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006028</affiliation-url><afid>60006028</afid><affilname>UNESP-Universidade Estadual Paulista</affilname><name-variant>Universidade Estadual Paulista</name-variant><affiliation-city>Sao Paulo</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115264156</affiliation-url><afid>115264156</afid><affilname>FAPESP/CNPq)</affilname><name-variant>FAPESP/CNPq)</name-variant><affiliation-city>Sao Paulo</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56653004700</author-url><authid>56653004700</authid><authname>Teixeira M.</authname><surname>Teixeira</surname><given-name>Mariana Teodoro</given-name><initials>M.T.</initials><afid>60006028</afid><afid>115264156</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56653004700</author-url><authid>56653004700</authid><authname>Teixeira M.</authname><surname>Teixeira</surname><given-name>Mariana Teodoro</given-name><initials>M.T.</initials><afid>60006028</afid><afid>115264156</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56462968900</author-url><authid>56462968900</authid><authname>Armelin V.</authname><surname>Armelin</surname><given-name>Vinicius AraÃºjo</given-name><initials>V.A.</initials><afid>60013792</afid><afid>115264156</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56462968900</author-url><authid>56462968900</authid><authname>Armelin V.</authname><surname>Armelin</surname><given-name>Vinicius AraÃºjo</given-name><initials>V.A.</initials><afid>60013792</afid><afid>115264156</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56653083000</author-url><authid>56653083000</authid><authname>Abe A.</authname><surname>Abe</surname><given-name>Augusto Shinya</given-name><initials>A.S.</initials><afid>60006028</afid><afid>115264156</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56653083000</author-url><authid>56653083000</authid><authname>Abe A.</authname><surname>Abe</surname><given-name>Augusto Shinya</given-name><initials>A.S.</initials><afid>60006028</afid><afid>115264156</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7003276938</author-url><authid>7003276938</authid><authname>Rantin F.</authname><surname>Rantin</surname><given-name>Francisco Tadeu</given-name><initials>F.T.</initials><afid>60013792</afid><afid>115264156</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7003276938</author-url><authid>7003276938</authid><authname>Rantin F.</authname><surname>Rantin</surname><given-name>Francisco Tadeu</given-name><initials>F.T.</initials><afid>60013792</afid><afid>115264156</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6508355537</author-url><authid>6508355537</authid><authname>Florindo L.</authname><surname>Florindo</surname><given-name>Luiz Henrique</given-name><initials>L.H.</initials><afid>60006028</afid><afid>115264156</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6508355537</author-url><authid>6508355537</authid><authname>Florindo L.</authname><surname>Florindo</surname><given-name>Luiz Henrique</given-name><initials>L.H.</initials><afid>60006028</afid><afid>115264156</afid></author><authkeywords>African catfish | Air breathing | Autonomic control | Hypoxia | Tachycardia</authkeywords><intid>2035993049</intid><source-id>23457</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929299371"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929299371?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929299371&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929299371&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0268401215000468"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929299371</prism:url><dc:identifier>SCOPUS_ID:84929299371</dc:identifier><eid>2-s2.0-84929299371</eid><dc:title>Reflective thoughts on the potential and challenges of wearable technology for healthcare provision and medical education</dc:title><dc:creator>Sultan N.</dc:creator><prism:publicationName>International Journal of Information Management</prism:publicationName><prism:issn>02684012</prism:issn><prism:volume>35</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:pageRange>521-526</prism:pageRange><prism:coverDate>2015-05-17</prism:coverDate><prism:coverDisplayDate>17 May 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijinfomgt.2015.04.010</prism:doi><pii>S0268401215000468</pii><dc:description>Â© 2015 Elsevier Ltd. All rights reserved. Developments in digital and communication technology are now reaching the realms that border on science fiction. Computing devices are no longer items that we use in our homes and places of work and carry in our bags and pockets. We can now wear those devices. This article focuses on this development. In doing so, it explores old and recent developments in wearable technology with a focus on their current and potential use in the field of healthcare and medical education. It also highlights the challenges that are likely to face this technology. Moreover, it attempts to provide some insights into the prospects of this technology from the theoretical perspective of the theory of disruptive innovations as proposed by Clayton Christensen and his colleagues from Harvard Business School.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113109990</affiliation-url><afid>113109990</afid><affilname>A'Sharqiyah University</affilname><name-variant>A'Sharqiyah University</name-variant><affiliation-city/><affiliation-country>Oman</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">1</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:16450198300</author-url><authid>16450198300</authid><authname>Sultan N.</authname><surname>Sultan</surname><given-name>Nabil</given-name><initials>N.</initials><afid>113109990</afid></author><authkeywords>Disruptive innovations | e-Health | Healthcare | Medical education</authkeywords><intid>35943716</intid><source-id>15631</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930212961"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930212961?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930212961&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930212961&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930212961</prism:url><dc:identifier>SCOPUS_ID:84930212961</dc:identifier><eid>2-s2.0-84930212961</eid><dc:title>Potassium urinary excretion and dietary intake: a cross-sectional analysis in 8-10 year-old children</dc:title><dc:creator>Oliveira A.</dc:creator><prism:publicationName>BMC Pediatrics</prism:publicationName><prism:eIssn>14712431</prism:eIssn><prism:volume>15</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:coverDate>2015-05-17</prism:coverDate><prism:coverDisplayDate>May 17, 2015</prism:coverDisplayDate><prism:doi>10.1186/s12887-015-0374-z</prism:doi><dc:description>Â© 2015 Oliveira et al.; licensee BioMed Central. Background: Data from studies assessing the intake of potassium, and the concomitant sodium-to-potassium ratio are limited. The aim of this study was to evaluate potassium and sodium-to-potassium ratio intake in 8-10 year-old children. Methods: A cross-sectional survey was carried out from January to June 2014 and data from 163 children (81 boys) were included. Potassium intake was estimated by 24-h urine collection and coefficient of creatinine was used to validate completeness of urine collections. Urinary sodium and sodium-to-potassium ratio were also analysed. A 24-h dietary recall was used to provide information on dietary sources of potassium. Height and weight were measured according to international standards. Results: The mean urinary potassium excretion was 1701 Â± 594 mg/day in boys, and 1682 Â± 541 mg/day in girls (p = 0.835); 8.0 % of children met the WHO recommendations for potassium intake. The mean sodium excretion was 2935 Â± 1075 mg/day in boys and 2381 Â± 1045 mg/day in girls (p &lt;0.001) and urinary sodium-to-potassium ratio was 3.2 Â± 1.4 in boys, and 2.5 Â± 1.1 in girls (p = 0.002). The mean fruit and vegetable intake was 353.1 Â± 232.5 g/day in boys, and 290.8 Â± 213.1 g/day in girls (p = 0.101). Conclusions: This study reported a low compliance of potassium intake recommendations in 8-10 year-old children. Health promotion interventions are needed in order to broaden public awareness of potassium inadequacy and to increase potassium intake.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007249</affiliation-url><afid>60007249</afid><affilname>Universidade do Porto</affilname><name-variant>Universidade do Porto</name-variant><affiliation-city>Porto</affiliation-city><affiliation-country>Portugal</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007249</affiliation-url><afid>60007249</afid><affilname>Universidade do Porto</affilname><name-variant>Universidade do Porto</name-variant><affiliation-city>Porto</affiliation-city><affiliation-country>Portugal</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007249</affiliation-url><afid>60007249</afid><affilname>Universidade do Porto</affilname><name-variant>Universidade do Porto</name-variant><affiliation-city>Porto</affiliation-city><affiliation-country>Portugal</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028845</affiliation-url><afid>60028845</afid><affilname>Sao Joao Hospital</affilname><name-variant>Hospital de S. JoÃ£o</name-variant><affiliation-city>Porto</affiliation-city><affiliation-country>Portugal</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007249</affiliation-url><afid>60007249</afid><affilname>Universidade do Porto</affilname><name-variant>Universidade do Porto</name-variant><affiliation-city>Porto</affiliation-city><affiliation-country>Portugal</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007249</affiliation-url><afid>60007249</afid><affilname>Universidade do Porto</affilname><name-variant>Universidade do Porto</name-variant><affiliation-city>Porto</affiliation-city><affiliation-country>Portugal</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname/><affiliation-city>Lisbon</affiliation-city><affiliation-country>Portugal</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010502</affiliation-url><afid>60010502</afid><affilname>WHO Regional Office for Europe</affilname><name-variant>WHO</name-variant><affiliation-city>Copenhagen</affiliation-city><affiliation-country>Denmark</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007249</affiliation-url><afid>60007249</afid><affilname>Universidade do Porto</affilname><name-variant>Universidade do Porto</name-variant><affiliation-city>Porto</affiliation-city><affiliation-country>Portugal</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">17</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56662688100</author-url><authid>56662688100</authid><authname>Oliveira A.</authname><surname>Oliveira</surname><given-name>Ana Catarina</given-name><initials>A.C.</initials><afid>60007249</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55881938400</author-url><authid>55881938400</authid><authname>PadrÃ£o P.</authname><surname>PadrÃ£o</surname><given-name>PatrÃ­cia</given-name><initials>P.</initials><afid>60007249</afid><afid>60007249</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55881938400</author-url><authid>55881938400</authid><authname>PadrÃ£o P.</authname><surname>PadrÃ£o</surname><given-name>PatrÃ­cia</given-name><initials>P.</initials><afid>60007249</afid><afid>60007249</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:24332684500</author-url><authid>24332684500</authid><authname>Moreira A.</authname><surname>Moreira</surname><given-name>AndrÃ©</given-name><initials>A.</initials><afid>60007249</afid><afid>60028845</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:24332684500</author-url><authid>24332684500</authid><authname>Moreira A.</authname><surname>Moreira</surname><given-name>AndrÃ©</given-name><initials>A.</initials><afid>60007249</afid><afid>60028845</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56662722300</author-url><authid>56662722300</authid><authname>Pinto M.</authname><surname>Pinto</surname><given-name>Mariana</given-name><initials>M.</initials><afid>60007249</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56662794500</author-url><authid>56662794500</authid><authname>Neto M.</authname><surname>Neto</surname><given-name>Mafalda</given-name><initials>M.</initials><afid>60007249</afid><afid>60007249</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56662794500</author-url><authid>56662794500</authid><authname>Neto M.</authname><surname>Neto</surname><given-name>Mafalda</given-name><initials>M.</initials><afid>60007249</afid><afid>60007249</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56662779100</author-url><authid>56662779100</authid><authname>Santos T.</authname><surname>Santos</surname><given-name>TÃ¢nia</given-name><initials>T.</initials><afid>60007249</afid><afid>60007249</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56662779100</author-url><authid>56662779100</authid><authname>Santos T.</authname><surname>Santos</surname><given-name>TÃ¢nia</given-name><initials>T.</initials><afid>60007249</afid><afid>60007249</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:8881942100</author-url><authid>8881942100</authid><authname>Madureira J.</authname><surname>Madureira</surname><given-name>Joana</given-name><initials>J.</initials><afid>60007249</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:6507293275</author-url><authid>6507293275</authid><authname>de Oliveira Fernandes E.</authname><surname>de Oliveira Fernandes</surname><given-name>Eduardo</given-name><initials>E.</initials><afid>60007249</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:6602386233</author-url><authid>6602386233</authid><authname>GraÃ§a P.</authname><surname>GraÃ§a</surname><given-name>Pedro</given-name><initials>P.</initials><afid>60007249</afid><afid/></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:6602386233</author-url><authid>6602386233</authid><authname>GraÃ§a P.</authname><surname>GraÃ§a</surname><given-name>Pedro</given-name><initials>P.</initials><afid>60007249</afid><afid/></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:23003366700</author-url><authid>23003366700</authid><authname>Breda J.</authname><surname>Breda</surname><given-name>JoÃ£o</given-name><initials>J.</initials><afid>60010502</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7006510556</author-url><authid>7006510556</authid><authname>Moreira P.</authname><surname>Moreira</surname><given-name>Pedro</given-name><initials>P.</initials><afid>60007249</afid><afid>60007249</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7006510556</author-url><authid>7006510556</authid><authname>Moreira P.</authname><surname>Moreira</surname><given-name>Pedro</given-name><initials>P.</initials><afid>60007249</afid><afid>60007249</afid></author><authkeywords>24-h dietary recall questionnaire | 24-h urinary excretion | Children | Fruit and vegetable | Potassium | Sodium</authkeywords><intid>536087504</intid><article-number>60</article-number><source-id>14521</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929335806"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929335806?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929335806&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929335806&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0378874115003128"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929335806</prism:url><dc:identifier>SCOPUS_ID:84929335806</dc:identifier><eid>2-s2.0-84929335806</eid><dc:title>Frequencies and prescription patterns of traditional Chinese medicine use among elderly patients in Taiwan: A population-based study</dc:title><dc:creator>Yang P.</dc:creator><prism:publicationName>Journal of Ethnopharmacology</prism:publicationName><prism:issn>03788741</prism:issn><prism:eIssn>18727573</prism:eIssn><prism:volume>169</prism:volume><prism:pageRange>328-334</prism:pageRange><prism:coverDate>2015-05-17</prism:coverDate><prism:coverDisplayDate>17 May 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jep.2015.04.046</prism:doi><pii>S0378874115003128</pii><dc:description>Â© 2015 Elsevier Ireland Ltd. Ethnopharmacological relevance: Traditional Chinese medicine (TCM), one of the most commonly used complementary and alternative medicines, has been receiving increasing attention among elderly patients. However, epidemiological reports and prescription patterns of geriatric TCM users are few. The aim of this study is to use data from a nationwide cohort database to analyze TCM use by the geriatric population in Taiwan from 2005 to 2009. Materials and methods: TCM outpatient claims data was obtained from the Taiwan National Health Insurance database. Data for elderly patients aged 65 years and older were included in the analysis during the study period. The demographic data, disease distributions, and frequencies and prescription patterns of TCM use by the geriatric population were analyzed. Results: The geriatric cohort included 97,210 patients, in which 46,883 patients (48%) had used TCM at least once, with a total of 723,478 TCM outpatient visits. Of these, 175,857 visits (24.3%) were prompted by "diseases of the musculoskeletal system and connective tissue"; more than half of patients with such diseases were treated using acupuncture and traumatology manipulative therapies. Overall, among the 552,835 visits during which Chinese herbal products (CHP) were prescribed, Shu-Jing-Huo-Xie-Tang and Dan Shen (Radix Salvia Miltiorrhizae) were the most frequently prescribed herbal formula and single herb, respectively, for elderly patients. In addition, Shu-Jing-Huo-Xie-Tang was also the most prescribed herbal formula for the most common disease categories of "diseases of the musculoskeletal system and connective tissue" among TCM elderly patients, followed by Du-Huo-Ji-Sheng-Tang, and Shao-Yao-Gan-Cao-Tang. Conclusion: This study elucidated the TCM utilization patterns of the geriatric population. However, additional studies are warranted to determine the safety and efficacy of these CHPs for use by elderly patients in further clinical trials.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031913</affiliation-url><afid>60031913</afid><affilname>Chang Gung Memorial Hospital</affilname><name-variant>Chang Gung Memorial Hospital</name-variant><affiliation-city>Taipei</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60090105</affiliation-url><afid>60090105</afid><affilname>Chang Gung University of Science and Technology</affilname><name-variant>Chang-Gung Institute of Technology</name-variant><affiliation-city>Taoyuan</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005429</affiliation-url><afid>60005429</afid><affilname>National Taiwan University</affilname><name-variant>National Taiwan University</name-variant><affiliation-city>Taipei</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005429</affiliation-url><afid>60005429</afid><affilname>National Taiwan University</affilname><name-variant>National Taiwan University</name-variant><affiliation-city>Taipei</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60073385</affiliation-url><afid>60073385</afid><affilname>National Taiwan University Hospital</affilname><name-variant>National Taiwan University Hospital</name-variant><affiliation-city>Taipei</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56643567900</author-url><authid>56643567900</authid><authname>Yang P.</authname><surname>Yang</surname><given-name>Pei Rung</given-name><initials>P.R.</initials><afid>60031913</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56643618400</author-url><authid>56643618400</authid><authname>Liang H.</authname><surname>Liang</surname><given-name>Hwey Fang</given-name><initials>H.F.</initials><afid>60090105</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56594147500</author-url><authid>56594147500</authid><authname>Chu Y.</authname><surname>Chu</surname><given-name>Yen Hua</given-name><initials>Y.H.</initials><afid>60031913</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56593899700</author-url><authid>56593899700</authid><authname>Chen P.</authname><surname>Chen</surname><given-name>Pau Chung</given-name><initials>P.C.</initials><afid>60005429</afid><afid>60005429</afid><afid>60073385</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56593899700</author-url><authid>56593899700</authid><authname>Chen P.</authname><surname>Chen</surname><given-name>Pau Chung</given-name><initials>P.C.</initials><afid>60005429</afid><afid>60005429</afid><afid>60073385</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56593899700</author-url><authid>56593899700</authid><authname>Chen P.</authname><surname>Chen</surname><given-name>Pau Chung</given-name><initials>P.C.</initials><afid>60005429</afid><afid>60005429</afid><afid>60073385</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56643302300</author-url><authid>56643302300</authid><authname>Lin Y.</authname><surname>Lin</surname><given-name>Yin Yin</given-name><initials>Y.Y.</initials><afid>60031913</afid></author><authkeywords>elderly | National Health Insurance Research Database | Traditional Chinese medicine</authkeywords><intid>535947352</intid><source-id>23015</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929358937"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929358937?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929358937&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929358937&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0304416514003560"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929358937</prism:url><dc:identifier>SCOPUS_ID:84929358937</dc:identifier><eid>2-s2.0-84929358937</eid><dc:title>ROS, thiols and thiol-regulating systems in male gametogenesis</dc:title><dc:creator>Conrad M.</dc:creator><prism:publicationName>Biochimica et Biophysica Acta - General Subjects</prism:publicationName><prism:issn>03044165</prism:issn><prism:eIssn>18728006</prism:eIssn><prism:volume>1850</prism:volume><prism:issueIdentifier>8</prism:issueIdentifier><prism:pageRange>1566-1574</prism:pageRange><prism:coverDate>2015-05-17</prism:coverDate><prism:coverDisplayDate>17 May 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bbagen.2014.10.020</prism:doi><pii>S0304416514003560</pii><dc:description>Â© 2014 Elsevier B.V. All rights reserved. Background During maturation and storage, spermatozoa generate substantial amounts of reactive oxygen species (ROS) and are thus forced to cope with an increasingly oxidative environment that is both needed and detrimental to their biology. Such a janus-faceted intermediate needs to be tightly controlled and this is done by a wide array of redox enzymes. These enzymes not only have to prevent unspecific modifications of essential cellular biomolecules by quenching undesired ROS, but they are also required and often directly involved in critical protein modifications. Scope of review The present review is conceived to present an update on what is known about critical roles of redox enzymes, whereby special emphasis is put on the family of glutathione peroxidases, which for the time being presents the best characterized tasks during gametogenesis. Major conclusions We therefore demonstrate that understanding the function of (seleno)thiol-based oxidases/reductases is not a trivial task and relevant knowledge will be mainly gained by using robust systems, as exemplified by several (conditional) knockout studies. We thus stress the importance of using such models for providing unequivocal evidence in the molecular understanding of redox regulatory mechanisms in sperm maturation. General significance ROS are not merely detrimental by-products of metabolism and their proper generation and usage by specific enzymes is essential for vital functions as beautifully exemplified during male gametogenesis. As such, lessons learnt from thiol-based oxidases/reductases in male gametogenesis could be used as a general principle for other organs as it is most likely not only restricted to this developmental phase. This article is part of a Special Issue entitled Redox regulation of differentiation and de-differentiation.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024007</affiliation-url><afid>60024007</afid><affilname>Helmholtz Center Munich German Research Center for Environmental Health</affilname><affiliation-city>Neuherberg</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026487</affiliation-url><afid>60026487</afid><affilname>Iwate University</affilname><name-variant>Iwate University</name-variant><affiliation-city>Morioka</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7202541824</author-url><authid>7202541824</authid><authname>Conrad M.</authname><surname>Conrad</surname><given-name>Marcus</given-name><initials>M.</initials><afid>60024007</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56582244500</author-url><authid>56582244500</authid><authname>Ingold I.</authname><surname>Ingold</surname><given-name>Irina</given-name><initials>I.</initials><afid>60024007</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56644650300</author-url><authid>56644650300</authid><authname>Buday K.</authname><surname>Buday</surname><given-name>Katalin</given-name><initials>K.</initials><afid>60024007</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:49661822500</author-url><authid>49661822500</authid><authname>Kobayashi S.</authname><surname>Kobayashi</surname><given-name>Sho</given-name><initials>S.</initials><afid>60024007</afid><afid>60026487</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:49661822500</author-url><authid>49661822500</authid><authname>Kobayashi S.</authname><surname>Kobayashi</surname><given-name>Sho</given-name><initials>S.</initials><afid>60024007</afid><afid>60026487</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:12766509500</author-url><authid>12766509500</authid><authname>Angeli J.</authname><surname>Angeli</surname><given-name>Jose Pedro Friedmann</given-name><initials>J.P.F.</initials><afid>60024007</afid></author><authkeywords>Glutathione peroxidase | Oxidative stress | Selenium | Selenoproteins | Spermatogenesis</authkeywords><intid>2035938616</intid><source-id>16829</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929352923"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929352923?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929352923&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929352923&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0304416514003614"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929352923</prism:url><dc:identifier>SCOPUS_ID:84929352923</dc:identifier><eid>2-s2.0-84929352923</eid><dc:title>The circadian clock and hypoxia in tumor cell de-differentiation and metastasis</dc:title><dc:creator>Jensen L.</dc:creator><prism:publicationName>Biochimica et Biophysica Acta - General Subjects</prism:publicationName><prism:issn>03044165</prism:issn><prism:eIssn>18728006</prism:eIssn><prism:volume>1850</prism:volume><prism:issueIdentifier>8</prism:issueIdentifier><prism:pageRange>1633-1641</prism:pageRange><prism:coverDate>2015-05-17</prism:coverDate><prism:coverDisplayDate>17 May 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bbagen.2014.10.025</prism:doi><pii>S0304416514003614</pii><dc:description>Â© 2014 Elsevier B.V. All rights reserved. Background Cancer is considered to develop due to disruptions in the tissue microenvironment in addition to genetic disruptions in the tumor cells themselves. The two most important microenvironmental disruptions in cancer are arguably tissue hypoxia and disrupted circadian rhythmicity. Endothelial cells, which line the luminal side of all blood vessels transport oxygen or endocrine circadian regulators to the tissue and are therefore of key importance for circadian disruption and hypoxia in tumors. Scope of review Here I review recent findings on the role of circadian rhythms and hypoxia in cancer and metastasis, with particular emphasis on how these pathways link tumor metastasis to pathological functions of blood vessels. The involvement of disrupted cell metabolism and redox homeostasis in this context and the use of novel zebrafish models for such studies will be discussed. Major conclusions Circadian rhythms and hypoxia are involved in tumor metastasis on all levels from pathological deregulation of the cell to the tissue and the whole organism. Pathological tumor blood vessels cause hypoxia and disruption in circadian rhythmicity which in turn drives tumor metastasis. Zebrafish models may be used to increase our understanding of the mechanisms behind hypoxia and circadian regulation of metastasis. General significance Disrupted blood flow in tumors is currently seen as a therapeutic goal in cancer treatment, but may drive invasion and metastasis via pathological hypoxia and circadian clock signaling. Understanding the molecular details behind such regulation is important to optimize treatment for patients with solid tumors in the future. This article is part of a Special Issue entitled Redox regulation of differentiation and de-differentiation.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019295</affiliation-url><afid>60019295</afid><affilname>Karolinska University Hospital</affilname><name-variant>Karolinska University Hospital</name-variant><affiliation-city>Stockholm</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009358</affiliation-url><afid>60009358</afid><affilname>Linkopings universitet</affilname><name-variant>LinkÃ¶ping University</name-variant><affiliation-city>Linkoping</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:24724437000</author-url><authid>24724437000</authid><authname>Jensen L.</authname><surname>Jensen</surname><given-name>Lasse Dahl</given-name><initials>L.D.</initials><afid>60019295</afid><afid>60009358</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:24724437000</author-url><authid>24724437000</authid><authname>Jensen L.</authname><surname>Jensen</surname><given-name>Lasse Dahl</given-name><initials>L.D.</initials><afid>60019295</afid><afid>60009358</afid></author><authkeywords>Angiogenesis | Cancer | Circadian | EMT | Hypoxia | Metastasis</authkeywords><intid>2035939278</intid><source-id>16829</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929305295"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929305295?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929305295&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929305295&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0925400515005377"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929305295</prism:url><dc:identifier>SCOPUS_ID:84929305295</dc:identifier><eid>2-s2.0-84929305295</eid><dc:title>Electrochemical determination of rosuvastatin calcium in pharmaceutical and human body fluid samples using a composite of vertically aligned carbon nanotubes and graphene oxide as the electrode material</dc:title><dc:creator>Silva T.</dc:creator><prism:publicationName>Sensors and Actuators, B: Chemical</prism:publicationName><prism:issn>09254005</prism:issn><prism:volume>218</prism:volume><prism:pageRange>51-59</prism:pageRange><prism:coverDate>2015-05-17</prism:coverDate><prism:coverDisplayDate>17 May 2015</prism:coverDisplayDate><prism:doi>10.1016/j.snb.2015.04.085</prism:doi><pii>S0925400515005377</pii><dc:description>Â© 2015 Elsevier B.V. All rights reserved. A novel electrochemical method for the determination of rosuvastatin calcium (RC) using a composite of vertically aligned carbon nanotubes and graphene oxide (VACNT-GO) as the electrode material is proposed. The VACNT-GO electrode was synthesized using a microwave-assisted chemical vapor deposition method followed by oxygen plasma treatment. The VACNT-GO electrode presented superhydrophilic behavior and fast charge transfer, which are very attractive for electrochemical applications. The RC molecule presented an oxidation process at +1.26 V vs. Ag/AgCl (3.0 mol L&lt;sup&gt;-1&lt;/sup&gt; KCl) in phosphate buffer solution (pH 2), and this redox behavior was explored for its voltammetric determination. Using square-wave adsorptive anodic stripping voltammetry (SWAdASV) under optimized conditions, the analytical curve was linear in RC concentration range from 0.48 to 46.72 Î¼mol L&lt;sup&gt;-1&lt;/sup&gt; with a limit of detection of 0.06 Î¼mol L&lt;sup&gt;-1&lt;/sup&gt;. The developed SWAdASV method was applied for RC quantification in commercial pharmaceutical samples, and the results are consistent with those obtained by the comparative spectrophotometric method at a confidence level of 95%. Moreover, RC was determined in human body fluid samples of urine and human serum.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013792</affiliation-url><afid>60013792</afid><affilname>Universidade Federal de Sao Carlos</affilname><name-variant>Federal University of SÃ£o Carlos</name-variant><affiliation-city>Sao Carlos</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100618353</affiliation-url><afid>100618353</afid><affilname>Research and Development Institute</affilname><name-variant>Research and Development Consultant</name-variant><affiliation-city>Rio de Janeiro</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:110265336</affiliation-url><afid>110265336</afid><affilname>National Institute for Space Research</affilname><name-variant>National Institute for Space Research</name-variant><affiliation-city>Sao Paulo</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55542615600</author-url><authid>55542615600</authid><authname>Silva T.</authname><surname>Silva</surname><given-name>Tiago Almeida</given-name><initials>T.A.</initials><afid>60013792</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55022701000</author-url><authid>55022701000</authid><authname>Zanin H.</authname><surname>Zanin</surname><given-name>Hudson</given-name><initials>H.</initials><afid>100618353</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:36725966000</author-url><authid>36725966000</authid><authname>Vicentini F.</authname><surname>Vicentini</surname><given-name>Fernando CampanhÃ£</given-name><initials>F.C.</initials><afid>60013792</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56212745900</author-url><authid>56212745900</authid><authname>Corat E.</authname><surname>Corat</surname><given-name>Evaldo JosÃ©</given-name><initials>E.J.</initials><afid>110265336</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7005951128</author-url><authid>7005951128</authid><authname>Fatibello-Filho O.</authname><surname>Fatibello-Filho</surname><given-name>Orlando</given-name><initials>O.</initials><afid>60013792</afid></author><authkeywords>Biological samples | Carbon-carbon composite | Graphene oxide | Pharmaceutical samples | Rosuvastatin calcium | Vertically aligned carbon nanotubes</authkeywords><intid>535946898</intid><source-id>25236</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929326458"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929326458?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929326458&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929326458&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0303846715001511"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929326458</prism:url><dc:identifier>SCOPUS_ID:84929326458</dc:identifier><eid>2-s2.0-84929326458</eid><dc:title>Selective use of transradial access for endovascular treatment of severe intracranial vertebrobasilar artery stenosis</dc:title><dc:creator>Gao F.</dc:creator><prism:publicationName>Clinical Neurology and Neurosurgery</prism:publicationName><prism:issn>03038467</prism:issn><prism:eIssn>18726968</prism:eIssn><prism:volume>134</prism:volume><prism:pageRange>116-121</prism:pageRange><prism:coverDate>2015-05-17</prism:coverDate><prism:coverDisplayDate>17 May 2015</prism:coverDisplayDate><prism:doi>10.1016/j.clineuro.2015.04.015</prism:doi><pii>S0303846715001511</pii><dc:description>Â© 2015 Elsevier B.V. All rights reserved. Objective: To study the feasibility and safety of transradial artery access for endovascular intervention of severe intracranial vertebrobasilar stenosis for selected patients not suitable for transfemoral access. Methods: This was a retrospective analysis of 58 patients who had undergone intervention for severe intracranial vertebrobasilar stenosis using transradial access between January 2012 and September 2014. The reasons for transradial access were traced. The outcome measures were the technical success rate, 30-day stroke or death in the territory of the culprit artery, periprocedural and access site complication rates. Results: Out of the 58 patients, 19 patients (32.8%) used the transradial approach due to poor iliofemoral artery access, 28 (48.3%) due to unfavorable brachiocephalic or subclavian artery anatomy, 11 (19%) due to unfavorable vertebral artery anatomy. The technical success rate was 100%. There were four periprocedural complications, one of which was asymptomatic. The 30-day stroke rate was 5.2% (3/58 patients), with two of them having no residual neurological deficits. There was no mortality. None had access site complications. Conclusions: For selected patients with severe intracranial vertebrobasilar stenosis with difficult femoral access or anatomical variations precluding provision of a stable support for intracranial intervention, the transradial approach was shown to be a safe and feasible alternative route of access. Future trials of endovascular treatment for intracranial posterior circulation strokes should take into account the route of access.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026707</affiliation-url><afid>60026707</afid><affilname>Capital Medical University China</affilname><name-variant>Capital Medical University</name-variant><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114428684</affiliation-url><afid>114428684</afid><affilname>China National Clinical Research Center for Neurological Diseases</affilname><name-variant>China National Clinical Research Center for Neurological Diseases</name-variant><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114439897</affiliation-url><afid>114439897</afid><affilname>Beijing Institute for Brain Disorders</affilname><name-variant>Beijing Institute for Brain Disorders</name-variant><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014234</affiliation-url><afid>60014234</afid><affilname>Queen Elizabeth Hospital Hong Kong</affilname><name-variant>Queen Elizabeth Hospital</name-variant><affiliation-city>Hong Kong</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">19</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55758475100</author-url><authid>55758475100</authid><authname>Gao F.</authname><surname>Gao</surname><given-name>Feng</given-name><initials>F.</initials><afid>60026707</afid><afid>114428684</afid><afid>114439897</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55758475100</author-url><authid>55758475100</authid><authname>Gao F.</authname><surname>Gao</surname><given-name>Feng</given-name><initials>F.</initials><afid>60026707</afid><afid>114428684</afid><afid>114439897</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55758475100</author-url><authid>55758475100</authid><authname>Gao F.</authname><surname>Gao</surname><given-name>Feng</given-name><initials>F.</initials><afid>60026707</afid><afid>114428684</afid><afid>114439897</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56643981500</author-url><authid>56643981500</authid><authname>Lo W.</authname><surname>Lo</surname><given-name>WaiTing Joyce</given-name><initials>W.J.</initials><afid>60014234</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56626570300</author-url><authid>56626570300</authid><authname>Sun X.</authname><surname>Sun</surname><given-name>Xuan</given-name><initials>X.</initials><afid>60026707</afid><afid>114428684</afid><afid>114439897</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56626570300</author-url><authid>56626570300</authid><authname>Sun X.</authname><surname>Sun</surname><given-name>Xuan</given-name><initials>X.</initials><afid>60026707</afid><afid>114428684</afid><afid>114439897</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56626570300</author-url><authid>56626570300</authid><authname>Sun X.</authname><surname>Sun</surname><given-name>Xuan</given-name><initials>X.</initials><afid>60026707</afid><afid>114428684</afid><afid>114439897</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56519100200</author-url><authid>56519100200</authid><authname>Ma N.</authname><surname>Ma</surname><given-name>Ning</given-name><initials>N.</initials><afid>60026707</afid><afid>114428684</afid><afid>114439897</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56519100200</author-url><authid>56519100200</authid><authname>Ma N.</authname><surname>Ma</surname><given-name>Ning</given-name><initials>N.</initials><afid>60026707</afid><afid>114428684</afid><afid>114439897</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56519100200</author-url><authid>56519100200</authid><authname>Ma N.</authname><surname>Ma</surname><given-name>Ning</given-name><initials>N.</initials><afid>60026707</afid><afid>114428684</afid><afid>114439897</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56602445000</author-url><authid>56602445000</authid><authname>Mo D.</authname><surname>Mo</surname><given-name>DaPeng</given-name><initials>D.</initials><afid>60026707</afid><afid>114428684</afid><afid>114439897</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56602445000</author-url><authid>56602445000</authid><authname>Mo D.</authname><surname>Mo</surname><given-name>DaPeng</given-name><initials>D.</initials><afid>60026707</afid><afid>114428684</afid><afid>114439897</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56602445000</author-url><authid>56602445000</authid><authname>Mo D.</authname><surname>Mo</surname><given-name>DaPeng</given-name><initials>D.</initials><afid>60026707</afid><afid>114428684</afid><afid>114439897</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56626566100</author-url><authid>56626566100</authid><authname>Xu X.</authname><surname>Xu</surname><given-name>XiaoTong</given-name><initials>X.</initials><afid>60026707</afid><afid>114428684</afid><afid>114439897</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56626566100</author-url><authid>56626566100</authid><authname>Xu X.</authname><surname>Xu</surname><given-name>XiaoTong</given-name><initials>X.</initials><afid>60026707</afid><afid>114428684</afid><afid>114439897</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56626566100</author-url><authid>56626566100</authid><authname>Xu X.</authname><surname>Xu</surname><given-name>XiaoTong</given-name><initials>X.</initials><afid>60026707</afid><afid>114428684</afid><afid>114439897</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7101812564</author-url><authid>7101812564</authid><authname>Miao Z.</authname><surname>Miao</surname><given-name>ZhongRong</given-name><initials>Z.</initials><afid>60026707</afid><afid>114428684</afid><afid>114439897</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7101812564</author-url><authid>7101812564</authid><authname>Miao Z.</authname><surname>Miao</surname><given-name>ZhongRong</given-name><initials>Z.</initials><afid>60026707</afid><afid>114428684</afid><afid>114439897</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7101812564</author-url><authid>7101812564</authid><authname>Miao Z.</authname><surname>Miao</surname><given-name>ZhongRong</given-name><initials>Z.</initials><afid>60026707</afid><afid>114428684</afid><afid>114439897</afid></author><authkeywords>Angioplasty | Endovascular | Radial artery | Stenosis | Transradial</authkeywords><intid>35945815</intid><source-id>14895</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929376547"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929376547?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929376547&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929376547&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0168365915003016"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929376547</prism:url><dc:identifier>SCOPUS_ID:84929376547</dc:identifier><eid>2-s2.0-84929376547</eid><dc:title>New trends in guided nanotherapies for digestive cancers: A systematic review</dc:title><dc:creator>Fernandes E.</dc:creator><prism:publicationName>Journal of Controlled Release</prism:publicationName><prism:issn>01683659</prism:issn><prism:eIssn>18734995</prism:eIssn><prism:volume>209</prism:volume><prism:pageRange>288-307</prism:pageRange><prism:coverDate>2015-05-17</prism:coverDate><prism:coverDisplayDate>17 May 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jconrel.2015.05.003</prism:doi><pii>S0168365915003016</pii><dc:description>Â© 2015 Elsevier B.V. All rights reserved. Digestive tract tumors are among the most common and deadliest malignancies worldwide, mainly due to late diagnosis and lack of efficient therapeutics. Current treatments essentially rely on surgery associated with (neo)adjuvant chemotherapy agents. Despite an upfront response, conventional drugs often fail to eliminate highly aggressive clones endowed with chemoresistant properties, which are responsible for tumor recurrence and disease dissemination. Synthetic drugs also present severe adverse systemic effects, hampering the administration of biologically effective dosages. Nanoencapsulation of chemotherapeutic agents within biocompatible polymeric or lipid matrices holds great potential to improve the pharmacokinetics and efficacy of conventional chemotherapy while reducing systemic toxicity. Tagging nanoparticle surfaces with specific ligands for cancer cells, namely monoclonal antibodies or antibody fragments, has provided means to target more aggressive clones, further improving the selectivity and efficacy of nanodelivery vehicles. In fact, over the past twenty years, significant research has translated into a wide array of guided nanoparticles, providing the molecular background for a new generation of intelligent and more effective anti-cancer agents. Attempting to bring awareness among the medical community to emerging targeted nanopharmaceuticals and foster advances in the field, we have conducted a systematic review about this matter. Emphasis was set on ongoing preclinical and clinical trials for liver, colorectal, gastric and pancreatic cancers. To the best of our knowledge this is the first systematic and integrated overview on this field. Using a specific query, 433 abstracts were gathered and narrowed to 47 manuscripts when matched against inclusion/exclusion criteria. All studies showed that active targeting improves the effectiveness of the nanodrugs alone, while lowering its side effects. The main focus has been on hepatocarcinomas, mainly by exploring glycans as homing molecules. Other ligands such as peptides/small proteins and antibodies/antibody fragments, with affinity to either tumor vasculature or tumor cells, have also been widely and successfully applied to guide nanodrugs to gastrointestinal carcinomas. Conversely, few solutions have been presented for pancreatic tumors. To this date only three nanocomplexes have progressed beyond pre-clinical stages: i) PK2, a galactosamine-functionalized polymeric-DOX formulation for hepatocarcinomas; ii) MCC-465, an anti-(myosin heavy chain a) immunoliposome for advanced stage metastatic solid tumors; and iii) MBP-426, a transferrin-liposome-oxaliplatin conjugate, also for advanced stage tumors. Still, none has been approved for clinical use. However, based on the high amount of pre-clinical studies showing enthusiastic results, the number of clinical trials is expected to increase in the near future. A more profound understanding about the molecular nature of chemoresistant clones and cancer stem cell biology will also contribute to boost the field of guided nanopharmacology towards more effective solutions.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003102</affiliation-url><afid>60003102</afid><affilname>Instituto Portugues de Oncologia de Francisco Gentil Porto</affilname><name-variant>Portuguese Oncology Institute</name-variant><affiliation-city>Porto</affiliation-city><affiliation-country>Portugal</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007249</affiliation-url><afid>60007249</afid><affilname>Universidade do Porto</affilname><name-variant>Universidade do Porto</name-variant><affiliation-city>Porto</affiliation-city><affiliation-country>Portugal</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007249</affiliation-url><afid>60007249</afid><affilname>Universidade do Porto</affilname><name-variant>Universidade do Porto</name-variant><affiliation-city>Porto</affiliation-city><affiliation-country>Portugal</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024825</affiliation-url><afid>60024825</afid><affilname>Universidade de Aveiro</affilname><name-variant>Universidade de Aveiro</name-variant><affiliation-city>Aveiro</affiliation-city><affiliation-country>Portugal</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013835</affiliation-url><afid>60013835</afid><affilname>Instituto Politcnico do Porto</affilname><name-variant>Polytechnic Institute of Porto</name-variant><affiliation-city>Porto</affiliation-city><affiliation-country>Portugal</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100597722</affiliation-url><afid>100597722</afid><affilname>Hospital Distrital de Evora</affilname><name-variant>Hospital de Ãvora</name-variant><affiliation-city>Evora</affiliation-city><affiliation-country>Portugal</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60034027</affiliation-url><afid>60034027</afid><affilname>Cooperativa de Ensino Superior, Politecnico e Universitario</affilname><name-variant>CESPU</name-variant><affiliation-city>Paredes</affiliation-city><affiliation-country>Portugal</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019826</affiliation-url><afid>60019826</afid><affilname>Universidade Fernando Pessoa</affilname><name-variant>University Fernando Pessoa</name-variant><affiliation-city>Porto</affiliation-city><affiliation-country>Portugal</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003102</affiliation-url><afid>60003102</afid><affilname>Instituto Portugues de Oncologia de Francisco Gentil Porto</affilname><name-variant>Portuguese Oncology Institute</name-variant><affiliation-city>Porto</affiliation-city><affiliation-country>Portugal</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">15</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55963109200</author-url><authid>55963109200</authid><authname>Fernandes E.</authname><surname>Fernandes</surname><given-name>Elisabete</given-name><initials>E.</initials><afid>60003102</afid><afid>60007249</afid><afid>60007249</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55963109200</author-url><authid>55963109200</authid><authname>Fernandes E.</authname><surname>Fernandes</surname><given-name>Elisabete</given-name><initials>E.</initials><afid>60003102</afid><afid>60007249</afid><afid>60007249</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55963109200</author-url><authid>55963109200</authid><authname>Fernandes E.</authname><surname>Fernandes</surname><given-name>Elisabete</given-name><initials>E.</initials><afid>60003102</afid><afid>60007249</afid><afid>60007249</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55939200600</author-url><authid>55939200600</authid><authname>Ferreira J.</authname><surname>Ferreira</surname><given-name>JosÃ© Alexandre</given-name><initials>J.A.</initials><afid>60003102</afid><afid>60024825</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55939200600</author-url><authid>55939200600</authid><authname>Ferreira J.</authname><surname>Ferreira</surname><given-name>JosÃ© Alexandre</given-name><initials>J.A.</initials><afid>60003102</afid><afid>60024825</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56644943100</author-url><authid>56644943100</authid><authname>Andreia P.</authname><surname>Andreia</surname><given-name>Peixoto</given-name><initials>P.</initials><afid>60003102</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56644515600</author-url><authid>56644515600</authid><authname>LuÃ­s L.</authname><surname>LuÃ­s</surname><given-name>Lima</given-name><initials>L.</initials><afid>60003102</afid><afid>60013835</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56644515600</author-url><authid>56644515600</authid><authname>LuÃ­s L.</authname><surname>LuÃ­s</surname><given-name>Lima</given-name><initials>L.</initials><afid>60003102</afid><afid>60013835</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56644380800</author-url><authid>56644380800</authid><authname>Barroso S.</authname><surname>Barroso</surname><given-name>SÃ©rgio</given-name><initials>S.</initials><afid>100597722</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:14014524100</author-url><authid>14014524100</authid><authname>Sarmento B.</authname><surname>Sarmento</surname><given-name>Bruno</given-name><initials>B.</initials><afid>60007249</afid><afid>60007249</afid><afid>60034027</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:14014524100</author-url><authid>14014524100</authid><authname>Sarmento B.</authname><surname>Sarmento</surname><given-name>Bruno</given-name><initials>B.</initials><afid>60007249</afid><afid>60007249</afid><afid>60034027</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:14014524100</author-url><authid>14014524100</authid><authname>Sarmento B.</authname><surname>Sarmento</surname><given-name>Bruno</given-name><initials>B.</initials><afid>60007249</afid><afid>60007249</afid><afid>60034027</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7202566947</author-url><authid>7202566947</authid><authname>Santos L.</authname><surname>Santos</surname><given-name>LÃºcio Lara</given-name><initials>L.L.</initials><afid>60003102</afid><afid>60019826</afid><afid>60003102</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7202566947</author-url><authid>7202566947</authid><authname>Santos L.</authname><surname>Santos</surname><given-name>LÃºcio Lara</given-name><initials>L.L.</initials><afid>60003102</afid><afid>60019826</afid><afid>60003102</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7202566947</author-url><authid>7202566947</authid><authname>Santos L.</authname><surname>Santos</surname><given-name>LÃºcio Lara</given-name><initials>L.L.</initials><afid>60003102</afid><afid>60019826</afid><afid>60003102</afid></author><intid>35943043</intid><source-id>23010</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929321195"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929321195?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929321195&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929321195&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0196978115001424"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929321195</prism:url><dc:identifier>SCOPUS_ID:84929321195</dc:identifier><eid>2-s2.0-84929321195</eid><dc:title>The activity of the nonsulfated sulfakinin Zopat-SK-1 in the neck-ligated larvae of the beetle Zophobas atratus</dc:title><dc:creator>Slocinska M.</dc:creator><prism:publicationName>Peptides</prism:publicationName><prism:issn>01969781</prism:issn><prism:eIssn>18735169</prism:eIssn><prism:volume>69</prism:volume><prism:pageRange>127-132</prism:pageRange><prism:coverDate>2015-05-17</prism:coverDate><prism:coverDisplayDate>17 May 2015</prism:coverDisplayDate><prism:doi>10.1016/j.peptides.2015.04.023</prism:doi><pii>S0196978115001424</pii><dc:description>Â© 2015 Elsevier Inc. All rights reserved. Insect sulfakinins (SKs) are multifunctional neuropeptides structurally and functionally homologous to the mammalian gastrin/cholecystokinin (CCK). It has been proposed that SKs play a role in modulating energy management in insects by interacting with adipokinetic hormone (AKH), the principle hormone controlling insect intermediary metabolism. To exclude head factors (including AKH) that influence the activity of the nonsulfated sulfakinin Zopat-SK-1 in the larvae of the beetle Zophobas atratus, ligature and in vitro bioassays were used. Our study showed that in the neck-ligated larvae, Zopat-SK-1 evoked a much more pronounced glycogenolytic effect in fat body tissue and a significantly higher hypertrahelosemic effect in hemolymph than in larvae without ligation. We found that the concentration of the sugar trehalose increased under hormonal treatment but no changes in glucose levels were observed. Under in vitro conditions, the maximal glycogenolytic effect of Zopat-SK-1 in fat body was observed at 10 pmol of hormone. Ligature and in vitro bioassays indicated that Zopat-SK-1 activity in the Z. atratus larvae is modulated by head signals and/or factors from the gastrointestinal tract. Our data indicate the existence of a brain-gastrointestinal axis that has a role in controlling of energy (carbohydrate) metabolism in the insect body. Moreover, these results, together with immunological evidence of a cholecystokinin-like (sulfakinin) receptor in the Z. atratus fat body, help us to better understand the SK signaling pathways and its physiological role in insect biology.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014168</affiliation-url><afid>60014168</afid><affilname>Uniwersytet im. Adama Mickiewicza w Poznaniu</affilname><name-variant>A. Mickiewicz University</name-variant><affiliation-city>Poznan</affiliation-city><affiliation-country>Poland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014168</affiliation-url><afid>60014168</afid><affilname>Uniwersytet im. Adama Mickiewicza w Poznaniu</affilname><name-variant>A. Mickiewicz University</name-variant><affiliation-city>Poznan</affiliation-city><affiliation-country>Poland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:24469178400</author-url><authid>24469178400</authid><authname>Slocinska M.</authname><surname>Slocinska</surname><given-name>M.</given-name><initials>M.</initials><afid>60014168</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:49961233200</author-url><authid>49961233200</authid><authname>Czubak T.</authname><surname>Czubak</surname><given-name>T.</given-name><initials>T.</initials><afid>60014168</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:24468525900</author-url><authid>24468525900</authid><authname>Marciniak P.</authname><surname>Marciniak</surname><given-name>P.</given-name><initials>P.</initials><afid>60014168</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7003704960</author-url><authid>7003704960</authid><authname>Jarmuszkiewicz W.</authname><surname>Jarmuszkiewicz</surname><given-name>W.</given-name><initials>W.</initials><afid>60014168</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6602141855</author-url><authid>6602141855</authid><authname>Rosinski G.</authname><surname>Rosinski</surname><given-name>G.</given-name><initials>G.</initials><afid>60014168</afid></author><authkeywords>Fat body | Insect | Ligation | Nonsulfated sulfakinin | Zopat-SK-1 | Zophobas atratus</authkeywords><intid>535945503</intid><source-id>14222</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929301918"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929301918?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929301918&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929301918&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0269749115002377"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929301918</prism:url><dc:identifier>SCOPUS_ID:84929301918</dc:identifier><eid>2-s2.0-84929301918</eid><dc:title>Characteristics of air pollutant dispersion around a high-rise building</dc:title><dc:creator>Zhang Y.</dc:creator><prism:publicationName>Environmental Pollution</prism:publicationName><prism:issn>02697491</prism:issn><prism:eIssn>18736424</prism:eIssn><prism:volume>204</prism:volume><prism:pageRange>280-288</prism:pageRange><prism:coverDate>2015-05-17</prism:coverDate><prism:coverDisplayDate>17 May 2015</prism:coverDisplayDate><prism:doi>10.1016/j.envpol.2015.05.004</prism:doi><pii>S0269749115002377</pii><dc:description>Â© 2015 Elsevier Ltd. All rights reserved. A numerical wind tunnel model was proposed. The computed results of the pollutant diffusion around a typical Hong Kong high-rise building model (at a linear scale of 1:30), were found to show a similar trend to the outcomes of self-conducted experimental measurements that the pathways of pollutant migration for windward and leeward pollutant emission are different. For the case with windward pollutant emission at the 3rd floor within a re-entry, the pollutant migrated downwards due to the downwash created by the wind. In contrast, for the case with leeward pollution emission, dispersion is dominated by intense turbulent mixing in the near wake and characterized by the upward migration of the pollutant in the leeward re-entry. The simulated results of haze-fog (HF) studies confirm that the pathway of pollutant migration is dominated by wind-structure interaction and buoyancy effect only plays a minor role in the dispersion process.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017803</affiliation-url><afid>60017803</afid><affilname>University of Western Sydney</affilname><name-variant>University of Western Sydney</name-variant><affiliation-city>Penrith</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025278</affiliation-url><afid>60025278</afid><affilname>Tsinghua University</affilname><name-variant>Tsinghua University</name-variant><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002836</affiliation-url><afid>60002836</afid><affilname>Hefei University of Technology</affilname><name-variant>Hefei University of Technology</name-variant><affiliation-city>Hefei</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008928</affiliation-url><afid>60008928</afid><affilname>Hong Kong Polytechnic University</affilname><name-variant>The Hong Kong Polytechnic University</name-variant><affiliation-city>Hong Kong</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56645021100</author-url><authid>56645021100</authid><authname>Zhang Y.</authname><surname>Zhang</surname><given-name>Y.</given-name><initials>Y.</initials><afid>60017803</afid><afid>60025278</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56645021100</author-url><authid>56645021100</authid><authname>Zhang Y.</authname><surname>Zhang</surname><given-name>Y.</given-name><initials>Y.</initials><afid>60017803</afid><afid>60025278</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7102194358</author-url><authid>7102194358</authid><authname>Kwok K.</authname><surname>Kwok</surname><given-name>K. C S</given-name><initials>K.C.S.</initials><afid>60017803</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56644018800</author-url><authid>56644018800</authid><authname>Liu X.</authname><surname>Liu</surname><given-name>X. P.</given-name><initials>X.P.</initials><afid>60002836</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56412386500</author-url><authid>56412386500</authid><authname>Niu J.</authname><surname>Niu</surname><given-name>J. L.</given-name><initials>J.L.</initials><afid>60008928</afid></author><authkeywords>Air pollutant | CFD | High-rise building | Leeward emission | Windward emission</authkeywords><intid>35943216</intid><source-id>23916</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929376896"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929376896?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929376896&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929376896&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0924424715002216"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929376896</prism:url><dc:identifier>SCOPUS_ID:84929376896</dc:identifier><eid>2-s2.0-84929376896</eid><dc:title>Transient submicron temperature imaging based on the fluorescence emission in an Er/Yb co-doped glass-ceramic</dc:title><dc:creator>Sedmak I.</dc:creator><prism:publicationName>Sensors and Actuators, A: Physical</prism:publicationName><prism:issn>09244247</prism:issn><prism:volume>230</prism:volume><prism:pageRange>102-110</prism:pageRange><prism:coverDate>2015-05-17</prism:coverDate><prism:coverDisplayDate>17 May 2015</prism:coverDisplayDate><prism:doi>10.1016/j.sna.2015.05.001</prism:doi><pii>S0924424715002216</pii><dc:description>Â© 2015 Elsevier B.V. All rights reserved. A comprehensive understanding of the transient heat- and mass-transfer processes on the submicron scale requires the development of novel, non-invasive, temperature-measurement techniques. Here, we present a fluorescence-based method for the non-invasive characterization of transient temperature fields on a submicron scale using a temperature-sensitive erbium/ytterbium co-doped transparent glass-ceramic. This inorganic material is more stable against degradation and photobleaching than traditional organic dyes. Transient heat-conduction experiments were performed on an Er:GPF1Yb0.5Er glass-ceramic sample, which was simultaneously used as a temperature sensor. The temperatures were determined by measuring the fluorescence spectrum and by measuring the intensity variations of the emission spectrum in the temperature range between 25 and 150Â°C. A spatial resolution of 400 nm was achieved across an approximately 200 Î¼m x 200 Î¼m field of view at an imaging frequency of 7 Hz. The conducted experiments demonstrate that Er-doped glass-ceramics permit non-invasive and transient thermal imaging and can be adopted for the analysis of heat-transfer processes on submicron scales.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031106</affiliation-url><afid>60031106</afid><affilname>University of Ljubljana</affilname><name-variant>University of Ljubljana</name-variant><affiliation-city>Ljubljana</affiliation-city><affiliation-country>Slovenia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023955</affiliation-url><afid>60023955</afid><affilname>Jozef Stefan Institute</affilname><name-variant>J. Stefan Institute</name-variant><affiliation-city>Ljubljana</affiliation-city><affiliation-country>Slovenia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008310</affiliation-url><afid>60008310</afid><affilname>Ecole Nationale Superieure de Chimie de Paris</affilname><name-variant>Ecole Nationale SupÃ©rieure de Chimie de Paris</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55279834400</author-url><authid>55279834400</authid><authname>Sedmak I.</authname><surname>Sedmak</surname><given-name>Ivan</given-name><initials>I.</initials><afid>60031106</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:25925479600</author-url><authid>25925479600</authid><authname>UrbanÄiÄ I.</authname><surname>UrbanÄiÄ</surname><given-name>Iztok</given-name><initials>I.</initials><afid>60023955</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6602433094</author-url><authid>6602433094</authid><authname>Å trancar J.</authname><surname>Å trancar</surname><given-name>Janez</given-name><initials>J.</initials><afid>60023955</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7003743029</author-url><authid>7003743029</authid><authname>Mortier M.</authname><surname>Mortier</surname><given-name>Michel</given-name><initials>M.</initials><afid>60008310</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56145107100</author-url><authid>56145107100</authid><authname>GolobiÄ I.</authname><surname>GolobiÄ</surname><given-name>Iztok</given-name><initials>I.</initials><afid>60031106</afid></author><authkeywords>Submicron spatial resolution | Temperature-dependent fluorescence | Transient thermal imaging | Transparent glass-ceramics</authkeywords><intid>535947229</intid><source-id>13660</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929378831"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929378831?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929378831&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929378831&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1369847815000753"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929378831</prism:url><dc:identifier>SCOPUS_ID:84929378831</dc:identifier><eid>2-s2.0-84929378831</eid><dc:title>Towards testing auditory-vocal interfaces and detecting distraction while driving: A comparison of eye-movement measures in the assessment of cognitive workload</dc:title><dc:creator>Niezgoda M.</dc:creator><prism:publicationName>Transportation Research Part F: Traffic Psychology and Behaviour</prism:publicationName><prism:issn>13698478</prism:issn><prism:volume>32</prism:volume><prism:pageRange>23-34</prism:pageRange><prism:coverDate>2015-05-17</prism:coverDate><prism:coverDisplayDate>17 May 2015</prism:coverDisplayDate><prism:doi>10.1016/j.trf.2015.04.012</prism:doi><pii>S1369847815000753</pii><dc:description>Â© 2015 Elsevier Ltd. Recently, there has been a growing need among researchers to understand the problem of cognitive workload induced by auditory-verbal-vocal tasks while driving in realistic conditions. This is due to the fact that we need (a) valid methods to evaluate in-vehicle electronic devices using voice control systems and (b) experimental data to build more reliable driver state monitoring systems. In this study, we examined the effects of cognitive workload induced by the delayed digit recall task (n-back) while driving. We used a high-fidelity driving simulator and a highway scenario with moderate traffic to study eye movements in realistic driving conditions. This study included 46 participants, and the results indicate that a change in pupil size is most sensitive for measuring changes in cognitive demand in auditory-verbal-vocal tasks. Less sensitive measures included changes in fixation location and blink rate. Fixation durations and the driving performance metrics did not provide sensitive measures of graded levels of cognitive demand.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100564071</affiliation-url><afid>100564071</afid><affilname>Motor Transport Institute</affilname><name-variant>Motor Transport Institute</name-variant><affiliation-city>Poznan</affiliation-city><affiliation-country>Poland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013756</affiliation-url><afid>60013756</afid><affilname>Uniwersytet Warszawski</affilname><name-variant>Warsaw University</name-variant><affiliation-city>Warsaw</affiliation-city><affiliation-country>Poland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56644420800</author-url><authid>56644420800</authid><authname>Niezgoda M.</authname><surname>Niezgoda</surname><given-name>Michal</given-name><initials>M.</initials><afid>100564071</afid><afid>60013756</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56644420800</author-url><authid>56644420800</authid><authname>Niezgoda M.</authname><surname>Niezgoda</surname><given-name>Michal</given-name><initials>M.</initials><afid>100564071</afid><afid>60013756</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:16445349800</author-url><authid>16445349800</authid><authname>Tarnowski A.</authname><surname>Tarnowski</surname><given-name>Adam</given-name><initials>A.</initials><afid>60013756</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56644414000</author-url><authid>56644414000</authid><authname>Kruszewski M.</authname><surname>Kruszewski</surname><given-name>MikoÅaj</given-name><initials>M.</initials><afid>100564071</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:23018630100</author-url><authid>23018630100</authid><authname>KamiÅski T.</authname><surname>KamiÅski</surname><given-name>Tomasz</given-name><initials>T.</initials><afid>100564071</afid></author><authkeywords>Auditory-vocal interfaces | Cognitive workload | Distraction detection | Driving simulator | Eye movements | n-back</authkeywords><intid>2035940211</intid><source-id>20897</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929470076"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929470076?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929470076&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929470076&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929470076</prism:url><dc:identifier>SCOPUS_ID:84929470076</dc:identifier><eid>2-s2.0-84929470076</eid><dc:title>The loss in expectation of life after colon cancer: A population-based study</dc:title><dc:creator>Andersson T.</dc:creator><prism:publicationName>BMC Cancer</prism:publicationName><prism:eIssn>14712407</prism:eIssn><prism:volume>15</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:coverDate>2015-05-17</prism:coverDate><prism:coverDisplayDate>May 17, 2015</prism:coverDisplayDate><prism:doi>10.1186/s12885-015-1427-2</prism:doi><dc:description>Â© 2015 Andersson et al.; licensee BioMed Central. To demonstrate how assessment of life expectancy and loss in expectation of life can be used to address a wide range of research questions of public health interest pertaining to the prognosis of cancer patients. Methods: We identified 135,092 cases of colon adenocarcinoma diagnosed during 1961-2011 from the population-based Swedish Cancer Register. Flexible parametric survival models for relative survival were used to estimate the life expectancy and the loss in expectation of life. Results: The loss in expectation of life for males aged 55 at diagnosis was 13.5 years (95 % CI 13.2-13.8) in 1965 and 12.8 (12.4-13.3) in 2005. For males aged 85 the corresponding figures were 3.21 (3.15-3.28) and 2.10 (2.04-2.17). The pattern was similar for females, but slightly greater loss in expectation of life. The loss in expectation of life is reduced given survival up to a certain time point post diagnosis. Among patients diagnosed in 2011, 945 life years could potentially be saved if the colon cancer survival among males could be brought to the same level as for females. Conclusion: Assessment of loss in expectation of life facilitates the understanding of the impact of cancer, both on individual and population level. Clear improvements in survival among colon cancer patients have led to a gain in life expectancy, partly due to a general increase in survival from all causes.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012311</affiliation-url><afid>60012311</afid><affilname>Karolinska Institutet</affilname><name-variant>Karolinska Institutet</name-variant><affiliation-city>Stockholm</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019295</affiliation-url><afid>60019295</afid><affilname>Karolinska University Hospital</affilname><name-variant>Karolinska University Hospital</name-variant><affiliation-city>Stockholm</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015216</affiliation-url><afid>60015216</afid><affilname>Akademiska Sjukhuset</affilname><name-variant>University Hospital</name-variant><affiliation-city>Uppsala</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60033125</affiliation-url><afid>60033125</afid><affilname>University of Leicester</affilname><name-variant>University of Leicester</name-variant><affiliation-city>Leicester</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:26537019100</author-url><authid>26537019100</authid><authname>Andersson T.</authname><surname>Andersson</surname><given-name>Therese M L</given-name><initials>T.M.L.</initials><afid>60012311</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7005513937</author-url><authid>7005513937</authid><authname>Dickman P.</authname><surname>Dickman</surname><given-name>Paul W.</given-name><initials>P.W.</initials><afid>60012311</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:25222710200</author-url><authid>25222710200</authid><authname>Eloranta S.</authname><surname>Eloranta</surname><given-name>Sandra</given-name><initials>S.</initials><afid>60012311</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56647910400</author-url><authid>56647910400</authid><authname>SjÃ¶vall A.</authname><surname>SjÃ¶vall</surname><given-name>Annika</given-name><initials>A.</initials><afid>60019295</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55794071700</author-url><authid>55794071700</authid><authname>Lambe M.</authname><surname>Lambe</surname><given-name>Mats</given-name><initials>M.</initials><afid>60012311</afid><afid>60015216</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55794071700</author-url><authid>55794071700</authid><authname>Lambe M.</authname><surname>Lambe</surname><given-name>Mats</given-name><initials>M.</initials><afid>60012311</afid><afid>60015216</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7402303348</author-url><authid>7402303348</authid><authname>Lambert P.</authname><surname>Lambert</surname><given-name>Paul C.</given-name><initials>P.C.</initials><afid>60012311</afid><afid>60033125</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7402303348</author-url><authid>7402303348</authid><authname>Lambert P.</authname><surname>Lambert</surname><given-name>Paul C.</given-name><initials>P.C.</initials><afid>60012311</afid><afid>60033125</afid></author><authkeywords>Colon cancer | Flexible parametric model | Life expectancy | Life years lost | Population-based | Survival | Sweden</authkeywords><intid>535964667</intid><article-number>412</article-number><source-id>28747</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929688318"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929688318?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929688318&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929688318&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929688318</prism:url><dc:identifier>SCOPUS_ID:84929688318</dc:identifier><eid>2-s2.0-84929688318</eid><dc:title>Frailty in advanced heart failure: a systematic review</dc:title><dc:creator>Jha S.</dc:creator><prism:publicationName>Heart Failure Reviews</prism:publicationName><prism:issn>13824147</prism:issn><prism:eIssn>15737322</prism:eIssn><prism:coverDate>2015-05-16</prism:coverDate><prism:coverDisplayDate>16 May 2015</prism:coverDisplayDate><prism:doi>10.1007/s10741-015-9493-8</prism:doi><dc:description>Â© 2015 Springer Science+Business Media New York Frailty is a common geriatric syndrome of increased vulnerability to adverse events. The prevalence of frailty among chronic heart failure (CHF) is high and confers a greater risk of adverse events including falls, hospitalisation and mortality. There have been few studies assessing frailty in CHF. A review of the key databases was conducted from 2004 to 2014 including the key search terms âfrail elderlyâ and âheart failureâ. The following electronic databases were searched: Medline, Cumulative Index for Nursing and Allied Health and Academic Search Complete, with reference lists being manually searched. Articles were included if frailty was assessed using a valid measuring tool in a population with a confirmed diagnosis of CHF. The search yielded a total of 393 articles with 8 articles being selected for review. The prevalence of frailty among those with CHF was high, ranging from 18 to 54 %. The frailty phenotype and geriatric assessments tools were the most common frailty measures utilised; high rates of co-morbidity, hospitalisation and mortality were identified. Frailty is common in CHF and is associated with adverse outcomes.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023932</affiliation-url><afid>60023932</afid><affilname>University of Technology Sydney</affilname><name-variant>University of Technology</name-variant><affiliation-city>Sydney</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028333</affiliation-url><afid>60028333</afid><affilname>University of New South Wales (UNSW) Australia</affilname><name-variant>University of New South Wales</name-variant><affiliation-city>Sydney</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023932</affiliation-url><afid>60023932</afid><affilname>University of Technology Sydney</affilname><name-variant>University of Technology</name-variant><affiliation-city>Sydney</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025702</affiliation-url><afid>60025702</afid><affilname>St. Vincent's Hospital Sydney</affilname><name-variant>St Vincent's Hospital</name-variant><affiliation-city>Sydney</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005248</affiliation-url><afid>60005248</afid><affilname>Johns Hopkins University</affilname><name-variant>Johns Hopkins University</name-variant><affiliation-city>Baltimore</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028061</affiliation-url><afid>60028061</afid><affilname>Victor Chang Cardiac Research Institute</affilname><name-variant>Victor Chang Cardiac Research Institute</name-variant><affiliation-city>Sydney</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56653032500</author-url><authid>56653032500</authid><authname>Jha S.</authname><surname>Jha</surname><given-name>Sunita R.</given-name><initials>S.R.</initials><afid>60023932</afid><afid>60025702</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56653032500</author-url><authid>56653032500</authid><authname>Jha S.</authname><surname>Jha</surname><given-name>Sunita R.</given-name><initials>S.R.</initials><afid>60023932</afid><afid>60025702</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56653038500</author-url><authid>56653038500</authid><authname>Ha H.</authname><surname>Ha</surname><given-name>Hakeem S K</given-name><initials>H.S.K.</initials><afid>60028333</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55793556200</author-url><authid>55793556200</authid><authname>Hickman L.</authname><surname>Hickman</surname><given-name>Louise D.</given-name><initials>L.D.</initials><afid>60023932</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56653399000</author-url><authid>56653399000</authid><authname>Hannu M.</authname><surname>Hannu</surname><given-name>Malin</given-name><initials>M.</initials><afid>60025702</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56427539900</author-url><authid>56427539900</authid><authname>Davidson P.</authname><surname>Davidson</surname><given-name>Patricia M.</given-name><initials>P.M.</initials><afid>60023932</afid><afid>60005248</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56427539900</author-url><authid>56427539900</authid><authname>Davidson P.</authname><surname>Davidson</surname><given-name>Patricia M.</given-name><initials>P.M.</initials><afid>60023932</afid><afid>60005248</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7202038362</author-url><authid>7202038362</authid><authname>Macdonald P.</authname><surname>Macdonald</surname><given-name>Peter S.</given-name><initials>P.S.</initials><afid>60025702</afid><afid>60028061</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7202038362</author-url><authid>7202038362</authid><authname>Macdonald P.</authname><surname>Macdonald</surname><given-name>Peter S.</given-name><initials>P.S.</initials><afid>60025702</afid><afid>60028061</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:14030594600</author-url><authid>14030594600</authid><authname>Newton P.</authname><surname>Newton</surname><given-name>Phillip J.</given-name><initials>P.J.</initials><afid>60023932</afid></author><authkeywords>Advanced heart failure | Frail elderly | Review</authkeywords><intid>535998354</intid><source-id>23234</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929377073"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929377073?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929377073&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929377073&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1089860315002062"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929377073</prism:url><dc:identifier>SCOPUS_ID:84929377073</dc:identifier><eid>2-s2.0-84929377073</eid><dc:title>Endothelial nitric oxide synthase polymorphism and prognosis in systolic heart failure patients</dc:title><dc:creator>Azzam N.</dc:creator><prism:publicationName>Nitric Oxide - Biology and Chemistry</prism:publicationName><prism:issn>10898603</prism:issn><prism:eIssn>10898611</prism:eIssn><prism:volume>47</prism:volume><prism:pageRange>91-96</prism:pageRange><prism:coverDate>2015-05-16</prism:coverDate><prism:coverDisplayDate>16 May 2015</prism:coverDisplayDate><prism:doi>10.1016/j.niox.2015.04.004</prism:doi><pii>S1089860315002062</pii><dc:description>Â© 2015 Elsevier Inc. All rights reserved. Background: The endothelial nitric oxide synthase (eNOS) gene single nucleotide polymorphism G894T is associated with thrombotic vascular diseases. However, its functional significance is controversial and data are scarce concerning its influence in heart failure (HF). Methods: We studied 215 patients with chronic systolic HF. DNA was analyzed for eNOS gene G894T polymorphism using PCR and DNA sequencing. Evaluation of clinical characteristics and analysis of factors associated with 2-year mortality were performed for the homozygous G-allele G894T variant (GG), relative to the TT and GT variants. Results: The genotype distributions of eNOS G894T alleles were: GG 135 patients (63%) and TT/GT 80 (37%). Two-year mortality was significantly higher in the GG variant (48%) than the combined TT/GT group (32%). The usage of nitrates was associated with increased 2-year mortality (HR 2.0, 95% CI 1.28-3.17; p=0.003), which was most significant in the GG group treated with nitrates (73.5%) in comparison to the TT/GT group not treated with nitrates (34%); HR 2.75, 95% CI 1.57-4.79, P&lt;0.001. Conclusions: Homozygosity for the G allele of the eNOS G894T polymorphism was associated with worse survival in systolic HF patients, especially in those treated with nitrates. ENOS polymorphism may result in different mechanistic interactions in HF than in thrombotic vascular diseases, suggesting that overexpression of NO may be associated with deleterious effects in systolic HF.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002999</affiliation-url><afid>60002999</afid><affilname>University of Haifa</affilname><name-variant>University of Haifa</name-variant><affiliation-city>Haifa</affiliation-city><affiliation-country>Israel</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016549</affiliation-url><afid>60016549</afid><affilname>Carmel Medical Center</affilname><name-variant>Lady Davis Carmel Hospital</name-variant><affiliation-city>Haifa</affiliation-city><affiliation-country>Israel</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016549</affiliation-url><afid>60016549</afid><affilname>Carmel Medical Center</affilname><name-variant>Lady Davis Carmel Hospital</name-variant><affiliation-city>Haifa</affiliation-city><affiliation-country>Israel</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022403</affiliation-url><afid>60022403</afid><affilname>Technion - Israel Institute of Technology</affilname><name-variant>Technion</name-variant><affiliation-city>Haifa</affiliation-city><affiliation-country>Israel</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60072445</affiliation-url><afid>60072445</afid><affilname>Hebrew University-Hadassah Medical School</affilname><name-variant>Hebrew University-Hadassah Medical School</name-variant><affiliation-city>Jerusalem</affiliation-city><affiliation-country>Israel</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100379104</affiliation-url><afid>100379104</afid><affilname>Poriya Medical Center</affilname><name-variant>Poriya Medical Center</name-variant><affiliation-city>Lower Galilee</affiliation-city><affiliation-country>Israel</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002765</affiliation-url><afid>60002765</afid><affilname>Bar-Ilan University</affilname><name-variant>Bar Ilan University</name-variant><affiliation-city>Ramat Gan</affiliation-city><affiliation-country>Israel</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">13</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6701651852</author-url><authid>6701651852</authid><authname>Azzam N.</authname><surname>Azzam</surname><given-name>Naiel</given-name><initials>N.</initials><afid>60002999</afid><afid>60016549</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6701651852</author-url><authid>6701651852</authid><authname>Azzam N.</authname><surname>Azzam</surname><given-name>Naiel</given-name><initials>N.</initials><afid>60002999</afid><afid>60016549</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55945029800</author-url><authid>55945029800</authid><authname>Zafrir B.</authname><surname>Zafrir</surname><given-name>Barak</given-name><initials>B.</initials><afid>60016549</afid><afid>60022403</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55945029800</author-url><authid>55945029800</authid><authname>Zafrir B.</authname><surname>Zafrir</surname><given-name>Barak</given-name><initials>B.</initials><afid>60016549</afid><afid>60022403</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35596811800</author-url><authid>35596811800</authid><authname>Fares F.</authname><surname>Fares</surname><given-name>Fuad</given-name><initials>F.</initials><afid>60002999</afid><afid>60016549</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35596811800</author-url><authid>35596811800</authid><authname>Fares F.</authname><surname>Fares</surname><given-name>Fuad</given-name><initials>F.</initials><afid>60002999</afid><afid>60016549</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7006509594</author-url><authid>7006509594</authid><authname>Smith Y.</authname><surname>Smith</surname><given-name>Yoav</given-name><initials>Y.</initials><afid>60072445</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56116684300</author-url><authid>56116684300</authid><authname>Salman N.</authname><surname>Salman</surname><given-name>Nabeeh</given-name><initials>N.</initials><afid>100379104</afid><afid>60002765</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56116684300</author-url><authid>56116684300</authid><authname>Salman N.</authname><surname>Salman</surname><given-name>Nabeeh</given-name><initials>N.</initials><afid>100379104</afid><afid>60002765</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56644484100</author-url><authid>56644484100</authid><authname>Nevzorov R.</authname><surname>Nevzorov</surname><given-name>Roman</given-name><initials>R.</initials><afid>100379104</afid><afid>60002765</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56644484100</author-url><authid>56644484100</authid><authname>Nevzorov R.</authname><surname>Nevzorov</surname><given-name>Roman</given-name><initials>R.</initials><afid>100379104</afid><afid>60002765</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:24168088800</author-url><authid>24168088800</authid><authname>Amir O.</authname><surname>Amir</surname><given-name>Offer</given-name><initials>O.</initials><afid>100379104</afid><afid>60002765</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:24168088800</author-url><authid>24168088800</authid><authname>Amir O.</authname><surname>Amir</surname><given-name>Offer</given-name><initials>O.</initials><afid>100379104</afid><afid>60002765</afid></author><authkeywords>Nitric oxide | Polymorphism | Systolic heart failure</authkeywords><intid>1535945024</intid><source-id>14200</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929678124"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929678124?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929678124&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929678124&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929678124</prism:url><dc:identifier>SCOPUS_ID:84929678124</dc:identifier><eid>2-s2.0-84929678124</eid><dc:title>US State-level income inequality and risks of heart attack and coronary risk behaviors: longitudinal findings</dc:title><dc:creator>Pabayo R.</dc:creator><prism:publicationName>International Journal of Public Health</prism:publicationName><prism:issn>16618556</prism:issn><prism:eIssn>1420911X</prism:eIssn><prism:coverDate>2015-05-16</prism:coverDate><prism:coverDisplayDate>16 May 2015</prism:coverDisplayDate><prism:doi>10.1007/s00038-015-0678-7</prism:doi><dc:description>Â© 2015 Swiss School of Public Health Objectives: To examine prospectively the association between US state income inequality and incidence of heart attack. Methods: We used data from the National Epidemiologic Survey on Alcohol and Related Conditions (n = 34,445). Respondents completed interviews at baseline (2001â2002) and follow-up (2004â2005). Weighted multilevel modeling was used to determine if US state-level income inequality (measured by the Gini coefficient) at baseline was a predictor of heart attack during follow-up, controlling for individual-level and state-level covariates. Results: In comparison to residents of US states in the lowest quartile of income inequality, those living in the second [Adjusted Odds Ratio (AOR) = 1.71, 95 % CI 1.16â2.53)], third (AOR = 1.81, 95 % CI 1.28â2.57), and fourth (AOR = 2.04, 95 % CI 1.26â3.29) quartiles were more likely to have a heart attack. Similar findings were obtained when we excluded those who had a heart attack prior to baseline. Conclusions: This study is one of the first to empirically show the longitudinal relationship between income inequality and coronary heart disease. Living in a state with higher income inequality increases the risk for heart attack among US adults.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001769</affiliation-url><afid>60001769</afid><affilname>University of Nevada, Reno</affilname><name-variant>University of Nevada</name-variant><affiliation-city>Reno</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115038872</affiliation-url><afid>115038872</afid><affilname>Harvard T.H. Chan School of Public Health</affilname><name-variant>Harvard T. H. Chan School of Public Health</name-variant><affiliation-city>Boston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115038872</affiliation-url><afid>115038872</afid><affilname>Harvard T.H. Chan School of Public Health</affilname><name-variant>Harvard T. H. Chan School of Public Health</name-variant><affiliation-city>Boston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029929</affiliation-url><afid>60029929</afid><affilname>Massachusetts General Hospital</affilname><name-variant>Massachusetts General Hospital</name-variant><affiliation-city>Boston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:14325928200</author-url><authid>14325928200</authid><authname>Pabayo R.</authname><surname>Pabayo</surname><given-name>Roman</given-name><initials>R.</initials><afid>60001769</afid><afid>115038872</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:14325928200</author-url><authid>14325928200</authid><authname>Pabayo R.</authname><surname>Pabayo</surname><given-name>Roman</given-name><initials>R.</initials><afid>60001769</afid><afid>115038872</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7103096477</author-url><authid>7103096477</authid><authname>Kawachi I.</authname><surname>Kawachi</surname><given-name>Ichiro</given-name><initials>I.</initials><afid>115038872</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7102852575</author-url><authid>7102852575</authid><authname>Gilman S.</authname><surname>Gilman</surname><given-name>Stephen E.</given-name><initials>S.E.</initials><afid>115038872</afid><afid>115038872</afid><afid>60029929</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7102852575</author-url><authid>7102852575</authid><authname>Gilman S.</authname><surname>Gilman</surname><given-name>Stephen E.</given-name><initials>S.E.</initials><afid>115038872</afid><afid>115038872</afid><afid>60029929</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7102852575</author-url><authid>7102852575</authid><authname>Gilman S.</authname><surname>Gilman</surname><given-name>Stephen E.</given-name><initials>S.E.</initials><afid>115038872</afid><afid>115038872</afid><afid>60029929</afid></author><authkeywords>Coronary heart disease | Income inequality | Longitudinal analysis | Multilevel modeling | Population-based study | Social determinants of health</authkeywords><intid>1535997917</intid><source-id>5300152615</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929692214"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929692214?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929692214&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929692214&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929692214</prism:url><dc:identifier>SCOPUS_ID:84929692214</dc:identifier><eid>2-s2.0-84929692214</eid><dc:title>Evaluation of right and left heart mechanics in patients with chronic thromboembolic pulmonary hypertension before and after pulmonary thromboendarterectomy</dc:title><dc:creator>Sunbul M.</dc:creator><prism:publicationName>International Journal of Cardiovascular Imaging</prism:publicationName><prism:issn>15695794</prism:issn><prism:eIssn>15730743</prism:eIssn><prism:coverDate>2015-05-16</prism:coverDate><prism:coverDisplayDate>16 May 2015</prism:coverDisplayDate><prism:doi>10.1007/s10554-015-0682-2</prism:doi><dc:description>Â© 2015 Springer Science+Business Media Dordrecht The aim of the present study was to evaluate of the right and left heart mechanics by two-dimensional (2D) speckle tracking echocardiography (STE) in chronic thromboembolic pulmonary hypertension (CTEPH) patients before and after pulmonary thromboendarterectomy (PTE). A total of 40 consecutive CTEPH patients (mean age 49.3 Â± 13.5 years, 27 female) were included. 2D STE was performed in all patients before, and 3 months, after PTE. 12 months of prognostic data were also recorded via the use of telephone calls. Postoperative 6-minute walk test (6MWT) distances were significantly longer than preoperative values (410.5 Â± 61.5 vs. 216.6 Â± 131.4 m, p &lt; 0.001). Postoperative left ventricular (LV) and right ventricular (RV) systolic functions (LV EF, TAPSE, RVS) were similar compared to preoperative values. While postoperative RV, right atrial (RA) and systolic pulmonary artery pressure measurements were significantly lower, LV and left atrial (LA) measurements were higher than preoperative values. Postoperative LV and RV global longitudinal strain (GLS) measurements were significantly higher than preoperative values. Postoperative LV global radial and circumferential strain measurements were similar to preoperative values. While postoperative RA reservoir and conduit functions were significantly higher, postoperative LA reservoir and conduit functions were similar to preoperative values. Correlation analysis revealed that baseline 6MWT distances were correlated with LV GLS, RV GLS, and RA reservoir and conduit functions in the preoperative and postoperative periods. 2D STE indices may help the clinician in assessing the effect of PTE on cardiac functions and may also be used for follow-up data in CTEPH patients.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004502</affiliation-url><afid>60004502</afid><affilname>Marmara Universitesi Tip Fakultesi</affilname><name-variant>Marmara University School of Medicine</name-variant><affiliation-city>Istanbul</affiliation-city><affiliation-country>Turkey</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112880325</affiliation-url><afid>112880325</afid><affilname>Sivas Numune Hospital</affilname><name-variant>Sivas Numune Hospital</name-variant><affiliation-city>Sivas</affiliation-city><affiliation-country>Turkey</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60086184</affiliation-url><afid>60086184</afid><affilname>T. C. Saglik Bakanligi, Mersin Devlet Hastanesi</affilname><name-variant>Mersin State Hospital</name-variant><affiliation-city>Mersin</affiliation-city><affiliation-country>Turkey</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004502</affiliation-url><afid>60004502</afid><affilname>Marmara Universitesi Tip Fakultesi</affilname><name-variant>Marmara University School of Medicine</name-variant><affiliation-city>Istanbul</affiliation-city><affiliation-country>Turkey</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55193197200</author-url><authid>55193197200</authid><authname>Sunbul M.</authname><surname>Sunbul</surname><given-name>Murat</given-name><initials>M.</initials><afid>60004502</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36997320400</author-url><authid>36997320400</authid><authname>Kivrak T.</authname><surname>Kivrak</surname><given-name>Tarik</given-name><initials>T.</initials><afid>112880325</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55586826000</author-url><authid>55586826000</authid><authname>Durmus E.</authname><surname>Durmus</surname><given-name>Erdal</given-name><initials>E.</initials><afid>60086184</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6603589108</author-url><authid>6603589108</authid><authname>Yildizeli B.</authname><surname>Yildizeli</surname><given-name>Bedrettin</given-name><initials>B.</initials><afid>60004502</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:8944973300</author-url><authid>8944973300</authid><authname>Mutlu B.</authname><surname>Mutlu</surname><given-name>Bulent</given-name><initials>B.</initials><afid>60004502</afid></author><authkeywords>Atrial functions | Chronic thromboembolic pulmonary hypertension | Pulmonary thromboendarterectomy | Speckle tracking echocardiography | Ventricular functions</authkeywords><intid>35996632</intid><source-id>37971</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929401041"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929401041?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929401041&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929401041&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929401041</prism:url><dc:identifier>SCOPUS_ID:84929401041</dc:identifier><eid>2-s2.0-84929401041</eid><dc:title>Effects of ivabradine on cardiac electrophysiology in dogs with age-related atrial fibrillation</dc:title><dc:creator>Li Y.</dc:creator><prism:publicationName>Medical Science Monitor</prism:publicationName><prism:issn>12341010</prism:issn><prism:eIssn>16433750</prism:eIssn><prism:volume>21</prism:volume><prism:pageRange>1414-1420</prism:pageRange><prism:coverDate>2015-05-16</prism:coverDate><prism:coverDisplayDate>16 May 2015</prism:coverDisplayDate><prism:doi>10.12659/MSM.894320</prism:doi><dc:description>Â© Med Sci Monit. Background: Ivabradine is an inhibitor of mixed Na&lt;sup&gt;+&lt;/sup&gt;-K&lt;sup&gt;+&lt;/sup&gt; current that could combine with HCN channels to reduce the transmembrane velocity of funny current (If), heart rate, and cardiac efficiency, and thus be used for the treatment of cardiovascular diseases such as chronic heart failure. As an ion channel blocker, Ivabradine is also a potential antiarrhythmic agent. Material/Methods: Twelve aging dogs (8â10 years old) underwent rapid atrial pacing for 2 months to induce age-related AF in this study. The dogs were randomly divided into the Ivabradine group and aging-AF group. The effects of Ivabradine on the electrophysiological parameters, including the effective refractory period (ERP) of the pulmonary veins and atrium, duration of AF, and inducing rate of AF, were investigated. Results: As compared to the aging-AF group, the ERPs of the left superior pulmonary vein (139.00Â±4.18 ms vs. 129.00Â±4.08 ms, P=0.005) and left auricle (135.00Â±3.53 ms vs. 122.00Â±4.47 ms, P=0.001) were significantly increased, while the duration of AF (46.60Â±5.07 s vs. 205.40Â±1.14 s, P=0.001) and inducing rate of AF (25% vs. 60%, P=0.001) were significantly decreased. Conclusions: Ivabradine could effectively reduce the inducing rate of AF, and thus be used as an upstream drug for the prevention of age-related AF.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022554</affiliation-url><afid>60022554</afid><affilname>Xinjiang Medical University</affilname><name-variant>Xinjiang Medical University</name-variant><affiliation-city>Urumqi</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022554</affiliation-url><afid>60022554</afid><affilname>Xinjiang Medical University</affilname><name-variant>Xinjiang Medical University</name-variant><affiliation-city>Urumqi</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56646631900</author-url><authid>56646631900</authid><authname>Li Y.</authname><surname>Li</surname><given-name>Yao Dong</given-name><initials>Y.D.</initials><afid>60022554</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56549419200</author-url><authid>56549419200</authid><authname>Ji Y.</authname><surname>Ji</surname><given-name>Yu Tong</given-name><initials>Y.T.</initials><afid>60022554</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56469963400</author-url><authid>56469963400</authid><authname>Zhou X.</authname><surname>Zhou</surname><given-name>Xian Hui</given-name><initials>X.H.</initials><afid>60022554</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56645484000</author-url><authid>56645484000</authid><authname>Jiang T.</authname><surname>Jiang</surname><given-name>Tao</given-name><initials>T.</initials><afid>60022554</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56446084500</author-url><authid>56446084500</authid><authname>Hong Y.</authname><surname>Hong</surname><given-name>Yi Fan</given-name><initials>Y.F.</initials><afid>60022554</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55924888000</author-url><authid>55924888000</authid><authname>Li J.</authname><surname>Li</surname><given-name>Jin Xin</given-name><initials>J.X.</initials><afid>60022554</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55258177100</author-url><authid>55258177100</authid><authname>Xing Q.</authname><surname>Xing</surname><given-name>Qiang</given-name><initials>Q.</initials><afid>60022554</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56645567400</author-url><authid>56645567400</authid><authname>Xiong J.</authname><surname>Xiong</surname><given-name>Jian</given-name><initials>J.</initials><afid>60022554</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56550026500</author-url><authid>56550026500</authid><authname>Yusufuaji Y.</authname><surname>Yusufuaji</surname><given-name>Yueerguli</given-name><initials>Y.</initials><afid>60022554</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:14069483400</author-url><authid>14069483400</authid><authname>Tang B.</authname><surname>Tang</surname><given-name>Bao Peng</given-name><initials>B.P.</initials><afid>60022554</afid></author><authkeywords>Aging | Arrhythmias | Atrial fibrillation | Cardiac | Ivabradine</authkeywords><intid>1535953979</intid><source-id>18344</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929683028"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929683028?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929683028&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929683028&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929683028</prism:url><dc:identifier>SCOPUS_ID:84929683028</dc:identifier><eid>2-s2.0-84929683028</eid><dc:title>Under-recognition of Low Blood Pressure Readings in Patients with Duchenne Muscular Dystrophy</dc:title><dc:creator>Masood S.</dc:creator><prism:publicationName>Pediatric Cardiology</prism:publicationName><prism:issn>01720643</prism:issn><prism:eIssn>14321971</prism:eIssn><prism:coverDate>2015-05-16</prism:coverDate><prism:coverDisplayDate>16 May 2015</prism:coverDisplayDate><prism:doi>10.1007/s00246-015-1191-8</prism:doi><dc:description>Â© 2015 Springer Science+Business Media New York Duchenne muscular dystrophy (DMD), a recessive sex-linked hereditary disorder, is characterized by degeneration, atrophy, and weakness of skeletal and cardiac muscle. The purpose of this study was to document the prevalence of abnormally low resting BP recordings in patients with DMD in our outpatient clinic. The charts of 31 patients with DMD attending the cardiology clinic at Rush University Medical Center were retrospectively reviewed. Demographic data, systolic, diastolic, and mean blood pressures along with current medications, echocardiograms, and documented clinical appreciation and management of low blood pressure were recorded in the form of 104 outpatient clinical visits. Blood pressure (BP) was classified as low if the systolic and/or mean BP was less than the fifth percentile for height for patients aged â¤17 years (n = 23). For patients â¥18 years (n = 8), systolic blood pressure (SBP) &lt;90 mmHg or a mean arterial pressure (MAP) &lt;60 mmHg was recorded as a low reading. Patients with other forms of myopathy or unclear diagnosis were excluded. Statistical analysis was done using PASW version 18. BP was documented at 103 (99.01 %) outpatient encounters. Low systolic and mean BP were recorded in 35 (33.7 %) encounters. This represented low recordings for 19 (61.3 %) out of a total 31 patients with two or more successive low recordings for 12 (38.7 %) patients. Thirty-one low BP encounters were in patients &lt;18 years old. Hispanic patients accounted for 74 (71.2 %) visits and had low BP recorded in 32 (43.2 %) instances. The patients were non-ambulant in 71 (68.3 %) encounters. Out of 35 encounters with low BP, 17 patients (48.6 %) were taking heart failure medication. In instances when patients had low BP, 22 (66.7 %) out of 33 echocardiography encounters had normal left ventricular ejection fraction. Clinician comments on low BP reading were present in 11 (10.6 %) encounters, and treatment modification occurred in only 1 (1 %) patient. Age in years (p = .031) and ethnicity (p = .035) were independent predictors of low BP using stepwise multiple regression analysis. Low BP was recorded in a significant number of patient encounters in patients with DMD. Age 17 years or less and Hispanic ethnicity were significant predictors associated with low BP readings in our DMD cohort. Concomitant heart failure therapy was not a statistically significant association. There is a need for enhanced awareness of low BP in DMD patients among primary care and specialty physicians. The etiology and clinical impact of these findings are unclear but may impact escalation of heart failure therapy.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018691</affiliation-url><afid>60018691</afid><affilname>Rush University Medical Center</affilname><name-variant>Rush University Medical Center</name-variant><affiliation-city>Chicago</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018691</affiliation-url><afid>60018691</afid><affilname>Rush University Medical Center</affilname><name-variant>Rush University Medical Center</name-variant><affiliation-city>Chicago</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018691</affiliation-url><afid>60018691</afid><affilname>Rush University Medical Center</affilname><name-variant>Rush University Medical Center</name-variant><affiliation-city>Chicago</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018691</affiliation-url><afid>60018691</afid><affilname>Rush University Medical Center</affilname><name-variant>Rush University Medical Center</name-variant><affiliation-city>Chicago</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56290699500</author-url><authid>56290699500</authid><authname>Masood S.</authname><surname>Masood</surname><given-name>Syed Asif</given-name><initials>S.A.</initials><afid>60018691</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55498856300</author-url><authid>55498856300</authid><authname>Kazmouz S.</authname><surname>Kazmouz</surname><given-name>Suhaib</given-name><initials>S.</initials><afid>60018691</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6603581443</author-url><authid>6603581443</authid><authname>Heydemann P.</authname><surname>Heydemann</surname><given-name>Peter</given-name><initials>P.</initials><afid>60018691</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56653549800</author-url><authid>56653549800</authid><authname>Li H.</authname><surname>Li</surname><given-name>Hong</given-name><initials>H.</initials><afid>60018691</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:21742825300</author-url><authid>21742825300</authid><authname>Kenny D.</authname><surname>Kenny</surname><given-name>Damien</given-name><initials>D.</initials><afid>60018691</afid></author><authkeywords>Blood pressure | Duchenne muscular dystrophy | Heart failure therapy | Under-recognition</authkeywords><intid>1035993060</intid><source-id>20526</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929416723"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929416723?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929416723&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929416723&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929416723</prism:url><dc:identifier>SCOPUS_ID:84929416723</dc:identifier><eid>2-s2.0-84929416723</eid><dc:title>Comorbidities of patients in tiotropium clinical trials: Comparison with observational studies of patients with chronic obstructive pulmonary disease</dc:title><dc:creator>Miravitlles M.</dc:creator><prism:publicationName>International Journal of COPD</prism:publicationName><prism:issn>11769106</prism:issn><prism:eIssn>11782005</prism:eIssn><prism:volume>10</prism:volume><prism:pageRange>549-564</prism:pageRange><prism:coverDate>2015-05-16</prism:coverDate><prism:coverDisplayDate>16 May 2015</prism:coverDisplayDate><prism:doi>10.2147/COPD.S71913</prism:doi><dc:description>Â© 2015 Miravitlles et al. Background: There is an ongoing debate on whether patients with chronic obstructive pulmonary disease (COPD) seen in real-life clinical settings are represented in randomized controlled trials (RCTs) of COPD. It is thought that the stringent inclusion and exclusion criteria of RCTs may prevent the participation of patients with specific characteristics or risk factors. Methods: We surveyed a database of patients recruited into 35 placebo-controlled tiotropium RCTs and also conducted a systematic literature review of large-scale observational studies conducted in patients with a documented diagnosis of COPD between 1990 and 2013. Patient demographics and comorbidities with a high prevalence in patients with COPD were compared between the two patient populations at baseline. Using the Medical Dictionary for Regulatory Activities (MedDRA; v 14.0), patient comorbidities in the pooled tiotropium RCTs were classified according to system organ class, pharmacovigilance (PV) endpoints, and Standardised MedDRA Queries to enable comparison with the observational studies. Results: We identified 24,555 patients in the pooled tiotropium RCTs and 61,361 patients among the 13 observational studies that met our search criteria. The Global initiative for chronic Obstructive Lung Disease (GOLD) staging of patients in the RCTs differed from that in observational studies: the proportion of patients with GOLD stages I+II disease ranged from 40.0% to 51.5% in the RCTs but 24.5% to 44.1% in the observational studies; for GOLD stage III or IV disease these ranges were 7.2%â45.8% (RCTs) and 13.7â42.1% (observational studies). The comorbidities with the highest prevalence reported in the RCTs and observational studies were: hypertension (39.4%â40.0% vs 40.1%â60.6%), other ischemic heart disease (12.3%â14.2% vs 12.5%â41.0%), diabetes (10.3%â10.9% vs 4.0%â38.9%), depression (8.5%â9.5% vs 17.0%â20.6%), and cardiac arrhythmia (7.8%â11.4% vs 11.3%â15.8%). Conclusion: The clinical profile of COPD patients treated in the tiotropium trial program appears to be largely in the range of clinical characteristics, including cardiovascular comorbidities, reported for âreal-life patients.â The tiotropium RCTs tended to include patients with more severe disease than the observational studies.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012486</affiliation-url><afid>60012486</afid><affilname>Hospital Universitari Vall d'Hebron</affilname><name-variant>Hospital Vall d'Hebron</name-variant><affiliation-city>Barcelona</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015875</affiliation-url><afid>60015875</afid><affilname>University of Aberdeen</affilname><name-variant>University of Aberdeen</name-variant><affiliation-city>Aberdeen</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012345</affiliation-url><afid>60012345</afid><affilname>Christian-Albrechts-Universitat zu Kiel</affilname><name-variant>University of Kiel</name-variant><affiliation-city>Kiel</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011807</affiliation-url><afid>60011807</afid><affilname>Boehringer Ingelheim Pharma GmbH &amp; Co. KG</affilname><name-variant>Boehringer Ingelheim Pharma GmbH and Co. KG</name-variant><affiliation-city>Ingelheim am Rhein</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011807</affiliation-url><afid>60011807</afid><affilname>Boehringer Ingelheim Pharma GmbH &amp; Co. KG</affilname><name-variant>Boehringer Ingelheim Pharma GmbH and Co. KG</name-variant><affiliation-city>Ingelheim am Rhein</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016782</affiliation-url><afid>60016782</afid><affilname>Brigham and Women's Hospital</affilname><name-variant>Brigham and Women's Hospital</name-variant><affiliation-city>Boston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113527639</affiliation-url><afid>113527639</afid><affilname>LungenClinic Grosshansdorf</affilname><name-variant>LungenClinic Grosshansdorf</name-variant><affiliation-city>Grosshansdorf</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7004909276</author-url><authid>7004909276</authid><authname>Miravitlles M.</authname><surname>Miravitlles</surname><given-name>Marc</given-name><initials>M.</initials><afid>60012486</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55629533100</author-url><authid>55629533100</authid><authname>Price D.</authname><surname>Price</surname><given-name>David</given-name><initials>D.</initials><afid>60015875</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7102576614</author-url><authid>7102576614</authid><authname>Rabe K.</authname><surname>Rabe</surname><given-name>Klaus F.</given-name><initials>K.F.</initials><afid>60012345</afid><afid>113527639</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7102576614</author-url><authid>7102576614</authid><authname>Rabe K.</authname><surname>Rabe</surname><given-name>Klaus F.</given-name><initials>K.F.</initials><afid>60012345</afid><afid>113527639</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55614811100</author-url><authid>55614811100</authid><authname>Schmidt H.</authname><surname>Schmidt</surname><given-name>Hendrik</given-name><initials>H.</initials><afid>60011807</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:14037752800</author-url><authid>14037752800</authid><authname>Metzdorf N.</authname><surname>Metzdorf</surname><given-name>Norbert</given-name><initials>N.</initials><afid>60011807</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7007048536</author-url><authid>7007048536</authid><authname>Celli B.</authname><surname>Celli</surname><given-name>Bartolome</given-name><initials>B.</initials><afid>60016782</afid></author><authkeywords>Baseline characteristics | Epidemiology | GOLD staging | Patient population | Real-life patients</authkeywords><intid>2035949614</intid><source-id>6200180178</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929688540"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929688540?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929688540&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929688540&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929688540</prism:url><dc:identifier>SCOPUS_ID:84929688540</dc:identifier><eid>2-s2.0-84929688540</eid><dc:title>Intracellular angiotensin (1â7) increases the inward calcium current in cardiomyocytes. On the role of PKA activation</dc:title><dc:creator>de Mello W.</dc:creator><prism:publicationName>Molecular and Cellular Biochemistry</prism:publicationName><prism:issn>03008177</prism:issn><prism:eIssn>15734919</prism:eIssn><prism:coverDate>2015-05-16</prism:coverDate><prism:coverDisplayDate>16 May 2015</prism:coverDisplayDate><prism:doi>10.1007/s11010-015-2449-4</prism:doi><dc:description>Â© 2015 Springer Science+Business Media New York The influence of intracellular administration of angiotensin (1â7) (Ang 1â7) on the inward calcium current was investigated in myocytes isolated from the left ventricle of Wistar Kyoto rat hearts using the patch-clamp technique. The results indicated: (1) the intracellular administration of Ang (1â7) (100 nM) enhanced the peak inward calcium current (I&lt;inf&gt;Ca&lt;/inf&gt;); (2) the intracellular administration of A779 (100 nM) which a Mas receptor inhibitor, abolished the effect of Ang (1â7) on the calcium current; (3) the activation of PKA and consequent phosphorylation of calcium channels seems to be the mechanism involved in the increment of calcium current induced by the heptapeptide because the intracellular dialysis of the PKA inhibitor suppressed the effect of the heptapeptide; (4) the effect of Ang (1â7) was not related to its secretion into the extracellular space; (5)intracellular dialysis of Ang II (100 nM) has an opposite effect and reduced the peak I&lt;inf&gt;Ca&lt;/inf&gt;; (6) extracellular administration of Ang II (100 nM) to cells previously dialyzed with Ang (1â7) also reduced the peak I&lt;inf&gt;Ca&lt;/inf&gt; previously enhanced by Ang (1â7); and (7) intracellular Ang (1â7) reduced the heart cell volume. Implications for heart contractility were discussed.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100449183</affiliation-url><afid>100449183</afid><affilname>UPR</affilname><name-variant>UPR</name-variant><affiliation-city>San Juan</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">1</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7007005723</author-url><authid>7007005723</authid><authname>de Mello W.</authname><surname>de Mello</surname><given-name>Walmor C.</given-name><initials>W.C.</initials><afid>100449183</afid></author><authkeywords>Angiotensin (1â7) | Calcium current | Heart | Intracellular</authkeywords><intid>1785998064</intid><source-id>14134</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929683075"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929683075?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929683075&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929683075&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929683075</prism:url><dc:identifier>SCOPUS_ID:84929683075</dc:identifier><eid>2-s2.0-84929683075</eid><dc:title>Effects of spa treatment on cardiac autonomic control at rest in healthy subjects</dc:title><dc:creator>Corsini A.</dc:creator><prism:publicationName>Sport Sciences for Health</prism:publicationName><prism:issn>18247490</prism:issn><prism:coverDate>2015-05-16</prism:coverDate><prism:coverDisplayDate>16 May 2015</prism:coverDisplayDate><prism:doi>10.1007/s11332-015-0221-5</prism:doi><dc:description>Â© 2015 Springer-Verlag Italia Purpose: Heart rate variability (HRV) was analyzed after a spa-course to test the hypothesis that cardiac autonomic modulation can reflect the feeling of relaxation and well-being induced by the treatment. Methods: Twenty healthy males were administered a spa-course, consisting in classic sauna (15 min), steam bath (10 min), and soft sauna (10 min), each of them followed by a cooling-off and a rest period. Heart rate (HR) and blood pressure (BP) were measured at rest in supine position before and after the treatment. HRV was analyzed in time and frequency domains and by PoincarÃ© plot. Results: After the treatment, systolic and diastolic BPs were decreased by about 13 and 6 mmHg, respectively (p &lt; 0.05 vs. before), while HR was unchanged (55 Â± 7 b/min). HRV time domain and PoincarÃ© parameters were significantly higher after than before the spa-course: SDNN, rMSSD, SD1 and SD2 increased by 31â35 %, NN50 and pNN50 by 64 %. The ratio SD1/SD2 was 0.6 Â± 0.1 in both conditions. No modification was found in normalized power of spectral component and in their ratio (LF/HF = 1.3 Â± 1.1, overall mean). Conclusions: The increase in HRV with no change in markers of sympatho-vagal interaction observed after the spa-course would suggest an enhanced vagal modulation of HR, possibly reflecting the relaxing effect of the treatment. HRV analysis could be a useful tool to monitor changes in individual psychophysiological condition.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115264291</affiliation-url><afid>115264291</afid><affilname>Istituto Clinico San Rocco</affilname><name-variant>Istituto Clinico San Rocco</name-variant><affiliation-city/><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015300</affiliation-url><afid>60015300</afid><affilname>Universita degli Studi di Brescia</affilname><name-variant>University of Brescia</name-variant><affiliation-city>Brescia</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56653174200</author-url><authid>56653174200</authid><authname>Corsini A.</authname><surname>Corsini</surname><given-name>Alessandro</given-name><initials>A.</initials><afid>115264291</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56653370800</author-url><authid>56653370800</authid><authname>Capogrosso M.</authname><surname>Capogrosso</surname><given-name>Michela</given-name><initials>M.</initials><afid>60015300</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7003425456</author-url><authid>7003425456</authid><authname>Perini R.</authname><surname>Perini</surname><given-name>Renza</given-name><initials>R.</initials><afid>60015300</afid></author><authkeywords>Autonomic system | Heart rate variability | Sauna | Spa treatment | Stress</authkeywords><intid>1535997050</intid><source-id>4900152601</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929439010"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929439010?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929439010&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929439010&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929439010</prism:url><dc:identifier>SCOPUS_ID:84929439010</dc:identifier><eid>2-s2.0-84929439010</eid><dc:title>Interactive virtual stent planning for the treatment of coarctation of the aorta</dc:title><dc:creator>Neugebauer M.</dc:creator><prism:publicationName>International Journal of Computer Assisted Radiology and Surgery</prism:publicationName><prism:issn>18616410</prism:issn><prism:eIssn>18616429</prism:eIssn><prism:coverDate>2015-05-16</prism:coverDate><prism:coverDisplayDate>16 May 2015</prism:coverDisplayDate><prism:doi>10.1007/s11548-015-1220-3</prism:doi><dc:description>Â© 2015 CARS Purpose: The coarctation of the aorta (CoA), a local narrowing of the aortic arch, accounts for 7 % of all congenital heart defects. Stenting is a recommended therapy to reduce the pressure gradient. This procedure is associated with complications such as the development of adverse flow conditions. A computer-aided treatment planning based on flow simulations can help to predict possible complications. The virtual stent planning is an important, intermediate step in the treatment planning pipeline. We present a novel approach that automatically suggests a stent setup and provides a set of intuitive parameters that allow for an interactive adaption of the suggested stent placement and induced deformation. Methods: A high-quality mesh and a centerline are automatically generated. The stent-induced deformation is realized through a deformation of the centerline and a vertex displacement with respect to the deformed centerline and additional stent parameters. The parameterization is automatically derived from the underlying data and can be optionally altered through a condensed set of clinically sound parameters. Results: The automatic deformation can be generated in about 25 s on a consumer system. The interactive adaption can be performed in real time. Compared with manual expert reconstructions of the stented vessel section, the mean difference of vessel path and diameter is below 1 mm. Conclusion: Our approach enables a medical user to easily generate a plausibly deformed vessel mesh which is necessary as input for a simulation-based treatment planning of CoA.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:109414690</affiliation-url><afid>109414690</afid><affilname>Institute for Medical Image Computing</affilname><name-variant>Institute for Medical Image Computing</name-variant><affiliation-city>Bremen</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029931</affiliation-url><afid>60029931</afid><affilname>Universitatsklinik Erlangen und Medizinische Fakultat</affilname><affiliation-city>Erlangen</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009113</affiliation-url><afid>60009113</afid><affilname>Deutsches Herzzentrum Berlin</affilname><name-variant>German Heart Institute</name-variant><affiliation-city>Berlin</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56646061700</author-url><authid>56646061700</authid><authname>Neugebauer M.</authname><surname>Neugebauer</surname><given-name>Mathias</given-name><initials>M.</initials><afid>109414690</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36940432500</author-url><authid>36940432500</authid><authname>GlÃ¶ckler M.</authname><surname>GlÃ¶ckler</surname><given-name>Martin</given-name><initials>M.</initials><afid>60029931</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6603944840</author-url><authid>6603944840</authid><authname>Goubergrits L.</authname><surname>Goubergrits</surname><given-name>Leonid</given-name><initials>L.</initials><afid>60009113</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56645997700</author-url><authid>56645997700</authid><authname>Kelm M.</authname><surname>Kelm</surname><given-name>Marcus</given-name><initials>M.</initials><afid>60009113</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6603086969</author-url><authid>6603086969</authid><authname>Kuehne T.</authname><surname>Kuehne</surname><given-name>Titus</given-name><initials>T.</initials><afid>60009113</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6507583811</author-url><authid>6507583811</authid><authname>Hennemuth A.</authname><surname>Hennemuth</surname><given-name>Anja</given-name><initials>A.</initials><afid>109414690</afid></author><authkeywords>CARDIOPROOF | Coarctation of the aorta | Computer-aided treatment | Geometric processing | Image processing | Stenting | Virtual stenting | VMTK | VTK</authkeywords><intid>35955050</intid><source-id>4700152490</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929340581"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929340581?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929340581&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929340581&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S001429991500357X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929340581</prism:url><dc:identifier>SCOPUS_ID:84929340581</dc:identifier><eid>2-s2.0-84929340581</eid><dc:title>Critical role of renal dipeptidyl peptidase-4 in ameliorating kidney injury induced by saxagliptin in Dahl salt-sensitive hypertensive rats</dc:title><dc:creator>Sakai M.</dc:creator><prism:publicationName>European Journal of Pharmacology</prism:publicationName><prism:issn>00142999</prism:issn><prism:eIssn>18790712</prism:eIssn><prism:volume>761</prism:volume><prism:pageRange>109-115</prism:pageRange><prism:coverDate>2015-05-16</prism:coverDate><prism:coverDisplayDate>16 May 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ejphar.2015.04.023</prism:doi><pii>S001429991500357X</pii><dc:description>Â© 2015 Elsevier B.V. All rights reserved. Saxagliptin, a potent dipeptidyl peptidase-4 (DPP-4) inhibitor, is currently used to treat type 2 diabetes mellitus, and it has been reported to exhibit a slower rate of dissociation from DPP-4 compared with another DPP-4 inhibitor, sitagliptin. In this study, we compared the effects of saxagliptin and sitagliptin on hypertension-related renal injury and the plasma and renal DPP-4 activity levels in Dahl salt-sensitive hypertensive (Dahl-S) rats. The high-salt diet (8% NaCl) significantly increased the blood pressure and quantity of urinary albumin excretion and induced renal glomerular injury in the Dahl-S rats. Treatment with saxagliptin (14 mg/kg/day via drinking water) for 4 weeks significantly suppressed the increase in urinary albumin excretion and tended to ameliorate glomerular injury without altering the blood glucose levels and systolic blood pressure. On the other hand, the administration of sitagliptin (140 mg/kg/day via drinking water) did not affect urinary albumin excretion and glomerular injury in the Dahl-S rats. Meanwhile, the high-salt diet increased the renal DPP-4 activity but did not affect the plasma DPP-4 activity in the Dahl-S rats. Both saxagliptin and sitagliptin suppressed the plasma DPP-4 activity by 95% or more. Although the renal DPP-4 activity was also inhibited by both drugs, the inhibitory effect of saxagliptin was more potent than that of sitagliptin. These results indicate that saxagliptin has a potent renoprotective effect in the Dahl-S rats, independent of its glucose-lowering actions. The inhibition of the renal DPP-4 activity induced by saxagliptin may contribute to ameliorating renal injury in hypertension-related renal injury.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114716167</affiliation-url><afid>114716167</afid><affilname>Kyowa Hakko Kirin Co., Ltd.</affilname><name-variant>Kyowa Hakko Kirin Co., Ltd.</name-variant><affiliation-city>Tokyo</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114716167</affiliation-url><afid>114716167</afid><affilname>Kyowa Hakko Kirin Co., Ltd.</affilname><name-variant>Kyowa Hakko Kirin Co., Ltd.</name-variant><affiliation-city>Tokyo</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56643848400</author-url><authid>56643848400</authid><authname>Sakai M.</authname><surname>Sakai</surname><given-name>Mariko</given-name><initials>M.</initials><afid>114716167</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6507313751</author-url><authid>6507313751</authid><authname>Uchii M.</authname><surname>Uchii</surname><given-name>Masako</given-name><initials>M.</initials><afid>114716167</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55356422700</author-url><authid>55356422700</authid><authname>Myojo K.</authname><surname>Myojo</surname><given-name>Kensuke</given-name><initials>K.</initials><afid>114716167</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56644198800</author-url><authid>56644198800</authid><authname>Kitayama T.</authname><surname>Kitayama</surname><given-name>Tetsuya</given-name><initials>T.</initials><afid>114716167</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56644275800</author-url><authid>56644275800</authid><authname>Kunori S.</authname><surname>Kunori</surname><given-name>Shunji</given-name><initials>S.</initials><afid>114716167</afid></author><authkeywords>Dahl salt-sensitive hypertensive rat | Kidney injury | Renal dipeptidyl peptidase-4 | Saxagliptin</authkeywords><intid>1535946030</intid><source-id>21333</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929678362"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929678362?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929678362&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929678362&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929678362</prism:url><dc:identifier>SCOPUS_ID:84929678362</dc:identifier><eid>2-s2.0-84929678362</eid><dc:title>Heterogeneity of Ventricular Sympathetic Nervous Activity is Associated with Clinically Relevant Ventricular Arrhythmia in Postoperative Patients with Tetralogy of Fallot</dc:title><dc:creator>Ono S.</dc:creator><prism:publicationName>Pediatric Cardiology</prism:publicationName><prism:issn>01720643</prism:issn><prism:eIssn>14321971</prism:eIssn><prism:coverDate>2015-05-16</prism:coverDate><prism:coverDisplayDate>16 May 2015</prism:coverDisplayDate><prism:doi>10.1007/s00246-015-1195-4</prism:doi><dc:description>Â© 2015 Springer Science+Business Media New York This study aimed to clarify whether there is an association between ventricular sympathetic nervous activity (SNA) and clinically relevant ventricular arrhythmia (a run of â¥3 consecutive ventricular beats, RVA) in postoperative patients with tetralogy of Fallot (TOF). We performed a retrospective study in a national referral center of pediatric cardiology in Japan. Twenty-four postoperative TOF patients (13 males, median age 17 years) undergoing myocardial &lt;sup&gt;123&lt;/sup&gt;I metaiodobenzylguanidine (MIBG) scintigraphy were included. We measured the heart-to-mediastinum ratio (HMR) and washout ratio (WR) from planar MIBG myocardial scintigraphy. Tomographic images and polar maps were generated with 20 segments. The standard deviation of percentage uptake of 20 segments (SD-uptake) as an index of heterogeneous MIBG uptake to the ventricular myocardium was calculated. We compared these MIBG-derived variables with the patientsâ clinical profiles, including ECG findings and hemodynamics. Eight of 24 patients had RVA (RVA group), and the other 16 did not have RVA (non-RVA group). There were no significant differences in the HMR (1.9 Â± 0.5 vs. 2.2 Â± 0.4) and WR (50 Â± 5 vs. 42 Â± 10) between the two groups. SD-uptake was significantly higher in the RVA group than in the non-RVA group (15 Â± 3 vs. 12 Â± 3, p = 0.03). QT dispersion (ms) was also higher in the RVA group than in the non-RVA group (53 Â± 23 vs. 44 Â± 18, p = 0.04). Multivariate logistic regression showed that SD-uptake and QT dispersion were independent predictors in the RVA group (p = 0.02, p = 0.03). In addition to greater QT dispersion, heterogeneous SNA is associated with RVA in TOF patients postoperatively.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>National Cerebral and Cardiovascular Center</affilname><name-variant>Department of Pediatric Cardiology</name-variant><affiliation-city>Osaka</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>National Cerebral and Cardiovascular Center</affilname><name-variant>Department of Radiology</name-variant><affiliation-city>Osaka</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:46661404000</author-url><authid>46661404000</authid><authname>Ono S.</authname><surname>Ono</surname><given-name>Shin</given-name><initials>S.</initials><afid/></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56653184900</author-url><authid>56653184900</authid><authname>Ohuchi H.</authname><surname>Ohuchi</surname><given-name>Hideo</given-name><initials>H.</initials><afid/></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56653082900</author-url><authid>56653082900</authid><authname>Miyazaki A.</authname><surname>Miyazaki</surname><given-name>Aya</given-name><initials>A.</initials><afid/></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56652885500</author-url><authid>56652885500</authid><authname>Abe T.</authname><surname>Abe</surname><given-name>Tadaaki</given-name><initials>T.</initials><afid/></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:22938151100</author-url><authid>22938151100</authid><authname>Kiso K.</authname><surname>Kiso</surname><given-name>Keisuke</given-name><initials>K.</initials><afid/></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56653132900</author-url><authid>56653132900</authid><authname>Yamada O.</authname><surname>Yamada</surname><given-name>Osamu</given-name><initials>O.</initials><afid/></author><authkeywords>&lt;sup&gt;123&lt;/sup&gt;I metaiodobenzylguanidine | Scintigraphy | Sympathetic nervous activity | Tetralogy of Fallot | Ventricular arrhythmia</authkeywords><intid>1785998742</intid><source-id>20526</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929698407"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929698407?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929698407&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929698407&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929698407</prism:url><dc:identifier>SCOPUS_ID:84929698407</dc:identifier><eid>2-s2.0-84929698407</eid><dc:title>SOS save our surgeons: Stress levels reduced by robotic surgery</dc:title><dc:creator>Hurley A.</dc:creator><prism:publicationName>Gynecological Surgery</prism:publicationName><prism:issn>16132076</prism:issn><prism:eIssn>16132084</prism:eIssn><prism:coverDate>2015-05-16</prism:coverDate><prism:coverDisplayDate>16 May 2015</prism:coverDisplayDate><prism:doi>10.1007/s10397-015-0891-7</prism:doi><dc:description>Â© 2015 Springer-Verlag Berlin Heidelberg Robotic-assisted laparoscopic surgery (RALS) is making an increasingly significant contribution to the field of gynaecological surgery. RALS offers similar patient benefits to standard laparoscopic surgery (SLS) with a potentially more ergonomically friendly and less stressful environment for the surgeon. However, our understanding of how RALS may potentially reduce physiological stress on the surgeon is currently limited. To assess how performing surgical tasks using RALS in comparison to SLS impacts on hypothalamic pituitary adrenal (HPA) axis function and sympathetic nervous system (SNS) activity, two key indicators of the physiological stress response. This study is an analytical, within subjects, crossover design study. Sixteen surgically inexperienced medical students performed tasks with both SLS and RALS instrumentation. Blood pressure (BP) was taken before and after task performance. Skin conductance level (SCL), heart rate (HR) and HR variability (HRV) were measured continuously during task performance. Pre- and post-task saliva samples were collected to determine cortisol levels using ELISA. SCL was significantly lower during RALS in comparison to SLS task performance (p &lt; 0.05). HR was significantly lower during RALS vs. SLS tasks (p &lt; 0.01). Both HRV measures were significantly higher during RALS vs. SLS tasks (p &lt; 0.01). Cortisol levels and BP were lower during RALS vs. SLS but did not reach statistical significance (p = 0.73 and p = 0.22, respectively). Stress can impair surgeonâs technical and nontechnical skills. These results indicate that the improved ergonomic setup of RALS has a beneficial impact on physiological indicators of stress. This also demonstrates the potential of RALS to reduce the negative effects of long-term stress exposure on the surgeon.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100425825</affiliation-url><afid>100425825</afid><affilname>Cork University Maternity Hospital</affilname><name-variant>Cork University</name-variant><affiliation-city>Wilton</affiliation-city><affiliation-country>Ireland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005857</affiliation-url><afid>60005857</afid><affilname>National University of Ireland, Cork, Alimentary Pharmabiotic Centre</affilname><name-variant>University College Cork</name-variant><affiliation-city>Cork</affiliation-city><affiliation-country>Ireland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025160</affiliation-url><afid>60025160</afid><affilname>University College Cork</affilname><name-variant>University College Cork</name-variant><affiliation-city>Cork</affiliation-city><affiliation-country>Ireland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56653194900</author-url><authid>56653194900</authid><authname>Hurley A.</authname><surname>Hurley</surname><given-name>A. M.</given-name><initials>A.M.</initials><afid>100425825</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7202257471</author-url><authid>7202257471</authid><authname>Kennedy P.</authname><surname>Kennedy</surname><given-name>P. J.</given-name><initials>P.J.</initials><afid>60005857</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56653408600</author-url><authid>56653408600</authid><authname>OâConnor L.</authname><surname>OâConnor</surname><given-name>L.</given-name><initials>L.</initials><afid>100425825</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:25023662900</author-url><authid>25023662900</authid><authname>Dinan T.</authname><surname>Dinan</surname><given-name>T. G.</given-name><initials>T.G.</initials><afid>60005857</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7003307517</author-url><authid>7003307517</authid><authname>Cryan J.</authname><surname>Cryan</surname><given-name>J. F.</given-name><initials>J.F.</initials><afid>60005857</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6602292136</author-url><authid>6602292136</authid><authname>Boylan G.</authname><surname>Boylan</surname><given-name>G.</given-name><initials>G.</initials><afid>60025160</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56461402300</author-url><authid>56461402300</authid><authname>OâReilly B.</authname><surname>OâReilly</surname><given-name>B. A.</given-name><initials>B.A.</initials><afid>100425825</afid></author><authkeywords>Laparoscopic | Minimally invasive surgery | Robotic | Stress</authkeywords><intid>1785997990</intid><source-id>130148</source-id></entry></search-results>
